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Abstract 
This thesis describes the use of both sulfuric acid and triflic acid, to promote 
hydroamination and hydroalkoxylation cyclisations for the formation of N- and O- 
heterocycles.  
Chapter 2 describes the synthesis of 2,2,6-trisubstetuted piperidine. A wide range of 
protecting groups has been employed in the cyclisation. A new, general and flexible 
method for the highly enantioselective synthesis of chiral piperidine and spiro-
piperidine has been developed. The main advantages of this synthetic method lie in 
the readily availability of the precursors. There is no reason why this reaction cannot 
find further application in natural product synthesis. 
Chapter 3 describes a miscellany of cascade and transannular cyclizations. 
The hydroamination has also been used to form the sterically crowded bridged 
isoquinuclidines through a transannular cyclisation, which would have rearranged to 
the less hindered products.  
We have also applied acid-catalyzed intramolecular cascade methodology to the 
synthesis of polycyclic hydroquinolines. 
Oxygen-centered transannular cyclisation has been compared with nitrogen-based 
examples, by acid-catalyzed hydroalkoxylation cyclisation to give only the sterically 
crowded bridged cineoles. 
Chapter 4 describes a new discovery of a novel N-to-O transfer reaction. 
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Chapter 1 
Introduction: 
Nitrogen plays a central role in determining the properties of very many organic compounds, 
usually by reason of its ability to form strong hydrogen bonds. This is true despite the many 
chemical forms which a nitrogen atom can adopt (Fig. 1.1.).  
 
 
Fig. 1.1. 
Because primary amines have two N-H bonds, hydrogen bonding is more significant in such 
compounds than in secondary amines. Tertiary amines cannot form hydrogen bonds between each 
other because they do not have a hydrogen attached to the nitrogen. Consequently, if one compares 
amines with the same molecular weight and similar structures, it is found that primary amines have 
higher boiling points than secondary amines and secondary amines have higher boiling points than 
tertiary amines (Fig. 1.2.). 
 
Fig. 1.2. 
Because groups attached to the nitrogen atom that are electron donating increase the basicity 
(increase pKa), dimethylamine is more basic than methylamine and both compounds are more basic 
than simple ammonia. Attaching a phenyl group to the ammonia molecule dramatically decreases 
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its basic properties due to resonance of the nitrogen lone pair with the benzene ring;  aniline is much 
less basic than methylamine as the lone pair of electrons on the nitrogen are conjugated to the        
π-electrons of the aromatic ring and are therefore less available for acid-base chemistry. Electron 
donating substituents can enhance basicity by pushing electron density toward nitrogen, enabling 
the nitrogen to share its lone pair of electrons more readily, but the aromatic ring will still serve as 
an electron sink by resonance, pulling electron density away from nitrogen and thereby reducing its 
ability to coordinate its lone pair electrons. Based on the electronic factors, tertiary amines should 
be more basic when compared to secondary amines the fact that the nitrogen atom is now highly 
sterically crowded, however, this is not usually the case. The addition of the third methyl group 
results in a slight decrease in basicity. This reduction in pKa is a result of steric factors (Fig. 1.3.).1 
  
Fig. 1.3. 
Amide groups are the key defining structural features in peptides, proteins and enzymes and 
form hydrogen bonds, which are very important in determining the secondary and tertiary structure 
of such compounds. Huggins in 1936 expected the importance of the hydrogen bond to be “… the 
most fruitful applications of hydrogen-bridge theory will be to a better understanding of the nature 
and behaviour of complicated organic substances such as gels, protein, starch, sugar, and other 
carbohydrates, chlorophyll, haemoglobin and related substances” (Fig. 1.4.).2  
 
Fig. 1.4. Hydrogen bond proposed by Huggins 
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Nitrogen can also be inside or part of an aromatic system. The lone pair electrons of nitrogen in 
pyrrole 15 are part of the aromatic system but can still form hydrogen bonds. In pyridine 16, the 
lone pair of electrons are not part of the aromatic system and hence is better at forming hydrogen 
bonds. Substituted purines 17 and pyrimidines 18 are very important units in nucleic acids (found in 
DNA and RNA) in which hydrogen bonding determines the structures and is also a key element in 
the formation and especially the structure of DNA, a building block of life (Fig. 1.5.).  
 
Fig. 1.5. 
In a DNA helix, each purine (Adenine A or Guanine G) is bonded specifically to one pyrimidine 
(Thymine T or Cytosine C) by two or three hydrogen bonds respectively. The hydrogen bonds are 
of two kinds: one links an amine to a carbonyl group and the other links an amine to an imine    
(Fig. 1.6.). 
      
Fig. 1.6. 
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A hydrogen attached to carbon is not expected to form hydrogen bonds. If, however, the carbon 
atom is sufficiently polarized by attachment to one or more electronegative atoms, the hydrogen in 
question may become loosely enough bound to serve as a bridge. This seems to be the case in the 
HCN molecule, in which the nitrogen is connected by a hydrogen bridge to an electronegative atom 
in another molecule.2 
 
Fig. 1.7. 
Nitro groups can also participate in intermolecular and intramolecular hydrogen bonding. 
Takemoto et al. reported novel, catalysed Michael reactions between malonates 24 and nitroolefins 
25. In this reaction, the thiourea catalyst seems to interact with the nitro group, facilitating 
formation of the corresponding nitronate which could be produced from the nitroalkane with the 
bifunctional thiourea 26 via hydrogen-bonding activation and subsequent deprotonation by the 
neighboring tertiary amino group (see structures 28 and 29) (Scheme 1.1.).3 
 
Scheme 1.1. 
Therefore, it is not surprising that pharmaceuticals usually contain multiple nitrogen atoms, the 
positions of which are usually primarily responsible for the observed bioactivity of many drugs and 
natural products. The piperidine structural is a ubiquitous ring feature of numerous naturally 
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occurring alkaloids.4 Anabasine 30 is a piperidine alkaloid found in the Nicotiana tabacum.5 Conine 
31 and conhydrine 32 are poisonous alkaloids found in poison hemlock Conium maculatum. Conine 
31 was the first of the alkaloids to be synthesized by Albert Ladenburg in 1886.6 Adaline alkaloid 
33 acts as part of the defence system of the European ladybird, adalia bipunctata. This alkaloid is 
proven feeding deterrents to spiders and ants.7 Spiro-alkaloid nankakurine 34 induced secretion of 
neurotrophic factors in human astrocytoma cells at a concentration of 1 μM.8 Pergolide 35 is 
a dopamine receptor agonist used in some countries for the treatment of Parkinson's disease.9 
Scopolamine 36 is a tropane alkaloid drug with muscarinic antagonist effects.10 Morphine 37 is the 
gold standard of analgesics used to relieve intense pain. The legal medicinal use of morphine11 in 
the United States of America exceeds 80,000 kg/year (Scheme 1.2.).  
 
     
Scheme 1.2. 
Hence, it is hardly surprising that there has been enormous interest in the development of many 
methods for the synthesis of carbon-nitrogen bonds.  
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Carbon-nitrogen bond synthesis: 
1- Gabriel synthesis:  
The preparation of primary amines 40 from the corresponding alkyl halides, in which potassium 
phthalimide 38 is first alkylated, is known as the Gabriel synthesis12 (Scheme 1.3.). 
 
Scheme 1.3. 
During synthetic studies by Rossi et al., β-benzoylamino phenylalanine 44, the secondary 
alcohol of an enantiopure oxazolidinone was mesylated then the sulfonate ester group of 41 was 
displaced with potassium phthalimide to give 42. Deprotection of the phthalimide without 
destruction of the oxazolidinone ring was achieved by treating 42 with dilute hydrazine to give the 
free amine 43 (Scheme 1.4.).13 
  
Scheme 1.4. 
2- Yields from nucleophilic substitution of ammonia are often poor as the product, a primary 
amine, is itself a nucleophile, which is usually more reactive than ammonia itself and can therefore 
react with more alkyl halide. The result is mixtures containing primary, secondary and tertiary 
amines and even quaternary ammonium salts, hence the value of the Gabriel synthesis (see above). 
This can be avoided by using another simple method for carbon-nitrogen formation: an SN2 reaction 
for the conversion of alcohols into tosylamides.14 This is illustrated by the reaction of potassium 
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tosylamide which was prepared by heating 1.5 equivalents each of KOH and p-toluenesulfonamide 
in DMF. Following complete dissolution of the base, one equivalent of mesylate 46 prepared from 
commercial (R)-alcohol 45 is added, in DMF. Purification of the reaction mixture obtained after one 
hour gave the desired tosylamide 47 in 80% yield with an enantiomeric excess of 94% (Scheme 
1.5). Hence, by lowering the reactivity of the amine nitrogen, a single SN2 displacement can be 
efficiently achieved.  
 
Scheme 1.5. 
3- Curtius Rearrangement:  
The thermal decomposition of acyl azides 51 to produce an isocyanate 52 is known as the Curtius 
rearrangement.15 These intermediate isocyanates 52 may be isolated, or their corresponding 
hydrolysis products may be obtained directly. If the reaction is carried out in the presence of water, 
an amine or an alcohol, the corresponding amine 53, urea 54 and carbamate 55 are formed, 
respectively (Scheme 1.16.). 
 
Scheme 1.6. 
Kim et al. used a key carbamate intermediate during their total synthesis of Pancratistatin 60 
via a Curtius rearrangement of the corresponding carboxylic acid 57 induced by 
diphenylphosphoryl azide (DPPA) in refluxing toluene, to give a rather stable isocyanate 
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intermediate 58 that required further treatment with NaOMe/MeOH to generate the 
corresponding carbamate 59 in 82% overall yield (Scheme 1.7.).16 
 
Scheme 1.7. 
4- Schmidt Reaction:  
The Schmidt reaction is similar to the Curtius rearrangement, except that in this reaction the azide is 
protonated and hence it proceeds via different intermediates. The acid-catalysed reaction of 
hydrazoic acid with electrophiles, such as carbonyls, tertiary alcohols or alkenes is known as the 
Schmidt reaction. After a rearrangement and extrusion of N2, amines, nitriles, amides or imines are 
produced, respectively. Aliphatic carboxylic acids 61 give amines 62 more easily than aromatic 
examples which need very strong acid catalysts; aldehydes 63 and ketones 65 react faster than 
carboxylic acids to give nitriles 64 and amides 66, respectively (Scheme 1.8.). 
 
Scheme 1.8. 
Tanaka and Suemune developed a practical procedure for the synthesis of various chiral 
disubstituted amino acids, from the β-keto ester 67, which was subjected to the Schmidt reaction to 
give the N-acetyl α-amino acid 68 without loss of the optical activity (Scheme 1.9.).17 
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Scheme 1.9. 
Kumar et al. report the synthesis of the methyl analogue 70 of crispine A 69 via an 
intramolecular Schmidt reaction. The indolizidine alkaloid known as crispine A, was isolated 
from carduus crispus, an European biennial introduced in North America having flower heads, 
and was found to exhibit significant antitumor activity against many human cancer lines.18 The 
intramolecular Schmidt reaction of azido-ketone 71 was successfully achieved using triﬂic acid 
(TfOH) at -5 to 0 oC and the resultant cyclized product 72 was isolated in 54% yield (Scheme 
1.10.).19  
 
Scheme 1.10. 
5- Amide reduction:  
An amide [e.g. 73] can be reduced to the corresponding amine 74 by lithium aluminum hydride 
(LiAlH4) and many related hydride sources (Scheme 1.11.). 
 
Scheme 1.11 
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6- Imine reduction:  
Reductive amination is another technique to alkylate amines. It consists of two subsequent 
reactions: first condensation of an amine 77 with an aldehyde 78 or a ketone to give an imine 79 
with elimination of water then reduction of the imine 79 to the corresponding amine 80 
(Scheme 1.12.). 
 
Scheme 1.12. 
7- Buchwald-Hartwig cross-coupling: 
In addition to many rearrangement methods toward C-N bond formation, nitrogen insertion 
reactions have increasingly been developed. In Buchwald-Hartwig cross-couplings, palladium(0) 
catalyses C-N bond formation between an aryl halide and an amine in the presence of base (Scheme 
1.13.).20  
 
Scheme 1.13. 
8- Hydroamination reaction: 
Hydroamination is a highly atom-economical process in which an amine N–H functionality is 
added across an unsaturated carbon–carbon linkage. This potentially highly useful process can give 
access to various nitrogen-containing compounds and ﬁne chemicals of many structural types as 
well as naturally occurring alkaloid skeletons. Recently, there has been much interest in alkene 
hydroamination. The addition of an amine N–H 84 functionality to unsaturated an carbon–carbon 
bond, either in an intermolecular [eqn. (1)] or intramolecular 86 [eqn. (2)] fashion, generates amines 
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in a waste-free, highly atom-economical manner starting from simple and inexpensive precursors 
(Scheme 1.14.).21 
 
Scheme 1.14. 
The intermolecular hydroamination of a 1,5-diene 88 by TsNH2 could be followed by a second 
intramolecular hydroamination to produce pyrrolidines 89 in an one-pot operation. A mixture of cis 
and trans products (37:63) was isolated in 64% yield with the use of four equivalents of the          
1,5-diene 88 in toluene with a catalytic amount of Ph3PAuOTf (5 mol%) (generated by mixing 
equal equivalents of Ph3PAuCl and AgOTf) at 95 °C for 15 h (Scheme 1.15.).
22 
 
Scheme 1.15. 
8.1. Intermolecular Acid-Catalyzed Hydroamination of Alkenes: 23 
Marcseková and Doye found that substituted anilines 90 reacted with olefins 91 in the presence 
of catalytic amounts of aqueous hydrogen iodide to give a mixture of the corresponding 
hydroamination and hydroarylation products, 92 and 93, respectively. Electron-withdrawing 
substituents on the aniline ring increase the overall yield of the reaction and favoured the formation 
of the hydroamination products 92 (Scheme 1.16. and Table 1.1.).24 
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Scheme 1.16.   
Table 1.1. Examples of hydroamination/hydroarylation of simple olefins with hydrogen iodide 
 
Anilines 90 
R1 = 
Olefin 91 
R2 = 
Temperature / 
°C 
Time / 
h 
Ratio of 92:93 Yield / % 
1 H H 5 4 3:2 98 
2 Cl H 35 24 2:3 86 
3 H Me 135 24 5:4 80 
 
Hartwig reported that additions of aliphatic amines to olefins in the presence of acid do not occur 
under mild conditions, presumably because the amine will be very largely protonated. The 
intermolecular additions of sulfonamides to alkenes catalyzed by triflic acid which were 
subsequently discovered by Hartwig are summarized in Scheme 1.17. The addition of p-
toluenesulfonamide TsNH2 94 to norbornene occurred within hours at room temperature to form the 
exo-addition product in 91% yield, while the addition of TsNH2 to cyclohexene and cyclooctene 
occurred within a day at 85 °C in 58% and 86% isolated yield (Scheme 1.17.).25  
 
Scheme 1.17. 
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The presence of the acid makes this kind of hydroamination related to the Ritter reaction, an old 
method where aliphatic or aromatic nitriles 98 are used as a nitrogen nucleophile to react with 
alkenes 99 or tertiary alcohols 102 under acidic conditions to give N-tert-alkylamides (Scheme 
1.18.).26 
 
Scheme 1.18. 
The mechanism of the Ritter reaction has been thoroughly studied. When an alkene 99 is used, 
the carbocation 104 is generated by protonation of the double bond. The cation is then attacked by 
the nitrogen atom of the nitrile to form nitrilium ion 105, which is then hydrolysed to produce the 
observed N-alkyl carboxamide (Scheme 1.19.). 
 
Scheme 1.19. 
The intramolecular Ritter reaction has been used by Compernolle et al. for the synthesis of a 
potential dopamine receptor ligand 110. A six membered lactam ring was formed upon treatment of 
the tertiary benzylic alcohol 108 with methanesulfonic acid. The benzylic carbocation thus 
generated was captured by the nitrogen of the cyano group (Scheme 1.20.).27 
 
Scheme 1.20. 
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Obviously, there is a basic incompatibility between an amine and an acid catalyst due to rapid 
salt formation and therefore the trend in reactivity is an increase in catalytic efficiency with 
decreasing anion coordination ability OTf - < NTf2 
–. Both hydroamination 113 and ortho-
hydroarylation 114 products are formed using 5 mol % of TfOH and HNTf2. These observations are 
consistent with the intermediacy of a stabilized carbenium ion and suggest that these 
transformations proceed along a reaction pathway similar to that of acid-catalyzed hydration, where 
either the heteroatom or the aromatic ring can act as the nucleophile (Scheme 1.21.).28 
 
Scheme 1.21. 
8.2.1 Intramolecular Acid-Catalyzed Hydroamination of Alkenes29 
Intramolecular hydroamination is of great interest, because nitrogen-containing heterocycles 
could be synthesized from amino olefins using such a reaction. The first examples of Brønsted acid-
catalyzed intramolecular hydroaminations were reported contemporaneously by Hartwig and 
Knight.30 Aminoalkenes 117 bearing an electron-withdrawing group at the nitrogen atom led to 
pyrrolidines and piperidines 118 in generally excellent yields in the presence of a substoichiometric 
amount of triflic acid in hot toluene (Scheme 1.22.). Lactams (X = O) were also prepared under the 
same reaction conditions starting from amides. In the case of using sulfuric acid as catalyst, yields 
were generally lower. In a proposed mechanism, the alkenyl tosylamide is protonated first at the 
tosylamide group, the proton is then transferred intramolecularly to the double bond, and finally, the 
resulting carbenium ion is trapped by the sulfonamide, which regenerates a proton, rendering the 
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process catalytic in acid. The regiochemistry of this process is determined mostly by the stability of 
the carbenium ion intermediate; thus, most of these transformations are overall unfavourable 5-
endo-trig cyclisations, according to Baldwin’s rules. Hartwig evaluated acid-catalyzed reactions of 
the aliphatic substrate Entry 2: both substrates underwent the acid catalyzed cyclization to form the 
formal Markovnikov cyclization product. The very electron deficient alkene [Entry 3] did not react, 
presumably because the low Lewis basicity of the double bond makes it less susceptible to 
protonation. Reactions that would form three- or four-membered rings did not occur because of 
rapid decomposition of the allylic amine precursors under the strongly acidic conditions. In 
addition, the six-membered ring Entry 4 was formed by a formal 6-endo-trig cyclization in excellent 
yield; prolonged heating was necessary to complete the reaction in the presence of sulfuric acid as 
the catalyst. Entry 5 which could form a seven-membered ring through an intermediate with 
benzylic stabilization or a six-membered ring through an unstabilized intermediate, gave the six-
membered ring by an overall 6-exo-trig process. Substrates containing the p-nitrophenylsulfonyl 
group [e.g. Entry 6] gave the cyclization products in excellent yields. Lactams [Entry 7] were 
obtained in essentially quantitative yield when the reaction were conducted in the presence of 
stoichiometric amount of triflic acid. A stoichiometric amount of acid was required because the 
protonated N-alkyl amide product is too weakly acidic to initiate cyclization of a second starting 
benzamide.  
 
Scheme 1.22. 
 
 
 
16 
Table 1.2. Selected Examples of Acid-Catalyzed Intramolecular Hydroamination of Protected 
Alkenylamines. 
Entry 1 2 3 4 5 6 7 
n 1 2 1 2 3 2 2 
Product 
118     
  
 
Yield % 83 95 0 83 51 96 99 
 
8.2.2 Acid-Catalysed Hydroamination Reactions in the Knight Group 
Amjad and Knight group found the exposure of the (E)-homoallylic sulfonamides 119 to 
iodocyclisation conditions in the presence of a proton source gave the thermodynamically more 
stable 2,5-cis diastereoisomers 122, whereas exposure to excess iodine in the presence of potassium 
carbonate showed a distinct preference for the formation of the 2,5-trans isomers 121. These results 
were thought to be due to an initial cyclisation via a chair-like transition state conformation 120, 
which leads to the 2,5-trans isomers 121, and which can then be followed by proton-induced cyclo-
reversion and re-closure and hence equilibrium towards, and eventually only, the more 
thermodynamically stable 2,5-cis isomers 122 (Scheme 1.23.). 
 
Scheme 1.23. 
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The stereochemical outcomes appear to follow largely the chair-like conformation 120, wherein 
the sp3-bonded group (R2) adopts an equatorial position during the initial cyclisation, under basic 
conditions, hence leading to kinetic products, the 2,5-trans isomers 121. Omission of the base leads 
to only the 2,5-cis isomers 122. The pathways were proven by exposing a 2,5-trans-pyrrolidine 121 
to a mixture of hydrogen iodine and iodine, when conversion into the cis-isomer 122 occurred 
rapidly. Acid-catalysed cyclo-reversion and equilibration to the thermodynamically more stable cis-
isomers 122 then follows (Scheme 1.24.).31  
 
Scheme 1.24. 
Amjad observed another signiﬁcant feature during extensions of this methodology to the 
formation of highly substituted proline analogues 123, which, in extreme cases, required prolonged 
exposure to large excesses of iodine in order to achieve complete conversion into the desired 
iodopyrrolidines 124 (Fig. 1.8.). When such cyclisations were carried out in the absence of base, the 
products 125 were sometimes accompanied by small amounts of the de-iodopyrrolidines. It was 
reasoned that one possibility was that direct acid-catalysed cyclisation was occurring to a limited 
extent to give the unexpected products 125. 
 
Fig. 1.8. 
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When these ideas were extended to alkyne systems, new and efficient approaches to dihydroiodo 
and iodopyrroles were found via 5-endo-dig cyclisations. However, when such cyclisations were 
carried out without any base present, a mixture of iodopyrroles and pyrroles were formed (Scheme 
1.25.).32  
 
Scheme 1.25. 
It was assumed that the hydrogen iodide HI produced in the initial stages of iodopyrrole 
formation was the acid which was causing cyclisation to give the pyrroles 128. This led to the 
development of new acid-catalysed approaches to pyrroles. All of this led to the idea of using acid-
catalysed cyclizations to form saturated N-heterocycles, especially pyrrolidines and piperidines. The 
prenyl amino esters 129 was synthesised to test this, the idea being that if this did not undergo 
smooth cyclisation, then the idea was not viable, because the cyclization should involve a relatively 
stabilized tertiary carbenium ion 130 (Scheme 1.26.). 
 
Scheme 1.26. 
In the event, Haskins and Knight, prepared pyrrolidine derivatives by using 
trifluoromethanesulfonic acid CF3SO3H (triflic acid, TfOH) as a catalyst in excellent yields.
33 Both 
prenyl derivatives 132 underwent rapid and very clean cyclisation when exposed to 0.4 equivalents 
of triflic acid at 0 oC to give essentially quantitative yields of the pyrrolidines 133. In contrast, the 
cinnamyl derivatives 136 required slightly more demanding conditions (0.6 eq. TfOH, 25 °C, 4.5 
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h). Understandably, cyclisation of the corresponding crotyl analogue 134 required heating to reflux 
to achieve complete reaction; the excellent yields of the resulting pyrrolidines 132 were, however, 
obtained. Spiro-Pyrrolidines can also be prepared using this chemistry: the ylidenecyclohexane 
derivative 138 gave an excellent return of the expected product 139 under the mildest set of 
conditions, indicating again the intermediacy of a tertiary carbenium ion (Scheme 1.27.). 
 
Scheme 1.27. 
The Knight group has had a longstanding interest in 5-endo-trig cyclisations. Almost 
simultaneously to the study of Schlummer and Hartwig34, Haskins and Knight demonstrated that 
triflic acid was an excellent catalyst for inducing overall 5-endo-trig cyclisation of homoallylic 
sulfonamides to give pyrrolidines. They applied this methodology to the synthesis of polycyclic 
compounds through a cationic cascade terminated by a sulfonamide group. For instance, geranyl 
derivative 140 underwent rapid cyclisation at 0 °C to give 90% isolated yield of the trans-annulated 
pyrrolidine 141, as a 3:2 epimeric mixture at the amino ester stereogenic centre. This assignment of 
structure was confirmed by a single crystal X-ray crystallographic determination of a separated 
sample of the major isomer of the glycine derivative (Scheme 1.28.). 
 
Scheme 1.28. 
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In plants, monoterpenes with ten carbons (C10) such as pinene are biosynthesized in the plastid 
from the C5 intermediates isopentenyl diphosphate (IPP) 145 and dimethylallyl diphosphate 
(DMAPP) 146 generated via the deoxyxylulose-5-phosphate (DXP) 144 pathway. Geranyl 
diphosphate synthase (GPPS) carries out a head-to-tail condensation of IPP 145 and DMAPP 146 to 
produce geranyl diphosphate (GPP, C10) 147, which is, in turn, cyclized by pinene synthase (PS) to 
produce either α- or β-pinene 148, 149 (Scheme 1.29.).  
Scheme 1.29. 
The pinene synthase cyclization mechanism of geranyl diphosphate GPP 147 to α- or β-pinene 148, 
149 is shown in (Scheme 1.30.).35 
 
Scheme 1.30. 
When Haskins attempted to extend acid-catalysed hydroamination chemistry to the synthesis of 
piperidines, she claimed that formation of such six-membered rings is particularly disfavoured. For 
example, exposure of the homoprenyl derivative of alaninate 153 to triflic acid gave only the 
pyrrolidine 154 (cis:trans ~ 3:2); isolated yield was in excess of 90%, although the less stable 
secondary carbocation was involved. The tertiary carbocation would give the piperidine product 
155 through an overall 6-endo-trig process, which is favoured according to Baldwin’s rules whereas 
secondary ion would give the pyrrolidine ring 154, which would occur through an overall 5-exo-trig 
process, which is also favoured by Baldwin’s rules (Scheme 1.31.). 
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Scheme 1.31. 
However, Haskins prepared the indolic terpene alkaloid α-cyclopiazonic acid 155 in 11 steps; the 
key step is a carbocationic cascade, terminated by a 4-nitrosulfonamide group and initiated by 
benzylic carbocation formation directly from the intermediate 158. Clearly the benzylic carbocation 
158 was not generated by double bond protonation, but rather by protonation of the benzylic alcohol 
to produce the benzylic carbocation 158 (Scheme 1.32.).36  
 
Scheme 1.32. 
The cyclization reaction was carried out on the tert-butyldiphenylsilyl (TBDPS) protected 
alcohol 160 with one equivalent of triflic acid for one hour at room temperature. Both the 
deprotection and the cascade cyclization were carried out in one step to generate the tetracyclic 
system 161 in 74% yield (Scheme 1.33.). 
 
Scheme 1.33. 
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Conclusion  
From the previously reported work of Hartwig and Knight, the acid-catalysed 
hydroamination reaction is a powerful method for the synthesis of nitrogen containing 
heterocycles. Both sulphuric acid and triflic acid are effective catalysts in these 
cyclizations with some limitations of using sulphuric acid in the case of cinnamyl alkene 
derivatives. New synthetic routes to such a wealthy of structures are always desirable, 
especially when new stereogenic centres are introduced in a controlled way. This 
potential is explored in the following chapter. 
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Chapter 2 
Acid-catalysed synthesis of piperidines 
Introduction: 
The importance of the piperidine ring in natural products and the successful results of using acid-
catalysed hydroamination reactions to synthesize pyrrolidines made us think in a logical way to 
extend this methodology toward piperidine synthesis. Piperidine syntheses have been studied 
extensively, as the development of new drugs containing six-membered ring heterocycles becomes 
more and more common. The synthesis of piperidines using very common C-N bond-formation is 
well known along with many rearrangements and ring expansions, which have has also been 
extensively studied, but many strategies are less common and are often used only in a few particular 
cases rather than as a general method.1 
    Piperdine synthesis 
    Watson and colleagues noted that a substructure search of the piperidine ring using the 
electronic version of the Drug Data Report (MDL Drug Data Report) which includes data from July 
1988 through to December 1998 revealed over 12,000 discrete piperidine entities that have been 
mentioned in clinical or preclinical studies.2 There are many different methods that have been used to 
construct piperidine rings and these have been reviewed.1 General and popular strategies include 
nucleophilic substitutions, reductive amination and the reaction of amines with alkenes and alkynes. 
1. Nucleophilic substitution 
Nucleophilic substitution is a reliable method of making piperidines, It is often used as the ﬁnal 
step, followed by deprotection of the functional groups present, if necessary. The main difﬁculty with 
this type of cyclisation compared to intermolecular nucleophilic substitution is the choice of the 
correct concentration of reagents. A too dilute reaction mixture gives a slow reaction and, if the 
reaction mixture is too concentrated or the intramolecular nucleophilic substitution is too slow, 
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polymerisation can occur. Halides, mesylates or tosylates are most commonly used as the leaving 
groups to form piperidines via intramolecular cycloaddition.3 The chloride 162 has been used by 
Hanessian et al4 in the synthesis of enantiomerically pure 2,3-piperidines (Scheme 2.1). Ring-closure 
using tert-BuOK as the base afforded the piperidine 163 in 45–55% yield. Oxidative cleavage, 
followed by reduction, afforded the target compound 164 in 62% yield (Scheme 2.1). 
 
Scheme 2.1 
Reaction of bis-tosylates with primary amines is also known in the literature and has been used 
more commonly from bis-mesylates/ tosylates than halogens. Kurth and co-workers5 cyclised the bis-
tosylate 165 using an excess of benzylamine at 85 oC. The reaction occurred in 90% yield and gave 
only the anti-piperidine 166 (Scheme 2.2). 
 
Scheme 2.2 
2. Reductive amination 
One of the most common methods for the synthesis of piperidines, if not the mostly widely used, 
is reductive amination. Indeed, piperidines can be synthesised from 1,5-amino-aldehydes in a one-pot 
procedure in the case of secondary amines or a two-pot procedure for primary amines. The two-step 
process involves the formation of an imine intermediate, followed by its reduction. Urban et al.6 
achieved the conjugate addition of the β-keto-amide 167 with acrolein to afford the desired aldehyde 
168 in 99% yield (Scheme 2.3). These workers found, however, that complete conversion of 168 into 
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a mixture of aminals 169 occurred on storage over several hours. Reduction of the amino-aldehyde 
168 or the aminals 169 with LiAlH4 resulted in a reductive cyclisation, yielding the racemic alcohol 
170 (Scheme 2.3). 
 
Scheme 2.3 
3. Reaction of amines with alkenes and alkynes 
3.1. Michael addition 
Michael addition plays an important role in the synthesis of piperidines. Control of the 
stereoselectivity is the main difﬁculty in this type of cyclisation. Armstrong et al.7 in their approach 
towards the synthesis of cylindrospermopsin, synthesised the first piperidine intermediate 172 via a 
Michael addition reaction. Treatment of the compound 171 with a catalytic amount of p-TsOH in 
reﬂuxing benzene gave the more stable N-Cbz-protected-2,6-cis-piperidine 172, as a single 
diastereoisomer in 74% yield (Scheme 2.4). 
 
Scheme 2.4 
Carretero et al. converted α,β-unsaturated sulfone 173 via a one-pot deprotection/Michael addition 
sequence into the piperidines 174 and 175 (Scheme 2.5). Complete N-Boc deprotection by treatment 
with trifluoroacetic acid afforded quantitatively the corresponding ammonium salt which, after 
isolation, was redissolved in THF, cooled to -78 °C and treated with ten equivalents of Et3N. The 
cyclization was complete in less than 30 min at -78 °C, giving piperidines 174 and 175 as a mixture 
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of cis and trans isomers in quantitative yield. The diastereoselectivity is affected by the substituent 
on nitrogen: the mechanistic rationales suggest an equilibrium between conformers 176 and 177 
exists, disfavoring 176 due to 1,3-diaxial interactions between the substituents.8, 9 
 
Scheme 2.5 
3.2.  Electrophile-Induced Cyclizations 
Deziel developed catalytic asymmetric syntheses of piperidines by using catalytic amounts of 
chiral C2-symmetric arylselenium triflate 179 to give diastereomerically pure trans-2,3-disubstituted 
piperidine 181 in 89% yield with an excellent 92% ee (Scheme 2.6). 9, 10 
 
Scheme 2.6 
4. Formation of Lactams 
MaGee et al.11 developed a convenient and general method for the synthesis of piperidinone 
lactams via the intramolecular trapping of ketenes. Reﬂuxing the ethoxyalkyne 182 in xylene 
afforded the desired piperidinone 184 in 81% yield. This reaction is believed to proceed via the 
ketene 183, which cyclises spontaneously under the reaction conditions (Scheme 2.7). 
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Scheme 2.7 
5. Ring Expansion 
Cossy observed the enantioselective ring expansion of pyrrolidines in the presence of 
trifluoroacetic anhydride and subsequent treatment with Et3N to give piperidines typically with ~ 
97% ee.12 Trans-3-Hydroxy-2-phenylpiperidine 188 was stereospecifically formed from chiral 2-
hydroxymethylpyrrolidine 185b. On the other hand, the diastereomeric pyrrolidine derivative 186a 
did not rearrange to cis-3-hydroxy-2-phenylpiperidine 187. This was taken as evidence for a tight ion 
pair mechanism, in which the initially formed trifluoroacetate undergoes substitution reaction with 
concomitant formation of the aziridinium ions 186a and 186b. Due to steric hindrance in the tight ion 
pair, attack of trifluoroacetate on the aziridinium ion 186a is strongly disfavored as compared to the 
isomeric 186b (Scheme 2.8).13, 9 
 
Scheme 2.8 
6. Aza-Prins piperidine synthesis 14 
The synthesis of piperidines was investigated by Martin and co-workers. Their strategy consisted 
of allowing homoallylic tosylamides to react with aldehydes in the presence of FeCl3 or FeBr3. 
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Homoallylic tosylamide 190 led preferentially to trans-2,4-disubstituted piperidines 192 (Scheme 
2.9).15  
 
Scheme 2.9 
The diastereoselectivity is inﬂuenced by the geometry of the intermediate iminium cation. The E-
iminium ion (precursor of the 2,4-trans product through cyclization via a chair-like transition state, 
followed by equatorial trapping of the resulting carbocation by X-) is more stable than the (Z)-
iminium ion by 0.78–1.77 kcal/mol, except when R is a benzyl group (Scheme 2.10).16  
 
Scheme 2.10 
7. Reduction of pyridines 
The synthesis of piperidines from pyridines is a well-known transformation and shown to be a 
very important synthetic tool for the preparation of 3,4,5-trisubstituted piperidine derivatives.17 
Access to piperidines containing a quaternary carbon via the reduction of pyridines is, however, not 
known in the literature for obvious reasons. The outcome of partially reducing pyridines is normally 
formation of 1,4-dihydro products.18 The Birch reduction of pyridines forms 1,4-dihydropyridines 
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that must be either stabilized by an electron-withdrawing group on nitrogen or transformed in situ, 
presumably to prevent autoxidation.19 The full reduction of pyridines to piperidines using hydrogen 
can be achieved using different catalysts such as Pd/C, PtO2 or Rh/C. The full reduction of 2,4-
pyridines 197 has been studied by Steiner et al. who found the best result in terms of 
diastereoselectivity to be using one equivalent of NaOH. They were able to efﬁciently scale up the 
reduction of the pyridine 197 to the desired syn 2,4-disubstituted piperidine 198, in 95% yield, which 
contained only 3% of the anti-diastereoisomer (Scheme 2.11).20 
 
Scheme 2.11 
8. Metal-catalyzed hydroamination 
Metal-catalyzed hydroamination of simple olefins is one of the most important strategies to 
prepare nitrogen-containing molecules.21, 22 It has been reported that gold(I)-catalyzed intramolecular 
hydroamination of tosylated amino olefins 199 and 201 is a very effective pyrrolidine synthesis. 
Several N-tosylated olefins were efficiently cyclized to afford pyrrolidines 200 and 202 in toluene 
with a catalytic amount of Ph3PAuOTf (5 mol%) (generated by mixing equal equivalents of 
Ph3PAuCl and AgOTf) (Scheme 2.12).
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Scheme 2.12 
A gold-catalyzed methodology involving a favoured 6-endo-dig cyclization has been applied to 
obtain dendrobate alkaloid (+)-241D 206, which has been isolated from the methanolic skin extracts 
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of the Panamanian poison frog Dendrobates specious24 and has shown to be a non-competitive 
blocker of acetylcholine to ganglionic nicotinic receptor channels.25 The gold-catalyzed 
intramolecular cyclisation of this intermediate β-amino ynone derivative 203 using PPh3AuCl in the 
presence of a silver salt in 1,2-dichloroethane at room temperature gave, in one hour, the expected 
enantiopure 4-pyridinone 204 in good yield. With this chiral synthon 204 in hand, the synthesis of 
dendrobate alkaloid (+)-241 D 206 was completed. Thus, acid-catayzed removal of the Boc-
protecting group was achieved before catalytic hydrogenation of the thus generated 2,3-
dihydropyridone 205 gave a unique cis-diastereoisomer in 78% isolated yield (Scheme 2.13). 
 
Scheme 2.13 
Takaki et al. reported investigations into FeCl3-catalyzed intramolecular hydroamination, in which 
they found that the iron activity was superior to that of other conventional transition-metal catalysts. 
The compatibility of FeCl3.6H2O (10 mol %) with various types of amino-olefins was investigated 
under the optimized conditions in air. In these cases of the 2,2-disubstituted amino-olefins 207 and 
209 were smoothly transformed into the corresponding pyrrolidine 208 and 210 in quantitative yield 
within two hours in 1,2-dichloroethane at 80 oC under air (Scheme 2.14).26 
 
Scheme 2.14 
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In the same report, consistent with 6-endo-trig cyclisations being unfavourable according to 
Baldwin’s rules,27 when Takaki et al. attempted to extend this methodology to the synthesis of 
piperidine derivatives, not surprisingly, they found that the construction of five-membered rings was 
more favorable than of six-membered rings under these conditions. Treatment of 2,2-dimethyl-1-(4-
toluenesulfonylamino)hex-5-ene 211 with FeCl3·6H2O gave pyrrolidine 212 in 72% yield, together 
with 2-methylpiperidine 213 (24%). On the other hand, 2,2-dimethyl-5-phenyl-1-(4-
toluenesulfonylamino)pent-4-ene 214 produced 2-phenylpiperidine 215 in 94% yield through 6-endo-
trig cyclization, but no 2-benzylpyrrolidine was detected (Scheme 2.15); presumably, a stabilized 
benzylic carbenium ion is involved in this case. 
 
Scheme 2.15 
These piperidine syntheses become limited however when a quaternary carbon is present at the 
centre which is undergoing nucleophilic attack, which generally fail when applied to tertiary 
electrophiles. Haskins and Knight found that exposure of homoprenyl derivative of alaninate 217 to 
triflic acid gave only pyrrolidine 218 (cis/trans ~3:2) in 88% overall yield despite the implication that 
a less stable secondary carbocation is involved. The formation of piperidine 216 is particularly 
disfavoured in this case. Similarly, treatment of the cyclohexenyl sulfonamide 220 with catalytic 
amounts of triflic acid did not give the expected spiro-piperidine 219 but rather the 
piperidine/pyrrolidine ring system 221. This result was unexpected as the cyclisation appears to 
proceed via a less stable secondary carbocation intermediate. The major diasteroisomer of pyrrolidine 
221, with the cyclohexyl and methyl ester substituent cis to one another, was confirmed by X-ray 
crystallographic analysis (Scheme 2.16).28 
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Scheme 2.16 
Haskins confirmed the structure of pyrrolidine 218 by constructing it through a different route, 
which had also been developed in the group (Scheme 2.17). Amino acid alanine ester was converted 
into the corresponding benzyl imine 222. The imine acts as a protecting group for the next step of the 
synthesis following the method developed by the Stork group.29 Imine 222 was deprotonated with 
LDA and then reacted with 1-bromo-4-methyl-2-pentene 224, which was prepared by SN2’ reaction 
of the alcohol 226.  
 
Scheme 2.17 
Subsequent hydrolysis of the imine and reprotection of the resulting amine 225 yields the 
cyclisation substrate. Iodocyclization of sulfonamide 227 under basic conditions gave an 
iodopyrrolidine 228 (2,5-trans : 2,5-cis 4:1) which was deiodinated by hydrogenolysis to yield the 
corresponding pyrrolidine 218. This pyrrolidine showed the same spectroscopic data as those 
displayed by the acid-catalyzed cyclization product, although the diastereomeric ratios were different 
(Scheme 2.18).30 
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Scheme 2.18 
It becomes clear that pyrrolidine 218 was formed in the acid-catalysed cyclization rather than the 
expected piperidine 216 (Scheme 2.16). This finding was particularly unexpected especially when 
compared with Hartwig’s piperidine synthesis. In 2002, he published a paper which reported that two 
piperidines 230 and 232 synthesized by overall 6-endo- and 6-exo- reaction using 0.2 equivalent of 
triflic acid in toluene at 100 oC. The cyclisation of sulfonamide 229 occurs via a benzylic carbocation 
rather than the corresponding and much less stabilized secondary carbocation intermediate. The 
cyclisation of sulfonamide 231 by contrast occurs via such a less stable secondary carbocation rather 
than the isomeric benzylic carbocation, the low yield 51% suggesting that this cyclisation is not 
especially a favoured one. It would be interesting to see what other products were formed in this 
reaction, particularly if these include the corresponding azepane ring.  It is noted that sulfonamide 
231 did not give any product when sulfuric acid was used as a catalyst, neither the piperidine nor the 
azepane (Scheme 2.19).  
 
Scheme 2.19 
Just before my arrival in Cardiff, a French Erasmus student, Alexis Dupauw, was visiting the 
group for three months and began a study of the unexpected inability to form piperidines by acid-
catalysed cyclisations (Scheme 2.20), which became my starting point. 
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His chosen unsaturated sulfonamide 236 was readily prepared from commercially-available 
ketone 233 by sequential oxime formation 234, reduction to the corresponding amine 235 and, 
finally, N-tosylation by para-methylbenzene sulfonyl chloride in the presence of triethylamine. Each 
of these three steps gave essentially quantitive yields (Scheme 2.20). At this time, it had been 
discovered by Henderson, another member of the group, that concentrated sulfuric acid could equally 
well be used in place of triflic acid, thereby both reducing costs significantly and also providing a 
much more ‘certain’ acid quality, as the sulfuric acid was sourced from a 1.5 L bottle whereas the 
extremely hygroscopic triflic acid came in relatively expensive 10 ml batches. Older samples were 
undoubtedly contaminated with varying levels of water. The major drawback with the use of 
concentrated sulfuric acid is its high viscosity, which meant that it was quite difficult to measure 
accurately a small quantity while keeping it dry. It was also essentially insoluble in the usual solvent 
for these acid-catalysed cyclisations, dichloromethane.  
Scheme 2.20 
All of Alexis’ experiments were carried out using concentrated sulfuric acid, c.H2SO4. The idea 
was the same as for the initial pyrrolidine synthesis (Scheme 1.27): protonation of the alkene group 
in unsaturated amine 236 should provide predominantly or only the tertiary carbenium ion 238, 
leading to the piperidine 237 (Scheme 2.21). 
 
Scheme 2.21 
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In one of his attempts to form piperidine 237, treatment of the sulfonamide 236 with 0.2 
equivalents of c.H2SO4 gave only the piperidine 237! Alexis tried many times to repeat the 
cyclisation to give the piperidine 237, but was unable to do so, despite working carefully. It was at 
this point that the present project began.  In this extended study, pyrrolidine 239 was the only product 
that could be found after 60 minutes of exposing sulfonamide 236 to catalytic amounts of pure 
concentrated sulfuric acid, c.H2SO4, at room temperature, 20 
oC, which formally involved formation 
of a secondary carbenium ion. This result was unexpected as the cyclisation appears to proceed via a 
less stable secondary carbocation intermediate but did confirm the original findings made by Haskins 
(Scheme 2.22).  
 
Scheme 2.22 
The evidence of cyclisation came from, mainly, 1H NMR analysis of the crude product. 
 i) The disappearance of =CH proton and NHTs proton at (δH = 4.91, 4.21 ppm respectively; Fig. 
2.1) confirmed the full conversion of sulfonamide 236 into a cyclic product. ii) The peak 
corresponding to NCH proton was distinguishable among the reactant sulfonamide 236 (δH = 3.41 – 
3.01 ppm) and both piperidine 237 (δH = 4.45 – 4.55 ppm), pyrrolidine 239 (δH = 3.66 – 3.32 ppm) 
products (Fig. 2.2 and 2.3). iii) Clearly, the methyl peaks on double bond =C(CH3)2 in sulfonamide 
236 (δH = 1.51 and 1.45 ppm, Fig. 2.1) completely have disappeared to give four peaks as doublet 
related to isopropyl CH(CH3)2 in pyrrolidine 239 cis/trans 1.4:1 (Fig. 2.2) and two sharp singlets in 
piperidine 237 (Fig. 2.3).  
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Figure 2.1 1H NMR spectrum of sulfonamide 236 in CDCl3 (400 MHz). 
 
 
                       
 
 
 
 
 
 
Figure 2.2 1H NMR spectrum of pyrrolidine 239 in CDCl3 (400 MHz) 
 
40 
 
 
                                           
                                                
                                            
 
 
 
 
 
Figure 2.3 1H NMR spectrum of N-tosyl piperidine 237 in CDCl3 (400 MHz). 
By repeating the reaction, as can be seen in Table 2.1, sulfonamide 236 was completely converted 
into pyrrolidine 239 after one hour at 20 oC (entry 1). There were no products after three hours at -30 
oC (entry 2).  There was still present about 75% of the starting material, sulfonamide 236 after two 
hours at -30 °C (entry 3). After 90 minutes of reaction at -10 °C, there was still present 53% of the 
sulfonamide 236 and pyrrolidine 239 started to appear in the reaction mixture with 35% piperidine 
237  (entry 4). The best result was after 60 minutes at 0 °C with 2% pyrrolidine 239 and 73% 
piperidine 237 as a major product present in the reaction mixture but still ca. 25% of starting material 
236 (entry 5). When the reaction was left for just 6 minutes at room temperature 20 oC, there was still  
48% starting material 236, but with 45% pyrrolidine 239 and 7% piperidine 237  (entry 6). Alexis’ 
original result (the 1H NMR which appeared as Fig. 2.3) could never be repeated despite many 
attempts, clearly there must be a very small “window’’ of acid concentration and reaction 
temperature. The reasonable result obtained in entry 5 allowed the separation by simple 
crystallization of a good sample of the desired piperidine 237; its 1H NMR spectrum is reproduced in 
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Fig. 2.3. The observed NCH resonance at δH = 4.45 – 4.55 ppm allowed for its easy quantification in 
mixtures with sulfonamide 236 and pyrrolidine 239 (Fig. 2.1 and 2.2). 
Table 2.1 c.H2SO4, DCM, percentages as determined from 1H NMR spectra integration depending on NCH 
proton, with N-Ts as a protecting group. 
Entry Time / min Temperature oC SM 236 : Pip 237: Py 239 
1 60 20 0 : 0 : 100 
2 180 -30 100 : 0 : 0 
3 120 -30 75 : 18 : 7 
4 90 -10 53 : 35: 12 
5 60 0 25 : 73 : 2 
6 6 20 48 :7: 45 
 
Extra evidence of cyclisation came from 13C NMR: sulfonamide 236 showed one quaternary 
carbon on double bond at 132.5 ppm and two methylene carbons at 37.3 and 24.2 ppm. Piperidine 
237 showed one quaternary carbon near to nitrogen at 58.2 ppm and three methylene carbons at 41.0, 
30.2 and 15.3 ppm. Pyrrolidine 239 showed no quaternary carbon on the center of the reaction, two 
methylene carbons and three methine carbons two of them near to nitrogen and another related to 
isopropyl group CH(CH3)2 ; as can be seen in Table 2.2. 
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Table 2.2 Some peaks from 13C NMR spectra of sulfonamide 236, piperidine 237 and pyrrolidine 239. 
13C NMR ppm    
Cq =C(CH3)2 : 132.5 NCq : 58.2 - 
CH 
=CH : 123.7 
NCH : 50.6 NCH : 51.3 2 x NCH, CH(CH3)2 
CH2 2 x CH2 : 37.3, 24.2 3 x CH2 : 41.0, 30.2, 15.3 2 x CH2 
 
The above evidence suggest that piperidine 237 is unstable under such acidic conditions. This 
conversion could possibly occur through a series of equilibria, where piperidine 237 is the kinetic 
product and pyrrolidine 239 the thermodynamic product (Scheme 2.23). We suggest this involves a 
new type of piperidine rearrangement. This rearrangement could be taking place because of steric 
hindrance in the suggested conformation of N-tosyl 2,2,6-trimethylpiperidine 237a  (Scheme 2.23).  
 
Scheme 2.23 
The structure of piperidine 237 was confirmed by X-ray crystallographic analysis: the methyl 
substituent was found to be in an axial orientation (Fig 2.4). It seems to be the same in solution: the 
6-H resonates at δH = 4.45 – 4.55 ppm in deuterated chloroform, CDCl3, as a broad resonance with a 
peak width at half height of ω1/2 < ca. 16-17 Hz. As this already contains a quartet of  J = 6.9 Hz, due 
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to coupling with the 6-methyl group, the presence of a large, trans-diaxial coupling of ca. 12-14 Hz 
is not possible. The broadened apparent pentet must be from a fifth coupling of ca. 6.9 Hz to one of 
the protons at the 5-position of the piperidine ring. The remaining proton must have a small coupling 
constant to the 6-H (< ~ 3 Hz) resulting in only peak broadening. With no large coupling, 6-H cannot 
be an axial proton and the 6-methyl group therefore must be axial. 
 
 
 
 
 
Figure 2.4 The X-ray structure of piperidine 237. Full crystallographic data is included in 
Appendix 1. 
 In 2,6-dimethylpiperidines  Chow et al.31 found that the favoured structure was where the α-
methyl groups were in an axial orientation (Figure 2.5) to avoid the interaction between the oxygen 
of the acyl group and the α-equatorial methyl, if they were so positioned. 
 
Figure 2.5 Structures of axial and equatorial of 2,6-dimethylpiperidine 241a,b 
Equatorially substituted 2-piperidines are well recognized to be less stable than their axially 
substituted isomers due to Al,3 strain so N-Boc piperidines 242a would be expected to undergo 
conformational equilibration to 242b (Figure 2.6). 32 
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Figure 2.6 
This phenomenon seems to be the same in N-tosyl-2,2,6-trimethylpiperidine 237. The interaction 
between the oxygen atoms of the tosyl group and the α-equatorial methyl in 237a is severe and thus 
the favoured structure is 237b, where the single α-methyl group is in an axial orientation (Figure 
2.7). 
 
Figure 2.7 
The reason behind using a tosyl group (Ts) as a protecting group was its high stability, which 
makes it compatible with a wide variety of reactions conditions. Although the tosyl group is very 
useful when carrying out reactions under harsh conditions, unfortunately, it is this very stability that 
makes it very difficult to remove without disrupting other sensitive functionalities in the molecule. 
Most detosylation reactions require some very harsh reducing conditions often based upon a single 
electron transfer mechanism. The electron source for this process is usually lithium or sodium in 
liquid ammonia. Electrons will attack the sulfur atom of the sulfonamide 243a which breaks the 
molecule into two parts 244a and 245 then the resulting sulfonyl radical 244a is further reduced with 
another electron to the corresponding anion 244b (Figure 2.8).33 
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Figure 2.8 
Although this radical reaction is very demanding in the synthesis of sensitive natural products, it 
has been used many times during such total syntheses. For example, removal of the N-tosyl 
protecting group in sulfonamide 246 was accomplished by treatment with lithium in ammonia which 
did not affect any stero-centers or the alkene and hydroxyl group during a total synthesis of 
Fawcettimine 248 (Scheme 2.24).34 
 
Scheme 2.24 
Since it has been found N-tosyl-2,2,6-trimethylpiperidine 237 was rapidly converted into the 
corresponding isopropyl pyrrolidine 239 under hydroamination conditions (Scheme 2.22), it was 
important to investigate if other piperidines would undergo the same rearrangement. In the present 
study, 2,2-dimethylpiperidine sulfonamide 249 was synthesized by acid catalyzed hydroamination 
reaction in the presence of 0.6 equivalent of sulfuric acid in just 50 minutes at room temperature (20 
°C) in an excellent yield of 98%. The evidence of cyclisation came from 1H NMR analysis. The 
disappearance of olefinic proton =CH and NHTs proton at δH = 4.91, 4.60 ppm respectively 
confirmed the full conversion of sulfonamide 249 into a cyclic product. The two methyl peaks on 
double bond =C(CH3)2 in sulfonamide 249 at δH = 1.58 and 1.46 ppm have moved to the high field as 
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a sharp singlet at 1.18 ppm. 13C NMR spectra of piperidine 250 showed a quaternary carbon at 57.9 
ppm (NCq) with four CH2 carbons at 43.7, 41.3, 26.2 and 20.5 ppm. Piperidine 250 showed no 
rearrangement to 2-isopropyl-1-tosylpyrrolidine 251 even after exposure to 0.4 equivalent of triflic 
acid for 18 hours at room temperature (20 °C). A trace of pyrrolidine 251 appeared after sulfonamide 
249 was refluxed with 0.5 equivalent of triflic acid for 1.5 hours in toluene (110 °C). Nearly 80% of 
piperidine 250 rearranged to pyrrolidine 251 after 25 hours of reaction with 0.5 equivalent of triflic 
acid in toluene (110 °C), as judged by the appearance of isopropyl CH(CH3)2 due to pyrrolidine 251 
in 1H NMR spectra (Scheme 2.25). 
 
Scheme 2.25 
Piperidine 250 was synthesized stating from prenyl bromide 252. Treatment of the anion of 
acetonitrile at -70 °C with prenyl bromide 252 by an SN2 reaction resulted in the formation of 5-
methyl-4-hexene nitrile 253.35 Reduction of this nitrile by LiAlH4 gave the corresponding amine 254. 
Finally N-tosylation using tosyl chloride in the presence of triethylamine in dichloromethane gave the 
desired sulfonamide 249. All of these reactions proceeded in essentially quantitive yields (Scheme 
2.26). This all seems consistent with the idea of steric hindrance causing the forgoing rearrangement 
(Scheme 2.23). 
 
Scheme 2.26 
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Recently, Saikia et al. also synthesized 2,2-dimethylpiperidine 250 by acid-catalyzed 
hydroamination reaction in the presence of boron trifluoride–diethyl ether as a Lewis acid in good 
yield (82%) (Scheme 2.27).36  
 
Scheme 2.27 
We confirmed the structure of piperidine 250 by X-ray crystallography. Full crystallographic data is 
included in the Appendix 2 
 
Figure 2.9 The X-ray structure of piperidine 250. 
Due to the limitations seen with tosyl (Ts) as a protecting group for the production of 2,2,6-
trimethylpiperidine, a new protecting group was needed. In the case of the acid-catalyzed cyclisation 
reaction, the protecting group obviously should be stable to strong acid. Para-nitrobenzenesulfonyl 
(p-nosyl; Ns) ia an analogue of the tosyl (Ts) protecting group, but can be readily removed. The nosyl 
group is more electron withdrawing than the tosyl protecting group, which could offer more benefit 
to the reaction as the lone pair of the nitrogen is less available, then protonation is more likely to 
occur on the dipole bond. On the other hand, the nitrogen-hydrogen bond will be weaker and more 
likely to cleave, which should help the cyclisations. Nosylation of an amine is a relatively simple 
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reaction and 4-nosyl chloride is a commercially available compound which reacts with an amine in 
the presence of triethylamine. Nosyl deprotection can be achieved by using sulfide anions which 
perform an ipso-attack on the benzene ring generating Meisenheimer complexes 257,37 which is 
stabilised by the electron withdrawing of the nitro group. This intermediate decomposes to the aryl 
sulphide 258, the liberated amine 259 and sulphur dioxide. A variety of sulphides have been used by 
Fukuyama38 for this denosylation reaction, including potassium thiophenolate and lithium 
thioglycolate (Figure 2.10).  
 
Figure 2.10 
Using nosyl (Ns) as a protecting group did not give better results (Scheme 2.32): as can be seen in 
Table 2.3, when nosyl sulfonamide 260 was treated with 0.5 equivalents of c.H2SO4 gave only 
pyrrolidines 269 after one hour at room temperature (entry 1). After 60 minutes of reaction at 0 °C, 
there was still 48% of the starting material 260 present and pyrrolidine 262 starts to appear in the 
reaction mixture 6% with 46% piperidine 261 (entry 2). The best result was after 180 min at 0 °C 
with 19% pyrrolidine 262 and 66% piperidine 261 as a major product, which was isolated by 
crystallization (entry 3). When the reaction has been left for just twenty minutes at room temperature 
(20 oC) there was still 13% starting material, but with 78% pyrrolidine 262 (entry 4).  
 
Scheme 2.28 
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Table 2.3 c.H2SO4, DCM, percentages as determined from 1H NMR spectra integration depending on NCH 
proton, N-Ns as a protecting group. 
Entry Time / min Temperature oC SM 260 : Pip 261 : Py 262  
1           60         20  0 : 0 : 100 
2      60          0 48 : 46 : 6 
3     180          0  15 : 66 : 19 
4      20         20 13 : 9 : 78 
 
The structure of piperidine 261 was confirmed by X-ray crystallographic analysis: the methyl 
substituent is in axial orientation once again (Fig 2.11). 
                                             
                                      
                                                 
                                           
 
 
 
 
 
 
 Figure 2.11 1H NMR spectrum of N-nosyl piperidine 261 in CDCl3 (400 MHz) with the X-ray 
structure. Full crystallographic data is included in the Appendix 3. 
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Steric hindrance is the key reason behind the Ts- and Ns- substituted piperidine sulfonamides 
rearrangements to pyrrolidines as the tosyl and nosyl groups are bulky groups. It seemed reasonable 
that if the steric bulk of the tosyl and nosyl groups was playing a role in the favoured synthesis of 
pyrrolidines over the piperidines then surely changing the bulk of the nitrogen protecting group to a 
smaller size could improve the chance of achieving a piperidine synthesis. Alternative protecting 
groups were therefore tried. Methanesulfonyl (mesylate, Ms), was chosen due to its chemical 
similarity to the tosyl and nosyl protecting groups. The mesylate belongs to the sulfonamide family 
of protecting groups but has less steric hindrance and is less electron withdrawing than the tosyl. The 
mesyl sulfonamide 263 was prepared in the same manner starting from the amine 235 (Scheme 2.29). 
 
Scheme 2.29 
Unfortunately, after more than four attempts of cyclisation in different conditions of time and 
sulfuric acid equivalents, methanesulfonamide 263 gave neither piperidine 264 nor pyrrolidine 265 
when treated with c.H2SO4. In fact all that was observed was starting sulfonamide 263 and some 
amine 235, where the methanesulfonyl group had been removed, thus making it a totally 
inappropriate protecting group for this type of acid-induced hydroamination reaction (Scheme 2.30). 
 
Scheme 2.30 
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Amides 
The amide functionality is ubiquitous in life, as proteins play a crucial role in virtually all 
biological processes such as enzymatic catalysis, transport/storage, antibodies and mechanical 
support. In bio-system, protein synthesis involve a sequence of amide bond formation between two α-
amino acids in very complex sequence of every protein. A deep analysis of the Comprehensive 
Medicinal Chemistry database revealed that the carboxamide group appears in more than 25% of 
known drugs. This can be expected, since carboxamides are neutral, stable and have both hydrogen-
bond accepting and donating properties. Amides can participate in hydrogen bonding with water and 
other protic solvents; the oxygen and nitrogen atoms can accept hydrogen bonds from water and the 
N-H hydrogen atoms can donate H-bonds. The strongly electron withdrawing nature of the carbonyl 
group by resonance  allows for delocalization of the lone pair electrons of nitrogen, which limits the 
ability of the nitrogen atom to coordinate with electrophiles and also reduces the electrophilic nature 
of the carbonyl in amides (Fig 2.12).39 
 
Fig 2.12 
Trifluoroacetamide 
Because of trifluoroacetamide stability to acidic conditions and the ease in which it may be 
removed under mildly basic condition, the trifluoroacetamide is one of the most useful protecting 
group. For example, it has been used by Snider in a martinellic acid total synthesis. The alcohol 267 
reacted with trifluoroacetic anhydride TFAA and triethylamine in dichloromethane to provide 
trifluoroacetamide 268. Hydrolysis of trifluoroacetamide 269 with potassium carbonate in methanol 
provided pure product 270 in 95% yield (Scheme 2.31).40  
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Scheme 2.31 
Generally, trifluoroacetamide is stable to acidic conditions such as trifluoroacetic acid (TFA) and 
single electron reducing agents like sodium/anthracene, which makes the trifluoroacetamide group 
one of the more useful amides as a protecting group. In addition, the ease in which trifluoroacetamide 
may be removed under mildly basic conditions can be an additional advantage. Acetamide 272 was 
prepared starting from the amine 235 and trifluoroacetic anhydride in the presence of pyridine in 
dichloromethane. Unfortunately, the trifluoroacetamide group was found to be unstable to our acidic 
hydroamination conditions. After exposure of trifluoroacetamide 272 to catalytic amount of sulphuric 
acid for 10 minute at 0 oC, the only product which could be seen was the deprotected amine and there 
was no trace of any piperidine 273 (Scheme 2.32). 
 
Scheme 2.32 
Acetamide and Benzamide: 
The acetamide and benzamide amine protecting groups have been widely used in synthesis 
because they offer the advantage of excellent stability to a wide range of conditions. The simplest 
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methodology for acetamide and benzamide preparation reacts the amine with a carboxylic acid 
anhydride or carboxylic acid chloride and a base. Generally, acetamide and benzamide deprotection 
requires harsh conditions than trifluoroacetamide such as refluxing in aqueous solutions of HCl for 
long periods (8-72 hours), which was not always compatible with sensitive functionality.41 
Acetamide: 
Jackson42 achieved an enantioselective cyclisation towards N-acetyl protected 5,5-dimethylproline 
methyl ester 276 from N-protected prenylglycines 274. After four hours of reaction with 20% triflic 
acid in toluene at 100 oC, acetamide 274 cyclised to the dimethylproline 275 in quantitative yield 
(96%). Acid catalysed hydrolysis of the protected proline 275 then afforded pure 5,5-dimethylproline 
276 in 90% yield and 98% ee after chromatography (Scheme 2.33). 
 
Scheme 2.33 
Acetamide 277 was prepared from the amine 235 and acetic anhydride in the presence of pyridine 
in dichloromethane. After five attempts of cyclisation under different conditions of time and 
temperature. After 50 min of reaction with c.H2SO4 at room temperature, acetamide 277 converted to 
piperidine 278 in 85% yield. After one hour of reaction at the same condition, a trace of starting 
material was observed in 1H NMR spectra and 13C NMR spectra showed a quaternary carbon at 70.7 
ppm (NCq, 2-C), methine carbon at 45.1 ppm (CHN, 6-CH) and three CH2 carbons (43.3, 37.3, 20.6 
ppm). After one hour of reaction with 0.5 equivalent of triflic acid at room temperature, the 
acetamide 277 did decomposed to starting amine 235, where the protecting group had been removed 
(Scheme 2.34). 
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Scheme 2.34 
Hartwig43  et al. found, acetamide 279 did not undergo cyclization reaction to pyrrolidine 280 
even after heating in toluene for 24 hours at 100 oC with 20% TfOH. They proposed that the higher 
Lewis basicity of the amide 279 prevented the reaction. The protonated carbonyl is apparently not 
acidic enough to transfer its proton to the olefin (Scheme 2.35). 
 
Scheme 2.35 
Benzamide: 
We were inspired by the successful example of a Brønsted acid-catalyzed intramolecular 
hydroamination reaction, which was reported by Schlummer and Hartwig,43 in which lactams 282 
were prepared after refluxing for 30 hours in toluene in the presence of stoichiometric amounts of 
triflic acid. These reactions were faster with the branched substrates 282b (Scheme 2.36). This 
extraordinarily surprising stability of lactams 282 gave us the idea of using benzamide as a protecting 
group. 
 
Scheme 2.36 
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The benzamide 285 was formed by reacting the benzoyl chloride with the amine 235. An 
additional equivalent of pyridine was required to trap the formed HCl and to avoid conversion of the 
amine into its unreactive HCl salt. Seventy percent of benzamide 285 reacted with 0.5 equivalent of 
triflic acid at 20 oC to give piperidine 286 after 10 min in good yield 60%. It is expected that some 
deprotection was happened and the resulting amine was lost during the work up (Scheme 2.37). 13C 
NMR spectra of piperidine 286 showed a quaternary carbon at 70.8 ppm (NCq, 2-C), methine carbon 
at 45.7 ppm (CHN, 6-CH) and three CH2 carbons (36.8, 24.7, 20.7 ppm). It has noticed in 
13C NMR 
spectra that the quaternary carbon (NCq) in piperidine acetamide 278 and benzamide 286 is shifted to 
the down field (ca. 71 ppm) comparing to the same quaternary in piperidine sulfonamide 237, 250 
and 261  (NCq, ca. 58 ppm). 
 
Scheme 2.37 
Methyl carbamate (Moc) and Benzyl carbamate (Cbz or Z): 
Methyl carbamate and benzyl carbamate groups can easily be formed from amines. Both methyl 
chloroformate ClCO2Me and benzyl chloroformate ClCO2CH2Ph are commercially available and can 
simply react with an amine in the presence of base.  
Benzyl carbamate 
The ﬁrst “modern” protecting group was the benzyloxycarbonyl (Z), which was developed in 1932 
by Bergmann and Zervas.44 Benzyloxycarbonyl ﬁts with the main characteristics associated with a 
protecting group: (1) it is easily introduced into the functional group; (2) it is stable to a broad range 
of reaction conditions; and (3) it is safely removed at the end of the synthetic process or when the 
functional group requires manipulation.45 
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Benzyl carbamate cleaves by catalytic hydrogenolysis46 and can be readily cleaved under acidic 
condition: acetic acid47, triflic acid48, methanesulfonic acid49 and trifluoroacetic acid.50 The expected 
mechanism of acidic benzyloxycarbonyl deprotection is that carbamate 287 becomes protonated to 
trigger loss of benzylic cation 289, which results in the carbamic acid 290 then decarboxylation of 
this gives the free amine 291 (Fig 2.13). 
 
Fig 2.13 
When Hartwig43 tried to examine the stability of benzyl carbamates to acidic conditions, he found 
that amide 292 did not undergo acid-catalysed hydroamination reaction even after heating in toluene 
for 24 hours at 100 oC with 20% TfOH; the same result was obtained with sulfuric acid (Scheme 
2.38). 
 
Scheme 2.38 
Obviously, benzyloxycarbonyl is quite unlikely to be stable in a such strong acidic conditions, but 
the wide usage of this important protecting group encouraged us to try it, especially as the amine 235 
had already been prepared in large quantity.  In the present project, benzyl carbamate 294 was 
prepared by reaction of the amine 235 with benzyl carbonochloridate (Scheme 2.39).  
 
Scheme 2.39 
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After seven minutes of reaction with catalytic amount of sulfuric acid at room temperature 
benzamide 294 gave the piperidine 295 (71%) and no rearrangement to pyrrolidine nor the starting 
benzyl carbamate 294 were observed just simple filtration over silica was needed (Scheme 2.40). 
 
 
Scheme 2.40 
Both 1H and 13C NMR spectra support the successful synthesis of piperidine 295; as can be seen 
from Fig 2.14, starting material 294 had clearly disappeared. Most obvious was the disappearance of 
the olefinic =CH at 5.10 ppm and NH proton at 3.70 – 3.53 ppm, with the appearance of the NCH of 
piperidine 295 at 4.35 – 4.25 ppm and OCH2Ph protons showing clear AB coupling system after 
cyclisation at δH 5.07 (d, J = 12.5, 1H, OCHAHB) and 5.02 (d, J = 12.5, 1H, OCHAHB)]. 13C NMR 
showed a quaternary carbon next to the nitrogen atom at 54.4 (NCq, 2-C), NCH (6-C) carbon at 48.3 
ppm, and three CH2 carbons on the piperidine ring at 39.2, 28.3 and 14.7 ppm (Fig 2.14). 
 
 
                         
 
 
 
                                                     
                                                      
 
 
 
 
 
 
Fig 2.14 1H and 13C NMR spectra of piperidine 295: a) proton; b) decoupled 13C; c) DEPT CH, CH3 
positive; CH2 negative.  
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    Methyl carbamate Moc 
Methyl carbamate can be cleaved by many methods, one widely used method employs 
trimethylsilyl iodide, TMSI. This electron rich carbamate is cleaved preferentially by running the 
reaction in refluxing dichloromethane with 2.2 equivalent of TMSI. The resulting product 297 was 
isolated in 95% yield; this step was used during a strychnine total synthesis (Scheme 2.41).51 
 
Scheme 2.41 
The effect of protecting group on acid-catalysed cyclisation reaction was studied widely in 
Knight’s group. When Haskins in Knight’s group heated Moc protected substrates 298 with two 
equivalents of triflic acid at 25 oC after two hours pyrrolidine 299 was formed in reasonable yield 
(69%) (Scheme 2.42).52 
 
Scheme 2.42 
In the present study, piperidine 301 was successfully synthesized after 55 min at room temperature 
with a catalytic amount of sulfuric acid (87% yield); no rearrangement to pyrrolidine nor the starting 
carbamate 300 were observed. The reactions did not require any chromatography as the reaction 
proceeded cleanly. The same piperidine carbamate gave an excellent yield 96% when triflic acid was 
used (0.4 equivalent) with somewhat less time (30 min) at the same temperature 20 oC (Scheme 
2.43). 
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Scheme 2.43 
From the appearance of the 1H-NMR spectrum of 2,2,6-trimethylpiperidine carbamate 301, clearly 
a single conformation at ambient temperature can be seen. The 6-H resonates at δH 4.24 – 4.17 
(pentet, J = ca. 6.9 Hz) in appearance exactly as the N-tosyl analogue. With no large coupling, 6-H 
cannot be in an axial position and the 6-methyl group therefor once again has an axial orientation, 
which is the same in the case of benzyl 2,2,6-trimethylpiperidine carboxylate (Fig 2.14a) where the 
6-H resonates at δH 4.35 – 4.25 (br. pentet, J = ca. 6.9 Hz). 
 
Fig 2.15 
The generality of this chemistry was next tested by using substituents that were somewhat less 
able to provide stabilisation of a positive charge, such as cinnamyl and crotyl. After much 
experimentation, the best conditions were found for both cinnamyl and crotyl. Cinnamyl ketone 303 
was synthesized by refluxing ethyl acetoacetate 302 with cinnamyl chloride in tetrahydrofuran in the 
presence of potassium carbonate K2CO3 for 20 hours (55% yield).
53 This was then converted into the 
oxime 304 by a standard oximination reaction then reduced by LiAlH4 to give the amine 305. Finally, 
carbamate was added by using methyl chloroformate in the presence of triethyl amine; all of these 
reactions proceeded in good yields. The cyclisation reaction of cinnamyl carbamate 306 was carried 
out with 0.5 equivalent of sulphuric acid at room temperature for 20 hours (Scheme 2.44).  
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Scheme 2.44 
Two possible carbenium ions can form from carbamate 306; however the benzylic carbenium ion 
306a is much more likely to form than the isomeric 306b due to the stabilisation afforded by the 
phenyl group, resulting in the exclusive formation of piperidine 307 after 20 hours of reaction using 
0.5 equivalent of sulphuric acid at ambient temperature, which were the optimum condithon found. 
The 1H NMR spectrum showed no starting material was present. Benzylic carbocation 306a would 
give the desired piperidine product 307 through an overall 6-endo-trig process, which is favoured 
according to Baldwin’s rules; whereas secondary ion 306b would give the pyrrolidine ring 308, 
which would occur through an overall 5-exo-trig process, which is also favoured by Baldwin’s rules 
(Scheme 2.45). 
 Scheme 2.45 
 A single isomer was formed and identified by a clear, rather high field methyl doublet at δH 0.70 
(J = 7.1 Hz, 3H) and two low field resonance at δH 4.51 – 4.42 and δH 5.41 ppm both integrating for 
one proton. The one resonating at δH 4.51 – 4.42 was the same in its appearance as all of the above 6-
H resonances at δH 4.51 – 4.42 (app. br. pentet, J = ca. 7 Hz). The resonance at δH 5.41 was narrower 
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and appeared as a broadened apparent doublet (J = ca. 5.2 Hz). This proton had, more important for 
comparison purposes with width at half height of ω1/2 = 10.4 Hz, which clearly excluded the presence 
of a large trans-diaxial coupling constant and hence placed the 6-phenyl group also in an axial 
position implying a 2,6-cis geometry for the 2-methyl-6-phenylpiperidine carboxylate 307a obtained. 
A trans-configuration would place one of the protons α-to the nitrogen atom in an axial position (Fig 
2.16 and 2.17). 
 
Fig 2.16 
 
 
 
                                               
 
 
 
 
 
 
Figure 2.17 1H NMR spectrum of 2-methyl-6-phenylpiperidine 307a, 6-CH proton width at half 
height of ω1/2 = 10.4 Hz, in CDCl3 (500 MHz). 
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Even with the likely distortion of the ring due to the single axial substituent, it is surely very likely 
that a single large coupling constant would be evident in the resonance of one of these protons. 
Presumably, the phenyl ring would be positioned at the angle shown above 307a, otherwise it would 
begin to interact sterically with the methyl group protons. Hence, the 2-methyl group is positioned 
over the face of phenyl group, which may explain its rather high chemical shift at δH 0.75 ppm. 
Further, the 3-equatorial proton is adjacent to the edge of the 6-phenyl group which would account 
for its low field position at δH 2.40 ppm, relative to remaining methylene protons, where it appears as 
a broadened doublet (J = 7.2 Hz), due to a single large germinal coupling with H3ax. Prolonged 
exposure to 0.4 equivalent of triflic acid at 20 oC for 20 hours caused significant (ca. 30%) 
conversion into what appeared to be isomeric pyrrolidines although this was not confirmed. In any 
event, this observation shows the importance of stopping the acid–catalysed cyclisation immediately 
it is completed.  
Crotyl oxime 309 was prepared starting from acetone oxime 308 in THF with n-butyllithium in 
hexane: the mixture was cooled to -78 oC, a solution of crotyl chloride 309 in THF was added 
dropwise. This was followed by LiAlH4 reduction to the amine 311 and finally the carbamate group 
was added.54 The cyclisation reaction of crotyl carbamate 312 was carried out with 0.5 equivalent of 
triflic acid at 40 oC for 3.5 hours to give pyrrolidine 313 (98%, cis:trans 1:1 ratio). In 1H NMR of the 
resonance at ca. δH 1.01 ppm (d, J = 6.0 Hz, 3H, CH3) another methyl triplet at 0.75 (t, J = 7.0 Hz, 
3H, CH3) related to the other methyl. In 
13C NMR, two methine groups (CHN) at δC 60.3 and 53.8 
ppm, three methylene groups at δC 37.0, 28.8 and 25.6 ppm (Scheme 2.46). 
 
Scheme 2.46 
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Secondary carbenium ions are more challenging to form than tertiary or benzylic examples. There 
are two possible secondary carbenium ions that can form from carbamate 312; these are both equally 
likely to form (Scheme 2.51). Trapping the secondary carbenium ion 312a will form pyrrolidine 313 
through a formally overall 5-exo - process. Carbenium ion 312b would form the 6-membered 
piperidine ring 314, through an overall 6-endo process. Such cyclisations involving secondary 
carbenium ion will require higher temperatures and longer reaction time than those having tertiary 
carbenium or benzylic ions. Both the pyrrolidine 313 and piperidine 314 would have been formed 
through a secondary carbenium ion. After extensive experimentation, complete conversion to a 
reasonably clean pyrrolidine 313 occurred in refluxed dichloromethane after 3.5 hours with 0.5 
equivalent of triflic acid (Scheme 2.47). 
     Scheme 2.47 
The absence of 2,6-dimethylpiperidine carboxylate 314 was confirmed by the preparation of an 
authentic sample of  cis-dimethylpiperidine carboxylate 316. The carbamate was added smoothly to 
commercial available cis-2,6-dimethylpiperidine 315 in quantative yield. The resonance at δH 4.30 – 
4.16 ppm in  1H NMR of dimethylpiperidine 316 related to two protons on carbons near to nitrogen 
(NCH, 2H) and a sharp doublet at δH 1.10 (d, J = 7.1,  6H, 2 x CH3) related to two methyl groups. In 
13C NMR spectra the resonance at δC 46.0 (2 x CHN, 2- and 6-CH) related to two methine groups, 
30.0 (2 x CH2, 3- and 5-CH2), 20.8 (2 x CH3), 13.7 (4-CH2) ppm (Scheme 2.48).  
 
Scheme 2.48 
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In view of the successful cyclisations of the prenyl derivatives, it was expected that it might well 
be possible to apply this methodology to the synthesis of spiro-piperidines, as this would also involve 
highly stabilised tertiary alkyl carbenium ions related to ion 238 (p. 37). Cyclohexylidene carboxylic 
acid 318 was prepared, using the Wittig reaction of cyclohexanone 317 with                                     
(4-carboxybutyl)triphenylphosphonium bromide using sodium hydride in THF (Scheme 2.49).55  
 
Scheme 2.49 
5-Cyclohexylidenepentanoic acid 318 was transformed into cyclohexylidene carbamate 319 
through a Curtius sequence by heating a solution of the acid 318, diphenylphosphoryl azide (DPPA) 
and triethylamine under reﬂux for 1 h, followed by addition of methanol with catalytic amount of 
copper(II) chloride CuCl2, and further heating of this mixture under reﬂux for 1 h (Scheme 2.50).56 
 
Scheme 2.50 
The spiro-piperidine 320 was successfully synthesized after 30 min at 0 oC with 0.4 equivalent of 
triflic acid (95% yield); no rearrangement to pyrrolidine nor the starting carbamate 319 were 
observed. The reactions did not require any chromatography as the reaction proceeded cleanly. From 
the appearance of the 1H-NMR spectrum, CH2 near to nitrogen resonates at δH 3.47 ppm as a triplet  
(t, J = 6.0, 2H, CH2N). From 
13C NMR spectrum a quaternary carbon came at δH 59.0 ppm and NCH2 
at 51.8 ppm (Scheme 2.51). 
 
Scheme 2.51 
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The successful synthesis of spiro-piperidine 320 should lead to be attempted in natural product 
spiro-cycles such as the azaspirocyclic alkaloids isolated from the skin extracts of the neotropical 
frog Dendrobates spiro-piperidine ‘’histrionicotoxin’’57 321 and nankakurine 34, a member of the 
Lycopodium alkaloid family that was isolated from the club moss Lycopodium lucidulum.58 It should 
also include rings that contain heteroatoms such as spiro-tetrahydropyran 322 and spiro-
tetrahydrofuran 323, which are useful for treating HIV infection and AIDS59 (Scheme 2.52). 
 
Scheme 2.52 
The retrosynthetic analysis of nankakurine 34 A and B leads to core of the luciduline 326, which 
syntheses have been reported60 (Scheme 2.53). The search for a general strategy to access 
Lycopodium alkaloids has led Overman to suggest the asymmetric total syntheses of nankakurines 34 
from luciduline 326.61 A few years later, the hypothesis became reality by Waters, who accomplished 
the total syntheses of the Lycopodium alkaloids nankakurines 34 A and B in 6 and 7 steps, 
respectively, via a sequence that passes through a third Lycopodium alkaloid, luciduline 326.62 
Retrosynthetic analysis of nankakurine 34 shows that the spiro-piperidine core could be generated by 
acid-catalysed hydroamination from carbamate 324 (Scheme 2.53). 
Scheme 2.53 
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The suggested acid-catalysed hydroamination synthesis of nankakurines 34 A and B starting from 
luciduline 326 can be achieved similar to spiro-piperidine 320 (Scheme 2.54). Luciduline carboxylic 
acid 325 could prepare by using the Wittig reaction followed by Curtius reaction to carbamate 324, 
then acid-catalysed hydroam ination to aza-spiro-lycopodium alkaloid 327 finally, carbamate 
deprotection to nankakurines 34 A by TMSI or by lithium aluminium hydride to  nankakurines 34B 
(Scheme 2.54). 
 
Scheme 2.54 
Asymmetric Synthesis of 2,2,6-trimethylpiperidine  
In organic synthesis, steroselective construction of a chiral carbon atom adjacent to the ring 
nitrogen atom in 2-subtituted piperidines has a special importance in total synthesis. The interest in 
the synthesis of substituted piperidines with stereo- and enantioselective manner have been 
increased.63 Developing a feasible and highly stereoselective route to synthesize piperidine with C-2 
stereogenic center away from ring closing metathesis is a very big challenge.64 The optically pure 2-
subtituted piperidine skeleton has been used as a bulding block in the synthesis of biologically active 
medicinal drugs and is observed in a wide range of natural products and medicinal drugs            
(Scheme 1.2.).65  
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Hodgson et. al.66 reported the asymmetric synthesis of α-alkylated aldehydes 331 using terminal 
epoxide 328 and examined the enamine derived from this and lithium 2,2,6-trimethylpiperidide 329. 
They found that the latter formed the corresponding enamine in good yield, and was bulky enough to 
avoid potentially competing allylic alcohol/amino alcohol formation. The enamine underwent 
effective C-alkylation to generate α-alkylated aldehydes 331. By contrast, the enamine derived from 
lithium 2,2,6,6-tetramethylpiperidine (LTMP) was slow to react, affording the α-methylated aldehyde 
in only 30% yield (Scheme 2.55). 
 
Scheme 2.55 
To ascertain how effective 2,2,6-trimethylpiperidine (TriMP) would be in a chiral context, 
Hodgson synthesized (R)-2,2,6-trimethylpiperidine 335 (>99.5:0.5 e.r.) by copper-catalyzed Grignard 
ring opening of enantiopure (R)-2-substituted aziridine 332 followed by formal intramolecular  
hydroamination reaction, a simple example of a Markovnikov type reaction of a terminal oleﬁn 334 
with a mercury(II) chloride. The amine was converted to its hydrochloride salt by the addition of 
hydrochloric acid in ether (2 M) to form the trimethylpiperidine salt, which re-crystallized in ethanol 
then the salt was dissolved in aqueous NaOH solution (3 M) to afford (R)-2,2,6-trimethylpiperidine 
(57%). N-Boc protected aziridine 332 itself was synthesized starting from racemic epoxide 336 using 
tert-butyl carbamate as the nucleophile, catalyzed by the chiral Co(III) complex called (R,R)-(–)-
N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt [AKR] (Scheme 2.56).  
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Scheme 2.56 
When methyl enamine (R)-330 was used as a single enantiomer in alkylations with ethyl iodide 
and allyl bromide, the corresponding α-alkylated aldehydes were formed in satisfactory e.r. values 
(88:12 e.r. and 84:16 e.r., respectively), with the sense of asymmetric induction as shown in Scheme 
2.57. Workup after enamine alkylation using AcOD/NaOAc/D2O showed no deuterium 
incorporation, indicating that no loss of enantiointegrity occurred during hydrolysis. 
 
Scheme 2.57 
In the present study, (S)-2,2,6-trimethylpiperidine  344 was synthesized starting from (S)-alaninol 
338 which was N-protected selectivity over oxygen by using methyl chloroformate ClCO2Me. The 
direct reaction of N-protected amino alcohol 339 with the Hata67 reagent (diphenyl disulfide and 
tributylphosphine), used under the modified conditions (76 oC, for 72 h), afforded the desired phenyl 
sulfide 340 in low yield (28%).68 The oxidation with aqueous hydrogen peroxide was carried out on 
phenyl sulfide 340 at 40 oC in methanol with two equivalent of 30% aqueous hydrogen peroxide 
H2O2 and a catalytic amount of sodium tungstate dehydrate Na2WO4.H2O to give sulfone 341 in good 
yield (88%)69 (Scheme 2.58). 
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Scheme 2.58 
Prenyl bromide was added to sulfone 341 by using n-BuLi in tetrahydrofuran at -78 oC to give an 
inseparable mixture of isomers 342. The acid-catalysed  cyclization reaction of sulfone 342 with 
sulfuric acid gave pure (S)-2,2,6-trimethyl-5-(phenylsulfonyl)piperidine 343 after two hours of 
reaction at ambient temperature in excellent yield of 98% then, followed desulfonylation reaction by 
magnesium in cold dry methanol to give (S)-trimethylpiperidine 344 (Scheme 2.59). 
 Scheme 2.59 
The intermediate sulfone 343 was observed as a single enantiomer. In 1H NMR, the 6-H resonates 
at δH 4.59 (qd, J = 6.9, 4.4 Hz, NCH) ppm in deuterated chloroform, CDCl3, as this already contains 
a quartet of J = 6.9 Hz, due to coupling with the 6-methyl group. With no large coupling, 6-H cannot 
be an axial proton and the 6-methyl group therefore once again has an axial orientation, which is the 
same in the case of benzyl 2,2,6-trimethylpiperidine carboxylate (Fig 2.14a) and 2,2,6-
trimethylpiperidine carbamate (Fig 2.15). Only one large coupling was observed for 5-H (343A), 
which resonates at δH 3.18 (ddd, J = 10.8, 7.6, 4.4 Hz, 1H, PhSO2CH) ppm. If 6-proton was axial 
(343B) we would expect two large coupling constants (Figure 2.18). 
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Conclusion  
The acid-catalysed cyclisation we have developed appears to offer a very fast route to substituted 
piperidines. The reaction proceeds quickly in good yields and the starting materials can readily be 
prepared from ketone in just three steps. We have been able to prepare a range of piperidines using 
this technique, included one hindered spiro compound and one highly enantioselective chiral 
piperidine.  
2,2,6-Trisubstituted piperidine underwent rearrangement to the corresponding pyrrolidine by using 
sulfonamide as the N-protecting group. A wide range of alternative protecting groups has also been 
employed in the cyclisation, thus solving the problem incurred in rearrangement to pyrrolidine. This 
problem has been solved by changing the protection group to carbamate and benzyloxycarbonyl 
which allowed 2,2,6-trimethylpiperidine to be isolated cleanly without any visible traces of 
pyrrolidine, thus solving another problem incurred in deprotection the sulfonamide products. The 
deprotection of sulfonamide protecting groups required very harsh chemistry comparing to 
carbamate. In the light of the result obtained when nosyl as a protecting group was used, it would be 
rewarding to use the nosyl group over tosyl. 
The concentrated sulfuric acid could equally well be used in place of triflic acid, thereby both 
reducing costs significantly and also providing a much more ‘certain’ acid quality. The major 
drawback with the use of concentrated sulfuric acid is its high viscosity, which meant that it was 
quite difficult to measure accurately a small quantity while keeping it dry. Although its availability 
and lower price gave sulfuric acid an advantageous cyclizing agent, over triflic acid, when using 
sulfuric acid as catalyst yields were generally lower. Triflic acid is relatively easier to handle, but it is 
not easy to keep it dry.  
A new, general and flexible method for the highly enantioselective synthesis of chiral piperidine 
has been developed. The main advantages of this synthetic method lie in the readily availability of 
the precursors. There is no reason why this reaction cannot find further application in natural product 
synthesis. The compatibility of applying the acid-catalysed methodology to related polyene cascade 
cyclisations and other bicyclic system syntheses will be focused on in the next chapter.  
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Chapter 3 
Acid-catalyzed cyclisations in synthesis 
3.1. Introduction   
Cascade reactions and transannular cyclizations are sophisticated methods for the construction of 
polycyclic natural products and molecules of theoretical and structural interest. An enormous 
variety of polyene systems and heterocyclic medium ring compounds with a wide range of 
functional groups has been reported to undergo these fascinating processes for modern synthetic 
chemistry. Such an intramolecular cyclization is largely dependent on the nature of the reaction, 
reactivity of the two end groups, and geometrical features of the reacting ring molecules.1 Both 
cascade and transannular cyclizations require a suitable conformation of substrates and prudent 
selection of functional groups. Multiple fused and bridged ring systems formed by cascade and 
transannular cyclizations are widespread in natural products and regularly shown to exhibit 
biological activity against a wide variety of human diseases.2 
3.2. Cascade cyclisations 
Cascade reactions are one of the most fascinating branches of organic chemistry, and one which 
has been the subject of intense research in recent years, as witnessed by the number of reviews that 
have appeared covering various aspects of these reactions. The remarkable benefits of cascade 
reactions are well established, having been recounted on numerous occasions, and include 
economies of time, labor, resource management, and waste generation.3 Perhaps the first example 
of a noticeable beautiful total synthesis is that of the alkaloid tropinone 346 reported as early as 
1917 by Robinson. It also demonstrates a cascade reaction, in which one molecule of 
succindialdehyde 347, methylamine 348, and either acetone dicarboxylic acid 349 or dicarboxylate 
react together to afford the natural substance in a simple one-pot procedure. Two consecutive 
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Mannich reactions are involved in this cascade reaction, the first one in an intermolecular and the 
second one in an intramolecular fashion (Scheme 3.1).4 
 
Scheme 3.1 
Lanosterol 357 is a tetracyclic triterpenoid all steroids are derived from. Lanosterol formation in 
animals and fungi proceeds via chair-boat-chair conformation of (3S)-epoxidosqualene 356, in a 
cascade cyclization which is activated by an acid-catalyzed cascade reaction. During this reaction 
the oxirane ring opens with participation by a neighboring π-bond. The cyclization proceeds to give 
a protosteryl cation, which then undergoes a series of 1,2-methyl and hydride shifts with proton 
elimination to yield the lanosterol skeleton and is then elaborated into cholesterol 358 (Scheme 
3.2).5  
 
Scheme 3.2 
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Perhydroquinoline alkaloids are varied in structure and have provided challenging targets for 
total synthesis.6 Luciduline 326, a cis-perhydroquinoline alkaloid, is isolated from Lycopodium 
lucidulum.7 Comins et al. have published a total synthesis of (+)-luciduline. The key steps are 
intramolecular Diels-Alder reaction and subsequent reduction leading to 361, which after retro-
Mannich ring opening is converted to enecarbamate 362 (Scheme 3.3).8  
 Scheme 3.3 
In summary, the asymmetric synthesis of (+)-luciduline 326 has been accomplished from readily 
available materials in 14 steps (10% overall) with a high degree of stereocontrol. Completion of the 
synthesis requires a novel tandem cationic alkylation/reduction cyclization reaction (Scheme 3.4). 
 
Scheme 3.4 
Acid-mediated cyclization of isoxazolone 364 was examined using 98% aq. H2SO4 in toluene at 2 
oC for two hours. Isoxazolone 364 would cyclise via its tautomer, the major product being 
isoxaxolone 366 (62% yield) accompanied by its cis-fused epimer 364 (10% yield). This 
unexpected preference for ring closure via acid-catalyst hydroamination reaction is of synthetic 
interest (Scheme 3.5). 
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Scheme 3.5 
Structure confirmation of trans product 366 was confirmed by catalytic hydrogenation ([PtO2], 
AcOH/AcOEt 3:1, 20 oC) to perhydroquinoline 370 (17% yield). The multistep transformation is 
believed to proceed via intermediates 368a,b in a reaction sequence involving hydrogenolysis of the 
nitrogen-oxygem N-O bond, tautomerism, decarboxylation, and stereoselective hydrogenation from 
the β-face (Scheme 3.6).9 
 
Scheme 3.6 
The first total synthesis of nankakurines B 34b was accomplished by Overman in 2008 via an acid-
catalysed cascade reaction. The desired nitrogen-terminated aza-Prins bis-cyclization could be 
realized by reaction of the methyl carbamate 371 with one equivalent of paraformaldehyde and 20 
equivalent of TFA at room temperature in chloroform. The yield of this reaction was low (20%) and 
the amount of 373 was 20 mg; after two additional reductive steps nankakurines B 34b was 
prepared. 1H and 13C NMR spectra of this product were quite different from those reported for 
nankakurine A,10 confirming that the initial structural assignment for this alkaloid was incorrect. 
80 
 
The total syntheses of (+)-nankakurine B 34b was accomplished in 14 steps (5 mg, 16% overall 
yield) (Scheme 3.7).11  
 Scheme 3.7 
Cationic polyene cyclisations may be used to synthesize two, three, four or even five rings in one 
step reactions. Although the first example of acid-catalyzed intramolecular hydroamination reaction 
was reported by Hartwig, the acid-catalyzed cyclizations which have been developed in Knight’s 
group offer a very wide range of routes to highly substituted pyrrolidines and piperidines, not only 
single saturated nitrogen containing heterocyclic compounds including very hindered spiro ones, 
but also polycyclic compounds. Haskins12 applied acid-catalyzed intramolecular hydroamination 
methodology to the synthesis of polycyclic compounds through a cationic cascade terminated by a 
sulfonamide group. Cationic polyene cyclisations have been previously used in the biomimetic 
synthesis of steroid skeleton for several years but not with nitrogen groups as terminators. When the 
geranyl sulfonamides 374 were treated with 0.4 equivalent of triflic acid under the midest set of 
reaction conditions (15 minutes at 0 oC), these underwent rapid cyclisation to give ca. 90% isolated 
yields of the trans-annulated pyrrolidines 375, both as  3:2 mixtures, epimeric at the amino ester 
stereogenic centre. This assignment of structure was confirmed by a single crystal X-ray 
crystallographic determination of a separated sample of the major isomer of the glycine derivative 
375. Sulfonamides 376 cyclized under the same conditions of the bicyclic systems 375 in 86% yield 
as 3:3:1:1 mixture of diaseroisomers 377. The tetracyclic compounds 379 were formed as a gross 
mixture of diaseroisomers in 80% yield. As expected, the yield of such reactions decreases as the 
number of rings formed increased (Scheme 3.8).13 
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Scheme 3.8 
In the present study, it was decided to see if such methodology would be extended to the formation 
of piperidine rings by using cascade cyclisations. Geranyl amine 382 was prepared starting from 
commercial available geranyl acetone 380, supplied as a mixture of cis- (approximately 35%) and 
trans- isomers, (neryl acetone and geranyl acetone) by the usual conversion into the corresponding  
oxime 381 then reduction with lithium aluminum hydride to give geranyl amine 382.  No attempt to 
separate the isomers was undertaken at any point in the synthesis, because it was considered that 
both of the cis- and trans-isomers would give the same carbocation intermediates in acid-catalysed 
reaction, if successful (Scheme 3.9).    
 
Scheme 3.9 
Finally, N-tosylation by para-methylbenzene sulfonyl chloride in the presence of triethylamine 
gave the sulfonamide 383. Tosyl geranyl sulfonamide 383 was treated with a catalytic amount of 
sulfuric acid in dichloromethane. After 1.5 h of the reaction at 0 oC, a 1H NMR spectrum showed 
that the resonances corresponding to the two olefinic protons (δH 4.91 – 4.71 ppm) had disappeared, 
whereas the NH proton (δH 4.52 ppm) did not disappear. However, two of the three methyl singlets 
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which had been on double bonds (1.45, 1.83 ppm) moved to the upfield to appear as two singlets at 
δH 1.10, 0.79 ppm, which suggest formation of the half cyclic compound 384. There was no trace of 
the expected bicyclic compound 385 as 1H NMR data showed a clear spectrum between δH 4.50 - 
4.00 ppm, where the NCH proton was to be found in piperidine 237, at 4.45 - 4.55 ppm. The 13C 
NMR spectrum enhanced this theory as two quaternary carbons appeared at δC 136.3 and 127.2 
ppm, due to quaternary carbons on a double bond and a quaternary carbon at high field δC 34.9 ppm 
(sp3 quaternary carbon). The same result has been noticed after 1.5 hours of reaction at room 
temperature (Scheme 3.10).  
 Scheme 3.10 
The structure of the half cyclic sulfonamide 384 was confirmed by preparing an authentic sample 
starting from β-ionone 386. The known reduction of β-ionone 386 with catechol borane in 
tetrahydrofuran gave the ketone 387 in good yield (80%).14 Classical oximination reaction of this 
ketone 387 produced the oxime 388, which was reduced to the amine 389 by lithium aluminium 
hydride in tetrahydrofuran. Finally, N-tosylation by tosyl chloride in the presence of triethylamine 
gave the corresponding sulfonamide 384b, which showed the same analytical and spectroscopic 
data as the sample obtained from the acid cyclisation (384a). Consistent with this, sulfonamide 
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384b did not undergo the acid-catalysed cyclisation to give the bicycle 385 even after 24 hours of 
reaction with concentrated sulfuric acid at room temperature in dichloromethane (Scheme 3.11).  
 
Scheme 3.11 
N-Nosylation by nosyl chloride in the presence of triethylamine gave the sulfonamide 390. It was 
hoped that the electron-withdrawing effect of the nitrophenyl group might weaken the N-H bond 
sufficiently to encourage the cascade cyclisation. Nosyl geranyl sulfonamide 390 was treated with 
catalytic amounts of sulfuric acid in dichloromethane and, after 1.5 h of reaction at 0 oC, the 
partially cyclised sulfonamide 391 was the major product. Its structure was confirmed by 
comparison with the authentic sulfonamide 384; the 1H NMR spectrum showed that the resonances 
corresponding to two olefinic protons at δH 5.03 – 4.87 ppm had disappeared, but the NH at 4.66 
ppm proton did not disappear. Two of three methyl singlets on double bond at (δH 1.54, 1.48 ppm) 
moved to the upfield to appear as two singlets at δH 0.79 and 0.78 ppm. The minor compounds were 
the spiro-pyrrolidines 392 (only trace <5%), which suggestion depended on NMR spectra. In the 1H 
NMR spectrum, a methine proton peak near to nitrogen atom as a multiplet at δH 3.54 – 3.46 ppm 
and methyl peaks as doublets at δH 1.10 and 0.81 ppm, which fits with pyrrolidine 262. From 13C 
NMR spectrum, a quaternary carbon at δC 60.0 ppm represents a spiro atom near to nitrogen, 
another sp3 quaternary carbon at high field δC 35.9 ppm and NCH peak at δC 51.9 ppm.  
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The same result has been noticed after two hours of reaction at room temperature, but the ratio of 
spiro-pyrrolidines 392 did not increased (Scheme 3.12). 
Scheme 3.12 
It would be ambitious but feasible to form two rings in a single step. Similarly, carbamate 393 
was prepared by the reaction of amine 382 with methyl chloroformate in the presence of 
triethylamine in dichloromethane. Geranyl carbamate 393 was treated with catalytic amount of 
concentrated sulfuric acid in dichloromethane; after one hour of the reaction, a 1H NMR spectrum 
showed that the resonances corresponding to olefinic protons at δH 5.10 – 4.96 ppm had 
disappeared, and no starting material was present the NH proton at δH 4.66 ppm had disappeared at 
the end of the reaction. As usual, CH proton near to nitrogen moved to downfield δH 4.08 – 3.99 
ppm. The singlets at δH 1.60 and 1.50 ppm representing the three methyl groups on double bonds 
moved further upfield to δH 1.25 and 0.80 ppm and the complexity of the spectrum increased. In the 
13C NMR spectrum, three quaternary carbons at δC 156.1, 59.6, 34.1 ppm, five CH2 signals δC 41.7, 
39.4, 25.0, 19.9, 14.4 were visible as a major isomer (ratio 6:1). Infrared spectroscopy showed an 
absorption band at υ/cm-1 1701 due to carbonyl carbamate confirmed the stability of protecting 
group. A very good yield was obtained (80%) which made us believe the hydroquinoline 394 had 
been formed (Scheme 3.13).  
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Scheme 3.13 
The structure could be derived from chair transition state 393a, where the geometry of the 
double bond in the starting material, causes the ring junction to be trans-geometry. Surprisingly, the 
1H NMR spectrum showed no diastereoisomers (depending on methyl resonances), but 13C NMR 
spectrum showed minor isomer (6:1 ratio) (Scheme 3.14). In the piperidine syntheses discussed in 
chapter 2, the methyl orientation was axial. 
 
Scheme 3.14 
Benzyl geranyl carbamate 395 reacted after one hour of the reaction in ice to give the 
hydroquinoline 396 (70% yield). The benzyloxycarbonyl protecting group had unexpected stability 
to this such strong acidic conditions to show OCH2Ph protons as a clear AB coupling system after 
cyclisation [δH 4.99 – 4.94 (d, J = 12.7 Hz, 1H, OCHAHB), 4.90 (d, J = 12.7 Hz, 1H, OCHAHB)]. 
13C NMR also showed a quaternary carbon next to the nitrogen atom at δC 59.9 (NCq), NCH (6-C) 
carbon at 48.7 ppm, and six CH2 carbons δC 66.1 (OCH2, Cbz group), 41.8, 39.4, 23.1, 19.9 and 14.8 
ppm (Scheme 3.15). Infrared spectroscopy showed an absorption band at (υ/cm-1 1694) due to 
carbonyl carbamate confirmed the stability of protecting group. Although we have no X-ray 
evidence to confirm the stereochemistry of this bicyclic product, it is expected to be the same as that 
obtained from the cyclisation of piperidines where the methyl orientation was axial. 
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Scheme 3.15 
In view of this success in hydroquinoline synthesis, we then focussed on the more extended 
farnesyl derivatives. It would be worth trying to build three rings in a single step, after first 
preparing more simple bicyclic system. (E,E)-Farnesyl acetone 400 was obtained from 
commercially available farnesol 397 through alkylation of farnesyl bromide 398, which was 
prepared by bromination of the alcohol 397 with phosphorus tribromide,15 with methyl acetoacetate 
and subsequent Krapcho decarboxylation16 (Scheme 3.16).17 
 
Scheme 3.16 
The carbamate 403 was prepared in exactly the same manner from (E,E)-farnesyl acetone 400 
through oximination to 401 then lithium reduction to amine 402 and finally carbamate addition to 
give carbamate 403 (Scheme 3.17). 
     Scheme 3.17 
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The carbamate 403 was transformed after one hour of reaction with half an equevelent of triflic 
acid at room temperature in dichloromethane, into what appeared to be the perhydro 
azaphenanthrene derivative 404, in 75% yield. The NMR spectra were very complex due to the 
nature of the tricyclic product and to the presence of five stereogenic centres and hence a possible 
32 diastereoisomers. There could be many other side products like methyl groups migration 
products. The proposed structure 404 is somewhat tentative. The complete disappearance of all 
olefinic resonances in the 1H NMR spectra of the products provided good indication of a successful 
cascade, although the complexity of the spectra in which all resonances except those associated 
with the methyl carbamate and CH proton next to nitrogen appeared at ca. 3.5 and 4.4 ppm, 
respectively provided neither structural proof nor definite isomer ratios. Although probably correct, 
this possible approach to the azaphenanthrene skeleton requires more optimisation, especially to try 
and control the stereoselectivity as well as to carry out separation and more complete 
characterisation of those isomers, which are formed. 
 
Scheme 3.18 
3.3. Transannular Cyclisations 
Transannular cyclization, the formation a new ring across an existing one, is an advanced 
method for the construction of polycyclic natural products and molecules of theoretical and 
structural interest. Like other such intramolecular cyclisations, transannular cyclizations are largely 
dependent on the nature of the reaction conditions, reactivity of the two end groups, and 
geometrical features of the reacting ring molecules.18 
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The known alkaloids library contains a huge number of azabicyclo compounds. Cocaine 405 was 
ﬁrst isolated by Niemann in 1860 from the leaves of the Peruvian Erythroxylon coca plant.19 
Epibatidine 406, a novel class of amphibian alkaloid, was first isolated by Daly and co-workers at 
the National Institutes of Health in a trace amount from the skin of the Ecuadorian poison frog, 
Epipedobates tricolor, of the family Dendrobatidae.20 Tropane 407 is a bicyclic amine that has a 
pyrrolidine and a piperidine ring sharing a common nitrogen atom and two carbon atoms [N-
methyl-8-azabicyclo[3.2.1]octane]. Tropane alkaloids such as tropinone 346 are characteristic of a 
class of ca. 200 alkaloids.21 (Fig 3.1)  
 
Fig 3.1 
The isoquinuclidine 408 (2-azabicyclo[2.2.2]octane) ring system, a semi-rigid boat form of the 
piperidine ring, is present in natural products possessing interesting pharmacological properties 
such as the alkaloids of Dioscorea hispida, typiﬁed by dioscorine 415.22 Dioscorine, an alkaloid 
found in the tropical yam, has been shown to be a toxic central nervous system depressant23 and a 
modulator of the nicotinic acetylcholine receptor. The biosynthesis of the isoquinuclidine moiety 
dioscorine suggested that nicotinic acid 409 is reduced to 3,6-dihydronicotinic acid 410, which 
reacts with the keto group of a branched 8-carbon unit derived from acetic acid 411 affords 
compound 412.  Decarboxylation, shift of a double bond in the dihydropyridine ring, and further 
reduction of the ring yields 413. An aldol condensation then leads to 414 which contains the 
isoquinuclidine ring system. Decarboxylation, N-methylation, and lactone formation then afford 
dioscorine 415 (Scheme 3.19).24 
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Scheme 3.19 
In the present project, the rearrangement of piperidine (tosyl and nosyl) to pyrrolidines described 
in the second chapter of this thesis and the difficulties of carrying out cascade reactions using the 
same nitrogen protecting groups led to a question. Does this always have to be the case? Can the 
synthesis of bridged compounds through transannular hydroaminations be achieved and, if so, what 
would be the optimum nitrogen protecting group?   
Commercially available (+/-)-limona ketone, (4-methylcyclohex-3-enyl)acetone, 416, was 
converted into sulfonamide 419. The reduction of oxime 417 to amine 418 gave a mixture of 
isomers. No attempt to separate the isomers was undertaken at any point in the synthesis.  It was 
considered that both of the cis- and trans-isomers would give the same carbocation intermediate in 
an acid-catalysed reaction (Scheme 3.20).  
 
Scheme 3.20 
The acid-catalyzed hydroamination cyclisation of sulfonamide 419 was carried out and 
monitored by TLC and 1H NMR.  The cyclisation reaction of sulfonamide 419 with concentrated 
sulfuric acid in dichloromethane at ice temperature, after four hours of reaction, a 1H NMR 
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spectrum showed no starting sulfonamide 419: both peaks related to the olefinic proton =CH at δH 
5.19 ppm and the NH proton at δH 4.51 ppm had disappeared suggesting complete reaction to give 
only the sterically crowded bridged piperidine 420 as a single diastereoisomer (Scheme 3.21).  
 
Scheme 3.21 
A simple flask to flask recrystallization of isoquinuclidine sulfonamide 420 gave colourless 
crystals m.p. 112 – 114 °C (Fig 3.2). In the 1H NMR spectrum, one methine proton next to nitrogen 
at δH 4.20 (NCH) was obvious and distinct upfield shifts of the methyl group to get two methyl 
peaks one as a doublet at δH 1.41 ppm and another as singlet 1.10 ppm, together with separation of 
protons into much more complex patterns, was suggestive of a cyclic structure. The 13C NMR 
spectrum also supported the proposed structure: one quaternary carbon at (NCq : 55.2 ppm) atom, 
two CH carbons at (NCH : 57.0 and CH : 31.5 ppm) and four CH2 carbons at (36.7, 30.1, 26.4, 19.2 
ppm) (Table 3.1). 
 
Fig 3.2 1H NMR spectrum of isoquinuclidine sulfonamide 420 in CDCl3 (400 MHz) with the X-ray 
structure. Full crystallographic data is included in the Appendix 4. 
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After one hour of reaction of sulfonamide 419 with a catalytic amount of sulphuric acid at 0 oC 
there was no evidence of formation of the alternative secondary carbocation product 421, which 
would have resulted in the less hindered cyclization. However, the rearranged product was fully 
formed after five hours of reaction with concentrated sulphuric acid at ambient temperature 20 oC 
(Scheme 3.22). 
 
Scheme 3.22 
 Evidence for this complete rearrangement came from 1H NMR analysis, which showed the 
complete disappearance of the olefinic proton in precursors 419, two methine protons next to 
nitrogen [δH 3.61 (d, J = 3.9 Hz, NCH), 3.56 – 3.47 (m, NCH) ppm] and distinct upfield shifts of 
the methyl groups which appeared as doublets at δH 1.10 and 0.81 ppm, together with separation of 
protons into much more complex patterns, suggestive of a cyclic structure, while the 13C NMR 
spectrum also supported the proposed structure four CH carbons at (2 x NCH 60.2, 55.3 and 2 x CH 
: 37.6 and 33.6 ppm) and three CH2 carbons at (2 x CH2 21.5 and 19.2 ppm) (Table 3.1). 
13C NMR 
ppm   
Cq NCq : 55.2 - 
CH 
NCH : 57.0 
CH : 31.5 
2 x NCH 60.2 and 55.3 
2 x CH : 37.6 and 33.6 
CH2 36.7, 30.1, 26.4 and 19.2 2 x CH2 21.5 and 19.2 
Table 3.1 Some peaks from 13C NMR spectra of azabicyclo 420 and rearranged azabicyclo 421, after 
ignoring tosyl group. 
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The nosylation of amine 418 with nosyl chloride in the presence of triethylamine in 
dichloromethane gave the nosyl-sulfonamide 422 in very good yield (85%) (Scheme 3.23). 
   
Scheme 3.23 
The use of nosyl group in these acid-catalysed cyclisation reactions has no marked effect on the 
rearrangement reaction. Exactly like tosyl sulfonamide 419, the nosyl sulfonamide 422 after four 
hours of reaction with concentrated sulphuric acid at 0 oC gave the tertiary carbocation product 423, 
which was distinguished in its 1H NMR spectrum with the peak at δH 4.20 ppm representing a 
proton next to nitrogen (NCH), a methyl doublet at δH 1.41 (d, J = 7.2, CH3) ppm and a methyl 
singlet at δH 1.14 ppm. 13C NMR spectrum also supported this structure: one quaternary carbon at 
δC 56.1 (NCq), two CH carbons at δC 57.0 (NCH) and 31.8 ppm and four CH2 carbons at (δC 36.2, 
30.6, 26.3 and 19.4) (Scheme 3.24 and Fig 3.3). 
 
Scheme 3.24 
After just one hour of reaction with concentrated sulphuric acid at 20 oC, the nosyl sulfonamide 
422 gave the alternative secondary carbocation product 424, the less hindered product. In the 1H 
NMR spectrum of this thermodynamic product 424, there were two proton peaks represent protons 
near to nitrogen at δH 3.71 (dd, J = 12.9, 6.3 Hz, NCH) and 3.40 – 3.23 (m, 1H, NCH) ppm and two 
methyl peaks as doublet at δH 1.41 (d, J = 6.6 Hz) and 0.91 (d, J = 6.4 Hz)  ppm. 13C NMR spectrum 
also did confirm this structure: no quaternary carbon was present in the area between 50 – 70 ppm, 
four CH carbons at δC 65.3 (NCH), 60.6 (NCH), 38.9 (CH) and 36.8 (CH) ppm and three CH2 
carbons at δC 37.4, 27.6 and 25.0 ppm were identified (Scheme 3.24 and Fig 3). 
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Scheme 3.24 
              
     Fig 3.4 1H and 13C NMR spectra of rearranged azabicyclo 424:                      
a) decoupled 13C; b) DEPT CH, CH3 positive; CH2 negative c) proton. 
    Fig 3.3 1H and 13C NMR spectra of azabicyclo 423: a) decoupled 13C;                     
 b) DEPT CH, CH3 positive; CH2 negative c) proton. 
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The structure of the thermodynamic azabicyclo product 424 was confirmed by X-ray 
crystallography (Fig 3.5). 
 
Fig 3.5 The X-ray structure of rearranged azabicyclo 424. Full crystallographic data is included in the Appendix 5. 
Although the rearrangement of piperidine to pyrrolidine of the N-tosyl 419 and N-nosyl 422 
sulfonamides is a great discovery, we did control it by using carbamate as a protecting group. The 
carbamate 425 did cyclize after one hour of reaction with half an equivalent of concentrated sulfuric 
acid at room temperature to give a single product 426 in excellent yield (92%) (Scheme 3.25).  The 
complete disappearance of the olefinic resonance and NH proton in the 1H NMR spectra of the 
product provided good indications of a successful cyclisation, although the complexity of the 
spectra in which all resonances except those associated with the methyl carbamate at δH 3.49 ppm 
and the CH proton next to nitrogen appearing at δH 4.57 – 4.46 ppm provided some structural proof. 
The most compelling evidence for the structure 426 came from very detailed analyses of the 13C 
NMR spectrum: one quaternary carbon at  δC 61.0 (NCq), two CH carbons at δC 56.5 (NCH) and 
31.3 (CH) and four CH2 carbons at  δC = 38.4, 30.1, 26.7 and 19.8 ppm, generally similar to 423. 
 
Scheme 3.25 
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In this extended study of the piperidine/pyrrolidine rearrangement, sulphonamide 429 was 
prepared starting from commercially available 4-methylcyclohexenyl methanol 427, which was 
tosylated then the sulfonamide group introduced by an SN2 reaction.
25 This is illustrated by the 
reaction of potassium tosylamide, which was prepared by heating 1.5 equivalents each of potassium 
hydroxide and p-toluenesulfonamide in DMF. Following complete dissolution of the base, one 
equivalent of tosylate 428 was added and the mixture heated to 120 oC. Purification of the reaction 
mixture obtained after one hour gave the desired tosylamide 429 in 89% yield (Scheme 3.26). 
 
Scheme 3.26 
Tosylamide 429 did cyclise to give only the tertiary carbocation product 430 after three hours of 
reaction with concentrated sulfuric acid at ambient temperature in 94% yield. There was no 
evidence of formation of the alternative secondary carbocation product 431, which would have 
resulted in this less hindered product, even after 20 hours with half equivalent of the acid (Scheme 
3.27). In particular, no methyl doublet was visible around δH 1.0 ppm in the 1H-NMR spectrum of 
the crude product, which was very pure and crystallized by itself and the structure was confirmed 
by X-ray crystallography. Full crystallographic data is included in the Appendix 6. 
 
Scheme 3.27 
Similarly, sulphonamide 435 was prepared starting from commercially available cyclohexenyl 
methanol 432, which was tosylated then the sulfonamide group introduced by an SN2 reaction.
25 
This is illustrated, as above, by the reaction of potassium tosylamide, which was prepared by 
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heating 1.5 equivalents each of potassium hydroxide and p-toluenesulfonamide in DMF. Following 
complete dissolution of the base, one equivalent of mesylate 433 was added and the mixture heated 
to 120o C for 1 h. Purification of the reaction mixture obtained after one hour gave the desired 
tosylamide 434 in 88% yield (Scheme 3.28). 
 
Scheme 3.28 
Treatment of the cyclohexenyl sulfonamide 434 with a catalytic amount of sulfuric acid gave the 
pyrrolidine ring system 435. This result was expected as either cyclisation would proceed via very 
similar secondary carbocation intermediate (Scheme 3.29). 
 
Scheme 3.29 
The structure of pyrrolidine 435 was confirmed by constructing it through a different route, 
which had also been developed in the group (Scheme 2.17).26 Iodocyclization of sulfonamide 434 
under acidic conditions gave an iodopyrrolidine 436 which was deiodinated by hydrogenolysis to 
yield the corresponding pyrrolidine 435. This pyrrolidine showed the same spectroscopic data as 
those displayed by the sulfuric acid-catalyzed cyclization product (Scheme 3.30). 
 
Scheme 3.30 
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Scheme 3.30 
      
 
      
Fig 3.4 1H NMR spectrum of the iodopyrrolidine 436 with the X-ray 
structure. Full crystallographic data is included in the Appendix 7. 
       Fig 3.3 1H NMR spectrum of azabicyclo 435. 
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The possibility of designing a “one-pot” sequence for the construction of highly complex 
molecules is a major driving force for many research programs. Tandem reaction and multistep one-
pot reactions allow construction of complex structures in one step to decrease the need for a 
purification steps and shorten syntheses to save money on chemicals and time in research. 
Moreover, tandem process is an attractive choice from a green chemistry point of view.27 Indeed, 
tandem reactions have attracted the attention of organic chemists for many reasons: 1- rapid 
increase in complexity; 2- powerful tool for construction of polycyclic systems; 3- many reactions 
can be applied; 4- selectivity can be controlled by conformation or by using catalyst. 
Veselovskii et al. found that when an equlmolar mixture of myrcene 437 and methylvinyl ketone 
438 was applied to the usual chromatographlc grade silica gel, SiO2, the [4+2] cycloaddition 
occurred effectively in the absence of any solvents and produced the anticipated Diels-Alder 
product 439 after heating at 50 oC for five hours.28  
The resulted ketone 439 was converted into the oxime 440 which was reduced by lithium 
aluminum hydride to amine 441. The reduction of oxime 440 to amine 441 gave mixture of isomers. 
No attempt to separate the isomers was undertaken.  It was considered that both isomers would give 
the same carbocation intermediate in acid-catalysed reaction and then perhaps polycyclic structure 
by multiple cyclisations (Scheme 3.31).  
 Scheme 3.31 
Carbamate 442 was prepared by the reaction of amine 441 with methyl chloroformate in the 
presence of triethylamine in dichloromethane. Carbamate 442 was treated with a catalytic amount 
of concentrated sulfuric acid in dichloromethane. After one hour of the reaction, a 1H NMR 
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spectrum showed that the resonances corresponding to olefinic protons at δH 5.28 and 5.10 ppm had 
disappeared, whereas the NH proton at δH 4.58 ppm did not disappear at the end of the reaction. The 
CH proton next to nitrogen at δH 3.67 – 3.60 ppm, the methoxy methyl group were still visible at δH 
3.64 ppm. In the 13C NMR spectrum, three quaternary carbons were visible at δC 156.6 : C=O, 
133.7 and 127.1 ppm (Scheme 3.32).  
 
Scheme 3.32 
Hence, only cyclisation to give the bicycle 443 had occurred, without any involvement of the 
carbamate 445 to give polycycles 444 and 446 (Scheme 3.33). 
 
Scheme 3.33 
3.4 Cyclisations of highly methylated cyclopentenyl carbamates and sulfonamides 
Focussing on a transannular cyclisation, what about transannular reactions involving five-
membered rings? 
Fortunately, from another project running in the group, Dr. Ian King had available a substantial 
supply of aldehyde 447 which was converted to the oxime 448 then into amine 449 by the standard 
lithium aluminium hydride reaction. The achievement of 2,2,6-trimethylpiperidine carbamate 
synthesis without any traces of pyrrolidine rearranged compound led us to try using carbamate as a 
protecting group instead of  sulfonamide. In the light of the result obtained when carbamate as a 
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protecting group was used, it should be rewarding to use it. Finally, carbamate was added to the 
amine 449 by using methyl chloroformate in the presence of triethylamine; all of these reactions 
proceeded in good yields (Scheme 3.34).    
 Scheme 3.34
 
The cyclisation reaction of the carbamate 450 was carried out under different conditions of time 
and temperature.  
After four hours of reaction with one equivalent of triflic acid at room temperature carbamate 
450 gave only bicyclo product 451 an inseparable 3:1 mixture of diastereoisomers. The 1H NMR 
spectrum showed that the resonances corresponding to olefinic proton at δH 5.12 had disappeared, 
and no starting material was present the NH proton at δH 4.82 ppm had disappeared at the end of the 
reaction. As usual, CH2 protons next to nitrogen moved to δH 3.41 – 3.28 ppm. The singlet at δH 
1.51 ppm representing the methyl group on double bond moved further upfield to δH 1.35 and 1.25 
ppm for diastereoisomers and the complexity of spectrum increased. In the 13C NMR spectrum, 
three quaternary carbons at δC 156.8 (C=O), 74.8 (NCq) and 46.0 ppm, four CH2 signals δC 49.1 
(NCH2), 43.2, 29.9 and 28.8 ppm were visible as a major isomer. Infrared spectroscopy showed an 
absorption band at υ/cm-1 1701 due to carbonyl carbamate confirmed the stability of protecting 
group. A quantitative yield was obtained (98%) which made us believe the bicyclo 451 had been 
formed (Scheme 3.35).  
 
Scheme 3.35 
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Whereas, the reaction with 0.5 equivalent of triflic acid at 80 oC gave only the Wagner-
Meerwein product 452 after two hours of reaction a 1H NMR spectrum showed that the resonance 
corresponding to the olefinic proton had disappeared, but the NH proton did not disappear. 
However, the 13C NMR spectrum enhanced this theory as two quaternary carbons appeared at δC 
142.1 and 129.8 ppm, due to quaternary carbons on a double bond and a quaternary carbon at high 
field δC 46.9 ppm (sp3 quaternary carbon). The cyclisation reaction of the carbamate 450 was also 
carried out with a catalytic amount of concentrated sulphuric acid at room temperature for four 
hours to give a mixture of bicyclo 451 and the Wagner-Meerwein product 452  (Scheme 3.36). 
 
Scheme 3.36 
An alternative literature approval is that nitrile 456 can be prepared via “abnormal” Beckmann 
reaction.29 Commercial available D-camphor 453 was converted into the corresponding oxime 454. 
Under basic conditions of triethylamine, the hydroxyl group was converted into a good leaving 
group by reaction with tosyl chloride. From the oxime toluenesulphonate 455, the inseparable 
“abnormal” Beckmann inseparable nitriles 456 and 457 were prepared. The seco-nitrile products 
rather than the normal lactam product of a Beckmann rearrangement were showed infrared band at 
2251 cm-l due to nitrile presence; in the 1H NMR spectrum, the olefinic proton at δH 5.23 (t, J = 1.2 
Hz, 1H, =CH) ppm and three methyls at δH 1.60, 1.06 and 0.84 ppm. In in 13C NMR spectrum, 
clearly nitrile carbon appeared at δC 119.3 ppm (Scheme 3.37). 
 
Scheme 3.37 
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The abnormal Beckmann nitriles 457 and 458  were then reduced by lithium aluminum hydride 
to the corresponding amines 459.  No attempt to separate the isomers was undertaken at any point in 
the synthesis, because it was considered that both of the isomers would give the same carbocation 
intermediates in acid-catalysed reaction (Scheme 3.38).
 
      
Scheme 3.38
 
After the reaction of amine 459 with tosyl chloride in the presence of triethylamine during the 
chromatography purification the sulfonamide 460 was separateed. After three hours of reaction with 
concentrated sulfuric acid at ice temperature sulfonamide 460 cyclised to the 
azabicyclo[3.2.1]octane 461 as a mixture 1:1 with rearrenged sulfonamide 462, which would have 
resulted in the Wagner-Meerwein rearrangement. The azabicyclo[3.2.1]octane 461 was separated 
by simple cristalization; the 13C NMR spectrum showed a quaternary carbon next to nitrogen (NCq) 
at δC 53.7 ppm and four CH2 carbons at δC 39.2  (NCH2), 33.3, 27.3 and 27.0 ppm. After four hours 
of reaction with concentrated sulfuric acid at room temperature sulfonamide 460 gave only the 
Wagner-Meerwein product 462 (Fig 3.5); a 1H NMR spectrum showed that the resonance 
corresponding to the olefinic proton had disappeared, but the NH proton at 4.17 (t, J = 5.7 Hz) ppm 
did not disappear (Scheme 3.39).  
 
Scheme 3.39
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The logical explanation of these abnormal products is as follows: the generation of the initial 
carbocation 460a was achieved by the acid, which was trapped by the lone pair of electrons on 
nitrogen to form the transannular product 461. At the same time the initial carbocation 460a has a 
tendency to rearrange to a thermodynamically more stable structure via a [1,2]-methyl shift to form 
a new carbocation 460b, which could end with the Wagner-Meerwein product 462 or fused cyclic 
product 463 (Scheme 3.40). 
 
Scheme 3.40
 
The isomeric nitrile 465 was prepared in a similar way. The difficulties of the classic Beckmann 
reaction (strongly acidic conditions or using pyridine with sulphonate esters) led Anilkumar and 
Chandrasekhar to develop relatively simple and mild conditions for this rearrangement. The 
camphor oxime 454 was converted into the corresponding ethyl carbonate 464 relatively simply and 
in high yield, via treatment with ethyl chloroformate in dichloromethane, in the presence of one 
equivalent of triethylamine at room temperature. The “abnormal” Beckmann rearrangement was 
catalysed by boron trifluoride etherate to give the less sterically crowded nitrile 465, which was 
then reduced by lithium aluminum hydride to the corresponding amine 466 (Scheme 3.41).30 
 
Scheme 3.41
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In the event, despite many attempts, both carbamate 467 and sulfonamide 468 were rearranged to 
give only the Wagner-Meerwein products 452 and 462 respectively, the structure of which were 
confirmed by comparison with previous data (Scheme 3.42 and Fig 3.5). 
 
Scheme 3.42 
 
                                   
                                    
 
 
 
 
 
 
 
 
Fig 3.5 1H NMR spectrum of the Wagner-Meerwein sulfonamide 462. 
Doubtless, 5,5-transannular cyclisation can be included in this acid-catalysed hydroamination 
chemistry, but not without much more experimentation. 
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3.5 Acid-catalysed Hydroalkoxylation Cyclisations  
One of the most straightforward synthetic approaches to substituted tetrahydrofurans and 
tetrahydropyrans oxygen heterocycles is intramolecular hydroalkoxylation of unsaturated alcohols. 
In particular, the intramolecular addition of the O–H bond across the unactivated C=C bond have 
drawn wide attention due to their high atom economy and synthetic efﬁciency. Recently, it was 
reported that intramolecular hydroalkoxylation of unactivated oleﬁns could be promoted by 
Brønsted acid with varying degrees of success.31 Dunach and Coulombela reported that in the 
presence of a catalytic amount of triﬂic acid, substituted tetrahydrofurans and tetrahydropyrans have 
been efﬁciently and selectively synthesized from the corresponding unsaturated alcohols. Moreover, 
such triﬂic acid-catalysed cyclisations can also be run in the absence of solvent, avoiding the use of 
large excess of protic acid which is used to effect this transformation. 6-Methyl-5-hepten-2-ol 469 
gave tetrahydropyran 470 in the presence of a catalytic amount of triﬂic acid, in good isolated yield 
(80%). They noted that the cyclisation of the alcohol 469 could be effected in the absence of solvent 
with 1 mol% of TfOH and the reaction was completed after 2 hours at 80 oC. Under the same 
conditions, the cyclisation of alcohol 471 afforded exclusively the corresponding tetrahydropyran 
isomer 472 after 1 h reaction, together with some polymers with an isolated yield of 21%. A 
terminal monosubstituted oleﬁn 473 could also be cyclised and the 5-membered cyclic ether 474 
was the only product obtained in quantitative yield according to GC analysis. The isolation of this 
volatile compound after extraction and distillation gave an isolated yield of 39% (Scheme 3.43).32   
 
Scheme 3.43 
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Linares-Palomino et al found that chlorosulfonic acid is an efﬁcient agent for cascade 
hydroalkoxylation cyclizations with internal nucleophilic termination, in a similar manner that is 
well-established with tetrahydrofurans and tetrahydropyrans formations. The cyclization of alcohol 
477 mainly yielded the trans-fused octahydrobenzopyran 478 after 10 min at room temperature 
with 5 equivalents of chlorosulfonic acid in 2-nitropropane; the ratio decreased to cis/trans 1:2.5 if 
the reaction was left for longer (Scheme 3.44).33  
 
Scheme 3.44 
The monoterpene 1,8-cineole 480, eucalyptol, is a major component of essential oils from 
Eucalyptus bractea  poly. 1,8-Cineole has a characteristic fresh and camphoraceous fragrance and 
pungent taste, so it is used for ﬂavouring of foods and cosmetics. 1,8-Cineole 480 is used in 
pharmaceutical preparations to treat coughs, muscular pain, neurosis, rheumatism, asthma and 
urinary stones.  It should also be mentioned that 1,8-cineole 480 and 1,4-cineole 481 have important 
phytotoxic properties which could render them various practical applications. 34 General synthesis 
of 1,8-cineole 480 and 1,4-cineole 481 is by isomerization of α-terpineol 479 catalyzed by acid. 
Lana, et al. reported the application of heteropoly acid H3PW12O40 (PW), as homogeneous and solid 
acid catalysts for the isomerization of α-terpineol 479 to cineoles 480 and 481 (Scheme 3.45).35  
 
Scheme 3.45 
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In order to compare oxygen-centered transannular cyclisation with our nitrogen-based examples, 
commercially available limona ketone, (4-methylcyclohex-3-enyl)acetone, 416 was converted into 
alcohol 482, followed by acid-catalyzed hydroalkoxylation cyclisation to give only the sterically 
crowded bridged 1,3-dimethyl-2-oxabicyclo[2.2.2]octane 483 after three hours of reaction with  
catalytic amount of sulphuric acid at 32 oC. In the 1H NMR spectrum, the proton next to oxygen  at 
δH 3.93 (OCH) ppm was obvious and distinct upfield shifts of the methyl group resulted in the 
appearance of two methyl peaks, one as a doublet at δH 1.10 ppm and another as a singlet 0.96 ppm, 
together with separation of other protons into much more complex patterns, suggestive of a cyclic 
structure. The 13C NMR spectrum also supported the proposed structure: one quaternary carbon at 
(OCq : 69.1 ppm), two CH carbons at OCH : 73.1 and CH : 29.7 ppm and four CH2 carbons at 32.6, 
32.1, 26.5, 19.7 ppm; there was no evidence of formation of the alternative secondary carbocation 
product 484, which would have resulted in the less hindered cyclization, but two doublet methyl 
groups and two OCH resonances. An unsurprising result: there was no rearranged product after 3 
hours of reaction with a catalytic amount of sulphuric acid in DCM at 32 oC (Scheme 3.46). 
          
Scheme 3.46 
The presence of the (4-methylcyclohex-3-enyl)methanol 427 in our chemical list was worthy to 
try the cyclisation rection. When the alcohol 427 was heated with a catalytic amount of sulfuric acid 
for 1.5 hours at 35 oC, it gave oxabicyclo-octane 485 in an excellent yield of 92%. Infrared data 
showed the absence of the alcohol functional group. The 1H NMR spectrum showed the 
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disappearance of the olefinic proton. In the 13C NMR spectrum one quaternary carbon was clearly at 
OCq 68.1 ppm. 
 As the rearrangement was in our minds during the whole time, there was no evidence of 
formation of the alternative secondary carbocation product 486, which would have resulted in this 
less hindered product (Scheme 3.47). 
 
Scheme 3.47 
During her laboratory work on acid-catalyzed intramolecular hydroamination reactions, A. 
Nazer, a six months exchange student in the Knight group, has synthesized dimethyl 3-
methylcyclopentene dicarboxylate 488 which was followed, in this study, by Krapcho 
decarboxylation to 3-methylcyclopentene carboxylate 489 then LiAlH4 reduction to free alcohol 
490, which gave the hydroalkoxylation product, 1-methyl-2-oxabicyclo[2.2.1]heptane 491, after 
1.5 hours of reaction with catalytic amount of sulphuric acid at 35 oC. The complete 
disappearance of the olefinic resonance proton in the 1H NMR spectra of the products provided 
good indications of successful cyclisation. The most compelling evidence for the structure 491 
came from detailed analyses of the 13C NMR spectrum: one quaternary carbon at  δC 78.2 (OCq) 
ppm, one CH carbon at δC 38.4 ppm, four CH2 carbons at  δC 76.6 (OCH2), 42.2, 36.1 and 28.8 
ppm and one methyl carbon at 26.9 ppm (Scheme 3.48). 
Scheme 3.48 
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Conclusion  
The acid-catalysed hydroamination and hydroalkoxylation we have developed appears to offer 
an excellent route to synthesise substituted bicyclic-compounds.  
The hydroamination has also been used to form sterically crowded, bridged alkaloid structures, 
exemplified by a new route to isoquinuclidines, through a transannular cyclisation, which can 
undergo rearrangement to the less hindered products. Some optimisation studies have revealed how 
these cyclisations can be controlled to give single products.  
In a preliminary study, we have also applied acid-catalyzed intramolecular cascade methodology to 
the synthesis of polycyclic perhydroquinolines. This initial work will require additional study of a 
number of related reactions before the methodology is completely defined, but the initial results do 
look promising. 
Oxygen-centered transannular cyclisations have been compared with nitrogen-based examples, by 
intramolecular, acid-catalyzed hydroalkoxylation reactions, which give only sterically crowded 
bridged 1,4-cineoles. 
The competition between these types of hydroamination and hydroalkoxylation and the 
rearrangement of the resulting N-heterocycles to O-heterocycles will be featured in the next 
Chapter.  
 
 
 
 
 
 
110 
 
                                                 
References  
1 a) Neukirch, H.; Guerriero, A.; D’Ambrosio, M. Eur. J. Org. Chem. 2003, 3969. b) Yamamoto, 
T.; Furukawa, T.; Saito, S.; Tanaka, K.; Tsuzuki, H. New J. Chem. 2002, 26, 1035. c) Laali, K. K.; 
Okazaki, T.; Mitchell, R. H.; Ward, T. R. J. Org. Chem. 2001, 66, 5329. d) Chu, Y.; White, J. B.; 
Duclos, B. A. Tetrahedron Lett. 2001, 42, 3815. e) Gard, M. N.; Reiter, R. C.; Stevenson, C. D. 
Org. Lett. 2004, 6, 393. f) Koizumi, T.; Harada, K.; Mochizuki, E.; Kokubo, K.; Oshima, T. Org. 
Lett. 2004, 6, 4081. 
2 Iqbal, M.; Black, R. J. G.; Winn, J. A. T.; Reeder, A. J.; Clarke, P. A. Org. Biomol. Chem., 2011, 
9, 5062. 
3 a) Tietze, L. F.; Beifuss, U., Angew. Chem. 1993, 105, 137; Angew. Chem. Int. Ed. Engl. 1993, 32, 
131; b) Tietze, L. F., Chem. Rev. 1996, 96, 115; c) Pellissier, H. Tetrahedron 2006, 62, 1619; d) 
Pellissier, H. Tetrahedron 2006, 62, 2143; e) Bunce, R. A. Tetrahedron 1995, 51, 13103. f) 
Nicolaou, K. C.; Edmons, D. J.; Bulger, P. G. Angew. Chem. Int. Ed. 2006, 45, 7134. 
4 a) Robinson, R. J. Chem. Soc. 1917, 111, 762. b) Nicolaou, K. C.; Vourloumis, D.; Winssinger, 
N.; Baran, P. S. Angew. Chem. Int. Ed. 2000, 39, 44. 
5 a) Tamelen, E. E. J. Am. Chem. Soc. 1982, 104, 6480. b) Corey, E. J.; Virgil, S. C.; Sarshar, S. J. 
Am. Chem. Soc. 1991, 113, 8171; c) Rees, H. H.; Goad, L. J.; Goodwin, T. W. Biochem. J. 1968, 
107, 417; d) Abe, I.; Rohmer, M.; Prestwich, G. D.  Chem. Rev. 1993, 93, 2189. 
e) Wendt, K. U.; Schulz, G. E.; Corey, E. J.; Liu, D. R.  Angew. Chem. Int. Ed. Engl. 2000, 39, 
2812. 
6 a) Ayer, W. A.; Trifonov, L. S. The Alkaloids; Cordell, G. A., Brossi, A., Eds.; Academic Press: 
San Diego, 1994, 45, 233-274. b) Blumenkopf, T. A.; Heathcock, C. H. Alkaloids: Chemical and 
Biological Perspectives; Pelletier, S. W., Ed.; Wiley: New York, 1985, 3,185. 
7 a) Schumann, D.; Naumann, A. Liebigs Ann. Chem. 1984, 1519. b) Szychowski, J.; MacLean, D. 
B. Can. J. Chem. 1979, 57, 1631. c) Scott, W. L.; Evans, D. A. J. Am. Chem. Soc. 1972, 94, 4779. 
d) Oppolzer, W.; Petrzilka, M. J. Am. Chem. Soc. 1976, 98, 6722. 
8 Comins, D. L.; Brooks, C. A.; Al-awar, R. S.; Goehring, R. R. Org. Lett., 1999, 1, 229. 
9 Linder, S. M.; Reichlin, D.; Simmons, D. P.; Snowden, R. L. Tetrahedron Lett. 1993, 34, 4789. 
10 Hirasawa, Y.; Morita, H.; Kobayashi, J. Org. Lett. 2004, 6, 3389. 
11 Nilsson, B. L.; Overman, L. E.; Alaniz, J. R.; Rohde, J. M. J. Am. Chem. Soc. 2008, 130, 11297. 
111 
 
                                                                                                                                                                  
12 Haskins, C. M.; Knight, D. W. Chem. Commun. 2002, 2724-2726. 
13 Haskins, C. M.; Knight, D. W. Tetrahedron, 2010, 66, 4150. 
14 Evans, D. A.; Fu, G. C. J. Org. Chem. 1990, 55, 5680. 
15 Jin, Y.; Roberts, F. G.; Coates, R. M. Org. Synth. 2007, 84, 43. 
16 Krapcho, A. P.; Glynn, G. A.; Grenon, B. J. Tetrahedron Lett. 1967, 215. 
17 a) Bouzbouz, S.; Kirschleger, B. Synthesis 1994, 714; b) Feld, B. K.; Weiss, G. A. Bio. Med. 
Chem. Lett. 2006, 16, 1665; c) Jin, Y.; Roberts, F. G.; Coates, R. M. Org. Synth. 2007, 84, 43. 
18 Harrowven, D. C.; Pattenden, G. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., 
Pattenden, G., Eds.; Pergamon Press: Oxford, 1991; Vol. 3, p 379. 
19 a) Willstätter, R.; Müller, W. Ber. Dtsch. Chem. Ges., 1898, 31, 2655; b) Leete, E. J. Am. Chem. 
Soc., 1982, 104, 1403; c) Hashimoto, T.; Yamada, Y.; Leete, E. J. Am. Chem. Soc., 1989, 111, 
1141; d) Leete, E.; Bjorklund, J. A.; Couladis, M. M.; Kim, S. H. J. Am. Chem. Soc., 1991, 113, 
9286. e) Humphreya, A. J.; O’Hagan, D. Nat. Prod. Rep., 2001, 18, 494.  
20 a) Daly, J. W. J. Nat. Prod. 1998, 61, 162; b) Spande, T. F.; Garraffo, H. M.; Edwards, M. W.; 
Yeh, H. J. C.; Pannel, L.; Daly, J. W. J. Am. Chem. Soc. 1992, 114, 3475; c) Fletcher, S. R.; Baker, 
R.; Chambers, M. S.; Hobbs, S. C.; Mitchell, P. J. J. Chem. Soc., Chem. Commun. 1993, 1216; d) 
Fletcher, S. R.; Baker, R. B.; Chambers, M. S.; Herbert, R. H.; Hobbs, S. C.; Thomas, S. R.; 
Verrier, H. M.; Watt, A. P.; Ball, R. G. J. Org. Chem. 1994, 59, 1771. 
21 a) Majewski, M.; Lazny, R. J. Org. Chem. 1995, 60, 5825. b) Maksay, G.; Nemes, P.; Biro, T. J. 
Med. Chem. 2004, 47, 6384; Mans, D. M.; Pearson, W. H. Org. Lett. 2004, 6, 3305. 
22 Faruk-Khan M. O. Bioorg. Med. Chem. 2007, 5, 3919. 
23 a) Page, C. B.; Pinder, A. R. J. Chem. Soc. 1964, 4811. b). Broadbent, J. L.; Schnieden, H. Br. J. 
Pharmacol. 1958, 13, 213. c) Nagata, K.; Aistrup, G. L.; Honda, H.; Shono, T.; Narahashi, T. 
Pestic. Biochem. Physiol. 1999, 64, 157. 
24 Edward L. J. Am. Chem. Soc., 1977, 99, 648. 
25 Marcotullio, M. C.; Campagna, V.; Sternativo, S.; Costantino, F.; Curini, M. Synthesis, 2006, 
2760. 
26 Amjad, M.; Knight, D. W. Tetrahedron Lett. 2006, 47, 2825. 
112 
 
                                                                                                                                                                  
27 a) Ho, T. Tandem Organic Reactions; Wiley-Interscience; New York, 1992. b) Tietze, L. F.; 
Beifuss, U. Angew. Chem., Int. Ed. Engl. 1993, 32, 131; c) Winkler, J. D. Chem. Rev. 1996, 96, 
167; d) Denmark, S. E.; Thorarensen, A. Chem. Rev. 1996, 96, 137. 
28 Veselovskii, V. V.; Gybln, A. S.; Lozanova, A. V.; Molseenkov, A. M.; Smit, W. A. Tetrahedron 
Lett. 1988, 29, 175. 
29 a) Whitham, G. H. J. Chem. Soc., 1960, 2016. b) Chelucci, G.; Delogu, G.; Gladiali, S.; 
Soccolini, F. J. Heterocyclic Chem. 1986, 23, 1395. 
30 a) Anilkumar, R.; Chandrasekhar, S. Tetrahedron Lett. 2000, 41, 5427. b) Mamaghani, M.; 
Samimi, H. A. Orient. J. Chem., 2008, 24, 837. 
31 a) Rosenfeld, D. C.; Shekhar, S.; Tameiyama, A.; Utsunomiya, M.; Hartwig, J. F. Org. Lett., 
2006, 8, 4179; b) Coulombel, L.; Dunach, E. Green Chem., 2004, 6, 499. c) Linares-Palomino, P. J. 
; Salido, S.;  Altarejos, J.; Sanchez, A. Tetrahedron Lett., 2003, 44, 6651. d)  Jeong, Y.; Kim, D.; 
Choi, Y.; Ryu, J. Org. Biomol. Chem., 2011, 9, 374; e) Coulombel, L.; Faviera, I.; Dunach, E. 
Chem. Commun., 2005, 2286. 
32 Coulombel, L.; Dunach, E. Green Chem., 2004, 6, 499. 
33 Linares-Palomino, P. J.; Salido, S.; Altarejos, J.; Sanchez, A. Tetrahedron Lett. 2003, 44, 6651. 
34 a) Horst, K.; Rychlik, M. Mol. Nutr. Food Res. 2010, 54, 1515. b) Lana, E. J. J.  Mol. Catal. A: 
Chemical, 2006, 259, 99; c) Santos, F. A.; Rao, V. S. N.  Phytother. Res. 2000, 14, 240. 
35 Lana, E. J.  J. Mol. Catal. A: Chemical, 2006, 259, 99. 
  
 
 
Chapter 4 
 
A Novel N-to-O Rearrangement 
 
113 
 
A Novel N-to-O Rearrangement 
Introduction: 
Nitrogen and oxygen are the atoms of life, from water H2O and urea NH2CONH2 to DNA helix. 
It is not surprising to say most natural products are nitrogen or oxygen containing compounds. 
Saturated oxygen and nitrogen heterocycles occur widely as components of natural products. 
Tetrahydropyrans (six-membered saturated O-containing ring) are components of monoterpenoid 
cineol 492, tetrahydrofurans (five-membered saturated O-containing ring) are components of 
spirocyclic ether theaspirane 493, pyrrolidine (five-membered saturated N-containing ring) is a 
component of nicotine 494 and piperidine (six-membered saturated N-containing ring) is a 
component of poisonous alkaloid coniine 31. Both dihydrofuran and piperidine are components of 
an important natural product morphine 37 (Fig. 4.1).  
 
Fig. 4.1 
It is known that many functional groups are unstable in acidic conditions especially in strong 
acid like sulfuric acid and super acids like trifluoromethanesulfonic acid CF3SO3H (triflic acid, 
TfOH), but we have got good evidence that the carboxylic acid ester in sulfonamide 495 was stable 
for four hours in triflic acid at 60 oC to give pyrrolidine 496 in an excellent yield of 91% (Scheme 
4.1).1 
 
Scheme 4.1 
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A tandem dehydration-THP cleavage-intramolecular hydroalkoxylation addition used to 
synthesize the aza-spiropyran 500 started from the Grignard addition of maleimide 497. Treatment 
of the THP-protected 4-hydroxybutyl magnesium bromide with maleimide 497 at −20 °C for 2.5 h 
afforded N,O-acetal 498 as an epimeric mixture in 7:1 ratio and with a combined yield of 89%. 
Exposure of the diastereomeric mixture of the N,O-acetal 499 to acidic conditions of p-toluene 
sulfonic acid TsOH as a catalyst in dichloromethane  at room temperature for half an hour resulted 
in the formation of the desired functionalized aza-spiropyran derivative 500 as a single diastereomer 
in quantitative yield. It could be seen clearly in this reaction that there is stability associated with 
some of the functional groups to the acidic conditions, but with the exception of the THP-ether 
group. However, the resulting alcohol undergoes smooth cyclisation (Scheme 4.2).2 
 
Scheme 4.2 
Haskins in the Knight Group studied the limitation of functional groups to acid catalysed-
hydroamination reactions. The functionalised amino-ester precursors allyl CH2CH=CH2 and 
sulfonyl CH2SO2Ph in sulfonamides 501 and 503 underwent smooth cyclisation to give the hoped-
for spiro-pyrrolidines 502 and 504 upon exposure to sub-stoichiometric amounts of triflic acid in 
ice-cold chloroform. Both products were isolated as 3:1 mixtures of only two diastereomers in 
unoptimised isolated yields about 70% (Scheme 4.3).1 
 
Scheme 4.3
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Aldehyde 505 is also able to survive the acidic reaction conditions and undergoes smooth 
cyclisation to give the corresponding pyrrolidine 506 in excellent yield (95%). The unprotected 
alcohol in precusor 507 competed with the sulfonamide as a trap for the carbocation to give 1:1 
mixture of pyrrolidine 508 and tetrahydropyran 509 (Scheme 4.4).
 
  
Scheme 4.4 
To incorporate alcohol groups in a controlled way was clearly a challenge, to this methodology, 
however, as almost all protecting groups for these are acid-sensitive. To mask the useful hydroxyl 
group, we expected benzyl ether (OBn) and para-methoxylbenzyl ether (OPMB) unlikely to survive 
in such acidic conditions. Trimethylsilyl ether OSi(CH3)3 and t-butyldimethylsilyl ether were also 
unlikely to survive at 20 oC. We then realised that perhaps acetate groups would indeed survive as 
the foregoing esters were not affected by the strong acid. We found benzyloxycarbonyl CO2CH2Ph 
survives in acidic condition at 20 oC (see p. 57 and 59) and CO2Me as well. It may be possible 
therefore to protect the hydroxyl group OH by acetate formation as ester groups are stable to the 
present acidic conditions (Scheme 4.5). 
 
Scheme 4.5 
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Preparation the cyclisation precursors 
Cyanoester derivatives 511 can be prepared from cyanoacetate 510 and allylic halides in reasonably 
good yields (55%).3 The prenyl bromide used was not completely pure, due to its sensitive nature; 
this could result in lower yield. In the case of using pure alkyl halide the yield was much better 
(74%) (Fig. 4.2). 
 
Fig. 4.2 
In all cases there was also formed double alkylated product 512 (ca. 20%), which was used in future 
to synthesise spiro-products (Scheme 4.6). The two product were separated by using column 
chromatography.  
 
Scheme 4.6 
Prenyl cyanoacetate 511 was reduced by lithium aluminium hydride to -amino alcohol 513. By 
selective addition of CO2Me to the more nucleophilic nitrogen over oxygen, unsaturated amino-
alcohol 514 was synthesized. Now the reactant was ready to test both the protected alcohol stability 
to acid and to find out which nucleophile (i.e. NH or OH) would trap the carbenium ion, generated 
when the substrate 514 is exposed to acid (Scheme 4.7). 
 
Scheme 4.7 
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In the event, when the alcohol group was blocked as the corresponding acetate 515, then only the 
piperidine 516 was formed after one hour of reaction at room temperature with a catalytic amount 
of sulfuric acid in an excellent yield of 93%. The products did not require any chromatographic 
purification as the reaction proceeded very cleanly. Infrared spectroscopy showed the absence of 
NH absorption and the presence of two carbonyl groups at υ/cm-1 1701 and 1730 due to carbamate 
carbonyl and acetate carbonyl, respectively, confirmed the stability of the acetate protecting group. 
So, acetate is suitable to protect alcohol groups in this chemistry a very useful finding. Both 1H and 
13C NMR spectra support the successful synthesis of piperidine 516; as can be seen from Fig 4.3, 
starting material 515 had clearly disappeared. Most obvious was the disappearance of the olefinic 
=CH at δH 5.02 ppm and NH proton at δH 4.94 ppm and the appearance of two ABX systems. Four 
methyls could be seen clearly; methoxy methyl at δH 3.55 ppm, methyl acetyl at δH 1.91 ppm and 
two methyls on quaternary carbons at δH 1.35 and 1.23 ppm. The 13C NMR spectrum showed a 
quaternary carbon next to a nitrogen atom at δC 54.8 ppm and four CH2 carbons, one next to oxygen 
at δC 66.4 ppm and three on the piperidine ring at δC 43.1 (NCH2), 36.2 and 21.3 ppm (Scheme 4.8, 
Table 4.1 and Fig 4.3). 
 
Scheme 4.8 
However, we were very much excited to know what would happen when we attempt to cyclise the 
free amino-alcohol 514, especially as this had not been tried before in the literature. It was clear that 
cyclisation had occurred after four hours of reaction at ice temperature with a catalytic amount of 
sulfuric acid in excellent yield (93%), as the olefinic =CH at 5.02 ppm had disappeared. 
Surprisingly, the NH proton at δH 4.60 ppm was still visible in a product with a most interesting    
118 
 
1H NMR spectrum (Fig 4.4). It was to our great surprise that the product clearly did not contain any 
piperidine residue and it was equally clear that the product was tetrahydropyran 517! By analysing 
the 1H NMR and 13C NMR spectra, we confirmed that tetrahydropyran 517 was formed. As can be 
seen from Fig 4.4, starting material 514 had clearly disappeared; the 13C NMR showed a quaternary 
carbon next to the oxygen atom at δC 71.3 ppm and four CH2 carbons one next to an oxygen at 64.3 
ppm, one next to nitrogen at δC 43.1, and two others at 35.1 and 23.7 ppm (Scheme 4.9, Table 4.1).  
           
Scheme 4.9 
Table 4.1 13C NMR spectra of piperidine 516 and tetrahydropyran 517. 
      13C NMR ppm 
Structure 
Cq CH CH2 CH3 
 
Ac-C=O : 171.0 
C=O : 156.9 
NCq : 54.8 
CH : 33.8 
OCH2 : 66.4 
NCH2 : 43.1 
36.2 and 21.3 
OCH3 : 51.9 
Ac-CH3 : 27.9 
24.5 and 20.8 
 
C=O : 157.2 
OCq : 71.3 
CH : 36.2 
OCH2 : 64.3 
NCH2 : 43.1 
35.1 and 23.7 
OCH3 : 52.1 
29.2 and 23.3 
The reactions involved are overall 6-endo-trig cyclisations and the intermediate carbocation is the 
same in both cases. A simple energy minimisation experiment performed using the programme 
Chem3D Pro calculated the total energy for tetrahydropyran 517 is 19.51 kcal/mol which is very 
close to piperidine 518 total energy 19.36 kcal/mol (Scheme 4.10). 
 
Scheme 4.10 
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The reactions are remarkably clean: the NMR spectra shown below were obtained from crude products. 
 
             
   Fig 4.3 1H and 13C NMR spectra of piperidine 516:     
    a) proton, b) decoupled 13C, c) DEPT CH2 positive; CH, CH3 negative.  
       Fig 4.4 1H and 13C NMR spectra of tetrahydropyran 517:                      
a) proton, b) decoupled 13C, c) DEPT CH2 positive; CH, CH3 negative. 
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We then hydrolysed the acetate with potassium carbonate to make an authentic sample of piperidine 
methanol 518 and treated the resulting alcohol 518 with acid, when it rearranged to the initial 
tetrahydropyran 517 after 20 hours of reaction at ambient temperature (Scheme 4.11). This appears 
to be a new rearrangement reaction! 
 
Scheme 4.11 
The structure of piperidine methanol 518 was confirmed by NMR (1H, 13C, COSY) spectroscopy, 
infra-red spectroscopy, and mass spectrometry analysis (Table 4.2, Fig 4.5 and Fig 4.6). In its 1H 
NMR spectrum, methyl acetyl at δH 1.91 ppm had disappeared and a new hydroxyl proton was 
visible also at δH 1.91. Methylene protons next to the hydroxyl group were moved to the upfiled 
(Table 4.2). The 13C NMR spectrum showed a quaternary carbon next to a nitrogen atom at δC 55.1 
ppm and four CH2 carbons, one next to oxygen at δC 65.2 ppm and three on the piperidine ring one 
next to a nitrogen atom at δC 42.7 (NCH2) and two others at 38.0 and 20.8 ppm. Three methyls 
could be seen clearly; methoxy methyl at δC 51.9 ppm and two other methyls on quaternary carbons 
at δC 27.6 and 24.8 ppm. (Scheme 4.8, Table 4.2 and Fig 4.3). 
Table 4.2 1H and 13C NMR spectrum of piperidine 518. 
13C NMR  ppm 
OCH2 
65.2 
NCH2 
42.7 
CH2 
38.0 
CH 
36.8 
CH2 
20.8 
1H NMR ppm 
3.46 (dd) 
3.42–3.38 (m) 
3.62 (dd) 
3.12 (dd) 
1.58–1.43 (m) 1.85–1.79 (m) 
1.22–1.07 (m) 
1.71–1.59 (m) 
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In the 1H 13C COSY spectrum (Fig 4.5 and Table 4.2), the left side of Fig 4.5 shows the 1-D 13C 
NMR spectrum (DEPT CH2 right; CH and CH3 left), and the top of the spectrum shows the 1-D 
1H 
NMR spectrum. The three cross peaks arising from the methyl groups are the easiest to identify. In 
the lower left of the COSY spectrum, we see a cross peak between the two methylene protons (the 
integral of resonance at δH 3.46 and 3.42 – 3.38 ppm) whose resonance is the carbon next to oxygen 
at δC 65.2 ppm. The cross peak between the carbon (6-C) next to nitrogen at δC 42.7 ppm resonates 
the two protons whose appearance is as doublets of doublets at δH 3.62 and 3.12 ppm. The cross 
peak between the methine proton is the carbon (5-C) at δC 36.8 ppm. We expect the cross peak 
between the carbon (3-C) at δC 38.0 ppm is the two protons whose resonsnce is the multiplet at δH 
1.58 – 1.43 ppm. In the upper right of the COSY spectrum, we see a cross peak correlating the 
resonance of the methylene protons (both multiplet δH 1.22 – 1.07 and 1.71 – 1.59 ppm) is the 
carbon (4-C) at δC 20.8 ppm (Table 4.2 and Fig 4.5). 
 
Fig 4.5 1H 13C COSY analysis of piperidine 518
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By analysing the 1H 1H COSY spectrum (Fig 4.6) we determined that there were two ABX systems. 
Tracing from the multiplet at δH 1.85 – 1.79 ppm, the methine proton at the carbon (5-C), is coupled 
not only to the 6-CH2N at (δH 3.62 and 3.12 ppm protons) and CH2O protons in the left at (δH 3.46 
and 3.42 – 3.38 ppm), but also to the 4-CH2 protons. Now we can confirm the multiplet at δH 1.58 – 
1.43 ppm is the two protons whose carbon is the carbon (3-C) at δC 38.0 ppm.
 
 
Fig 4.6 1H 1H COSY analysis of piperidine 518 
While the initial piperidine protected alcohol 516 had a formula of C12H21NO4, the piperidine 
methanol 518 showed m/z = 201.1365 for the formula C10H19NO3 [M]
+. This was confirmed by 
high resolution measurements and so confirmed the piperidine methanol 518. Also, infrared 
spectroscopy showed the presence of hydroxyl group absorption at υ/cm-1 3416 and the presence of 
the carbamate group at υ/cm-1 1684. 
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Sulfonamide 519 was prepared after selective addition of tosyl to nitrogen over oxygen in a similar 
way to that described in Scheme 4.7, but at -78 oC. Then tetrahydropyran 520 formed from 
sulfonamide 519 in quantitative yield after just one hour of reaction with concentrated sulfuric acid 
at ice temperature. There was no trace of any piperidine 521; the NH proton was still visible and 
there were three sharp methyl singlets related to methyl tosyl at δH 2.34 ppm and two methyl groups 
on quaternary carbon at δH 1.02 and 1.00 ppm in 1H NMR spectum. When the alcohol group was 
protected as the corresponding acetate 522, then only the piperidine 523 was formed at room 
temperature, which was distinguished by its 1H and 13C NMR spectra. In 1H NMR, both olifinic 
proton (=CH) at δH 4.98 – 4.87 ppm and NH proton at δH 4.79 ppm had disappeared to confirm the 
complete reaction. Four methyl signals could be seen clearly; aryl methyl at δH 2.27 ppm, methyl 
acetyl at δH 1.91 ppm and two methyls on quaternary carbon at δH 1.25 and 1.03 ppm. The stability 
of acetate was confirmed by infrared spectroscopy, which showed an absorption band at υ/cm-1 
1737 due to the carbonyl group, again showing the stability of this protecting group. The 13C NMR 
showed a quaternary carbon next to the nitrogen atom at δC 57.8 ppm and four CH2 carbons one 
next to oxygen at δC 65.9 ppm and three on the piperidine ring at δC 45.4 (NCH2), 39.8 and 23.2 
ppm.  Morever, we were delighted to find that there was no rearrangement to pyrrolidine 524, 
where an isopropyl group was not seen in the NMR spectra (no isopropyl group). When the acetate 
was hydrolysed and the resulting alcohol 521 was treated with acid, it rearranged to the initial 
tetrahydropyran 520 (Scheme 4.12). 
 Scheme 4.12 
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The same chemistry was repeated to synthesize more substituted tetrahydropyran derivatives and 
piperidine derivatives. The particular starting materials were chosen, first because they are 
commercially available and further to test the pattern of this chemistry upon the reaction conditions. 
Prenyl cyanoacetate 523 was synthesized smoothly in excellent yield (95%), and was used directly 
without further purification to give amino-alcohol 524 after lithium aluminium hydride reduction, 
then carbamate was added at nitrogen at ice temperature to give the N-protected amino-alcohol 525 
(Scheme 4.13). 
 
Scheme 4.13 
When the free amino-alcohol 514 was exposure to a catalytic amount of concentrated sulfuric acid 
for two hours at 0 oC in dry dichloromethane, 1H NMR analysis of the crude reaction mixture 
suggested that the product of the reaction was the tetrahydropyran 526, which did not need any 
purification. It was clear that the cyclisation had occurred in an excellent yield of 98%. This was 
believed due to the disappearance of the olefinic =CH at δH 5.15 ppm, but the NH proton at 4.73 
ppm was still visible and the appearance of a new singlet at 1.13 ppm which is characteristic of six 
protons of the two methyls at the 6-position of the tetrahydropyran 526 ring. The 1H NMR spectrum 
of the product also revealed another singlet at δH 0.80 ppm which is characteristic of the three 
protons of the methyl in the 3-position of the product 526. The 13C NMR spectrum revealed a 
quaternary carbon next to the oxygen at δC 71.3  ppm and four CH2 carbons one next to oxygen at 
δC 68.5 ppm, one next to nitrogen at 47.3 and two on the ring at  32.1and 27.1 ppm (Scheme 4.14). 
 
Scheme 4.14 
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In the event, when the alcohol group was blocked as the corresponding acetate 527, then only the 
piperidine 528 was formed after one hour of reaction at ambient temperature in an excellent yield of 
97%. The products did not require any chromatographic purification as the reaction proceeded very 
cleanly. Infrared spectroscopy showed the absence of NH absorption and the presence of the 
carbonyl group at υ/cm-1 1699. Both 1H and 13C NMR spectra support the successful synthesis of 
piperidine 528; starting material 527 had clearly disappeared. Most obvious was the disappearance 
of the olefinic =CH at δH 5.07 ppm and NH proton at δH 4.91 ppm, with the appearance of two AB 
systems one next to oxygen at δH 3.75 and another next to nitrogen at 3.31 (d, J = 13.9 Hz, 1H, 
NCHAHB) and 2.96 (d, J = 13.9 Hz, 1H, NCHAHB). Five methyls could be seen clearly; methoxy 
methyl at δH 3.54 ppm, methyl acetyl at δH 1.99 ppm and two methyls on quaternary carbon at δH 
1.33 and 1.30 ppm and tinaly a singlet at δH 0.88 ppm which is characteristic of three protons in the 
5-position. The 13C NMR showed four quaternary carbons: two of these in the downfield at δC 
171.1 and 157.0 ppm, one next to the nitrogen atom at δC 55.0 ppm and anther quaternary at the 5-
position of the ring at 34.4 ppm. Four CH2 carbons were present, one next to oxygen at δC 70.2 ppm 
and three on the piperidine ring at δC 47.6 (NCH2), 36.4 and 28.1 ppm. When the acetate was 
hydrolysed in piperidine 528, the resulting alcohol 529 showed the appearance of hydroxyl proton 
at 1.84 ppm as a broad singlet and a clear AB system next to oxygen at 3.48 and 2.83 (both d, J = 
14.1 Hz, 1H) ppm. When the alcohol 529 was treated with acid, it rearranged to the initial 
tetrahydropyran 526 after 18 h at room temperature (Scheme 4.15). 
 
Scheme 4.15   
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Benzyl bromide was added to ethyl cyanoacetate in the presence of sodium hydride in 
dimethylformamide to give 530, then prenyl cyanoacetate 531 was synthesized smoothly in 
excellent yield (93%), which used directly without further perfection to give amino-alcohol 532 
after lithium aluminium hydride reduction. Then the carbamate was added at nitrogen at ice 
temperature to give the N-protected amino-alcohol 533 (Scheme 4.16). 
 
Scheme 4.16 
However, when the alcohol group was protected as the corresponding acetate 534, then only the 
piperidine 535 was formed after one hour of reaction at room temperature with catalytic amount of 
sulfuric acid in excellent yield of 98%. The crude reaction mixture did require some 
chromatography as it showed some impurity; it could be because the starting reactant was not pure 
enough. Both 1H and 13C NMR spectra supported the successful synthesis of piperidine 535; 
starting material 534 had clearly disappeared. Most obvious was the disappearance of the olefinic 
proton at δH 5.19 ppm and NH proton at δH 4.78 ppm, with the appearance of two new AB systems. 
The 13C NMR showed a quaternary carbon next to the nitrogen at δC 55.3 ppm and four CH2 
carbons one next to oxygen at δC 67.3 ppm and three on the piperidine ring at δC 46.4 (NCH2), 41.2 
and 38.2 ppm. The acetate was hydrolysed in piperidine 535, and subsequent rearrangement of the 
resulting alcohol 536 gave the tetrahydropyran 537 which was also synthesized starting from 
amino-alcohol 533 after one hour of reaction at room temperature (98%) (Scheme 4.17). 
127 
 
 
Scheme 4.17 
The double alkylated product 512 was reduced by lithium aluminium hydride to a mino-alcohol 
538, then selective addition of tosyl to nitrogen over oxygen gave the N-tosyl free alcohol 539, 
which was subject to catalytic amount of sulfuric acid in dry dichloromethane to synthesis spiro-
product 540 after just one hour of reaction at ice temperature in 97% isolated yield. Infrared 
spectroscopy showed the absence of NH absorption or alcohol. 1H NMR spectrum supported the 
successful synthesis of the product 540. Starting material 539 had clearly disappeared. This was 
confirmed by disappearance of the olefinic protons at δH 5.02 ppm and the NH proton at δH 4.94 
ppm, and the appearance of two AB systems. The 13C NMR showed a quaternary carbon next to the 
oxygen at δC 71.8 ppm, a quaternary carbon next to the nitrogen at δC 58.2 and spiro-quaternary 
carbon at 32.9 ppm. Six CH2 carbons one next to oxygen at δC 67.9 ppm, one next to nitrogen  at δC 
49.1 ppm and four on the rings at δC 37.9, 31.7, 28.5 and 28.1 ppm, which are compatible with 13C 
NMR data for tetrahydropyran 520 and piperidine 523 (Scheme 4.18). 
 
 
Scheme 4.18 
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The generality of the new rearrangement was next tested by using substituent such as cinnamyl. 
Cinnamyl cyanoacetate 542 was synthesized by reaction of ethyl cyanoacetate 510 in the presence 
of sodium hydride with cinnamyl chloride 541 in DMF. The double alkylated product 543 was 
present. The two products were separated by using column chromatography (Scheme 4.19).  
 
Scheme 4.19
 
Cinnamyl cyanoacetate 542 was then converted into the amino-alcohol 544 by a standard lithium 
aluminium hydride redaction. Finally, carbamate was added by using methyl chloroformate in the 
presence of triethylamine at ice temperature; all of these reactions proceeded in good yields. The 
cyclisation reaction of cinnamyl carbamate 545 was carried out with 0.5 equivalent of triflic acid at 
room temperature after six hours of reaction some starting material (ca. 20%) was still noticeable, 
which could be seen in the 1H NMR spectrum by the presence of olefinic protons at 7.12 and 6.35 
ppm. After 20 hours of reaction with 0.5 equivalent of triflic acid at ambient temperature, no 
starting material could be seen and tetrahydropyran 546 was formed as an approximately 2:1 
mixture of diasteroisomers, but was accompanied by extensive decomposition and multiple peaks 
from unidentified products. The ratio was measured according to the integration of methoxy in the 
protecting group, but a pure sample of the tetrahydropyran 546 was not separable (Scheme 4.20). 
 
 Scheme 4.20 
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Alcohol 545 was protected and then subjected to 0.5 equivalent of triflic acid at room temperature; 
no starting material could be seen after six hours in the 1H NMR spectrum and piperidine 548 was 
formed as an approximately 1:1 mixture of diasteroisomers. The 1H NMR spectrum also showed 
some impurities which could be removed by column chromatography. The ratio was measured 
according to the integration of methoxy function in the N-protecting group. Analysis of the 13C 
NMR data showed a new CH peak at 776 ppm, a characteristic shift for a carbon next to nitrogen 
(Scheme 4.21). 
 
Scheme 4.21 
By comparison to the prenyl derivatives, the cinnamyl derivatives required more time to obtain both 
phenyltetrahydropyran and phenylpiperidine. In the case of alcohol cyclisation, the reaction was 
very slow and resulted in extensive decomposition. The previous results in Chapter 2 lead us to 
assume that the cyclisation of crotyl derivative would probably not be useful to try using this 
methodology, so this particular cyclisation was not attempted in this time.  
We found in Chapter 2 (p.50), the steric hindrance was the key reason behind the tosyl and nosyl 
substituted piperidine rearrangements to pyrrolidines as the tosyl and nosyl groups are bulky 
groups. To study the effect of sufonamide on this new N- to O-rearrangement, sulfonamide 549 was 
synthesized from amino alcohol 544 (Scheme 4.22). 
 
Scheme 4.22 
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Surprisingly, sulfonamide free alcohol 549 underwent smooth cyclization in 0.5 equivalent of triflic 
acid after one hour at room temperature to give (6-phenyl-1-tosylpiperidin-3-yl)methanol 550 as a 
2:1 mixture of diastereoisomers which were not separated. NMR analysis was used to confirm the 
structures of the diasteroisomers. The 1H NMR spectrum showed no starting material was present 
by the disappearance of the olefinic protons at δH 5.87 and 5.58 and the NH proton at δH 4.70 ppm 
with the increasing in the complexity of the spectrum. Two new low field resonances were visible at 
δH 5.21 (d, J = 4.8 Hz, 1H, 6-H) and 5.05 (t, J = 4.5 Hz, 1H, 6-H) ppm both integrating for one 
proton for each isomer (Fig 4.7a). The resonance at δH 5.21 was narrower and appeared as an 
apparent doublet (J = 4.8 Hz) with width at half height of ω1/2 = 10.7 Hz. The resonance at δH 5.05 
appeared as apparent triplet (J = 4.5 Hz) with width at half height of ω1/2 = 11.0 Hz (Fig 4.7a 
expansion). The 13C NMR spectrum confirmed the piperidine 550 structure; resonances at δC 56.4 
and 54.9 (2 x CHN, major/minor) were related to two methine carbons. The structure of 
tetrahydropyran 551 was excluded, as the literature survey4 showed that methine carbon in 2-pheny 
tetrahydropyran was expected to be at ca. >80 ppm in 13C NMR spectrum. The structure of 
piperidine 550 was confirmed by cyclisation of O-protected sulfonamide 552 reaction to piperidine 
553 which gave an identical spectra to the piperidine prepared starting from free alcohol 549, except 
for a slight difference in the ratio of stereoisomers (Scheme 4.23). 
 
Scheme 4.23 
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Fig 4.7 1H and 13C NMR spectra of (6-phenyl-1-tosylpiperidin-3-yl)methanol 550 
a) proton, b) decoupled 13C, c) DEPT CH, CH3 positive; CH2 negative. 
The double cinnamyl product 543 was reduced by lithium aluminium hydride to amino-alcohol 554, 
then selective addition of CO2Me to nitrogen over oxygen gave N-protected free alcohol 555, which 
was subject to catalytic amount of sulfuric acid in dry dichloromethane to synthesis spiro-product 
556 after 24 hours of reaction at 37 oC as a 3:1 mixture of diastereoisomers which were not 
separated. 1H NMR spectrum supported the successful synthesis of the product 556. Starting 
material had clearly disappeared. This confirmed by disappearance of the olefinic protons and the 
NH proton (Scheme 4.24). The 13C NMR of spiro[5.5]undecane 556 was compatible with 13C NMR 
for tetrahydropyran 546 and piperidine 548 in Scheme 4.20 and Scheme 4.21. 
 
Scheme 4.24
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Following these successful results, a logical extension of this methodology was its application to 
some pyrrolidines and tetrahydrofurans syntheses and the pattern of this rearrangement. Therefore, 
the cyclisation precursor was prepared from the reaction of 3-chloro-2-methylprop-1-ene 557 with 
ethyl cyanoacetate 510 in the presence of sodium hydride in DMF. The double alkylated product 
559 was separated by using column chromatography (Scheme 4.25).  
 
Scheme 4.25 
The cyanoacetate 558 was reduced by lithium aluminium hydride to -amino alcohol 560. By 
selective addition of CO2Me to nitrogen over oxygen unsaturated amino-alcohol 561 was 
synthesized. (Scheme 4.26). 
 
Scheme 4.26
 
Thus tetrahydrofuran 562 was formed in an excellent total yield of 97% after just one hour of 
reaction with concentrated sulfuric acid at ice temperature, by overall 5-exo-trig cyclisation 
according to Baldwin’s rules. In 1H NMR, There was no trace of starting material 561: both olefinic 
protons =CH2 at δH 4.81 and 4.73 ppm had disappeared to confirm the complete reaction. There was 
no trace of any pyrrolidine 563 as NH proton was still visible in the 1H NMR spectrum and there 
were three sharp methyl singlets related to methyl carbamate at δH 3.60 ppm and two methyl groups 
on quaternary carbon at δH 1.23 and 1.12 ppm. The 13C NMR showed a quaternary carbon next to 
the oxygen atom at δC 80.9 ppm and three CH2 carbons one next to oxygen at δC 69.9  ppm, one 
next to nitrogen  at δC 45.4 (NCH2) and another on the ring at 42.7 ppm. 
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When the alcohol group was protected as the corresponding acetate 564, then only the pyrrolidine 
565 was formed in quantitative yield at room temperature, which was distinguished by its 1H and 
13C NMR spectra. In 1H NMR, the NH proton at δH 4.92 ppm and olefinic protons =CH2 at δH 4.75 
and 4.67 ppm had completely disappeared to confirm the complete reaction. The 13C NMR showed 
a quaternary carbon next to the nitrogen atom at δC 60.9 ppm and three CH2 carbons one next to 
oxygen at δC 65.8 ppm and two on the pyrrolidine ring at δC 50.6 (NCH2) and 44.7 ppm.  When the 
acetate was hydrolysed and the resulting alcohol 563 was treated with acid, it rearranged to the 
initial tetrahydrofuran 562 in an excellent yield of 97% (Scheme 4.27). 
Scheme 4.27 
 
                                
                                    
 
 
 
 
 
Fig 4.8 1H and 13C NMR spectra of tetrahydrofuran 562 a) decoupled 13C, b) proton. 
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Sulfonamide 566 was prepared by selective addition of tosyl to nitrogen over oxygen in a similar 
way to that described before. When sulfonamide 566 was subjected to catalytic amounts of sulfuric 
acid in dry dichloromethane the starting material disappeared after just one hour of reaction at 0 oC. 
Thus tetrahydrofuran 567 was formed as a mixture with ca. 20% of pyrrolidine 568 and excellent 
total yield of 97%. The ratios were measured from the integrals of the 1H NMR resonances 
corresponding to the tosyl group. There was no trace of any starting material 566 as the olefinic 
protons at δH 4.76 and 4.67 ppm had disappeared.  There were two methyl singlets related to methyl 
tosyl ca.  2.34 ppm in 1H NMR spectrum. The key quaternary carbon (OCq) at δC 81.0 ppm related 
to tetrahydrofuran 567 and another small quaternary carbon (NCq) at δC 65.0 ppm referred to 
pyrrolidine 568  (Scheme 4.28).  
 
Scheme 4.28 
Pure pyrrolidine 568 was synthsized after the alcohol group was protected as the corresponding 
acetate 569, then only the pyrrolidine 570 was formed at ice temperature in quantitive yield, which 
was distinguished by its 1H and 13C NMR spectra. In 1H NMR, all NH proton at δH 4.95 ppm and 
olifinic protons =CH2 at δH 4.72 and 4.61 ppm had disappeared, which confirmed the complete 
reaction. Then the acetate group was hydrolysed and pyrrolidine methanol 568 was formed. The 13C 
NMR showed a quaternary carbon next to the nitrogen atom at δC 65.5 ppm and three CH2 carbons 
one next to oxygen at δC 64.4 ppm and two on the pyrrolidine ring at δC 51.8 (NCH2) and 45.6 ppm.   
One CH carbon at 38.0 ppm (Fig 4.9 and Scheme 4.29). 
 
Scheme 4.29 
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 Fig 4.9 1H and decoupled 13C NMR spectra of pyrrolidine methanol 568. 
Spirocyclic Frameworks 
Spirocyclic framework structures have a well-defined three-dimensional spatial arrangement that 
exhibit specificity of action with biological receptors and enzymes.5 We had seen that double 
addition occurred when ethyl cyanoacetate reacted with alkyl halide 557 (Scheme 4.25), so that 
double alkylated products 559 was also isolated. The advantage of these double reactions was taken 
the two compounds were separated by column chromatography and gave a chance to investigate the 
compatibility of dual acid-catalysed cyclization reactions. The double alkylated product 559 was 
reduced by lithium aluminium hydride to amino-alcohol 569, then selective addition of tosyl to 
nitrogen over oxygen gave N-tosyl free alcohol 570, which was subjected to a catalytic amount of 
sulfuric acid in dry dichloromethane to synthesise spiro-product 571 after just one hour of reaction 
at room temperature in quantitative yield. Infrared spectroscopy showed no NH absorption or the 
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presence of alcohol. A 1H NMR spectrum confirmed the successful synthesis of the oxa-
azaspiro[4.4]nonane 571. As can be seen in Fig 4.10; starting material 570 had clearly disappeared. 
This was confirmed by disappearance of the NH proton at δH 5.12 ppm, olefinic protons at δH 4.90 
and 4.76 ppm and of the hydroxyl proton at 2.29 ppm. The 13C NMR showed a quaternary carbon 
next to the oxygen at δC 80.2 ppm, a quaternary carbon next to the nitrogen at δC 64.8 and spiro-
quaternary carbon at 48.5 ppm. Four CH2 carbons one next to oxygen at δC 75.6 ppm, one next to 
nitrogen  at δC 59.2 ppm and two on the rings at δC 52.7 and 49.7 ppm. Five methyl groups were 
present at δC 29.2, 29.1, 29.0, 28.3, 21.5ppm (Fig 4.10, Scheme 4.30 and Table 4.3).  
 
Scheme 4.30 
 
Fig 4.10 1H and decoupled 13C NMR spectra of oxa-azaspiro[4.4]nonane 568 
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The spiro-structure was confirmed by NMR (1H, 13C, COSY) spectroscopy, infrared spectroscopy, 
and mass spectrometry analysis.  The 13C NMR data obtained were consistent with the published 
data by Chuan He et. al.,6 who reported that gold(I) catalyzed intrarmolecular 
hydroamination/hydroalkoxylation of olefin 570 to give oxa-azaspiro 571 after ten hours of reaction 
with a catalytic amount of Ph3PAuOTf (generated by mixing equal equivalents of Ph3PAuCl and 
AgOTf ) at 85 oC in toluene (Scheme 4.31 and Table 4.3). 
 
Scheme 4.31 
Table 4.3 13C NMR spectra of oxa-azaspiro 571. 
13C ppm Cq CH OCH2 NCH2 CH2 CH3 
Chuan He 
142.9 and 137.9 
OCq : 80.2 
NCq : 64.7 
spiro Cq : 49.4 
 
129.4 (2 x CH) 
127.3 (2 x CH) 
75.4 59.1 
52.5 
48.5 
29.1, 29.1, 
29.0, 28.3, 
21.5 
D. W. 
Knight 
142.8 and 138.1 
OCq : 80.2 
NCq : 64.8 
 spiro Cq : 49.7 
 
129.4 (2 x CH) 
127.3 (2 x 2H) 
75.6 59.2 
52.7 
48.5 
29.2, 29.1, 
29.0, 28.3, 
21.5   
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A small sample of the amino-alcohol 569 (ca. 200 mg) was also converted into the carbamate 572 
as protecting group. Cleanly, the synthesis of oxa-azaspiro[4.4]nonane 573 was achieved by double 
acid-catalysed cyclization reactions after one hour of reaction with catalytic amount of sulfuric acid 
at room temperature in quantitative yield. The 13C NMR showed a quaternary carbon next to the 
oxygen at δC 79.9 ppm, a quaternary carbon next to the nitrogen at δC 60.3 and spiro-quaternary 
carbon at 48.2 ppm. Four CH2 carbons one next to oxygen at δC 75.8 ppm, one next to nitrogen  at 
δC 58.2 ppm and two on the rings at δC 50.7 and 50.0 ppm. Five methyl groups were present at 51.4 
(OCH3), 29.4, 28.8, 27.2 and 26.8 ppm (Scheme 4.32). As can be seen in Table 4.4, the 
13C NMR 
of spiro-nonane 573 was compatible with 13C NMR for tetrahydrofuran 562 and pyrrolidine 563. 
 
Scheme 4.32
 
Table 4.4 13C NMR spectra of tetrahydrofuran 562, pyrrolidine 563 and spiro[4.4]nonane 573. 
      13C NMR ppm 
Structure 
Cq CH2 CH3 
 
C=O : 157.2 
OCq : 80.9 
OCH2 : 69.9 
NCH2 : 44.1 
42.7 
OCH3 : 52.8 
28.7  and 27.7 
 
C=O : 157.5 
NCq : 60.9 
OCH2 : 64.8 
NCH2 : 50.5 
29.8 
OCH3 : 51.8 
25.6 (2 x CH3) 
 
C=O : 153.8 
OCq : 79.9 
NCq : 60.3 
spiro-Cq : 48.2 
OCH2 : 75.8 
NCH2 : 58.2 
50.7 and 50.0 
OCH3 : 51.8 
29.4, 28.8, 27.2 
and 26.8 
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Transannular Cyclisations 
Amino-alcohol 574 was the target to study the transannular N vs O cyclisation. A standard 
disconnection of the required cyclopentene ring 575 indicated that a route employing Grubbs’ 
metathesis7 would be suitable chemistry to start from relatively simple starting materials. 
Substituted oxa- and aza-bicyclo compounds can be made, showing the wide range application of 
this chemistry, starting from alkyl halides 577 and 578 (Scheme 4.33).  
 
Scheme 4.33
 
It was decided to first focus on a simplified model, with the transannular precursor simplified to 
a methyl group. Synthesising this methyl model 558 was achieved as before (Scheme 4.25), 
followed a second allylation by allyl bromide 577 in the presence of sodium hydride to give 
substituted cyanoacetate 579 (87%). It is known that, Grubbs' catalyst is a ruthenium carbene 
complex and there are three generations of the reagent available, which are compatable with a wide 
range of solvents. Grubbs’ second generation catalyst had been available within the group, so a 
simple ring closing metathesis using this catalyst was used to form the cyclopentene ring 580, 
which was then reduced by lithium aluminium hydride to the amino-alcohol 581 (Scheme 4.34). 
 
Scheme 4.34 
Sulfonamide 582 was prepared by selective addition of tosyl to nitrogen over oxygen in a similar 
way as described before. When sulfonamide 582 was subjected to a catalytic amount of sulfuric 
acid in dry dichloromethane, the starting material disappeared after just one hour of reaction at 
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ambient temperature. Thus oxabicyclo 583 was formed as a mixture with azabicyclo 584 as an 
inseparable mixture (3:1) in an excellent total yield of (92%). There was good evidence for the 
presence of rearrangement to azabicyclo 585 < 5%, which would have been formed through a less 
stable secondary carbenium ion. The evidence came mainly from the 1H NMR spectrum; there was 
no trace of any starting sulfonamide 582 as the olefinic proton at δH 5.06 ppm had disappeared.  The 
resonances corresponding to the tosyl group about δH 7.00 – 7.70 ppm and the broad methyl singlet 
related to methyl tosyl ca. 2.34 ppm suggested the presence of three compounds. A methyl doublet 
at δH 1.48 ppm referred to the rearranged compound 585. The key quaternary carbon (OCq) at ca. 
87.0 ppm related to oxabicyclo 583, another small quaternary carbon (NCq) at ca. 71.0 ppm 
referred to azabicyclo 584, NCH carbon was present ca. 45.0 ppm. Further studies would be 
necessary to confirm this result (Scheme 4.35).  
 
Scheme 4.35
 
After the alcohol group was protected as the corresponding acetate 587, then only the azabicyclo 
587 was formed at room temperature in an excellent yield (95%), which was distinguished by its 1H 
and 13C NMR spectra. In 1H NMR, all olefinic proton at δH 5.09 and NH proton at δH 4.99 ppm had 
disappeared to confirm the complete reaction. The 13C NMR showed a quaternary carbon next to 
the nitrogen at δC 70.8 ppm, another quaternary carbon at δC 46.8 ppm and five CH2 carbons, one 
next to oxygen at δC 65.5 ppm, one next to nitrogen (NCH2) at δC 58.5 ppm. Clearly, three CH2 
carbons could be seen; one between two quaternaries at δC 49.0 and and two others at 36.1, 32.1 
ppm. Three methyl carbons close to each other were at 21.5, 20.7 and 19.4 ppm (Scheme 4.36). 
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Scheme 4.36 
A pure authentic sample of pyrrolidine 584 (Scheme 4.35) was synthsized after the alcohol group 
was deprotected. The 1H NMR showed a new ABX system reflexed the coupling between OCH2 
protons with hydroxyl group at δH 3.35 (dd, J = 8.5, 3.2 Hz, 1H) and 3.27 (dd, J = 8.5, 1.4 Hz, 1H). 
The 13C NMR showed a quaternary carbon next to the nitrogen at δC 70.9 ppm, another quaternary 
carbon at δC 49.2 ppm.  The CH2 carbon next to oxygen was at δC 64.4 ppm, which showed no big 
difference comparing with CH2 carbon next to oxygen in protecting alcohol 587 at δC 65.5 ppm. 
There were two methyl carbons at 21.5 and 19.5 ppm. Treatment of cyclic free methanol 584 with 
concentrated sulfuric acid gave similar result to that reaction reported above (Scheme 4.34) for the 
sample prepared by cyclisation of the sulfonamide 582 (Scheme 4.37). 
 
Scheme 4.37 
This obstacle of equilibrium could be avoided by changing the size of the ring to 
cyanocyclohexene 588. It is expected the best way to prepare ethyl cyanocyclohexene carboxylate 
588 by Grubbs metathesis. Initially, a standard disconnection of the required methyl cyclohexene 
ring 588 indicated that a route employment Grubbs’ metathesis would be suitable chemistry to start 
from a relatively simple starting materials. This methodology requires five steps to end with 
cyanocyclohexene 588 (Scheme 4.38). 
 
Scheme 4.38 
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 It was previously described by Zhu et al. a procedure in which isoprene 591 was used to trap the 
methylidene cyanoacetate generated in situ in a Diels–Alder process with the assistance of 
copper(II) acetate monohydrate.8 In light of this, cyanocyclohexene carboxylate 588 was prepared 
in one step practical reaction by this methodology. Heating ethyl cyanoacetate, isoprene 591 and 
two equivalent of paraformaldehyde in the presence copper(II) acetate monohydrate at 80 oC in 
toluene-acetic acid 1:1 gave methyl cyanocyclohexene carboxylate 588 in excellent yield 94% 
(Scheme 4.39).9  
 
Scheme 4.39 
Sulfonamide 591 was prepared after selective addition of tosyl to nitrogen over oxygen. The cineol 
framework 592 could be formed from in excellent yield (91%) after just one hour of reaction with 
concentrated sulfuric acid at ice temperature. In 1H NMR spectrum, the NH proton was still visible 
and there were two sharp methyl singlets related to methyl tosyl at δH 2.25 ppm and one methyl 
group on quaternary carbon at δH 0.90 ppm. The 13C NMR showed two quaternary carbons; one 
next to the oxygen atom (OCq) at δC 69.1 ppm and another at 32.4 ppm. Six CH2 carbons one next 
to oxygen at δC 71.7 ppm one next to nitrogen at δC 49.4 ppm, four on the rings,  which showed  a 
plane of symmetry  at δC 32.1 (2 x CH2), 28.0 (2 x CH2) ppm (Scheme 4.40).   
 
Scheme 4.40 
When the alcohol group was protected as the corresponding acetate 594, then only the azabicyclo-
octane 595 was formed at room temperature, which was distinguished by its 1H and 13C NMR 
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spectra. In 1H NMR, both olefinic proton (=CH) at δH 5.14 ppm and NH proton at δH 4.98 ppm had 
disappeared to confirm complete reaction. Three methyl signals could be seen clearly; aryl methyl 
at δH 2.36 ppm, methyl acetyl at δH 2.01 ppm and one methyl on quaternary carbon at δH 1.27 ppm. 
The stability of acetate was confirmed by infrared spectroscopy, which showed an absorption band 
at υ/cm-1 1740 due to the carbonyl group, again showing the stability of this protecting group. The 
13C NMR showed a quaternary carbon next to the nitrogen atom at δC 55.2 ppm and another at 34.0 
ppm. Six CH2 carbons one next to oxygen at δC 69.4 ppm, one next to nitrogen at δC 53.8 and four 
the rings at δC 33.0 (2 x CH2), 27.1 (2 x CH2) ppm (Scheme 4.41). 
 
Scheme 4.41 
Carbamate 596 was prepared from amino-alcohol 591. Then cineole framework 597 could be 
formed in quantitive yield (98%) after just one hour of reaction with concentrated sulfuric acid at 
room temperature. In 1H NMR spectum the NH proton was still visible and there were two sharp 
methyl singlets related to methyl carbamate at δH 3.61 ppm and one methyl group on quaternary 
carbon at δH 1.02 ppm (Fig 4.9). The 13C NMR showed three quaternary carbons; a carbonyl carbon 
at δC 157.2 ppm, one next to the oxygen atom (OCq) at δC 68.9 ppm and another at 33.0 ppm. Six 
CH2 carbons one next to oxygen at δC 71.7 ppm one next to nitrogen at δC 47.1 ppm, four on the 
rings,  which showed  a plane of symmetry  at δC 32.1 (2 x CH2), 27.8 (2 x CH2) ppm. Two methyl 
carbamate (OCH3) was at δC 52.1 ppm and one methyl carbon on quaternary carbon at δC 26.3 ppm  
(Scheme 4.42 and Fig 4.9).   
 
Scheme 4.42    
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In the 1H 13C correlation spectrum (Fig 4.9), the left side of Fig 4.9 shows the 1-D 13C NMR 
spectrum (DEPT CH2 right; CH and CH3 left), and the top of the spectrum shows the 1-D 
1H NMR 
spectrum. The two cross peaks arising from the methyl groups are the easiest to identify. In the 
lower left of the COSY spectrum, we see a cross peak between the two methylene protons (the 
integral of resonance at δH 3.71 – 3.49 ppm) whose resonance is the carbon next to oxygen at δC 
71.7 ppm. The cross peak between the carbon next to nitrogen at δC 47.1 ppm resonates the two 
protons whose appearance is as doublets at δH 2.89 (d, J = 6.5 Hz, 2H) ppm. In the upper right of 
the COSY spectrum, a cross peak correlating the resonance of the methylene protons (both 
multiplet δH 1.79 – 1.67 (m, 2H, CH2) and 1.57 – 1.40 (m, 6H, 3 x CH2) ppm are the carbons at δC 
32.1 (2 x CH2) and 27.8 (2 x CH2) ppm (Fig 4.11). 
                                                                          
 
 
 
 
 
 
 
 
 
Fig 4.11 1H 13C COSY analysis oxabicyclo-octane 597. 
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The oxabicyclo-octane 597 was very pure and crystallized by itself and the structure was 
confirmed by X-ray crystallography (Fig 3.12). 
  
Fig 3.12 The X-ray structure of oxabicyclo-octane 597. Full crystallographic data is included in 
the Appendix 8. 
When the alcohol group was protected as the corresponding acetate 598, then only the azabicyclo-
octane 599 was formed at room temperature, which was confirmed by its 1H NMR spectrum. Both 
olefinic proton (=CH) and NH proton had disappeared to confirm the complete reaction. Three 
methyl signals could be seen; methoxy methyl at δH 3.55 ppm, methyl acetyl at δH 1.97 ppm and 
one methyl on quaternary carbon at δH 1.42 ppm. (Scheme 4.43). 
 
 
Scheme 4.43 
This chemistry showed variety in application, both cineol 597 and isoquinuclidine 599 frameworks 
were synthesized in excellent yields by acid-catalysed transannular cyclizations. 
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Cascade cyclisations 
As hydroquinolines were studied before in Chapter 3, it was decided to see if such methodology 
would be extended to the formation of six membered rings by using cascade cyclisations.  
Geranyl cyanoacetate 601 was synthesized by refluxing ethyl cyanoacetate 510 with geranyl  
bromide 600 in ethanol in the presence of potassium carbonate for 20 hours (75% yield),10 which 
was then reduced by LiAlH4 to give the amino-alcohol 602 (Scheme 4.44).  
  
Scheme 4.44 
Finally, carbamate was added the amino-alcohol 602 by using methyl chloroformate in the presence 
of triethylamine. Unusually, the reaction mixture was left stirring overnight, then chromatographic 
purification showed a trace of cyclic carbamate 604 as a side product (ca. 2%). The structure of 
cyclic carbamate 604 was deduced by 1H and 13C NMR spectroscopy. In the 1H NMR spectrum, an 
NH proton at δH 5.08 ppm and two olefinic protons at δH 5.06 – 4.95 ppm were visible. There were 
two ABX systems. The 13C NMR spectrum showed five CH2 carbons: one next to oxygen at δC 70.2 
ppm, one next to nitrogen atom at δC 45.3 ppm and three CH2 carbons next to double bonds at δC 
39.7, 27.3 and 26.5 ppm (Scheme 4.45).
 
 
Scheme 4.45 
It was perhaps fortunate that the cyclic carbamate 607 was not similarly formed during the 
preparation of carbamate 605, or during the acid-catalysed cyclisations. Carbamate free alcohol 605 
clearly could be converted into cyclic carbamate 607 under acidic conditions (Fig 3.13). 
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Fig 3.13 
Having separated the cyclic carbamate by-product 604, the cyclisation reaction of geranyl 
carbamate 603 was carried out with a catalytic amount of sulfuric acid at room temperature for one 
hour. Cascade reaction showed the same chemistry; the octahydro chromene skeleton 608 was 
synthsized directly from free alcohol 603 in an excellent yield of 90% as a mixture of major and 
minor isomers. The 1H NMR spectrum showed that the resonances corresponding to the two 
olefinic protons had disappeared, whereas the NH proton did not disappear. The singlets at δH 1.68 
and 1.61 ppm representing the three methyl groups on double bonds moved further upfield as two 
isomers (ratio 2:1) were formed and the complexity of spectrum increased. In the 13C NMR 
spectrum, a major isomer showed three quaternary carbons at δC 157.2 (C=O), 74.7 (OCq), and 34.0 
ppm, six CH2 signals δC 64.0 (OCH2), 42.4 (NCH2), 41.5, 40.0, 23.6 and 21.1 ppm and two CH 
carbons at δC 52.9 and 38.8 ppm (Scheme 4.46). 
 
Scheme 4.46
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The structure could be derived from chair transition state, where the geometry of the double bond in 
the starting material, causes the ring junction likely to be trans-fused and the side chain up or 
dowon. This seems to be consistent with the MM2 energies calculated using the CS Chem3D Pro 
program (Fig 3.14). This information allows us to envisage a double-chair conformation for the 
trans-fused isomer 608B, where the side chain is equatorial, but more investigations are needed to 
confirm the detailed structures of the two products. 
 Fig 3.14 
After the alcohol group was protected as the corresponding acetate 609, then only the 
perhydroquinoline 610 was formed by one hour of reaction with a catalytic amount of sulfuric acid 
in a very good isolated yield of 84%. This was distinguished by its 1H and 13C NMR spectra. In the 
1H NMR, all olefinic protons at δH 5.09 – 4.96 ppm and NH proton at 4.90 ppm had disappeared 
with a trace of an unidentified compound formed at less than 10%. Three singlets at δH 1.61 and 
1.53 ppm representing three methyl groups on double bonds moved further upfield to be as six 
singlets as two isomer (ratio 2:1) were formed, the complexity of spectrum increased. In the 13C 
NMR spectrum, a major isomer showed a quaternary carbon next to nitrogen at δC 60.9 ppm, sp3  
quaternary carbon at 34.2 ppm, two CH carbons 51.9 and 34.2 ppm and six CH2 carbons at δC 66.8 
(OCH2), 44.3 (NCH2), 41.2, 38.5, 32.8 and 22.9  ppm (Scheme 4.47). 
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Scheme 4.47 
Thus, octahydro-chromene and perhydroquinoline skeletons were synthsized directly from the 
corresponding geranyl amino-alcohols in excellent yields after only one hour of reaction with 
catalytic amounts of sulfuric acid. 
 
Conclusions:  
The novel rearrangement was first discovered using the amino-alcohol 514 and works with both 
carbamate and tosylate derivatives, which rearranged to the initial tetrahydropyran 517 after 
reaction with the acid at ambient temperature (Scheme 4.48). However, when the alcohol is blocked 
by acetylation, the corresponding piperidines 516 are formed. Significantly, these reactions also 
showed that an acetyl group was suitable as an alcohol protecting group in this type of chemistry. 
 
Scheme 4.48
 
The inclusion of additional substituents (R = CH3 and CH2Ph) has no obvious affect on the 
reactions (Scheme 4.49). 
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Scheme 4.49
 
Exactly the same occurred with the corresponding five-membered rings (Scheme 4.50).  
 
Scheme 4.50
 
Surprisingly, sulfonamide free alcohol 549 gave piperidine 550. This structure was confirmed by O-
protected sulfonamide reaction which gave identical spectra to that piperidine starting from free 
alcohol (Scheme 4.51).  
 
Scheme 4.51 
The synthesis of spiro-compounds was achieved by double acid-catalysed cyclization reactions 
(Scheme 4.52). 
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Scheme 4.52 
The transannular example showed only a trace of rearrangement to the O-heterocyclic product 
593 under the previous conditions (18 hours at room temperature) Scheme 4.48.   
 
Scheme 4.53 
Formation of the half-cyclised sulfonamide 384 (p. 82) showed that steric factors probably play 
an important role in these cyclisations. However, the cascade example was successful with the 
carbamate derivative 603, which cyclized smoothly, again showing the utility of acetate protection, 
to give both bicyclic systems 608 and 610 (Scheme 4.54). A few studies on the N-  O-
rearrangement gave mixed results and were not clean. 
 
Scheme 4.54 
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Future work: 
1- Amino acid derivatives:  
The cyclohexenes 616 derived from dehydroalanine 614 by Diles-Alder cyclisation should cyclise 
to give the proline homologues 617 which may well undergo subsequent rearrangement to the O-
heterocycles 618, following reduction (Scheme 4.55). The incorporation of more substituents and 
examination of many different ring sizes could open up useful new routes to a whole series of 
proline analogues. 
 
Scheme 4.55 
2- Hydrothiolation vs hydroamination 
Related competitions between sulphur and nitrogen nucleophiles could also open up new 
approaches to many saturated heterocyclic systems. 
 
Scheme 4.56 
As two differing structures can thus be obtained from a single precursor, these strategies should find 
many applications in efficient and flexible heterocyclic synthesis. 
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There are also many opportunities to modify the nature of the acid catalyst used. In particular, the 
use of solid phase super acids such as Nafion-H offers the prospect of developing a flow system for 
carrying out this type of cyclisation chemistry. As yet, no Lewis acids have been tested in place of 
triflic or sulfuric acids; there are many types of such catalysts which have at least the required level 
of acidity. If successful, these too could be used in potentially very efficient flow systems and hence 
contribute to the conversion of this methodology into very environmentally friendly chemistry, 
despite the fact that it relies on very powerfully acidic conditions. 
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Chapter 5 
 
 Experimental 
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5.1 General experimental details  
Reagents were obtained from Aldrich, Alfa Aesar, Lancaster, Fluka and Strem chemical suppliers 
and used as received unless otherwise specified. Solvents and reagents were purified according to 
the procedures of Perrin, Armarego and Perrin.1 Dichloromethane and toluene were dried by 
refluxing over, and distilling from, calcium hydride. Ethanol was dried by refluxing over 
magnesium, followed by distillation.  Anhydrous diethyl ether and tetrahydrofuran were obtained 
by refluxing over sodium with sodium benzophenone ketyl as indicator, followed by distillation. 
“Petrol” refers to petroleum ether b.p. 40 - 60 °C, “ether” refers to diethyl ether.  
All aqueous solutions were saturated unless otherwise stated. All non-aqueous reactions were, 
unless otherwise stated, conducted using oven or flame-dried glassware and under an atmosphere 
of dry nitrogen. “Dried” refers to the addition of dried magnesium sulfate (MgSO4) to remove 
trace amounts of water at the work-up stage. “Filtered” refers to the removal of solid residues by 
gravity filtration of organic solutions through filter paper. “Evaporated” refers to the distillation of 
volatiles using a Büchi rotary evaporator attached to a 20 L Charles Austen pump at approx. 8 
mbar, heated with a water bath typically between 20 and 40 °C.  “Degassed” refers to bubbling 
nitrogen gas through the solvent for 30 minutes.   
Solid carbon dioxide and an acetone bath (-78 °C) or an ice-water bath (0 - 5 °C) were used to 
obtain low temperatures; “r.t.” stands for room temperature; “b.p.” stands for boiling point; “m.p.” 
stands for melting point. Heated reactions were conducted in a stirred oil bath heated on a 
magnetically stirred hotplate. 
All reactions were followed and monitored by TLC, 1H NMR, 13C NMR and mass spectrometry as 
appropriate. TLC analysis refers to analytical thin layer chromatography, using aluminium-backed 
plates coated with Merck Kieselgel 60 GF254.  Product spots were viewed either by the quenching 
of UV fluorescence, or by staining with a solution of 2% aqueous potassium permanganate.  
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Column chromatography refers to flash column chromatography using head pressure by means of 
compressed air according to the procedure of Still,2 and using Merck Kieselgel 60 H silica or 
Matrix silica 60.  Melting points were recorded using a Kofler Heated Stage Micro Melting Point 
apparatus and are uncorrected. Infra-red spectra were recorded in the range 4000-600 cm-1 using a 
Shimadzu 8400S series FTIR instrument, a diamond prism supported by a ZnSe lens, a solution in 
CDCl3. All absorptions are quoted in wave numbers (cm
-1).  
1H NMR spectra (δH) were recorded using an Avance Bruker DPX 400 (400 MHz).  13C NMR 
spectra (δH) were recorded using an Avance Bruker DPX 400 (500 MHz), with 13C NMR spectra 
(δC) recorded at 125 MHz unless otherwise stated.  Spectra were obtained as dilute solutions in 
deuterated chloroform, unless otherwise stated, in which case spectra were obtained in dilute 
solutions of fully deuterated dimethyl sulfoxide (DMSO-d6).  The chemical shifts were recorded 
relative to residual chloroform (7.26 or 77.0 ppm) as an internal standard unless otherwise stated, 
in which case chemical shifts were recorded relative to partially deuterated dimethyl sulfoxide 
(2.50 or 39.52).3  Abbreviations used for the multiplicities are s (singlet), d (doublet), t (triplet), q 
(quartet), br. (broad), dd (doublet of doublets), dt (doublet of triplets), td (triplet of doublets), m 
(unresolved multiplet), app. (apparent) or as a combination of these multiplicities. All coupling 
constants (J) are recorded in Hertz (Hz).  Assignments were made on the basis of chemical shift 
and coupling constant data using DEPT-90, DEPT-135, COSY, NOESY, HSQC and HMBC 
experiments where required. 
Mass spectrometric data were determined using a Waters GCT Premier instrument using electron 
ionisation (EI) unless otherwise stated, in which case mass spectrometric data were determined 
using a Waters LCT Premier XE instrument (LRMS) or Agilent 5975C Series GC/MSD (GC-MS) 
using pressure chemical ionisation (APCI) or electrospray ionisation (ES) as indicated.  High 
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resolution mass spectrometric data were determined with the molecular formula corresponding to 
the observed signal using the most abundant isotopes of each element. 
A literature reference associated with the title of compound means it is not a novel compound and 
any data recorded in this thesis matches well with those reported in the associated references, 
unless otherwise stated. 
5.2 General Procedures  
General Procedure A: Amine Protiction by Ts, Ns, CO2Me and Cbz (PG.).4 
The amine (1.0 eq.) was dissolved in dry dichloromethane (1 ml mmol-1) and the solution cooled 
in ice-water. Triethylamine (1.1 eq.) and the PG. chloride (1.1 eq.) were added sequentially. The 
resulting mixture was allowed to warm to room temperature over 2 h then quenched with water (1 
ml mmol-1) and 2M hydrochloric acid (1 ml mmol-1). The aqueous phase was extracted with 
dichloromethane (3 x 1 ml mmol-1). The combined organic extracts were washed with brine (0.5 
ml mmol-1) then dried, filtered and concentrated under reduced pressure to yield the crude product 
which was purified by filtration through a pad of silica gel or, if necessary, by column 
chromatography (gradient elution of silica gel with 0 - 100% dichloromethane in hexanes) to give 
the pure title compound. 
General Procedure B: Acid Catalyst Cyclization Reactions with sulfuric acid H2SO4. 
The starting compound (1.00 mmol)  was taken up in anhydrous dichloromethane (5 ml) and the 
solution was cooled in ice-water. Concentrated sulfuric acid (0.3 - 0.5 eq.) was then added. The 
completed reaction was quenched with saturated aqueous potassium carbonate (5 ml). The 
separated aqueous layer was extracted with dichloromethane (2 x 5 ml) and the combined organic 
extracts were dried, filtered and evaporated to yield the product.  
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General Procedure C: Reductions of oximes or cyanoacetates to the corresponding amines 
or amino-alcohols using lithium aluminium hydride; typical method. 
The oxime or cyanoacetate (19 mmol, 1.0 eq.) was dissolved in dry tetrahydrofuran (30 ml) and 
the solution added dropwise to a stirred suspension of lithium aluminium hydride (0.76 g, 20 
mmol, 1.1 eq. or 0.86 g, 45.5 mmol, 2.5 eq. in the case of a cyanoacetate, or as stated in an 
individual experiment) in tetrahydrofuran (20 ml) cooled in ice-water. The suspension was then 
refluxed for 3 h and subsequently cooled in an ice-water bath. When it was cold, water (5 ml) and 
15% aqueous NaOH (5 ml) were added sequentially and the resulting mixture then stirred for one 
hour. The precipitated salts were then filtered off and washed with tetrahydrofuran (40 ml). The 
combined filtrates were concentrated and the liquid residue extracted with dichloromethane (2 x 
10 ml). The combined extracts were dried and concentrated to give the amine or amino-alcohol, 
which was typically sufficiently pure to be used immediately in a subsequent step.  
Solvent quantities were scaled in line with foregoing quantities for different scales of reaction. 
5.3. Experimental Procedures 
6-Methylhept-5-en-2-one oxime 2345 
 
To a solution of the ketone 233 (2.52 g, 20 mmol, 1.0 eq) and hydroxylamine hydrochloride (2.09 
g, 30 mmol, 1.5 eq) in ethanol (30 ml) was added sodium acetate (1.0 g, 12.2 mmol) in one 
portion. The reaction mixture was heated at 40 oC for 2 h and then concentrated on a rotary 
evaporator. The residue was partitioned between ether (50 ml) and water (10 ml). The separated 
organic layer was dried and evaporated to give the oxime 234 (2.70 g, 95%) as a 3:1 mixture of 
isomers and as a colourless liquid which was used directly in the next step. All data obtained were 
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in accordance with those previously reported in the literature:5 δH 9.75 – 8.00 (br. s, NOH), 5.30– 
5.00 (m, 1H, =CH), 2.24 – 2.10 (m, 4H, 2 × CH2), 1.91 (2 x s, 3H,  E:Z isomers 3:1 ratio, CH3),* 
1.70 (s, 3H, CH3), 1.63 (s, 3H, CH3). δC 158.7 (Cq), 132.7 (Cq), 122.8 (CH), 35.8 (CH2), 25.7 
(CH3), 25.0 (CH2), 17.6 (CH3), 13.5 (CH3).  
* 3:1 ratio determined after expansion of the apparent singlet. 
6-Methylhept-5-en-2-amine 2356 
 
By general procedure C, the oxime 235 (2.70 g, 19 mmol, 1.0 eq.) was reduced using lithium 
aluminium hydride (0.38 g, 20 mmol, 1.1 eq.) to give the amine 236 (2.20 g, 90%) as a clear oil, 
which was used directly in the next step. All data obtained were in accordance with those 
previously reported in the literature:6 δH 5.10 – 5.00 (m, 1H, =CH), 2.85 (app. sext, 1H, J = ca. 6.5 
Hz, NCH), 2.10 – 1.89 (m, 2H, CH2), 1.60 (s, 3H, CH3), 1.57 (s, 3H, CH3), 1.40 – 1.20 (m, 2H, 
CH2), 0.95 (d, 3H, J = 6.3 Hz, CH3). δC 133.2 (Cq), 124.2 (CH), 46.6 (NCH), 35.9 (CH2), 25.7 
(CH2), 25.0 (CH3), 21.0 (CH3), 17.7 (CH3). 
N-(6-Methylhept-5-en-2-yl)-4-methyl benzenesulfonamide 2367 
 
By general procedure A, p-tosyl chloride (2.10 g, 11.0 mmol, 1.1 eq.) was added to the amine 235 
(1.20 g, 10.0 mmol, 1.0 eq.) and Et3N (1.25 ml, 11.0 mmol) to give the sulfonamide 236 as a clear 
oil (2.1 g, 75%). All data obtained were in accordance with those previously reported in the 
literature:7 δH 7.74 – 7.64 (m, 2H), 7.27 – 7.21 (m, 2H), 4.91 - 4.85 (m, 1H, =CH), 4.21 (d, J = 8.1 
Hz, NH), 3.41 – 3.01 (m, 1H, NCH), 2.36 (s, 3H, ArCH3), 1.92 – 1.86 (m, 2H, CH2), 1.51 (s, 3H, 
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CH3), 1.45 (d, J = 1.3 Hz, 3H, CH3), 1.30 (dt, J = 7.7, 6.5 Hz, 2H, CH2), 0.97 (d, J = 6.5 Hz, 3H, 
CH3). δC 154.6 (Cq), 143.3 (Cq), 132.5 (Cq), 129.2 (2 x CH), 126.3 (2 x CH), 123.7 (CH), 50.6 
(NCH), 37.3 (CH2), 26.6 (ArCH3), 24.2 (CH2),  21.7 (CH3), 21.4 (CH3), 17.5 (CH3). IR (neat) 
υ/cm-1: 3282, 2970, 2924, 1599, 1303, 1150. HRMS (EI) m/z calculated for C15H23NO2S [M]+ = 
281.1450; found: 281.1443. 
1-Toluenesulfonyl-2,2,6-trimethylpiperidine 237 
 
By general procedure B, to sulfonamide 236 (140 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen, concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for one hour at 0 oC to give the piperidine 237 (105 mg, 75% after crystallization 
in dichloromethane/hexanes) as sharp, colourless crystals, m.p. 82 – 83°C. δH 7.74 (d, J = 8.2 Hz, 
2H), 7.27 (d, J = 8.2 Hz 2H), 4.45 – 4.55 (m, 1H, NCH), 2.41 (s, 3H, ArCH3), 1.84 – 1.75 (m, 
2H), 1.70 – 1.65 (m, 1H), 1.53 (s, 3H, CH3), 1.32 (d, J = 6.9 Hz, 3H, CH3), 1.45 – 1.35 (m, 3H, 
CH2 and CH), 1.07 (s, 3H, CH3). δC 142.2 (Cq), 140.0 (Cq), 129.4 (2 x CH), 126.2 (2 x CH), 58.2 
(Cq, 2-C), 51.3 (NCH, 6-CH), 41.0 (CH2), 30.9 (ArCH3), 30.2 (CH2), 29.6 (CH3), 22.6 (CH3), 
22.6 (CH3), 15.3 (CH2). IR (neat) υ/cm-1: 2936, 2873, 1599, 1465, 1321, 1158, 1141, 1095. HRMS 
(EI) m/z calculated for C15H23NO2S [M]
+ = 281.1450; found: 281.1453. 
(Cis and trans)-2-Isopropyl-5-methyl-1-tosylpyrrolidine 239 
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By general procedure B, to sulfonamide 236 (88 mg, 0.3 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (2 drops) was added and the resulting mixture stirred for 
1 h at 20 oC to give the pyrrolidine 239 (82 mg, 93%) (1.4:1 ratio) as a colourless oil. All data 
obtained were in accordance with those previously reported in the literature:8 Major -2-isopropyl-
5-methylpyrrolidine:  δH 7.62 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 3.66 – 3.62 (m, 1H, 
NCH), 3.32 (dd, J = 12.4, 7.0 Hz, 1H, NCH), 2.30 (s, 3H, Ar-CH3), 2.03 – 1.93 (m, 1H, CH), 1.85 
– 1.78 (m, 2H, CH2), 1.58 – 1.51 (m, 1H, CH), 1.37 – 1.29 (m, 1H, CH), 1.14 (d, J = 6.4 Hz, 3H, 
CH3), 0.74 (d, J = 7.0 Hz, 3H, CH3), 0.50 (d, J = 6.8 Hz, 3H, CH3). 
Minor -2- isopropyl-5-methylpyrrolidine: δH 7.63 (d, J = 8.0 Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 
4.06 – 3.98 (m, 1H, NCH), 3.66 – 3.62 (m, 1H, NCH), 2.33 (s, 3H, Ar-CH3), 1.67 – 1.62 (m, 1H, 
CH), 1.58 – 1.51 (m, 1H, CH), 1.48 – 1.39 (m, 2H, CH2), 1.33 – 1.25 (m, 1H, CH), 1.20 (d, J = 6.4 
Hz, 3H, CH3), 0.88 (d, J = 6.9 Hz, 3H, CH3), 0.82 (d, J = 6.7 Hz, 3H, CH3). 
5-Methyl-4-hexenenitrile 2539 
 
n-Butyllithium (12.8 ml of a 1.6 M solution in hexanes, 20.0 mmol, 1.05 eq) was added via 
syringe to a solution of acetonitrile (0.86 g, 20 mmol, 1.05 eq) in dry tetrahydrofuran (50 ml) at -
70 °C. After stirring the mixture at -70 °C for 15 min, the bromide 252 (2.90 g, 19 mmol, 1.0 eq) 
in dry tetrahydrofuran (25 ml) was added. The mixture was stirred at -50 °C for 0.5 h and at room 
temperature for a further 2 h. Saturated aqueous ammonium chloride (50 ml) was added and the 
resulting mixture extracted with ether (3 x 10 ml). The combined organic extracts were dried, 
filtered and evaporated to yield the nitrile 253 (1.90 g, 85%) as a yellowish oil. All data obtained 
were in accordance with those previously reported in the literature:9 δH 5.16 – 4.97 (m, 1H, =CH), 
2.27 (t, J = 6.6 Hz, 2H, CH2), 2.22 (q, J = 6.9 Hz, 2H, CH2), 1.65 (s, 3H, CH3), 1.58 (s, 3H, CH3). 
δC 135.8 (Cq), 122.4 (=CH), 119.6 (CN), 25.7 (CH3), 24.1 (CH2), 17.9 (CH2), 17.8 (CH3). 
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5-Methylhex-4-en-1-amine 254 
 
By general procedure C, 5-methyl-4-hexene nitrile 253 (1.90 g, 17 mmol, 1.0 eq.) was reduced 
using lithium aluminium hydride (0.76 g, 20 mmol, 1.1eq.) to give the amine 254 (1.57 g, 83%) as 
a clear oil, which was used directly in the next step. All data obtained were in accordance with 
those previously reported in the literature:8 δH 5.04 – 5.10 (m, 1H, =CH), 2.69 – 2.44 (m, 2H, 
CH2N), 1.90 – 2.08 (m, 2H, CH2), 1.63 (s, 3H, CH3), 1.53 (s, 3H, CH3), 1.21 – 1.10 (m, 2H, CH2). 
δC 132.2 (Cq), 122.9 (=CH), 42.8 (CH2N), 30.3 (CH2), 25.6 (CH2), 17.8 (CH3), 17.6 (CH3). 
N-(5-Methylhex-4-en-1-yl)-4-methyl benzenesulfonamide 24910 
 
By general procedure A, p-tosyl chloride (2.10 g, 11.0 mmol, 1.1 eq.) was added to the amine 254 
(1.10 g, 10.0 mmol, 1.0 eq.) and Et3N (1.25 ml, 11.0 mmol, 1.1 eq.) to give the sulfonamide 249 as 
a clear oil (1.19 g, 46%). All data obtained were in accordance with those previously reported in 
the literature:8 δH 7.68 (d, J = 8.2 Hz, 2H), 7.20 (d, J = 8.2 Hz, 2H), 4.91 (t, J = 7.2 Hz, 1H, =CH), 
4.60 (t, J = 6.1 Hz, 1H, NH), 2.85 (td, J = 7.2, 6.1 Hz, 2H, CH2N), 2.36 (s, 3H, ArCH3), 1.95 – 
1.79 (m, 2H, CH2), 1.58 (s, 3H, CH3), 1.46 (s, 3H, CH3), 1.41 (p, J = 7.2 Hz, 2H, CH2). δC 143.3 
(Cq), 137.1 (Cq), 132.7 (Cq), 129.6 (2 x CH), 127.1 (2 x CH), 124.0 (=CH), 42.9 (CH2N), 29.6 
(CH2), 25.6 (ArCH3), 25.0 (CH2), 21.5 (CH3), 17.6 (CH3). IR (neat) υ/cm-1: 3287, 2928, 2257, 
1599, 1323, 1157, 1094, 907, 814. HRMS (EI) m/z calculated for C14H21NO2S [M]
+ = 267.1293; 
found: 267.1287. 
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2,2-Dimethyl-1-tosylpiperidine 2508 
 
By general procedure B, to sulfonamide 249 (112 mg, 0.42 mmol, 1.0 eq) in dry dichloromethane 
(10 ml) under nitrogen, concentrated sulfuric acid (25 mg, 0.25 mmol, 0.6 eq) was added and the 
resulting mixture stirred for 50 min at room temperature to give the piperidine 250 (110 mg, 98%) 
as yellowish crystals, m.p. 66 – 67 °C. All data obtained were in accordance with those previously 
reported in the literature:8 δH 7.64 – 7.53 (m, 2H), 7.23 – 7.10 (m, 2H), 3.40 (t, J = 6.0 Hz, 2H, 
CH2N), 2.31 (s, 3H, Ar CH3), 1.61 – 1.42 (m, 4H, 2 x CH2), 1.35 (t, J = 6.7 Hz, 2H, CH2), 1.18 (s, 
6H, 2 x CH3). δC 142.5 (Cq) , 140.5 (Cq), 129.4 (2 x CH), 126.9 (2 x CH), 57.9 (Cq, 2-C), 43.7 
(CH2N), 41.3 (CH2), 26.2 (ArCH3), 26.2 (CH2), 21.4 (2 x CH3), 20.5 (CH2). IR (neat) υ/cm-1: 
2930, 2866, 1599, 1454, 1157, 1319, 1139, 943, 814, 673. HRMS (EI) m/z calculated for 
C14H21NO2S [M]
+ = 267.1293; found: 267.1287. 
2-Isopropyl-1-tosylpyrrolidine 251 
 
The sulfonamide 249  (0.14 g, 0.5 mmol) was dissolved in dry toluene (10 ml) and to this triflic 
acid (76 mg, 46 µl, 0.5 mmol) was added and the resulting solution stirred for 25 h at 110 oC. The 
reaction was allowed to cool and was then quenched with saturated aqueous potassium carbonate 
(10 ml). The quenched solution was then separated and the aqueous layer was extracted with ether 
(3 x 10 ml). The combined organic solutions were dried and evaporated to give the pyrrolidine 
251 as a yellow oil (113 mg, 81%). All data obtained were in accordance with those previously 
reported in the literature:11 δH 7.74 (d, J = 8.3 Hz, 2H), 7.52 (d, J = 8.3 Hz, 2H), 3.70 (dt, J = 8.1, 
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5.1 Hz, 1H, NCH), 3.25 – 3.21 (m, 2H, NCH2), 2.24 (s, 3H, ArCH3), 2.16 – 2.15 ( m, 1H, CH), 
1.85 (p, J = 6.9 Hz, 2H, CH2), 1.65 – 1.54 (m, 2H, CH2), 0.85 (d, J = 6.0 Hz, 3H, CH3), 0.81 (d, J 
= 6.8 Hz, 3H, CH3).  
N-(6-Methylhept-5-en-2-yl)-4-nitrobenzenesulfonamide 260 
 
By general procedure A, p-nitrobenzenesulfonyl chloride (1.24 g, 5.62 mmol, 1.7 eq.) was added 
to the amine 235 (0.40 g, 3.3 mmol, 1.0 eq.) and Et3N (0.8 ml, 4.0 mmol, 1.2 eq.) to give the nosyl 
derivative 260 (0.50 g, 50%). as a clear oil. δH 8.37 – 8.19 (m, 2H), 8.07 – 7.94 (m, 2H), 4.91 (d, J 
= 8.3 Hz, NH), 4.91 – 4.62 (m, 1H, =CH), 3.50 – 3.11 (m, 1H, NCH), 1.93 – 1.68 (m, 2H), 1.56 (s, 
3H), 1.44 (d, J = 1.3 Hz, 3H), 1.34 (dt, J = 7.7, 6.6 Hz, 2H), 1.01 (d, J = 6.6 Hz, 3H). δC 149.8 
(Cq), 147.3 (Cq), 132.7 (Cq), 128.2 (2 x CH), 124.3 (2 x CH), 122.7 (CH), 50.3 (CH), 37.3 (CH2), 
25.6 (CH3), 24.2 (CH2), 21.7 (CH3), 17.6 (CH3). IR (neat) υ/cm-1: 3295, 2967, 2922, 2855, 1607, 
1530, 1350, 1306, 1160, 1092. HRMS (EI) m/z calculated for C14H20N2O4S [M]
+ = 312.1144; 
found: 312.1138. 
1-(4-Nitrophenylsulfonyl)-2,2,6-trimethylpiperidine 261 
 
By general procedure B, to sulfonamide  260 (125 mg, 0.4 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting mixture 
stirred for three hours at 0 oC to give the piperidine 261 (76 mg, 61% after crystallization from 
dichloromethane/hexanes) as sharp, yellowish crystals, m.p. 124 – 127°C. δH 8.13 (d, J = 8.0 Hz, 
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2H), 7.82 (d, J = 8.0 Hz, 2H), 4.40 – 4.34 (m, 1H, NCH), 1.74 – 1.60 (m, 1H), 1.60 – 1.50 (m, 
2H), 1.45 – 1.38 (m, 2H), 1.36 (s, 3H, CH3), 1.32 (d, J = 7.0 Hz, 3H, CH3), 1.26 – 1.14 (m, 1H), 
1.07 (s, 3H, CH3). δC 151.2 (Cq), 149.3 (Cq), 127.4 (2 x CH), 124.2 (2 x CH), 58.3 (Cq, 2-C), 52.3 
(NCH, 6-CH), 41.0 (CH2), 30.9 (CH3), 30.6 (CH2), 29.0 (CH3), 23.6 (CH3), 15.3 (CH2). 
IR (neat) υ/cm-1: 2978, 2942, 2868, 1604, 1524, 1346, 1167, 1134, 1095, 1034, 747. HRMS 
(APCI) m/z calculated for C14H21N2O4S [M+H]
+ = 313.1222; found: 313.1221. 
(Cis and trans)- 2-Isopropyl-5-methyl-1-(4-nitrophenylsulfonyl)pyrrolidine 262 
 
By general procedure B, to sulfonamide 260 (145 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting mixture 
stirred for 2 hours at 20 oC to give the pyrrolidine 262 (137 mg, 94%) (cis:trans 2:1 ratio) as a 
colourless oil. Cis-2-isopropyl-5-methylpyrrolidine:  δH 8.31 – 8.19 (m, 2H), 7.98 – 7.93 (m, 2H), 
4.09 (dt, J = 11.9, 5.8 Hz, 1H, 2-H), 3.79 – 3.72 (m, 1H, 5-H), 2.36 – 2.32 (m, 1H), 2.31 – 2.23 
(ddt, J = 13.8, 6.9, 4.6 Hz, 1H), 1.91 – 1.87 (m, 1H), 1.56 – 1.48 (m, 1H),  1.44 (ddt, J = 13.8, 7.0, 
4.6 Hz, 1H), 1.20 (d, J = 6.4 Hz, 3H, CH3), 0.81 (d, J = 4.9 Hz, 3H, CH3), 0.47 (d, J = 6.9 Hz, 3H, 
CH3). δC 149.6 (Cq), 148.3 (Cq), 128.7 (CH), 128.0 (2 x CH), 124.2 (2 x CH), 65.2 (NCH), 58.4 
(NCH), 32.8 (CH2), 29.7 (CH), 23.4 (CH2), 21.2 (CH3), 19.8 (CH3), 15.3 (CH3).  
Trans-2- isopropyl-5-methylpyrrolidine: δH 8.34 – 8.28 (m, 2H), 8.09 – 8.04 (m, 2H), 3.68 – 3.58 
(m, 1H, 2-CH), 3.37 (dd, J = 12.5, 7.0 Hz, 1H), 2.06 – 2.00 (m, 1H), 1.87 – 1.81 (m, 1H), 1.71 
(ddd, J = 8.6, 5.2, 2.7 Hz, 1H), 1.68 – 1.59 (m, 1H), 1.26 (d, J = 6.9 Hz, 3H, CH3), 0.79 (dd, J = 
6.8, 5.0 Hz, 1H), 0.92 (d, J = 6.9 Hz, 3H, CH3), 0.86 (d, J = 6.7 Hz, 3H, CH3). δC 150.0 (Cq), 
144.0 (Cq), 128.7 (CH), 128.0 (2 x CH), 124.2 (2 x CH),  67.9 (NCH), 57.8 (NCH), 31.9 (CH2), 
31.4 (CH), 25.4 (CH2), 21.2 (CH3), 20.0 (CH3), 15.3 (CH3). 
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N-(6-Methylhept-5-en-2-yl)methanesulfonamide 26312 
 
By general procedure A, methanesulfonyl chloride (0.63 g, 5.5 mmol, 1.1 eq.) was added to the 
amine 235 (0.60 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol, 1.1 eq.) to give the N-mesyl 
derivative 263 as a clear oil (0.70 g, 68%). All data obtained was in accordance with that 
previously reported:8 δH 5.17 – 4.99 (m, 1H, =CH), 4.89 – 4.67 (m, 1H, NH), 3.11 – 2.98 (m, 1H, 
NCH), 2.98 (s, 3H, Ms-CH3), 2.23 – 1.91 (m, 2H, CH2), 1.87 – 1.69 (m, 2H, CH2), 1.67 (d, J = 1.5 
Hz, 3H, CH3), 1.64 (s, 3H, CH3), 1.41 (d, J = 6.2 Hz, 3H, CH3). 
N-(6-Methylhept-5-en-2-yl)-2,2,2-trifluoroacetamide 272 
 
A solution of the amine 235 (0.60 g, 5.0 mmol, 1.0 eq.), trifluoroacetic anhydride (0.73 g, 5.5 
mmol, 1.1 eq.) and pyridine (0.6 ml, 5.5 mmol, 1.1 eq.) in dry dichloromethane (10 ml) was stirred 
for 6 h at room temperature. The mixture was quenched with water (5 ml). The separated aqueous 
layer was extracted with dichloromethane (2 x 5 ml) and the combined organic solutions were 
washed with saturated aqueous copper(II) sulfate (5 ml) and water (5 ml) then dried and 
concentrated to give the trifluoroacetamide 272 as a clear oil (0.70 g, 68%). δH 6.88 - 6.67 (m, 1H, 
NH), 5.10 – 4.50 (m, 1H, =CH), 3.99 – 3.51 (m, 1H, NCH), 1.95 – 2.05 (m, 2H, CH2), 1.60 (s, 3H, 
CH3), 1.51 (s, 3H, CH3), 1.50 – 1.45 (m, 2H, CH2), 1.14 (d, J = 6.7 Hz, 3H, CH3). δC 156.6 (q, J = 
36.6 Hz, Cq), 132.8 (Cq), 123.0 (=CH), 115.9 (q, J = 288.0 Hz, CF3), 46.3 (NCH),  35.9 (CH2), 
25.6 (CH3), 24.4 (CH2), 20.1 (CH3), 17.5 (CH3). IR (neat) υ/cm-1: 3293, 2978, 2924, 1699, 1557, 
1182, 723. HRMS (EI) m/z calculated for C10H16F3NO [M]
+ = 223.1184; found: 223.1179. 
                                                                                                                                                            166 
N-(6-Methylhept-5-en-2-yl)acetamide 277 
 
By general procedure A, acetyl chloride (0.43 g, 5.5 mmol, 1.1 eq.) was added to the amine 235 
(0.60 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol) to give the acetamide 277 as a clear oil 
(0.5 g, 63%). δH 6.25 (d, J = 8.7 Hz, 1H, NH), 5.10 – 4.89 (m, 1H, =CH), 3.97 – 3.73 (m, 1H, 
NCH), 1.96 – 1.90 (m, 2H, CH2), 1.88 (s, 3H, COCH3), 1.59 (s, 3H, CH3), 1.51 (s, 3H, CH3), 1.47 
– 1.28 (m, 2H), 1.04 (d, J = 6.6 Hz, 3H, CH3). δC 169.5 (Cq), 131.7 (Cq), 123.6 (=CH), 44.9 
(NCH), 36.7 (CH2), 25.5 (CH3), 24.6 (CH2), 23.2 (CH3), 20.9 (CH3), 20.7 (CH3). IR (neat) υ/cm-1: 
3269, 2969, 2928, 1722, 1640, 1549, 1441, 1373, 1284. HRMS (EI) m/z calculated for C10H19NO 
[M]+ = 169.1467; found: 169.1463. 
1-Acetyl-2,2,6-trimethylpiperidine 278 
 
By general procedure B, to the amide 277 (151 mg, 0.9 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting mixture 
stirred for 50 min at room temperature to give the piperidine 278 as a colourless oil (149 mg, 
99%). δH 3.94 – 3.79 (m, 1H, NCH), 1.87 (s, 3H, Ac-CH3), 1.45 – 1.24 (m, 6H, 3 x CH2), 1.10 (d, 
J = 6.4 Hz, 3H, CH3), 1.04 (s, 3H, CH3), 1.03 (s, 3H, CH3). δC 169.6 (C=O), 70.7 (Cq, 2-C), 45.1 
(NCH, 6-CH), 43.3 (CH2), 37.3 (CH2), 29.2 (Ac-CH3), 23.4 (CH3), 21.0 (2 x CH3), 20.6 (CH2). IR 
(neat) υ/cm-1: 3293, 2964, 2934, 2870, 1672, 1549, 1448, 1373, 1259, 1161, 1089, 1012, 910, 796, 
731. HRMS (EI) m/z calculated for C10H19NO [M]
+ = 169.1467; found: 169.1466. 
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N-(6-Methylhept-5-en-2-yl)benzamide 285 
 
By general procedure A, benzoyl chloride (0.77 g, 5.5 mmol, 1.1 eq.) was added to the amine 235 
(0.60 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol, 1.1 eq.) to give the benzamide 285 (0.83 
g, 72%) as a clear oil. δH 7.74 – 7.59 (d, J = 7.1, 2H), 7.44 – 7.37 (m, 1H), 7.43 – 7.23 (m, 2H), 
6.35 (br. s, 1H, NH), 5.07 (br. t, J = 7.1, =CH), 4.26 – 4.00 (m, 1H, NCH), 2.01 (dt, J = 10.6, 7.1 
Hz, 2H, CH2), 1.60 (d, J = 1.4 Hz, 3H, CH3), 1.51 (s, 3H, CH3), 1.48 - 1.52 (m, 2H, CH2), 1.16 (d, 
J = 6.5 Hz, 3H, CH3). δC 135.1 (Cq), 132.2 (Cq) , 131.2 (CH), 128.5 (2 x CH), 126.8 (2 x CH), 
123.8 (CH), 45.7 (CH), 36.9 (CH2), 25.7 (CH3), 24.70 (CH2), 21.0 (CH3), 17.7 (CH3). IR (neat) 
υ/cm-1: 3320, 2967, 2931, 1716, 1640, 1578, 1541, 1491, 1450, 1276, 1161, 910, 723. HRMS 
(APCI) m/z calculated for C15H22NO [M+H]
+ = 232.1701; found: 232.1712.  
1-Benzoyl-2,2,6-trimethylpiperidine 286 
 
By general procedure B, to the amide 285 (0.23 g, 1 mmol) in dry dichloromethane (10 ml) under 
nitrogen triflic acid (76 mg, 46 µl, 0.5 mmol, 0.5 eq) was added and the resulting mixture stirred 
for 10 min at room temperature to give the piperidine 286 as a colourless oil (138 mg, 60%). δH 
7.65 (dd, J = 6.9, 2.2 Hz, 2H), 7.41 – 7.36 (m, 1H), 7.36 – 7.29 (m, 2H), 4.20 – 4.05 (m, 1H, 
NCH), 1.49 – 1.44 (m, 4H, 2 x CH2), 1.39 – 1.33 (m, 2H, CH2), 1.16 (d, 3H, J = 6.5 Hz, CH3), 
1.12 (s, 3H, CH3), 1.11 (s, 3H, CH3). δC 166.9 (C=O), 131.2 (CH), 128.5 (2 x CH), 127.0 (2 x 
CH), 70.8 (Cq, 2-C), 45.7 (NCH, 6-CH), 36.8 (CH2), 29.4 (Ac-CH3), 25.7 (CH3), 24.7 (CH2) 21.0 
(2 x CH3), 20.7 (CH2). IR (neat) υ/cm-1: 3302, 2963, 2930, 1717, 1603, 1578, 1537, 1491, 1271, 
1160, 910, 731. HRMS (APCI) m/z calculated for C15H22NO [M+H]
+ = 232.1701; found: 
232.1701.  
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Benzyl N-(6-methylhept-5-en-2-yl)carbamate 294 
 
By general procedure A, benzyl chloroformate (0.95 g, 5.5 mmol, 1.1 eq.) was added to the amine 
235 (0.60 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol, 1.1 eq.) to give the Z-carbamate 294 
as a clear oil (0.90 g, 70%). δH 7.37 – 7.20 (m, 5H), 5.15 – 4.90 (m, 4H), 3.70 – 3.53 (m, 1H, 
NCH), 2.00 – 1.87 (m, 2H, CH2), 1.64 (s, 3H, CH3), 1.54 (s, 3H, CH3), 1.42 – 1.28 (m, 2H, CH2), 
1.05 (d, J = 7.1, 3H, CH3). δC 156.1 (Cq, C=O), 137.3 (Cq), 128.4 (2 x CH), 127.9 (CH), 127.7 (2 
x CH), 123.9 (=CH),  66.5 (OCH2Ph), 48.3 (NCH), 39.2 (CH2), 29.7 (CH3), 28.3 (CH2), 27.8 
(CH3), 21.9 (CH3). IR (neat) υ/cm-1: 2967, 2936, 1696, 1456, 1329, 1290, 1148, 1062, 773, 696. 
HRMS (EI) m/z calculated for C16H23NO2 [M]
+ = 261.1729; found: 261.1730. 
Benzyl 2,2,6-trimethylpiperidine-1-carboxylate 295 
 
By general procedure B, to carbamate 294 (130 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting mixture 
stirred for 3 min at room temperature to give the piperidine 295 as a colourless oil (92 mg, 71%). 
δH 7.32 – 7.27 (m, 4H), 7.25 – 7.20 (m, 1H), 5.07 (d, J = 12.5, 1H, OCHAHB), 5.02 (d, J = 12.5, 
1H, OCHAHB),  4.35 – 4.25 (m, 1H, NCH), 1.76 – 1.54 (m, 3H), 1.50 – 1.47 (m, 2H, CH2), 1.41 
(s, 3H, CH3), 1.40 – 1.37 (m, 1H), 1.32 (s, 3H, CH3), 1.13 (d, J = 6.9 Hz, 3H, CH3). δC 156.1 (Cq), 
137.2 (Cq), 128.5 (2 x CH), 127.8 (2 x CH), 127.7 (CH), 66.4 (OCH2), 54.4 (Cq, 2-C), 48.3 
(NCH, 6-CH), 39.2 (CH2), 29.8 (CH3), 28.3 (CH2), 27.8 (CH3), 21.9 (CH3), 14.7 (CH2). IR (neat) 
υ/cm-1: 2967, 2935, 1695, 1496, 1456, 1329, 1300, 1148, 1063, 1049, 1028, 696. HRMS (APCI) 
m/z calculated for C16H23NO2 [M]
+ = 261.1729; found: 261.1732. 
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Methyl 6-methylhept-5-en-2-ylcarbamate 300 
 
By general procedure A, methyl chloroformate (1.50 ml, 20 mmol) was added to the amine 235 
(2.20 g, 17.5 mmol) and Et3N (2.5 ml, 22 mmol) to give the carbamate 300 as a clear oil (0.61 g, 
38%). δH 5.05 - 4.95 (m, 1H, =CH), 4.75 (br. s, 1H, NH), 3.50 –  3.60  (m, 1H, NCH), 3.59 (s, 3H, 
OCH3), 1.94 (app. q, 2H, J = 7.5 Hz, CH2), 1.61 (s, 3H, CH3), 1.52 (s, 3H, CH3), 1.42 – 1.30 (m, 
2H, CH2), 1.06 (d, 3H, J = 6.0 Hz, CH3). δC 156.3 (C=O), 131.8 (Cq), 123.5 (=CH), 51.6 (OCH3), 
46.7 (NCH), 36.9 (CH2), 25.4 (CH3), 24.4 (CH2), 21.0 (CH3), 17.4 (CH3). IR (neat) υ/cm-1: 3374, 
2967, 2915, 1723, 1527, 1441, 1234, 885. HRMS (EI) m/z calculated for C10H19NO2 [M]
+ = 
185.1416; found: 185.1414. 
Methyl 2,2,6-trimethylpiperidine-1-carboxylate 301 
 
By general procedure B, to methyl carbamate 300 (180 mg, 1.41 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 50 min at room temperature to give the piperidine 301 (157 mg, 87%) as a 
colourless oil. δH 4.24 – 4.17 (m 1H, NCH), 3.55 (s, 3H, OCH3), 1.71 – 1.60 (m, 4H, 2 × CH2), 
1.55 – 1.45 (m, 2H, CH2), 1.42 (s, 3H, CH3), 1.25 (s, 3H, CH3), 1.10 (d, 3H, J = 6.9 Hz, CH3). δC 
156.8 (C=O), 54.1 (Cq, 2-C), 51.6 (CH3O), 48.1 (NCH, 6-CH), 39.0 (CH2), 29.5 (CH3), 28.2 
(CH2), 27.7 (CH3), 21.8 (CH3), 14.6 (CH2). IR (neat) υ/cm-1: 2949, 2872, 1701, 1438, 1342, 1332, 
1303, 1288, 1148, 1192. HRMS (APCI) m/z calculated for C10H20NO2 [M+H]
+ = 186.1494; found: 
186.1493. 
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6-Phenylhex-5-en-2-one 30313 
 
A mixture of ethyl acetoacetate 302 (5.12 g, 40 mmol, 1.0 eq.), cinnamyl chloride (6.10 g, 40 
mmol, 1.0 eq.), anhydrous potassium carbonate (6.63 g, 40 mmol, 1.0 eq.) and ethanol (50 ml) 
was reﬂuxed overnight. The solvent was removed by atmospheric distillation. The residue was 
diluted with water (20 ml) and extracted with ether (2 × 20 ml). The combined organic layers were 
washed with water (3 × 5 ml), brine (3 × 5 ml), then dried and evaporated. The crude product was 
separated by silica gel column chromatography (eluting silica gel with 0 - 10% dichloromethane in 
hexanes) to give the ketone 303 (3.83 g, 55% yield) as a yellow oil. All data obtained were in 
accordance with those previously reported in the literature:13 δH 7.35 – 7.13 (m, 4H), 7.10 – 7.05 
(m, 1H), 6.40 (d, J = 15.6, 1H, =CH), 6.20 (dt, J = 15.6, 6.8, 1H, =CH), 2.50 (t, J = 6.8, 2H, 3-
CH2), 2.41 (app. q, J = 6.8, 2H, 4-CH2), 2.02 (s, 3H, CH3). δC 207.7 (C=O), 137.5 (Cq), 130.8 
(CH), 128.8 (CH), 128.6 (CH), 128.5 (CH), 128.0 (CH), 127.1 (CH), 126.0 (CH), 43.1 (CH2), 29.9 
(CH3), 27.1 (CH2). 
6-Phenylhex-5-en-2-one oxime 30414 
 
To a solution of ketone 303 (3.80 g, 22 mmol, 1.0 eq) and hydroxylamine hydrochloride (2.09 g, 
30 mmol, 1.4 eq) in ethanol (30 ml) was added sodium acetate (1.0 g, 12.2 mmol) in one portion. 
The reaction mixture was heated at 40 oC for 2 h and then concentrated on a rotary evaporator. 
The residue was partitioned between ether (50 ml) and water (10 ml). The separated organic layer 
was dried. Evaporation provided the oxime 304 (3.70 g, 90%) as a 2:1 mixture of isomers as a 
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thick yellow liquid, which was used directly in the next step. All data obtained were in accordance 
with those previously reported in the literature:14 δH 7.41 (br. s, NOH), 7.26 – 7.15 (m, 4H), 7.12 – 
7.06 (m, 1H), 6.36 – 6.26 (m, 1H, =CH), 6.10 (dt, J = 15.8, 6.7 Hz, 1H), 2.37 – 2.29 (m, 2H), 2.29 
– 2.23 (m, 2H), 1.83 (s, 2H, CH3, major isomer), 1.79 (s, 1H, CH3, minor isomer). δC 140.8 (Cq), 
137.6 (Cq), 132.5 (CH), 129.0 (CH), 128.3 (2 x CH), 126.9 (CH), 126.0 (2 x CH), 45.6 (CH2), 
41.8 (CH2), 38.2 (CH3). 
6-Phenylhex-5-en-2-amine 30515 
 
By general procedure C, the oxime 304 (3.70 g, 19.5 mmol) was reduced using lithium aluminium 
hydride (0.38 g, 20 mmol) to give the amine 305 (2.40 g, 70%) as thick yellow oil, which was 
sufficiently pure to be used directly in the next step. All data obtained were in accordance with 
those previously reported in the literature:15  δH 7.28 – 7.15 (m, 4H), 7.14 – 7.06 (m, 1H), 6.31 (dt, 
J = 15.7, 1.5 Hz, 1H, =CH), 6.12 (dt, J = 15.7, 6.8 Hz, 1H, =CH), 2.80 – 2.71 (m, 1H, NCH),  2.22 
– 2.07 (m, 2H, CH2), 1.42 (td, J = 7.9, 6.4 Hz, 2H, CH2), 1.01 (d, J = 6.3 Hz, 3H, CH3). 
 
Methyl (6-phenylhex-5-en-2-yl)carbamate 306 
 
By general procedure A, methyl chloroformate (0.75 ml, 10 mmol, 1.5 eq.) was added to the 
amine 305 (1.10 g, 6.85 mmol, 1.0 eq.) and Et3N (1.25 ml, 11 mmol, 1.2 eq.) to give the 
carbamate 306 as a clear oil (0.72 g, 48%). δH 7.31 – 7.16 (m, 4H), 7.14 – 7.10 (m, 1H), 6.32 (d, J 
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= 15.9 Hz, 1H, =CH), 6.20 – 6.05 (m, 1H, =CH), 4.45 (br. s, 1H, NH), 3.76 – 3.64 (m, 1H, NCH), 
3.58 (s, 3H, OCH3), 2.19 (td, J = 8.5, 5.4 Hz, 2H, CH2), 1.53 (td, J = 8.5, 4.2 Hz, 2H, CH2), 1.10 
(d, J = 6.5 Hz, 3H, CH3). δC 156.4 (Cq), 137.7 (Cq), 130.4 (CH), 129.8 (CH), 128.5 (2 x CH), 
126.9 (CH), 126.0 (2 x CH), 51.9 (OCH3), 46.9 (NCH), 36.9 (CH2), 29.5 (CH2), 21.3 (CH3). IR 
(neat) υ/cm-1: 3323, 2934, 1696, 1520, 1449, 1248, 1192, 1072, 909, 723, 694. HRMS (EI) m/z 
calculated for C14H19NO2 [M]
+ = 233.1416; found: 233.1414. 
 
Methyl cis-2-methyl-6-phenylpiperidine-1-carboxylate 307 
 
By general procedure B, to carbamate 306 (233 mg, 1.0 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (50 mg, 0.5 mmol) was added and the resulting mixture 
stirred for 20 h at room temperature to give the piperidine 307 as a colourless oil (203 mg, 87%). 
δH 7.30 – 7.20 (m, 4H), 7.17 – 7.06 (m, 1H), 5.41 (br. d, J = ca. 5.2, 1H, 6-H), 4.51 – 4.42 (m, 1H, 
2-H), 3.70 (s, 3H, OCH3), 2.37 (dd, J = 11.5, 2.0 Hz, 1H), 1.83 – 1.61 (m, 3H, CH2 and CH), 1.52 
– 1.45 (m, 1H), 1.46 – 1.39 (m, 1H), 0.75 (d, J = 7.1 Hz, 3H, CH3). δC 157.2 (C=O), 142.5 (Cq), 
128.1 (2 x CH), 126.6 (2 x CH), 126.4 (CH), 52.7 (NCH, 6-CH), 51.6 (OCH3), 46.9 (NCH, 2-CH), 
30.5 (CH2), 27.0 (CH2), 20.5 (CH3), 15.0 (CH2). IR (neat) υ/cm-1: 2934, 2859, 1693, 1531, 1445, 
1361, 1330, 1248, 1094, 1068, 1028. HRMS (EI) m/z calculated for C14H19NO2 [M]
+ = 233.1416; 
found: 233.1413. 
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(E)-Hept-5-en-2-one oxime 310 
 
To a solution of of acetone oxime 308 (0.73 g, 10 mmol, 1.0 eq) in dry tetrahydrofuran (20 ml), 
maintained under a nitrogen atmosphere, was added dropwise n-butyl lithium (13.2 ml of a 1.55 M 
solution in hexanes, 20 mmol, 2.0 eq). The mixture was cooled to -78 oC, and a solution of crotyl 
chloride 309 (0.90 g, 10 mmol, 1.0 eq) in dry tetrahydrofuran (10 ml) was added dropwise. 
Stirring was continued for 2 h, then the solution was allowed to warm to room temperature and 
was stirred for a further two hours. The mixture was then poured into ice-cold water, the organic 
layer was separated, and the aqueous layer extracted with dichloromethane (3 x 20 ml). The 
combined organic solutions were dried and the solvents evaporated to give the oxime 310 (1.01 g, 
80%) as a mixture of isomers (2:1) as a yellow liquid, which was sufficiently pure to be used 
directly in the next step: δH 9.19 (br. s, 1H, NOH), 5.49 – 5.07 (m, 2H, 2 x =CH), 2.31 (dt, J = 8.8, 
6.8 Hz, 2H, CH2), 2.21 – 1.95 (m, 2H, CH2), 1.75 (s, 1H, CH3, minor isomer), 1.74 (s, 2H, CH3, 
major isomer), 1.54 (d, J = 6.2, 3H, 7-CH3). δC 158.5 (Cq), 130.0 (=CH), 125.7 (=CH), 28.5 
(CH2), 28.3 (CH2), 20.0 (CH3, isomers), 19.9 (CH3, isomers), 17.8 (CH3). IR (neat) υ/cm-1: 3246, 
2920, 2885, 1663, 1441, 1370, 1330. HRMS (EI) m/z calculated for C7H13NO [M]
+ = 127.0997; 
found: 127.0998. 
Hept-5-en-2-amine 31116 
 
Using general procedure C, the foregoing oxime 310 (1.01g, 7.9 mmol, 1.0 eq.) was reduced by 
lithium aluminium hydride (0.19 g, 20 mmol, 1.2eq.) to give the amine 311 (0.65 g, 73%) as a 
                                                                                                                                                            174 
clear oil, which was sufficiently pure to be used directly in the next step. All data obtained were in 
accordance with those previously reported in the literature:16 δH 5.40 – 5.15 (m, 2H, 2 x =CH), 
2.78 – 2.70 (m, 1H, NCH), 2.01 – 1.80 (m, 2H, CH2), 1.50 (s, 3H, CH3), 1.33 – 1.16 (m, 2H, CH2), 
0.96 (d, J = 6.2, 3H, 7-CH3). δC 131.0 (=CH), 125.0 (=CH), 46.5 (NCH), 39.9 (CH2), 29.5 (CH2), 
23.9 (CH3), 17.9 (CH3). 
Methyl hept-5-en-2-ylcarbamate 312 
 
By general procedure A, methyl chloroformate (0.47 g, 5 mmol, 1.0 eq.) was added to the amine 
311 (0.56 g, 5.5 mmol, 1.0 eq.) and Et3N (0.62 ml, 5.5 mmol, 1.1 eq.) to give the carbamate 312 
as a clear oil (0.57 g, 72%). δH 5.40 – 5.15 (m, 2H, 2 x =CH), 4.40 (br. s, 1H, NH),  3.61 – 3.54 
(m, 1H, NCH), 3.54 (s, 3H, OCH3), 2.01 – 1.80 (m, 2H, CH2), 1.50 (d, J = 4.9 Hz, 3H, CH3), 1.39 
– 1.33 (m, 2H, CH2), 0.96 (d, J = 6.2 Hz, 3H, 7-CH3). δC 156.4 (C=O), 130.4 (=CH), 125.4 (=CH), 
51.8 (OCH3), 46.7 (NCH, 2-CH), 37.0 (CH2), 29.0 (CH2), 21.2 (CH3), 17.8 (CH3). IR (neat) υ/cm-
1: 3327, 2966, 2931, 1695, 1531, 1450, 1352, 1250, 1192, 1078, 964, 777. HRMS (EI) m/z 
calculated for C9H17NO2 [M]
+ = 171.1259; found: 171.1258. 
Methyl (cis/trans) 2-ethyl-5-methylpyrrolidine-1-carboxylate 313 
 
To a stirred solution of the carbamate 312 (171 mg, 1.0 mmol) in dry dichloromethane (10 ml) 
under nitrogen, cooled in an ice-water bath, was added triflic acid (76 mg, 46 µl, 0.5 mmol, 0.5 
eq). The resulting mixture stirred was stirred at 40 °C for 3.5 hours to give the pyrrolidines 313 
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(cis:trans 1:1 ratio)  (167 mg, 98%) as a colourless oil, which was not separable into its two 
components. 
Trans-2-ethyl-5-methylpyrrolidine: δH 3.90 – 3.80 (m, 1H), 2.64 – 3.60 (m, 1H), 3.60 (s, 3H, 
OCH3), 1.99 – 1.91 (m, 2H, CH2), 1.77 – 1.70 (m, 2H, CH2), 1.56 – 1.50 (m, 1H), 1.17 – 1.07 (m, 
1H), 1.01 (d, J = 6.0 Hz, 3H, CH3), 0.75 (t, J = 7.0 Hz, 3H, CH3). δC 156.1 (C=O), 60.3 (NCH), 
53.8 (NCH), 52.1 (OCH3), 37.0 (CH2), 28.8 (CH2), 25.6 (CH2), 22.7 (CH3), 12.2 (CH3). 
Cis-2-ethyl-5-methylpyrrolidine: δ 3.90 – 3.80 (m, 1H), 2.64 – 3.60 (m, 1H), 3.60 (s, 3H, OCH3), 
1.99 – 1.91 (m, 2H, CH2), 1.77 – 1.70 (m, 2H, CH2), 1.56 – 1.50 (m, 1H), 1.17 – 1.07 (m, 1H), 
1.07 (d, J = 6.0 Hz, 3H), 0.77 (t, J = 7.0 Hz, 3H). δC 155.2 (C=O), 60.0 (NCH), 53.0 (NCH), 52.0 
(OCH3), 36.9 (CH2), 30.0 (CH2), 23.4 (CH2), 22.7 (CH3), 11.2 (CH3). IR (neat) υ/cm-1: 2967, 
2935, 1690, 1533, 1454, 1379, 1250, 1163, 1097, 1040, 912, 775, 731, 638. HRMS (EI) m/z 
calculated for C9H17NO2 [M]
+ = 171.1259; found: 171.1262. 
Methyl cis-2,6-dimethylpiperidine-1-carboxylate 31617 
 
By general procedure A, methyl chloroformate (0.37 ml, 5.0 mmol, 1.0 eq.) was added to 
commercial cis-2,6-dimethylpiperidine 315 (Aldrich; 0.56 g, 5.0 mmol, 1.0 eq.) and Et3N (0.62 
ml, 5.5 mmol, 1.1 eq.) to give the piperidine carbamate 316 (0.85 g, 100%) as a clear oil. All data 
obtained were in accordance with those previously reported in the literature:17 δH 4.30 – 4.16 (m, 
2H), 3.62 (s, 3H, OCH3), 1.75 – 1.60 (m, 1H), 1.60 – 1.43 (m, 4H, 2 x CH2), 1.38 (dp, J = 12.6, 
3.5 Hz, 1H), 1.10 (d, J = 7.1,  6H, 2 x CH3). δC 156.3 (C=O), 52.2 (OCH3), 46.0 (2 x NCH, 2- and 
6-CH), 30.0 (2 x CH2, 3- and 5-CH2), 20.8 (2 x CH3), 13.7 (4-CH2). IR (neat) υ/cm-1: 2969, 2937, 
1691, 1441, 1400, 1344, 1311, 1275, 1255, 1192, 775. HRMS (EI) m/z calculated for C9H17NO2 
[M]+ = 171.1259; found: 171.1258. 
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5-Cyclohexylidenepentanoic acid 31818 
 
A mixture of (4-carboxybutyl)triphenylphosphonium bromide (5.32 g, 12 mmol, 4.0 eq) in dry 
tetrahydrofuran (20 ml) and cyclohexanone 317 (300 mg, 3.0 mmol, 1.0 eq) in dry tetrahydrofuran 
(10 ml) was treated with sodium hydride (288 mg, 12 mmol, 4.0 eq) in dry THF (10 ml) under 
nitrogen, and the resulting orange mixture was stirred at room temperature for 6 h. The reaction 
was quenched with water (20 ml) and acidified to pH 2 using 10% hydrochloric acid. The 
separated aqueous layer extracted with ether (3 x 30 ml). The combined organic layers were 
washed with brine (5 ml), dried and evaporated to afford the acid 318 (215 mg, 42%) as an oil, 
which was used without further purification in the next step. All data obtained were in accordance 
with those previously reported in the literature:19  δH 11.00 (br. s, 1H, COOH), 4.97 (t, J = 7.3, Hz, 
1H, =CH), 2.28 (t, J = 7.5 Hz, 2H, CH2), 2.05 – 2.01 (m, 2H, CH2), 2.00 (t, J = 6.9 Hz, 2H, CH2), 
1.96 (t, J = 7.4 Hz, 2H, CH2), 1.60 (app. p, J = 7.4 Hz, 2H, CH2), 1.51 – 1.37 (m, 6H, 3 x CH2).  
δC 179.7 (Cq, COOH), 141.0 (Cq), 119.9 (=CH), 37.2 (CH2), 33.3 (CH2), 28.7 (2 x CH2), 27.8 
(CH2), 26.9 (CH2), 26.3 (CH2), 25.0 (CH2). 
Methyl (4-cyclohexylidenebutyl)carbamate 31920 
 
Diphenylphosphoryl azide (DPPA) (0.24 ml, 1.16 mmol, 1.0 eq) and triethylamine (0.15 ml, 0.16 
mmol, 1.0 eq) were added to a solution of the acid 318 (195 mg, 1.16 mmol, 1.0 eq) in dry toluene 
(10 ml) and the mixture was reﬂuxed for 1 h then cooled. Copper(II) chloride (10 mg, 0.1 mmol) 
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and dry methanol (10 ml) were then added. The mixture was reﬂuxed for a further 1 h then cooled 
and concentrated in vacuo. The solid residue was dissolved in ether (30 ml) and the resulting 
solution successively washed with saturated aqueous sodium bicarbonate (10 ml) and water (10 
ml). The solution was then dried, ﬁltered and evaporated to give the crude product which was 
purified by column chromatography (eluting silica gel with 0 - 100% dichloromethane in hexanes) 
to give the carbamate 319 (42 mg, 18%) as colourless oil.. δH 4.97 (br. t, J = 7.4 Hz, 1H, =CH), 
4.61 (br. s, 1H, NH), 3.59 (s, 3H, OCH3), 3.10 (t, J = 6.8 Hz, 2H, CH2), 2.10 – 1.90 (m, 6H, 3 x 
CH2), 1.50 – 1.35 (m, 8H, 4 x CH2). δC 156.6 (C=O), 140.6 (Cq), 120.0 (=CH), 52.0 (OCH3), 40.7 
(CH2), 37.2 (CH2), 37.2 (CH2), 33.2 (CH2), 30.3 (CH2), 28.7 (CH2), 28.6 (CH2), 25.0 (CH2). IR 
(neat) υ/cm-1: 3325, 2924, 2852, 1705, 1531, 1446, 1384, 1255, 1190, 1026, 777. HRMS (EI) m/z 
calculated for C12H21NO2 [M]
+ = 211. 1572; found: 211. 1576. 
 Methyl 1-azaspiro[5.5]undecane-1-carboxylate 320 
 
To a stirred solution of the carbamate 319 (21 mg, 0.05 mmol) in dry dichloromethane (10 ml) 
under nitrogen, cooled in an ice-water bath, was added triflic acid acid (3 mg, 1.8 µl, 0.02 mmol, 
0.4 eq). The resulting mixture stirred was stirred at 0 °C for 0.5 h to give spiro-piperidine  320 (20 
mg, 95%) as a clear, colourless oil. δH 3.50 (s, 3H, OCH3), 3.47 (app. t, J = 6.0, 2H, CH2N), 3.40 – 
3.30 (m, 2H, CH2), 2.47 – 2.40 (m, 2H, CH2), 1.58 – 1.47 (m, 4H, 2 x CH2), 1.47 – 1.32 (m, 8H, 4 
x CH2). δC 156.4 (C=O), 58.9 (Cq), 51.8 (OCH3), 40.7 (CH2), 33.0 (CH2), 31.0 (CH2), 25.5 (CH2), 
23.5 (CH2), 22.8 (2 x CH2), 21.9 (CH2), 17.12 (CH2). IR (neat) υ/cm-1: 2924, 2859, 1719, 1441, 
1377, 1293, 1190, 1140, 1082, 1066, 760. HRMS (APCI) m/z calculated for C12H21NO2 [M]
+ = 
211.1572; found: 211.1569.  
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(S)-Methyl N-(1-hydroxypropan-2-yl)carbamate 339 
 
By general procedure A, methyl chloroformate (2.83 ml, 36.6 mmol, 1.1 eq.) was added to the (S)-
(+)-alaninol 338 (2.50 g, 33.3 mmol, 1.0 eq.) and Et3N (3.5 ml, 36.6 mmol, 1.1 eq.) at – 20 oC to 
give the carbamate 339 as a clear oil (2.70 g, 61%), which was sufficiently pure to be used 
directly in the next step. δH 5.41 – 5.17 (m, 1H, NH), 3.85 – 3.69 (m, 1H), 3.63 (s, 3H, OCH3), 
3.60 – 3.53 (m, 1H), 3.47 (dd, J = 10.6, 5.1 Hz, 2H, OCH2), 1.12 (d, J = 6.6 Hz, 3H). δC 157.3 
(C=O), 65.7 (OCH2), 51.5 (OCH3), 48.8 (NCH), 16.6 (CH3). IR (neat) υ/cm-1: 3393, 3311, 2972, 
2942, 1712, 1532, 1454, 1260, 1190, 1193, 1097, 1074, 1053, 993, 779. HRMS (EI) m/z 
calculated for C5H11NO3 [M]
+ = 133.0739; found: 133.0738. 
(S)-(+)-Methyl N-(1-(phenylthio)propan-2-yl)carbamate 34021 
 
A solution of carbamate 339 (2.70 g, 20.3 mmol, 1.0 eq.), diphenyl disulfide (13.30 g, 3.0 eq.) and 
tributylphosphine (16.40 g, 4.0 eq.) in dry tetrahydrofuran (50 ml) under nitrogen was refluxed for 
72 h. The cooled mixture was diluted with ether (50 ml) and washed with 2 M sodium hydroxide 
(20 ml) and brine then dried. After evaporation, the crude product was purified by column 
chromatography (eluting silica gel with 0 - 100% dichloromethane in hexanes) to give the sulfide 
340 (1.30 g, 28%) as a colourless oil: [α]20D +20.0 (c 1.0 g/100 ml, CH3OH); δH 7.23 (d, J = 7.6 
Hz, 2H), 7.14 (t, J = 7.6 Hz, 2H), 7.02 (t, J = 7.6 Hz, 1H), 4.78 – 4.59 (m, 1H, NH), 3.80 – 3.69 
(m, 1H, NCH), 3.48 (s, 3H, OCH3), 3.01 (dd, J = 14.1, 6.1 Hz, 1H, PhSHAHB), 2.81 (dd, J = 14.1, 
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6.0 Hz, 1H, PhSCHAHB), 1.09 (d, J = 6.6 Hz, 3H, CH3). δC 156.1 (C=O), 135.9 (Cq), 129.3 (2 x 
CH), 128.8 (2 x CH), 126.1 (CH), 51.9 (OCH3), 46.5 (NCH), 40.2 (PhSCH2), 19.8 (CH3). IR 
(neat) υ/cm-1: 3312, 2971, 1710, 1583, 1514, 1481, 1452, 1439, 1348, 1327, 1242, 1192, 1053, 
1024, 779, 737. HRMS (EI) m/z calculated for C11H15NO2S [M]
+ = 225.0824; found: 225.0825. 
 
(S)-(-)-Methyl N-(1-(phenylsulfonyl)propan-2-yl)carbamate 341 
 
Phenyl sulphide 240 (1.30 g, 5.0 mmol, 1.0 eq) and sodium tungstate (15 mg, 0.05 mmol) were 
added to methanol (10 ml) at 40 ºC. After the resulting mixture was stirred for 2 minutes, 30% 
aqueous hydrogen peroxide (1.80 ml, 15.0 mmol, 3.0 eq) was added dropwise. After 3 h, the 
mixture was diluted with saturated aqueous sodium thiosulfate (5 ml) and the bulk of the solvents 
evaporated. The residue was extracted with dichloromethane (3 x 10 ml) and the combined 
extracts dried, filtered through a bed of silica gel and evaporated to give the sulfone 341 (1.30 g, 
88% yield) as a colourless oil:  [α]20D -8.89 (c 0.9 g/100 ml, CH3OH); δH 7.87 (d, J = 7.5 Hz, 2H), 
7.61 (d, J = 7.5 Hz, 1H), 7.50 (t, J = 7.5 Hz, 2H), 5.14 (br. s, 1H, NH), 4.02 – 3.96 (m, 1H, NCH), 
3.51 (s, 3H, OCH3), 3.42 (dd, J = 14.3, 5.5 Hz, 1H, PhSO2CHAHB), 3.15 (dd, J = 14.3, 5.5 Hz, 1H, 
PhSO2CHAHB), 1.31 (d, J = 6.8 Hz, 3H, CH3). δC 155.8 (C=O), 139.9 (Cq), 133.8 (CH), 129.4 (2 
x CH), 127.9 (2 x CH), 52.0 (OCH3), 43.6 (NCH), 24.3 (PhSO2CH2), 20.5 (CH3). IR (neat) υ/cm-1: 
3362, 2976, 1699, 1528, 1447, 1304, 1254, 1178, 1101, 1084, 1053, 779, 737. HRMS (EI) m/z 
calculated for C11H15NO4S [M]
+ = 257.0722; found: 257.0727. 
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Methyl (2S, 3RS)-(6-methyl-3-(phenylsulfonyl)hept-5-en-2-yl)carbamate 34222 
 
A solution of the phenyl sulfone 341 (1.30 g, 5 mmol, 1.0 eq.) in dry tetrahydrofuran (10 ml) at -
78 oC was treated with n-butyl lithium (4.24 ml, of a 2.5 M solution in hexanes, 10.5 mmol, 2.1 
eq). After stirring for 0.5 h, a solution of prenyl bromide (0.72 ml, 5.5 mmol 1.1 eq.) in 
tetrahydrofuran (5 ml) was added. The cooling bath was removed and the reaction mixture was 
stirred for 3 h then diluted with ether (50 ml). The resulting solution was washed with water (10 
ml). The separated aqueous phase was extracted with ether (2 x 20 ml) and the combined organic 
solutions washed sequentially with 10% hydrochloric acid (20 ml), 5% aqueous sodium 
bicarbonate (20 ml) and brine (20 ml), then dried, filtered and evaporated. Separation of the 
residue on silica gel using 50:50 hexanes/dichloromethane gave the homologated sulfone 342 
(0.89 g, 54%) as a yellow oil and a 2:1 mixture of diastereoisomers, which were not separated.  
The major isomer showed: δH 7.95 – 7.82 (m, 2H), 7.67 – 7.60 (m, 1H), 7.60 – 7.46 (m, 2H), 5.37 
(d, J = 8.6 Hz, 1H, NH), 4.81 – 4.92 (m, 1H, =CH), 4.36 – 4.2 (m, 1H, NCH), 3.60 (s, 3H, OCH3), 
3.30 (dt, J = 7.9, 6.4 Hz, 1H, PhSO2CH), 2.52 – 2.23 (m, 2H, CH2), 1.54 (s, 3H, CH3), 1.47 (s, 3H, 
CH3), 1.37 (d, J = 7.0 Hz, 3H). δC 156.0 (C=O), 139.4 (Cq), 133.7 (CH), 129.2 (2 x CH), 128.3 (2 
x CH), 119.4 (=CH), 67.1 (NCH), 52.0 (OCH3) , 46.2 (PhSO2CH), 25.6 (CH3), 24.2 (CH2), 17.8 
(CH3), 17.6 (CH3). 
The minor isomer showed: δH 7.95 – 7.82 (m, 2H), 7.67 – 7.60 (m, 1H), 7.60 – 7.46 (m, 2H), 6.0 
(d, J = 8.6 Hz, 1H, NH), 4.81 – 4.92 (m, 1H, =CH), 4.22 – 4.18 (m, 1H, NCH), 3.68 (s, 3H, 
OCH3), 3.21 (dt, J = 7.9, 6.4 Hz, 1H, PhSO2CH), 2.52 – 2.23 (m, 2H, CH2), 1.67 (s, 3H, CH3), 
1.40 (s, 3H, CH3), 1.37 (d, J = 7.0 Hz, 3H). δC 156.0 (C=O), 136.0 (Cq), 133.7 (CH), 129.2 (2 x 
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CH), 128.3 (2 x CH), 118.3 (=CH), 68.4 (NCH), 52.0 (OCH3), 47.0 (PhSO2CH), 26.1 (CH2), 25.6 
(CH3), 17.8 (CH3), 17.6 (CH3).  
The whole sample showed IR (neat) υ/cm-1: 3370, 2972, 1715, 1512, 1447, 1302, 1248, 1178, 
1101, 1084, 1070, 914, 727. HRMS (APCI) m/z calculated for C16H24NO4S [M+H]
+ = 326.1426; 
found: 326.1428. 
 
(6S)-(-)-Methyl-2,2,6-trimethyl-5-(phenylsulfonyl)piperidine-1-carboxylate 343 
 
By general procedure B, to carbamate 342 (163 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (3 drops) was added and the mixture stirred for 2 h at 
room temperature to give the piperidine 343 (159 mg, 98%) as a colourless oil: [α]20D -23.33 (c 
0.6 g/100 ml, CH3OH);  δH 7.67 (d, J = 7.8 Hz, 2H), 7.44 (t, J = 8.6, 1.3 Hz, 1H), 7.40 – 7.22 (m, 
2H), 4.59 (qd, J = 6.9, 4.4 Hz, 1H, 6-H), 3.43 (s, 3H, OCH3), 3.18 (ddd, J = 10.8, 7.7, 4.4 Hz, 1H, 
PhSO2CH), 2.02 (dddd, J = 13.8, 11.2, 7.5, 4.1 Hz, 1H), 1.93 – 1.83 (m, 1H), 1.35 – 1.28 (m, 2H), 
1.24 (d, J = 6.9 Hz, 3H, CH3), 1.20 (s, 3H, CH3), 1.10 (s, 3H, CH3). δC 155.6 (C=O), 138.7 (Cq), 
133.9 (CH), 129.3 (2 x CH), 128.4 (2 x CH), 61.7 (NCH), 54.2 (Cq), 52.1 (OCH3), 47.2 
(PhSO2CH), 36.0 (CH2), 29.1 (CH3), 27.3 (CH3), 18.9 (CH3), 15.9 (CH2). IR (neat) υ/cm-1: 2964, 
1697, 1514, 1446, 1338, 1305, 1084, 1070, 727, 690. HRMS (EI) m/z calculated for C16H23NO4S 
[M]+ = 325.1348; found: 325.1336. 
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 (S)-Methyl 2,2,6-trimethylpiperidine-1-carboxylate 34423 
 
A mixture of substrate 344 (137 mg, 0.42 mmol) and magnesium (146 mg, 6.0 mmol) in dry 
methanol (10 ml) was stirred for 20 h at room temperature. The reaction mixture was poured into 
cold 0.5 N HCl (10 ml) and extracted with dichloromethane (3 x 15 ml). The combined organic 
layers were washed with saturated aqueous sodium bicarbonate (5 ml), then dried, filtered, and 
evaporated to give piperidine 344 (64 mg, 82%) as colourless oil. All data obtained were in 
accordance with those previously reported in the piperidine 301 (p. 169). 
(E/Z)-6,10-Dimethylundeca-5,9-dien-2-one oxime 381 
 
To a solution of (E/Z 35:65)-geranyl acetone 380 (Aldrich, 3.90 g, 20 mmol, 1.0 eq) and 
hydroxylamine hydrochloride (2.09 g, 30 mmol, 1.5 eq) in ethanol (30 ml) was added sodium 
acetate (1.00 g, 12.2 mmol) in one portion. The reaction mixture was heated at 40 oC for 2 h and 
then concentrated on a rotary evaporator. The residue was partitioned between ether (150 ml) and 
water (50 ml). The separated organic layer was dried. Evaporation provided the oxime 381 (3.10 g, 
74%) as an inseparable 2:1 mixture of E/Z isomers as a colourless liquid, which was pure enough 
and which was used directly in the next step. δH (selected resonances) 5.10– 4.90 (m, 2H, =CH), 
2.14 – 2.21 (m, 6H, 3× CH2), 1.75 (s, 2H, CH3 , E-isomer), 1.75 (s, 1H, CH3 , Z-isomer), 1.65 (s, 
3H, CH3), 1.53 (s, 3H, CH3). Major (E)-isomer δC 158.1 (Cq, C=NOH), 136.2 (Cq), 131.3 (Cq), 
124.2 (=CH), 123.3 (=CH), 39.6 (CH2), 36.1 (CH2), 28.8 (CH2), 25.7 (CH3), 25.0 (CH2), 17.6 
(CH3), 15.95 (CH3). Minor (Z)-isomer δC 158.6 (C=NOH), 136.4 (Cq), 131.6 (Cq), 124.2 (=CH), 
123.6 (=CH), 43.7 (CH2), 31.9 (CH2), 28.9 (CH2), 22.4 (CH3), 22.2 (CH2), 20.0 (CH3), 17.6 
(CH3).
24  
                                                                                                                                                            183 
6,10-Dimethylundeca-5,9-dien-2-amine 382 
 
Using general procedure C, the foregoing oxime 381 (3.10 g, 14.8 mmol, 1.0 eq.) was reduced by 
lithium aluminium hydride (0.76 g, 20 mmol, 1.4 eq.) to give the amine 382 (2.85 g, 99%) as a 
clear oil. δH 5.10 - 4.96 (m, 2H, 2 × =CH), 2.85 (sext, 1H, J = 6.3 Hz, NCH), 2.00 – 1.85 (m, 
6H,CH2), 1.80 – 1.70 (m, 2H, CH3), 1.60 (s, 3H, CH3), 1.55 (s, 3H, CH3), 1.35 – 1.28 (m, 2H, 
CH2), 0.98 (d, 3H, J = 6.4 Hz, CH3).
24 The sample was >95% pure and was used immediately in 
the next step. 
(E/Z)-N-(6,10-Dimethylundeca-5,9-dien-2-yl)-4-methylbenzenesulfonamide 383 
 
By general procedure A, p-tosyl chloride (1.0 g, 5.5 mmol, 1.1 eq.) was added to the amine 382 
(1.0 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol, 1.1 eq.) to give the sulfonamide 383 (0.84 
g, 47%) as a thick, clear oil (2:1 mixture of isomers). δH 7.56 (d, J = 8.2 Hz, 2H), 7.12 (d, J = 8.2 
Hz, 2H), 4.91 – 4.78 (m, 1H, =CH), 4.71 (br. t, J = 7.0 Hz, 1H, =CH), 4.52 (d, J = 8.1 Hz, 1H, 
NH), 3.15 – 3.01 (m, 1H, NCH), 2.20 (s, 3H, ArCH3), 1.86 – 1.74 (m, 2H, CH2), 1.74 – 1.66 (m, 
2H, CH2), 1.66 – 1.85 (m, 2H, CH2), 1.45 (s, 3H, CH3), 1.40 (s, 1H, CH3 , Z-isomer),  1.38 (s, 3H, 
CH3), 1.29 (s, 2H, CH3 , E-isomer), 1.23 – 1.09 (m, 2H, CH2), 0.82 (d, J = 6.5 Hz, 3H, CH3). E-
isomer: δC 143.1 (Cq), 138.3 (Cq), 135.9 (Cq), 131.5 (Cq), 129.6 (2 x CH), 127.1 (2 x CH), 124.2 
(=CH), 123.1 (=CH), 49.8 (NCH), 39.6 (CH2), 37.7 (CH2), 26.5 (CH2), 24.0 (CH3), 21.6 (CH2), 
17.7 (CH3), 16.0 (CH3), 14.1 (CH3). Z-isomer: δC 131.7 (Cq), 123.4 (=CH), 39.7 (CH2), 21.7 
(CH3)-only 4 distinct peaks.  
The whole sample showed IR (neat) υ/cm-1: 3296, 2969, 2930, 1599, 1321, 1158, 1091, 814, 661. 
HRMS (EI) m/z calculated for C20H31NO2S [M]
+ = 349.2076; found: 349.2078.  
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4-Methyl-N-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl)benzenesulfonamide 384 
 
By general procedure B, to sulfonamide 383 (200 mg, 0.6 mmol) in dry dichloromethane (10 ml) 
under nitrogen, concentrated sulfuric acid (2 drops) was added and the mixture stirred for 1 h at 0 
oC to give the sulfonamide 384 as a colourless oil (190 mg, 95%). δH 7.52 (d, J = 8.2 Hz, 2H), 7.66 
(d, J = 8.2 Hz, 2H), 4.71 (d, J = 8.4 Hz, 1H, NH), 3.27 – 2.95 (m, 1H, NCH), 2.34 (s, 3H, ArCH3), 
1.87 – 1.72 (m, 3H, CH and CH2), 1.72 – 1.63 (m, 1H), 1.48 – 1.40 (m, 2H, CH2), 1.39 (s, 3H, 
CH3), 1.35 – 1.24 (m, 4H, 2 x CH2), 1.10 (d, J = 6.6 Hz, 3H, CH3), 0.79 (s, 3H, CH3), 0.78 (s, 3H, 
CH3). δC 143.1 (Cq), 138.4 (Cq), 136.3 (Cq), 129.6 (2 x CH), 127.2 (Cq), 127.1 (2 x CH), 50.8 
(NCH), 39.8 (CH2), 37.9 (CH2), 34.9 (Cq), 32.7 (CH2), 28.5 (2 x CH3), 24.8 (CH2), 21.6 (CH3), 
21.4 (CH3), 19.7 (CH3), 19.5 (CH2). IR (neat) υ/cm-1: 3296, 2969, 29306, 1599, 1321, 1158, 1091, 
814, 661. HRMS (EI) m/z calculated for C20H31NO2S [M]
+ = 349.2076; found: 349. 2076. 
4-(2,6,6-Trimethylcyclohex-1-en-1-yl)butan-2-one 387 
 
To a 2 M solution of borane in THF (10 ml, 20 mmol) under nitrogen and cooled in ice-water was 
added a solution of catechol (2.20 g, 20 mmol) in dry THF (10 ml) over 0.5 h with efficient 
stirring. The reaction mixture was then stirred without cooling for 1 h, before recooling in ice-cold 
water. A solution of β-ionone 386 (1.92 g, 10 mmol) in dry THF (50 ml) was added. The resulting 
solution is stirred for 1 h at room temperature and then quenched by the addition of acetone (20 
ml), followed by saturated aqueous ammonium chloride (10 ml). The resulting mixture was 
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extracted with dichloromethane (2 x 25 ml) and the combined extracts dried and concentrated to 
give the ketone 387 (1.56 g, 80%) as a clear oil, which was used directly in the next step. All data 
obtained were in accordance with those previously reported in the literature:25 δH 2.45 (app. dt, J = 
8.2, 7.5 Hz, 1H), 2.23 – 2.13 (m, 1H), 2.10 (s, 3H, CH3), 1.87 – 1.76 (m, 4H, 2 x CH2), 1.52 (s, 
3H, CH3), 1.37 – 1.28 (m, 4H, 2 x CH2), 0.88 (s, 6H, 2 x CH3). 
4-(2,6,6-Trimethylcyclohex-1-en-1-yl)butan-2-one oxime 388 
 
To a solution of the ketone 387 (1.56 g, 8.0 mmol) and hydroxylamine hydrochloride (1.04 g, 15 
mmol) in methanol (30 ml) was added sodium acetate (1.00 g, 12.2 mmol) in one portion. The 
reaction mixture was heated at 40 oC for 2 h and then concentrated on a rotary evaporator. The 
residue was partitioned between ether (50 ml) and water (10 ml). The separated organic layer was 
dried and evaporated to give the oxime 388 (1.20 g, 71%) as a 2:1 mixture of isomers and as a 
colourless liquid, which was used directly in the next step: δH 2.22 – 2.13 (m, 2H, CH2), 2.12 – 
2.03 (m, 2H, CH2), 1.87 (s, 2H, isomer), 1.82 (s, 1H, isomer), 1.53 – 1.50 (m, 2H, CH2), 1.37 – 
1.26 (m, 2H, CH2), 0.89 (s, 6H, 2 x CH3). Major isomer δC 157.2 (Cq), 136.7 (Cq), 133.5 (Cq), 
40.7 (CH2), 39.8 (CH2), 34.9 (Cq), 32.7 (CH2), 28.5 (2 x CH3), 25.4 (CH2), 23.3 (CH3), 19.7 
(CH3), 19.5 (CH2). Minor isomer δC 39.9 (CH2), 32.8 (CH2), 28.4 (CH3), 19.8 (CH2); only four 
distinct peaks.  
The whole sample showed IR (neat) υ/cm-1: 3366, 2955, 2928, 2903, 1512, 1470, 1445, 1362, 
1260, 1096. HRMS (EI) m/z calculated for C13H23NO [M]
+ = 209.1780; found: 209.1783. 
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4-(2,6,6-Trimethylcyclohex-1-en-1-yl)butan-2-amine 38926 
 
By general procedure C, the oxime 388 (1.2 g, 5.7 mmol) was reduced using lithium aluminium 
hydride (0.38 g, 10 mmol) to give the amine 389 (1.00 g, 89%) as a clear oil, which was used 
directly in the next step. δH 2.81 (m, 1H, NCH), 1.99 – 1.84 (m, 4H, 2 x CH2), 1.53 (s, 3H, CH3), 
1.50 – 1.44 (m, 2H, CH2), 1.37 – 1.30 (m, 4H, 2 x CH2), 1.02 (d, J = 6.3 Hz, 3H, CH3), 0.91 (s, 
6H, 2 x CH3). δC 137.1 (Cq), 126.7 (Cq), 47.9 (NCH), 40.7 (CH2), 39.9 (CH2), 34.9 (Cq), 32.7 
(CH2), 28.5 (2 x CH3), 25.4 (CH2), 23.3 (CH3), 19.7 (CH3), 19.5 (CH2). IR (neat) υ/cm-1: 3264, 
2963, 2926, 2866, 1458, 1375, 908. HRMS (APCI) m/z calculated for C13H26N [M+H]
+ = 
196.2065; found: 196.2058.  
 
4-Methyl-N-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl)benzenesulfonamide 384 
 
By general procedure A, p-tosyl chloride (1.00 g, 5.5 mmol, 1.1 eq.) was added to the amine 389 
(1.00 g, 5.1 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol) to give the sulfonamide 384 (1.50 g, 84%) 
as a thick, clear oil, which showed 1H and 13C resonances completely identical to the sample 
obtained from the partial cyclisation reaction (p.184). 
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N-(6,10-Dimethylundeca-5,9-dien-2-yl)-4-nitrobenzenesulfonamide 390 
 
By general procedure A, p-nitrobenzenesulfonyl chloride (1.24 g, 5.6 mmol, 1.1 eq.) was added to 
the amine 382 (1.00 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol) to give the sulfonamide 
390 (1.00 g, 54%) as yellow oil (2:1 mixture of isomers). δH 8.31 (d, J = 8.2 Hz, 2H), 7.95 (d, J = 
8.2 Hz, 2H), 5.03 – 4.91 (m, 1H, =CH), 4.87 (t, J = 5.7 Hz, 1H, =CH), 4.66 (d, J = 7.8 Hz, 1H, 
NH), 3.41 – 3.22 (m, 1H, NCH), 2.01 – 1.90 (m, 2H, CH2), 1.90 – 1.70 (m, 4H, 2 x CH2), 1.60 (s, 
3H, CH3), 1.54 (s, 1H, CH3 , Z-isomer), 1.52 (s, 3H, CH3), 1.48 (s, 3H, CH3), 1.44 (s, 2H, CH3 , E-
isomer), 1.40 – 1.29 (m, 2H, CH2), 1.02 (d, J = 6.6 Hz, 3H, CH3). E-isomer: δC 149.9 (Cq), 147.3 
(Cq), 136.5 (Cq), 131.7 (Cq), 131.5 (Cq), 128.2 (2 x CH), 124.3 (2 x CH), 124.1 (=CH), 123.3 
(=CH), 50.5 (NCH), 39.6 (CH2), 37.7 (CH2), 26.8 (CH2), 26.7 (CH3), 24.0 (CH2), 23.3 (CH3), 21.8 
(CH3),  17.6 (CH3), 16.0 (CH3). Z-isomer: δC 131.8 (Cq), 123.4 (=CH), 37.9 (CH2), 26.7 (CH2)- 
only four distinct peaks.  
The whole sample showed IR (neat) υ/cm-1: 3281, 2968, 2928, 2858, 1530, 1433, 1306, 1092, 852, 
750, 687. HRMS (EI) m/z calculated for C19H28N2O4S [M]
+ = 380.1770; found: 380. 1763. 
4-Nitro-N-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl)benzenesulfonamide 391 and  
2,6,6,10-Tetramethyl-1-((4-nitrophenyl)sulfonyl)-1-azaspiro[4.5]decane 392 
 
By general procedure B, to sulfonamide 390 (235 mg, 0.62 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (3 drops) was added and the reaction stirred for 1.5 h at 
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0 oC to give the sulfonamide 391 and Spiro-pyrrolidine 392 (total 218 mg, 93%) as a colourless 
oil.  
Sulfonamide 391 δH 8.41 (d, J = 8.2 Hz, 2H), 8.17 (d, J = 8.2 Hz, 2H), 5.10 (d, J = 8.2 Hz,  1H, 
NH), 3.43 – 3.24 (m, 1H, NCH), 1.95 – 1.73 (m, 4H, 2 x CH2), 1.48 – 1.40 (m, 2H, CH2), 1.46 (s, 
3H, CH3), 1.40 - 1.33 (m, 4H, 2 x CH2), 1.10 (d, J = 6.6 Hz, 3H, CH3), 0.88 (s, 3H, CH3), 0.86 (s, 
3H, CH3). δC 149.9 (Cq), 147.3 (Cq), 135.9 (Cq), 128.2 (2 x CH), 127.6 (Cq), 124.4 (2 x CH), 
51.4 (NCH), 39.6 (CH2), 37.9 (CH2), 34.9 (Cq), 32.6 (CH2), 28.5 (CH3), 24.8 (CH2), 21.7 (CH3), 
19.7 (CH2), 19.3 (2 x CH3). 
Spiro-pyrrolidine 392: δH 3.54 – 3.43 (m, 1H, NCH), 1.10 (d, J = 5.7 Hz, 3H, CH3), 0.81 (d, J = 
5.5 Hz, 3H, CH3); only 3 distinct peaks. δC 67.8 (NCq), 51.9 (NCH), 37.0 (CH2), 35.9 (Cq), 36.0 
(CH2); only 5 distinct peaks. 
The whole sample showed IR (neat) υ/cm-1: 3281, 2922, 1705, 1532, 1456, 1354, 1165, 1091, 914, 
855, 737. HRMS (EI) m/z calculated for C19H28N2O4S [M]
+ = 211. 1572; found: 211. 1576. 
Methyl 6,10-dimethylundeca-5,9-dien-2-ylcarbamate 393 
 
By general procedure A, methyl chloroformate (0.75 ml, 12 mmol, 1.3 eq.) was added to the 
foregoing amine 382 (1.95 g, 10 mmol, 1.0 eq.) and Et3N (2.5 ml, 22 mmol, 1.2 eq.) to give the 
carbamate 393 as a clear oil (0.71 g, 28%). δH 5.10 – 4.96 (m, 2H, 2 ×  =CH), 4.66 (br. s, 1H, 
NH), 3.60 (sext, 1H, J = 6.3 Hz, NCH), 3.52 (OCH3), 2.00 – 1.85 (m, 6H, 3 x CH2), 1.60 (s, 3H, 
CH3), 1.50 (s, 6H, 2 x CH3), 1.42 – 1.30 (m, 2H, CH2), 1.06 (d, 3H, J = 6.7 Hz, CH3). δC 156.4 
(CO2), 135.7 (Cq), 131.5 (Cq), 124.3 (=CH), 123.5 (=CH), 51.8 (OCH3), 47.0 (NCH), 39.6 (CH2), 
31.9 (CH2), 26.7 (CH2), 25.6 (CH3), 24.4 (CH2), 23.3 (CH3), 17.6 (CH3), 15.9 (CH3).  
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Z-isomer: δC 131.6 (Cq), 124.4 (=CH), 32.1 (CH2), 24.5 (CH2)- only four distinct peaks. 
IR (neat) υ/cm-1: 3333, 2970, 2931, 1695, 1531, 1450, 1375, 1252, 1078, 777. HRMS (EI) m/z 
calculated for C15H27NO2 [M]
+ = 253. 2042; found: 253. 2036. 
 
Methyl 2,5,5,8a-tetramethyloctahydroquinoline-1(2H)-carboxylate 394 
 
By general procedure B, to the carbamate 393 (140 mg, 0.6 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting mixture 
stirred for 1 h at room temperature to give the octahydroquinoline 394 (112 mg, 80%) as a 
colourless oil and an inseparable 6:1 mixture of diastereoisomers. The major diastereoisomer 
showed: δH 4.08 – 3.99 (m, 1H, NCH), 3.61 (dd, J = 9.7, 4.1 Hz, 1H), 3.56 (s, 3H, OCH3), 3.09 
(dtd, J = 13.1, 3.5, 1.6 Hz, 1H), 1.89 (ddd, J = 19.3, 9.8, 4.8 Hz, 1H), 1.80 – 1.69 (m, 1H), 1.57 – 
1.51 (m, 1H), 1.42 (dq, J = 5.5, 3.2 Hz, 2H), 1.36 – 1.32 (m, 1H), 1.32 – 1.29 (m, 1H), .25 (s, 3H, 
CH3), 1.20 (d, J = 6.5, 3H, CH3), 1.18 – 1.01 (m, 1H), 0.82 (s, 6H, 2 x CH3), 0.73 (dd, J = 8.9, 5.1 
Hz, 1H). δC 156.1 (Cq), 59.6 (Cq), 51.7 (OCH3), 48.6 (CH), 46.5 (CH), 41.7 (CH2), 39.4 (CH2), 
34.1 (Cq), 31.8 (CH3) 25.0 (CH2), 21.6 (CH3), 20.6 (CH3), 19.9 (CH2), 19.7(CH3), 14.4 (CH2). 
The minor diastereoisomer could be characterized by δC 53.6 (Cq), 37.1 (CH2), 36.4 (CH2), 38.3 
(CH3), 36.9 (CH3), 19.9 (CH2), 13.6 (CH3).  
The whole sample showed IR (neat) υ/cm-1: 2937, 1701, 1693, 1512, 1344, 1244, 1087, 987, 775. 
HRMS (EI) m/z calculated for C15H27NO2 [M]
+ = 253. 2042; found: 253. 2042. 
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Benzyl (6,10-dimethylundeca-5,9-dien-2-yl)carbamate 395 
 
By general procedure A, benzyl chloroformate (0.95 g, 5.5 mmol, 1.1 eq.) was added to the amine 
382 (1.00 g, 5.0 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol) to give the Z-carbamate 395 as a 
clear oil (0.88 g, 52%). δH 7.30 – 7.19 (m, 5H), 5.02 - 4.91 (m, 4H, 2 x =CH, OCH2), 4.54 (br. d, J 
= 13.3 Hz, 1H, NH), 3.64 – 3.50 (m, 1H, NCH), 2.07 – 1.81 (m, 6H, 3 x CH2), 1.60 (s, 3H, CH3), 
1.49 (s, 3H, CH3), 1.48 (s, 3H, CH3), 1.42 – 1.29 (m, 2H, CH2), 1.07 (d, J = 5.1 Hz, 3H, CH3). δC 
154.5 (CO2), 136.4 (Cq), 136.0 (Cq), 131.1 (Cq), 128.4 (2 x CH), 127.9 (2 x CH), 124.2 (CH), 
123.3 (2 x CH), 66.4 (OCH2), 46.9 (NCH), 39.6 (CH2), 37.5 (CH2), 26.6 (CH2), 25.6 (CH3), 24.2 
(CH2), 21.2 (CH3), 17.6 (CH3), 15.8 (CH3). IR (neat) υ/cm-1: 3337, 2969, 2920, 1696, 1526, 1452, 
1244, 1060, 1028, 735, 698. HRMS (EI) m/z calculated for C21H31NO2 [M]
+ = 329. 2355; found: 
329. 2347. 
Benzyl 2,5,5,8a-tetramethyloctahydroquinoline-1(2H)-carboxylate 396 
 
By general procedure B, to Z-carbamate 395 (165 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the reaction mixture 
was stirred for 1 h at 0 oC to give the octahydroquinoline 396 (116 mg, 70%) as a colourless oil. 
δH 7.29 – 7.18 (m, 4H), 7.24 – 7.21 (m, 1H), 4.99 – 4.94 (d, J = 12.7 Hz, 1H, OCHAHB), 4.90 (d, J 
= 12.7 Hz, 1H, OCHAHB), 4.08 – 4.00 (m, 1H, NCH), 3.09 (dtd, J = 13.1, 3.5, 1.6 Hz, 1H), 1.89 – 
1.77 (m, 2H, CH2), 1.67 (ddd, J = 10.6, 7.7, 4.6 Hz, 2H, CH2), 1.42 (d, J = 5.8 Hz, 2H, CH2), 1.40 
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– 1.31 (m, 2H, CH2), 1.22 (s, 3H, CH3), 1.16 (d, J = 6.9 Hz, 3H, CH3), 1.04 – 0.96 (m, 1H), 0.84 – 
0.77 (m, 1H), 0.75 (s, 6H, 2 x CH3). δC 156.2 (Cq), 136.7 (Cq), 128.5 (CH), 128.4 (2 x CH), 127.9 
(2 x CH), 66.1 (OCH2), 59.9 (Cq), 48.7 (NCH), 41.8 (CH2), 39.4 (CH2), 34.2 (Cq), 33.0 (CH3) 
23.1 (CH2), 21.0 (CH3), 19.6 (CH3),  19.9 (CH2),  19.7(CH3), 14.8 (CH2). IR (neat) υ/cm-1: 2872, 
2855, 1694, 1552, 1393, 912, 731. HRMS (EI) m/z calculated for C21H31NO2 [M]
+ = 329.2355; 
found: 329.2348. 
(2E,6E)-1-Bromo-3,7,11-trimethyldodeca-2,6,10-triene 39827 
 
To a stirred solution of (E,E)-farnesol 397 (2.20 g, 10 mmol) in petroleum ether (10 ml) was 
added phosphorus tribromide (2.71 g, 10 mmol). The resulting solution was stirred at 0 °C for 1 h. 
The mixture was treated with cold brine (5 ml) and extracted with ether. The organic extracts dried 
and concentrated to give crude farnesyl bromide 398 (2.79 g, 98%) which was used without any 
purification. All data obtained were in accordance with those previously reported in the 
literature:27 δH 5.42 (t, J = 8.5 Hz, 1H, =CH), 5.14 – 4.98 (m, 2H, 2 x =CH), 4.09 (d, J = 7.0 Hz, 
2H, CH2Br), 2.30 – 1.97 (m, 8H, 4 x CH2), 1.77 (s, 3H, CH3), 1.66 (s, 6H, 2 x CH3), 1.59 (d, J = 
3.8 Hz, 3H, CH3).  
(4E,8E)-Methyl 2-acetyl-5,9,13-trimethyltetradeca-4,8,12-trienoate 39928 
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A 60% dispersion of sodium hydride in mineral oil (0.42 g, 10.5 mmol) was washed with hexanes 
(3 x 10 ml) and suspended in dry DMF (50 ml). Methyl acetoacetate (1.16 ml, 10.8 mmol) was 
added dropwise. After 0.5 h, the resulting solution was treated with farnesyl bromide 398 (2.79 g, 
9.8 mmol) and stirred for 4 h. The reaction mixture was quenched with water (10 ml) and 
extracted with ether (3 x 30 ml). The combined organic extracts were dried and concentrated. 
Column chromatography (dichloromethane/ hexanes, 1:19) of the crude afforded the acetoacetate 
399 (2.27 g, 72%) as a colourless oil. All data obtained were in accordance with those previously 
reported in the literature:28 δH 5.10 – 4.88 (m, 3H), 3.66 (s, 3H), 3.37 (dt, J = 7.6, 4.5 Hz, 1H), 
2.49 (t, J = 7.4 Hz, 2H), 2.15 (s, 3H), 2.10 - 1.98 (m, 5H), 1.98 - 1.90 (m, 3H), 1.61 (d, J = 1.1 Hz, 
3H), 1.56 (s, 3H), 1.54 (s, 3H), 1.51 (s, 3H).  
(5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one 40029 
 
The foregoing acetoacetate 399 (2.27 g, 7.0 mmol) in dimethyl sulfoxide/water (50 ml : 0.5 ml) 
containing sodium chloride NaCl (1.0 g, 17 mmol ) was refluxed for 3 h. Cold water (10 ml) was 
added and the resulting mixture extracted with ether (3 x 30 ml). The combined organic layers 
were dried and concentrated to yield the ketone 400 (1.80 g, 64%) as a colourless oil. All data 
obtained were in accordance with those previously reported in the literature:30 δH 5.10 – 4.93 (m, 
3H, 3 x =CH), 2.36 (dd, J = 11.1, 7.3 Hz, 2H), 2.24 – 2.13 (m, 2H, CH2), 2.05 (s, 3H, CH3), 2.01 – 
1.93 (m, 4H, 2 x CH2), 1.93 – 1.84 (m, 4H, 2 x CH2), 1.61 (s, 6H, 2 x CH3), 1.53 (s, 6H, 2 x CH3). 
δC 158.3 (C=O), 136.3 (Cq), 135.3 (Cq), 131.3 (Cq), 124.9 (=CH), 124.0 (=CH),  122.5 (=CH), 
39.63 (CH2), 36.2 (CH2), 29.8 (CH2), 26.61 (CH2), 24.9 (CH3), 24.7 (CH2), 24.8 (CH2), 23.4 
(CH3), 17.7 (CH3), 16.1 (CH3), 13.3 (CH3). 
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(5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one oxime 40130 
 
To a solution of ketone 400 (1.80 g, 6.9 mmol, 1.0 eq) and hydroxylamine hydrochloride (0.70 g, 
10 mmol, 1.4 eq) in methanol (30 ml) was added sodium acetate (1.0 g, 12.2 mmol) in one 
portion. The reaction mixture was heated at 40 oC for 2 h and then concentrated on a rotary 
evaporator. The residue was partitioned between ether (50 ml) and water (10 ml). The separated 
organic layer was dried. Evaporation provided the oxime 401 (1.90 g, 100%) as a 2:1 mixture of 
isomers as a colourless liquid which was used directly in the next step: δH 5.10 – 4.90 (m, 3H, 
=CH), 2.20 – 2.10 (m, 2H, CH2), 2.14 – 2.21 (m, 10H, 5 x CH2), 1.77 (s, 2H, CH3, isomer), 1.75 
(s, 1H, CH3, isomer), 1.65 (s, 6H, 2 x CH3), 1.53 (s, 6H, 2 x CH3). 
(5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-amine 402 
 
The oxime 401 (1.90 g, 6.8 mmol, 1.0 eq.) was dissolved in dry tetrahydrofuran (30 ml) and the 
solution added dropwise to a suspension of lithium aluminium hydride (0.38 g, 10 mmol, 1.4 eq.) 
in tetrahydrofuran (20 ml) at 0 °C. The suspension was then refluxed for 3 h and subsequently 
cooled to 0 °C. When it was cold, water (5 ml) and 15% aqueous NaOH (5 ml) were added 
sequentially and the resulting mixture then stirred for one hour. The precipitated salts were then 
filtered off and washed with tetrahydrofuran (40 ml). The combined filtrate was concentrated, then 
the liquid residue extracted with dichloromethane (2 x 20 ml) and the combined extracts dried and 
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concentrated to give the amine 402 (1.20 g, 67%) as a yellow oil which was used directly in the 
next step. δH 5.10 - 4.96 (m, 3H, 3 ×  =CH), 2.88 – 2.80 (m, NCH), 2.00 – 1.85 (m, 10H, 5 x CH2), 
1.6 (s, 6H, 2 x CH3), 1.55 (s, 6H, 2 x CH3), 1.35 - 1.28 (m, 2H, CH2), 1.01 (d, 3H, J = 4.4 Hz, 
CH3). δC 135.1 (Cq), 135.0 (Cq), 131.5 (Cq),  125.0 (=CH), 124.3 (=CH),  123.5 (=CH), 46.7 
(NCH), 39.7 (2 x CH2), 31.9 (CH2), 26.7 (CH2), 25.6 (CH3), 24.4 (2 x CH2), 23.3 (2 x CH3), 17.7 
(CH3), 15.9 (CH3). IR (neat) υ/cm-1: 3462, 2971, 2936, 1740, 1705, 1445, 1244, 1084, 1049, 912. 
HRMS (AP) m/z calculated for C18H34N [M+H]
+ = 264.2691; found: 264.2696. 
Methyl ((5E,9E)-6,10,14-trimethylpentadeca-5,9,13-trien-2-yl)carbamate 403 
 
By general procedure A, methyl chloroformate (0.38 ml, 5 mmol, 1.1 eq.) was added to the amine 
402 (1.20 g, 4.5 mmol, 1.0 eq.) and Et3N (0.6 ml, 5.5 mmol, 1.2 eq.) to give the carbamate 403 
(0.80 g, 55%) as a clear oil. δH 5.21 – 5.02 (m, 3H, 3 x =CH), 4.53 (br. d, J = 6.6 Hz, 1H, NH), 
3.77 – 3.68 (m, 1H, NCH), 3.66 (s, 3H, OCH3), 2.16 - 1.98 (m, 10H, 5 x CH2), 1.70 (s, 6H, 2 x 
CH3), 1.62 (s, 6H, 2 x CH3), 1.50 - 1.41 (m, 2H, CH2), 1.15 (d, J = 6.4 Hz, 3H, CH3).  δC 156.4 
(Cq), 135.7 (Cq), 135.4 (Cq), 131.5 (Cq), 125.0 (=CH), 124.3 (=CH), 123.5 (=CH), 51.8 (OCH3), 
47.0 (NCH), 39.7 (2 x CH2), 31.9 (CH2), 26.7 (CH2), 25.6 (CH3), 24.4 (2 x CH2), 23.3 (2 x CH3), 
17.7 (CH3), 15.9 (CH3). IR (neat) υ/cm-1: 3323, 2965, 2926, 1700, 1532, 1451, 1377, 1248, 1078. 
HRMS (EI) m/z calculated for C20H35NO2 [M]
+ = 321.2668; found: 321.2674. 
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Methyl 3,4a,7,7,10a-pentamethyldodecahydrobenzo[f]quinoline-4(4aH)-carboxylate 404 
 
To the foregoing carbamate 403 (161 mg, 0.5 mmol) in anhydrous dichloromethane (10 ml), 
cooled in an ice bath was added triflic acid (3 mg, 1.8 µl, 0.02 mmol, 0.4 eq), and the reaction 
mixture was stirred without cooling for one hour. The reaction was quenched by the addition of 
saturated aqueous potassium carbonate (2 ml). The separated organic layer was dried and 
evaporated to give the cyclised product 404 (120 mg, 75%) as a colourless oil. δH (whole sample) 
4.39 – 1.34 (s, m, 1H, NCH), 3.56 (s, 3H, OCH3), 1.72 – 1.63 (m, 2H, CH2), 1.47– 1.52  (m, 4H, 2 
x CH2), 1.36 – 1.23 (m, 4H, 2 x CH2), 1.19 – 1.10 (m, 6H, 3 x CH2), 0.87 (s, 3H, CH3), 0.86 (s, 
3H, CH3), 0.85 (s, 3H, CH3), 0.84 (d, J = 6.8 Hz, 3H, CH3), 0.79 (s, 3H, CH3).  
The whole sample showed IR (neat) υ/cm-1: 2934, 2872, 1701, 1528, 1452, 1252, 1084, 908, 722. 
HRMS (EI) m/z calculated for C20H35NO2 [M]
+ = 321.2668; found: 321.2666. 
1-(4-Methylcyclohex-3-en-1-yl)ethanone oxime 41731 
 
To a solution of commercial (+/-) limona ketone 416 (2.76 g, 20 mmol, 1.0 eq) and hydroxylamine 
hydrochloride (2.09 g, 30 mmol, 1.5 eq) in methanol (30 ml) was added sodium acetate (1.00 g, 
12.2 mmol) in one portion. The reaction mixture was heated at 40 oC for 2 h and then concentrated 
on a rotary evaporator. The residue was partitioned between ether (50 ml) and water (10 ml). The 
separated organic layer was dried and evaporated to give the E-oxime 417 (3.00 g, 97%) as a 
colourless oil, which was used directly in the next step. All data obtained were in accordance with 
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those previously reported in the literature:31 δH  5.10 – 5.18 (m, 1H, =CH), 3.24 (pent, J = 7.0 Hz, 
1H), 2.18 – 2.03 (m, 1H), 1.85 – 1.76 (m, 4H, 2 x CH2), 1.76 – 1.65 (m, 1H), 1.62 (s, 3H, CH3), 
1.40 (s, 3H, CH3), 1.36 – 1.25 (m, 1H). 
1-(4-Methylcyclohex-3-en-1-yl)ethanamine 418 
 
By general procedure C, the oxime 417 (3.0 g, 19.6 mmol) was reduced using lithium aluminium 
hydride (0.76 g, 20 mmol) to give the amine 418 (2.60 g, 96%) as a clear oil and an inseparable 
1:1 mixture of diastereoisomers, which was used directly in the next step: Diastereoisomer A - δH 
5.28 (t, J = 10.0 Hz, H, =CH), 2.75 – 2.66 (m, 1H, NCH), 1.94 – 1.86 (m, 4H, 2 x CH2), 1.66 (s, 
3H, CH3), 1.33 – 1.36 (m, 2H, CH2), 1.37 (dddt, J = 8.9, 8.4, 6.8, 5.7 Hz, 1H), 1.02  (d, J = 7.2, 
3H). δC 134.0 (Cq), 120.0 (=CH), 51.0 (NCH), 40.8 (CH), 30.4 (CH2), 27.7 (CH2), 25.4 (CH2), 
23.4 (CH3),  20.3 (CH3). Diastereoisomer B - δH 2.66 – 2.58 (m, 1H, NCH), 1.30 (dddt, J = 8.9, 
8.4, 6.8, 5.7 Hz, 1H) only 2 distinct peaks. δC 120.6 (=CH), 41.0 (CH),  28.0 (CH2); only 3 distinct 
peaks. IR (neat) υ/cm-1: 3279, 2887, 2855, 1659, 1437, 1377, 1153, 951. HRMS (ES) m/z 
calculated for C9H18N [M+H]
+ = 140.1439; found: 140.1440. 
4-Methyl-N-(1-(4-methylcyclohex-3-en-1-yl)ethyl)benzenesulfonamide 419 
 
 
By general procedure A, p-tosyl chloride (1.00 g, 5.5 mmol, 1.1 eq.) was added to the amine 418 
(0.70 g, 5.0 mmol, 1.0 eq.) and Et3N (0.62 ml, 5.5 mmol) to give the sulfonamide 419 (1.28 g, 
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87%)  as a clear oil and as an inseparable 1:1 mixture of diastereoisomers. Diastereoisomer A - δH  
7.69 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 5.19 (br. s, 1H, =CH), 4.51 – 4.42 (m, 1H, NH), 
3.21 – 3.11 (m, 1H, NCH), 2.35 (s, 3H, ArCH3), 2.01 - 1.82 (m, 4H, 2 x CH2), 1.53 (s, 3H, CH3), 
1.40 (dd, J = 7.0, 4.2 Hz, 1H), 1.28 – 0.98 (m, 1H), 0.89 (d, J = 6.7 Hz, 3H). δC 143.2 (Cq), 138.30 
(Cq), 134.0 (Cq), 129.5 (CH), 127.0 (CH), 120.0 (=CH), 53.8 (NCH), 39.7 (CH), 30.1 (CH2), 27.8 
(CH2), 25.2 (CH2), 23.3 (CH3),  21.4 (CH3), 18.8 (CH3). Diastereoisomer B: δH 0.88 (d, J = 6.7 
Hz, 3H) - only 1 distinct peak. δC 133.9 (Cq), 53.7 (NCH), 39.5 (CH), 29.9 (CH2), 27.5 (CH2), 
25.0 (CH2) - only 6 distinct peaks. The whole sample showed IR (neat) υ/cm-1: 3289, 2920, 1599, 
1433, 1321, 1159, 1089, 914, 814, 731, 665. HRMS (ES) m/z calculated for C16H24NO2S [M+H]
+ 
= 294.1528; found: 294.1514. 
1,3-Dimethyl-2-tosyl-2-azabicyclo[2.2.2]octane 420 
 
By general procedure B, to sulfonamide 419 (117 mg, 0.4 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added, and the mixture stirred 
for 4 h at 0 oC to give the bicyclo-octane 420 (111 mg, 95%) as a colourless crystals, m.p. 112 – 
114 °C.  δH 7.78 (d, J = 8.2 Hz, 2H), 7.27 (d, J = 8.2 Hz, 2H), 4.14 (qd, J = 6.4, 3.7 Hz, 1H, NCH), 
2.43 (s, 3H, Ar CH3), 1.98 – 1.89 (m, 1H), 1.89 – 1.81 (m, 1H), 1.78 (s, 1H), 1.71 – 1.66 (m, 1H), 
1.65 – 1.58 (m, 1H), 1.45 (d, J = 6.4 Hz, 3H, CH3), 1.19 (s, 3H, CH3). δC 142.5 (Cq), 140.9 (Cq), 
129.5 (2 x CH), 127.0 (2 x CH), 57.0 (NCH), 55.2 (Cq), 36.7 (CH2), 31.5 (CH), 30.1 (CH2), 26.4 
(CH2), 26.3 (CH3), 22.2 (CH3), 21.4 (CH3), 19.2 (CH2). IR (neat) υ/cm-1: 2930, 1597, 1456, 1329, 
1311, 1076, 1160, 1078, 980, 878, 739. HRMS (EI) m/z calculated for C16H23NO2S [M]
+ = 
293.1450; found: 293.1448. 
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(1R,4S,5R,7R)-4,7-Dimethyl-6-tosyl-6-azabicyclo[3.2.1]octane 421 
 
By general procedure B, to sulfonamide 419 (127 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the mixture stirred 
for 5 h at 20 oC to give the [3.2.1]-azabicyclo-octane 421 (122 mg, 96%) as a colourless oil. δH 
7.58 (d, J = 8.0 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 3.61 (d, J = 3.9 Hz, 1H, NCH), 3.56 – 3.47 (m, 
1H, NCH), 2.28 (s, 3H, ArCH3), 2.13 (app. s, 1H), 1.98 (app. s, 1H), 1.82 (d, J = 4.0 Hz, 1H), 
1.41 – 1.37 (m, 2H, CH2), 1.31 – 1.26 (m, 1H), 1.21 (d, J = 6.8 Hz, 3H, CH3), 1.15 – 1.08 (m, 1H), 
0.88 (ddd, J = 11.4, 10.1, 5.1 Hz, 1H), 0.83 (d, J = 6.3 Hz, 3H, CH3), 0.71 (dd, J = 6.8, 3.9 Hz, 
1H). δC 143.1 (Cq), 139.1 (Cq), 129.5 (2 x CH), 127.0 (2 x CH), 60.2 (NCH), 55.3 (NCH), 37.6 
(CH), 33.6 (CH), 31.4 (CH2), 26.3 (CH3), 21.5 (CH2), 21.0 (CH3), 20.5 (CH3), 19.2 (CH2). IR 
(neat) υ/cm-1: 2957, 2930, 1458, 1333, 1155, 1091, 812. HRMS (ES) m/z calculated for 
C16H24NO2S [M+H]
+ = 294.1528; found: 294.1524. 
N-(1-(4-Methylcyclohex-3-en-1-yl)ethyl)-4-nitrobenzenesulfonamide 422 
 
By general procedure A, p-nitrobenzenesulfonyl chloride (1.24 g, 5.5 mmol, 1.1 eq.) was added to 
the amine 418 (0.70 g, 5.0 mmol, 1.0 eq.) and Et3N (0.62 ml, 5.5 mmol) to give the Ns-
sulfonamide 422 (1.39 g, 85%) as a yellow oil and as an inseparable 1:1 mixture of 
diastereoisomers. Diastereoisomer A δH 8.41 (d, J = 8.0 Hz, 2H), 8.13 (d, J = 8.0 Hz, 2H), 5.12 
(br. s, 1H, =CH), 5.09 – 4.84 (m, 1H, NH), 3.36 – 2.96 (m, 1H, NCH), 2.00 – 1.79 (m, 4H, 2 x 
CH2), 1.50 (s, 3H, CH3), 1.29 – 1.12 (m, 2H, CH2), 0.99 (d, J = 6.7 Hz, 3H, CH3). δC 149.9 (Cq), 
                                                                                                                                                            199 
147.5 (Cq), 134.1 (Cq), 128.2 (2 x CH), 124.3 (2 x CH), 119.5 (=CH), 54.5 (NCH), 39.6 (CH), 
30.0 (CH2), 27.9 (CH2), 27.5 (s), 25.3 (CH2), 23.3 (CH3), 19.2 (CH3). Diastereoisomer B: δH 0.90 
(d, J = 6.7 Hz, 3H) - only 1 distinct peak. δC 149.9 (Cq), 147.2 (Cq), 134.1 (Cq), 128.2 (2 x CH), 
124.3 (2 x CH), 119.4 (=CH), 54.3 (NCH), 39.4 (CH), 29.8 (CH2), 27.5 (CH2), 25.1 (CH2), 23.3 
(CH3), 19.1 (CH3).  
The whole sample showed IR (neat) υ/cm-1: 3327, 2930, 1529, 1433, 1351, 1310, 1165, 1092, 914, 
852, 736. HRMS (ES-VE) m/z calculated for C15H19N2O4S [M+H]
+ = 323.1066; found: 323.1077. 
1,3-Dimethyl-2-(4-nitrophenylsulfonyl)-2-azabicyclo[2.2.2]octane  423 
 
By general procedure B, to Ns-sulfonamide 422 (131 mg, 0.4 mmol) in dry dichloromethane (10 
ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the reaction 
stirred for 4 h at 0 oC to give the azabicyclo-octane 423 (126 mg, 96%) as yellowish crystals, m.p. 
155 – 158°C. δH 8.31 – 8.19 (m, 2H), 8.06 – 7.96 (m, 2H), 4.23 – 4.01 (m, 1H, NCH), 1.84 (ddd, J 
= 11.2, 5.9, 2.5 Hz, 1H), 1.72 – 1.65 (m, 1H), 1.65 – 1.58 (m, 1H), 1.41 (d, J = 7.2, 3H, CH3), 1.32 
– 1.16 (m, 2H, CH2), 1.14 (s, 3H, CH3). δC 150.0 (Cq), 140.9 (Cq), 128.5 (2 x CH), 124.1 (2 x 
CH), 57.0 (NCH), 56.1 (Cq), 36.2 (CH2), 31.8 (CH), 30.6 (CH2), 26.4 (CH3), 26.3 (CH2), 21.4 
(CH3), 19.4 (CH2). IR (neat) υ/cm-1: 2938, 1525, 1338, 1302, 1161, 1085, 983, 910, 855. HRMS 
(EI) m/z calculated for C15H20N2O4S [M]
+ = 324.1144; found: 324.1146. 
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(1R,4S,5R,7R)-4,7-Dimethyl-6-((4-nitrophenyl)sulfonyl)-6-azabicyclo[3.2.1]octane 424 
 
By general procedure B, to sulfonamide 422 (142 mg, 0.44 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the reaction stirred 
for 1 h at 20 oC to give the [3.2.1]-azabicyclo-octane 424 (132 mg, 93%) as yellowish crystals 
m.p. 174 – 177 °C. δH 8.34 – 8.28 (m, 2H), 7.99 – 7.95 (m, 2H), 3.71 (dd, J = 12.9, 6.3 Hz, 1H, 
NCH), 3.40 – 3.23 (m, 1H, NCH), 1.96 (d, J = 3.3 Hz, 1H), 1.65 (dd, J = 4.7, 2.6 Hz, 1H), 1.58 – 
1.53 (m, 1H), 1.53 – 1.45 (m, 2H, CH2), 1.41 (d, J = 6.6 Hz, 3H, CH3), 1.35 – 1.30 (m, 1H), 1.30 – 
1.25 (m, 1H), 1.25 – 1.22 (m, 1H), 0.91 (d, J = 6.4 Hz, 3H, CH3). δC 150.0 (Cq), 140.9 (Cq), 129.0 
(2 x CH), 124.1 (2 x CH), 65.3 (NCH), 60.6 (NCH), 38.9 (CH), 37.4 (CH2), 36.8 (CH), 27.6 
(CH2), 25.0 (CH2), 19.4 (CH3), 15.6 (CH3). IR (neat) υ/cm-1: 2934, 1525, 1348, 1306, 1157, 1090, 
855. HRMS (EI) m/z calculated for C15H20N2O4S [M]
+ = 324.1144; found: 324.1142. 
Methyl (1-(4-methylcyclohex-3-en-1-yl)ethyl)carbamate 425 
 
By general procedure A, methyl chloroformate (0.38 ml, 5 mmol, 1.0 eq.) was added to the amine 
418 (0.70 g, 5.0 mmol, 1.0 eq.) and Et3N (0.62 ml, 5.5 mmol) to give the carbamate 425 (0.76 g, 
77%) as a clear oil and as an inseparable 1:1 mixture of diastereoisomers. Diastereoisomer A δH 
5.27 (br. s, 1H, =CH), 5.09 – 4.84 (m, 1H, NH), 3.35 – 3.29 (m, 1H, NCH), 3.25 (s, 3H, OCH3),  
2.06 – 1.80 (m, 4H, 2 x CH2), 1.79 – 1.60 (m, 1H), 1.53 – 1.42 (m, 1H), 1.31 – 1.08 (m, 4H, 2 x 
CH2), 1.08 (d, J = 6.7 Hz, 3H, CH3). δC 156.7 (Cq), 133.9 (Cq), 120.0 (=CH), 51.6 (OCH3), 50.7 
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(NCH), 39.4 (CH), 30.1 (CH2), 28.2 (CH2), 25.6 (CH2), 23.3 (CH3), 18.5 (CH3). Diastereoisomer 
B δH 1.00 (d, J = 6.7 Hz, 3H, CH3) - only 1 distinct peak. δC 133.8 (Cq), 50.6 (NCH), 39.3 (CH), 
30.2 (CH2), 28.0 (CH2), 25.7 (CH2) - only 7 distinct peaks. The whole sample showed IR (neat) 
υ/cm-1: 3337, 2933, 1694, 1531, 1452, 1252, 1105, 1167, 912, 777. HRMS (EI) m/z calculated for 
C11H19NO2 [M]
+ = 197.1416; found: 197.1407. 
Methyl 1,3-dimethyl-2-azabicyclo[2.2.2]octane-2-carboxylate 426 
 
By general procedure B, to the carbamate 425 (100 mg, 0.6 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting mixture 
stirred for 1 h at room temperature to give the bicyclo-octane 426 (92 mg, 92%) as a colourless 
oil.  δH 4.51 - 4.44 (m, 1H, NCH), 3.49 (s, 3H, OCH3), 1.72 (dd, J = 8.3, 4.0 Hz, 1H), 1.66 – 1.48 
(m, 2H, CH2), 1.46 – 1.37 (m, 2H, CH2), 1.32 – 1.15 (m, 4H, 2 x CH2), 1.06 (s, 3H, CH3), 0.97 (d, 
J = 6.7 Hz, 3H, CH3). δC 156.8 (C=O), 61.0 (NCq) 56.5 (NCH), 51.7 (OCH3), 38.4 (CH2), 31.3 
(CH), 30.8 (CH3), 30.1 (CH2), 26.7 (CH2), 19.9 (CH3), 19.8 (CH2). IR (neat) υ/cm-1: 2928, 2862, 
1694, 1528, 1452, 1260, 910, 730. HRMS (EI) m/z calculated for C11H19NO2 [M]
+= 197. 1416; 
found: 197. 1411. 
 (4-Methylcyclohex-3-en-1-yl)methyl methanesulfonate 428 
 
To a stirred solution of the alcohol 427 (1.26 g, 10.0 mmol) in pyridine (10 ml), tosyl chloride 
(1.91 g, 10 mmol) was added. After 2 h the reaction mixture was diluted with H2O (10 ml), 
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acidified to pH 4 with HCl (5%) and extracted with dichloromethane (3 × 15 ml). The combined 
organic layers were washed with water (2 × 5 ml), brine (2 × 5 ml) then dried and evaporated to 
give the tosylate 428 (2.80 g, 100%), which was used without further purification. δH 7.69 (d, J = 
8.3 Hz, 2H), 7.26 (d, J = 8.3 Hz, 2H), 5.18 (br. s, 1H, =CH), 3.80 (d, J = 6.7 Hz,  2H, OCH2), 2.35 
(s, 3H, ArCH3), 2.12 – 1.98 (m, 1H, CH), 1.98 – 1.81 (m, 3H, CH and CH2), 1.80 – 1.62 (m, 2H, 
CH2), 1.56 (s, 3H, CH3), 1.37 – 1.21 (m, 1H, CH). δC 144.8 (Cq), 133.9 (Cq), 129.8 (2 x CH), 
127.8 (2 x CH), 119.0 (=CH), 74.4 (OCH2), 36.3 (ArCH3), 34.0 (CH), 28.8 (CH2), 27.7 (CH2), 
24.9 (CH2), 21.4 (CH3). 
4-Methyl-N-(4-methylcyclohex-3-en-1-ylmethyl)benzenesulfonamide 429 
 
Potassium hydroxide (0.67 g, 12 mmol) was dissolved in DMF (20 ml) at 120 °C and tosylamide 
(1.71 g, 10 mmol) was added to the resulting solution. After 0.5 h, a solution of the tosylate 428 
(2.80 g, 10 mmol) in DMF (20 ml) was added. After 1 h the reaction mixture was cooled, diluted 
with water (10 ml) and extracted with ether (4 × 15 ml). The combined organic layers were 
washed with water (3 × 5 ml), brine (3 × 5 ml) then dried and evaporated. The crude product was 
purified by silica gel column chromatography (eluting silica gel with 0 - 100% dichloromethane in 
hexanes) to give the sulfonamide 429 (2.48 g, 89%) as a clear oil. δH 7.77 – 7.58 (m, 2H), 7.37 – 
7.13 (m, 2H), 5.21 – 5.16 (m, 1H, =CH), 5.09 (t, J = 6.2 Hz, 1H, NH), 2.80 – 2.62 (m, 2H, NCH2), 
2.33 (s, 3H, ArCH3), 2.00 – 1.87 (m, 1H), 1.83 – 1.74 (m, 2H, CH2), 1.69 – 1.59 (m, 1H), 1.65 – 
1.61 (m, 1H, CH), 1.60 – 1.52 (m, 1H),  1.52 – 1.48 (m, 3H, CH3), 1.21 – 1.04 (m, 1H). δC 143.2 
(Cq), 137.3 (Cq), 134.0 (Cq), 129.7 (2 x CH), 127.0 (2 x CH), 119.7 (=CH), 48.4 (NCH2), 33.5 
(CH), 29.2 (2 x CH2), 27.8 (CH2), 23.4 (CH3),  21.5 (CH3). IR (neat) υ/cm-1: 3269, 2924, 1437, 
1323, 1160, 1096, 814. HRMS (EI) m/z calculated for C15H21NO2S [M]
+ = 279.1293; found: 
279.1293. 
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1-Methyl-2-tosyl-2-azabicyclo[2.2.2]octane 430 
 
By general procedure B, to sulfonamide 429 (180 mg, 0.64 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added, the reaction stirred for 3 
h at 20 oC to give the azabicyclo-octane 430 (169 mg, 94%) as a colourless crystals, m.p. 135 – 
138 °C. δH 7.71 – 7.58 (m, 2H), 7.20 (d, J = 7.1 Hz, 2H), 3.52 (d, J = 2.5 Hz, 2H, NCH2), 2.35 (s, 
3H, ArCH3), 1.83 (dd, J = 5.9, 3.0 Hz, 1H, CH), 1.70 – 1.60 (m, 2H, CH2), 1.53 – 1.40 (m, 4H, 2 x 
CH2), 1.34 – 1.25 (m, 2H, CH2), 1.23 (s, 3H, CH3). δC 142.1 (Cq), 140.3 (Cq), 129.4 (2 x CH), 
127.0 (2 x CH), 54.6 (Cq), 52.7 (CH2N), 34.7 (2 x CH2), 26.4 (CH3),  25.9 (CH), 24.6 (2 x CH2), 
21.5 (CH3). IR (neat) υ/cm-1: 2920, 1454, 1329, 1158, 1094, 816. HRMS (EI) m/z calculated for 
C15H21NO2S [M]
+ = 279.1293; found: 279.1292. 
Cyclohex-3-en-1-ylmethyl methanesulfonate 433 
 
To a stirred solution of the alcohol 432 (1.12 g, 10.0 mmol) in pyridine (10 ml), methanesulfonyl 
chloride (1.14 g, 10 mmol) was added dropwise. After 2 h the reaction mixture was diluted with 
water (10 ml), acidified to pH 4 with HCl (5%) and extracted with dichloromethane (3 × 15 ml). 
The combined organic layers were washed with water (2 × 5 ml), brine (2 × 5 ml), then dried and 
evaporated to give the mesylate 433 (1.90 g, 100%). The product was used directly without further 
purification. δH 5.71 – 5.46 (m, 2H, 2 x =CH), 4.04 (d, J = 6.6 Hz, 2H, OCH2), 2.95 (s, 3H, Ms-
CH3), 2.04 – 1.98 (m, 4H, 2 x CH2), 1.81 – 1.70 (m, 2H, CH2), 1.41 – 1.23 (m, 1H, CH). δC 127.1 
(=CH), 125.0 (=CH), 74.0 (OCH2), 37.0 (CH), 33.3 (Ms-CH3), 27.5 (CH2), 25.2 (CH2), 24.0 
(CH2). 
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N-(Cyclohex-3-en-1-ylmethyl)-4-methylbenzenesulfonamide 434 
 
Potassium hydroxide (0.67 g, 12 mmol) was dissolved in DMF (20 ml) at 120 °C and tosylamide 
(2.00 g, 12 mmol) was added to the resulting solution. After 0.5 h, a solution of the foregoing 
mesylate 433 (1.90 g, 10 mmol) in DMF (20 ml) was added. After 1 h, the reaction mixture was 
cooled, diluted with water (10 ml) and extracted with ether (4 × 15 ml). The combined organic 
layers were washed with water (3 × 5 ml), brine (3 × 5 ml) then dried and evaporated. The crude 
product was purified by silica gel column chromatography (eluting silica gel with 0 - 100% 
dichloromethane in hexanes) to give the sulfonamide 434 (2.30 g, 88%) as a clear oil. δH 7.78 (d, J 
= 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 5.63 – 5.58 (m, 2H, NCH2), 5.18 (br. s, 1H, NH), 2.83 (t, 
J = 6.2 Hz, 2H, CH2), 2.43 (s, 3H, ArCH3), 2.15 – 2.10 (m, 1H, CH), 2.10 – 1.89 (m, 2H, CH2), 
1.83 – 1.50 (m, 3H, CH and CH2), 1.33 – 1.03 (m, 1H, CH). δC 143.3 (Cq), 137.1 (Cq), 129.7 (2 x 
CH), 127.0 (2 x CH), 125.4 (2 CH), 48.5 (NCH2), 33.7 (CH), 29.1 (CH2), 26.0 (CH2), 24.3 (CH2), 
21.4 (CH3). IR (neat) υ/cm-1: 3281, 2916, 1431, 1306, 1094, 814. HRMS (EI) m/z calculated for 
C14H19NO2S [M]
+ = 265.1137; found: 265.1135. 
6-Tosyl-6-azabicyclo[3.2.1]octane 435 
 
By general procedure B, to sulfonamide 434 (284 mg, 1.07 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (50 mg, 0.5 mmol) was added and the resulting mixture 
stirred for 20 h at 20 oC. The crude product was purified by silica gel column chromatography 
(eluting silica gel with 0 - 100% dichloromethane in hexanes)  to give the azabicyclo-octane 435 
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(207 mg, 73%) as a yellow oil. δH 7.65 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.2 Hz, 2H), 4.09 – 3.98 
(m, 1H, NCH), 3.21 (dd, J = 9.4, 5.4 Hz, 1H, NCHAHB), 3.18 (dd, J = 9.4, 2.4 Hz, 1H, NCHAHB), 
2.35 (s, 3H, ArCH3), 2.28 (br. s, 1H, CH), 1.83 – 1.77 (m, 1H, CH), 1.68 – 1.57 (m, 1H, CH), 1.57 
– 1.47 (m, 1H, CH), 1.47 – 1.35 (m, 1H, CH), 1.30 – 1.25 (m, 1H, CH), 1.22 – 1.10 (m, 2H, CH2), 
1.18 (d, J = 5.4 Hz, 1H). δC 142.9 (Cq), 136.3 (Cq), 129.6 (2 x CH), 127.1 (2 x CH), 58.2 (NCH), 
52.3 (NCH2), 37.4 (CH2),  35.1 (CH), 32.0 (CH2), 30.2 (CH2), 21.5 (ArCH3), 18.5 (CH2). IR (neat) 
υ/cm-1: 2934, 1454, 1331, 1158, 1091, 814. HRMS (EI) m/z calculated for C14H19NO2S [M]+ = 
265.1137; found: 265.1138. 
(1S,4S,5S)-4-Iodo-6-tosyl-6-azabicyclo[3.2.1]octane 43732 
 
To a stirred solution of the sulfonamide 434 (240 mg, 0.9 mmol, 1.0 eq.) in dry dichloromethane 
(20 ml) was added iodine (0.69 g, 2.7 mmol, 3.0 eq.) at 0 oC. The reaction was then stirred without 
cooling for 36 h. The mixture was then quenched with saturated aqueous sodium thiosulfate (10 
ml) and the resulting mixture extracted with dichloromethane (3 × 10 ml). The combined organic 
extracts were dried, ﬁltered and the solvent evaporated to yield the crude product, which was 
puriﬁed by column chromatography (eluting silica gel with 0 - 100% dichloromethane in hexanes) 
to give the iodo-azabicyclo-octane 436 (0.32 g, 91%) as sharp, colourless crystals m.p. 116 – 118 
°C; δH 7.47 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 4.27 (t, J = 4.2 Hz, 1H, NCH), 3.93 (t, J 
= 5.0 Hz,  1H, CHI), 3.06 (d, J = 9.7 Hz, 1H, NCHAHB), 3.03 – 2.98 (m, 1H, NCHAHB), 2.20 (s, 
3H, ArCH3), 2.13 – 2.08 (m, 2H, CH2), 2.08 – 2.03 (m, 1H, CH), 1.68 (dd, J = 15.9, 5.2 Hz, 1H, 
CH), 1.57 (td, J = 13.5, 5.3 Hz, 1H, CH), 1.29 – 1.22 (m, 1H, CH), 0.90 (dt, J = 11.8, 5.2 Hz, 1H, 
CH). δC 143.5 (Cq), 135.4 (Cq), 129.8 (2 x CH), 127.0 (2 x CH), 62.6 (NCH), 52.9 (NCH2), 34.4 
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(CH), 34.2 (CH2), 31.0 (CH), 29.6 (CH2), 26.1 (CH2), 21.5 (ArCH3). IR (neat) υ/cm-1: 2945, 1597, 
1445, 1342, 1159, 1024, 980, 903, 814, 667. HRMS (EI) m/z calculated for C14H18INO2S [M]
+ = 
391.0103; found: 391. 0093.  
6-Tosyl-6-azabicyclo[3.2.1]octane 435 
 
The iodobicyclo-octane 436 (70 mg, 0.18 mmol) was dissolved in dry methanol (5 ml). 
Triethylamine (0.2 ml) was added followed by 10% palladium on active carbon (50 mg). The 
resulting mixture was stirred under a hydrogen atmosphere for 20 h, then filtered and concentrated 
in vacuo. The residue was dissolved in dichloromethane (10 ml) and washed with saturated 
aqueous potassium carbonate (5 ml) before being dried, filtered and evaporated to yield the 
azabicyclo-octane 435 (43 mg, 90%) as a colourless oil, which showed the same analytical data as 
the sample obtained from the acid catalysed cyclisation above (p. 204). 
1-(4-(4-Methylpent-3-en-1-yl)cyclohex-3-en-1-yl)ethanone 43933 
 
Myrcene 437 (1.36 g, 10 mmol, 1.0 eq) and methyl vinyl ketone 438 (0.70 g, 10 mmol, 1.0 eq) 
was applied to the usual chromatographic grade silica gel (1.50 g). The mixture was heated at 50 
oC for 5 h. The silica was then washed with ether (3 x 10 ml) and the combined filtrates 
concentrated to give the ketone 439 (1.66 g, 80%) as a clear oil. All data obtained were in 
accordance with those previously reported in the literature:33 δH 5.20 (d, J = 3.7 Hz, 1H, =CH), 
4.92 (tdd, J = 6.9, 2.6, 1.3 Hz, 1H, =CH), 2.41 – 2.30 (m, 1H, CH), 2.00 (s, 3H, COCH3), 1.91 – 
1.78 (m, 8H, 4 x CH2), 1.21 – 1.25 (m, 2H, CH2), 1.51 (s, 3H, CH3), 1.43 (s, 3H, CH3). 
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(E)-1-(4-(4-Methylpent-3-en-1-yl)cyclohex-3-en-1-yl)ethanone oxime 44033 
 
To a solution of ketone 440 (1.66 g, 8 mmol, 1.0 eq) and hydroxylamine hydrochloride (0.70 g, 10 
mmol, 1.25 eq) in methanol (30 ml) was added sodium acetate (1.0 g, 12.2 mmol) in one portion. 
The reaction mixture was heated at 40 oC for 2 h and then concentrated on a rotary evaporator. 
The residue was partitioned between ether (50 ml) and water (10 ml). The separated organic layer 
was dried. Evaporation provided the oxime 440 (1.70 g, 96%) as a colourless liquid which was 
used directly in the next step. δH 9.50 – 9.25 (br. s, 1H, NOH), 5.33 (br. s, 1H, =CH), 5.02 (tdd, J 
= 6.9, 2.6, 1.3 Hz, 1H, =CH), 2.39 – 2.24 (m, 1H, CH), 2.03 – 1.91 (m, 8H, 4 x CH2), 1.91 – 1.85 
(m, 2H, CH2), 1.81 (s, 3H, CH3), 1.61 (s, 3H, CH3), 1.53 (s, 3H, CH3). 
1-(4-(4-Methylpent-3-en-1-yl)cyclohex-3-en-1-yl)ethanamine 44133 
 
According to general procedure C, the oxime 440 (1.70 g, 7.7 mmol, 1.0 eq.) was reduced using 
lithium aluminium hydride (0.38 g, 10 mmol, 1.3 eq.) to give the amine 441 (1.40 g, 88%) as a 
yellow oil as an inseparable 1:1 mixture of diastereoisomers, which was used directly in the next 
step. Diastereoisomer A δH 5.31 (app. br. s, 1H, =CH), 5.05 – 4.98 (m, 1H, =CH), 2.74 – 2.66 (m, 
1H, NCH), 2.00 (dd, J = 18.0, 11.5 Hz, 2H, CH2), 1.90 (dt, J = 14.5, 8.9 Hz, 2H, CH2), 1.68 (dd, J 
= 10.6, 5.7, Hz, 2H, CH2), 1.61 (s, 3H, CH3), 1.53 (s, 3H, CH3) 1.38 – 1.22 (m, 4H, 2 x CH2), 1.22 
– 1.08 (m, 1H, CH), 0.98 (d, J = 3.2 Hz, 3H, CH3). Diastereoisomer B δH 2.66 – 2.56 (m, 1H, 
NCH), 1.00 – 0.99 (m, 1H, CH), 1.01 (d, J = 3.2 Hz, 3H, CH3) - only 3 distinct peaks. 
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Methyl (1-(4-(4-methylpent-3-en-1-yl)cyclohex-3-en-1-yl)ethyl)carbamate 442 
 
By general procedure A, methyl chloroformate (0.76 ml, 10 mmol, 1.5 eq.) was added to the 
amine 441 (1.40 g, 6.8 mmol, 1.0 eq.) and Et3N (1.2 ml, 11 mmol, 1.6 eq.) to give the carbamate 
442 (1.47 g, 82%) as a clear oil as an inseparable 1:1 mixture of diastereoisomers. 
Diastereoisomer A δH 5.28 (d, J = 12.2 Hz, 1H, =CH), 5.01 (t, J = 6.9 Hz, 1H, =CH), 4.61 (d, J = 
8.1 Hz, 1H, NH), 3.65 – 3.59 (m, 1H, NCH),  3.58 (s, 3H, OCH3), 2.05 – 1.94 (m, 3H, CH and 
CH2), 1.93 – 1.84 (m, 3H, CH and CH2), 1.67 (dd, J = 21.6, 8.2 Hz, 2H, CH2), 1.60 (s, 3H, CH3), 
1.52 (s, 3H, CH3), 1.27 – 1.09 (m, 1H, CH), 1.08 – 1.05 (d, J = 4.1 Hz, 3H, CH3). δC 156.6 (CO2), 
137.6 (Cq), 131.3 (Cq), 124.3 (=CH), 119.6 (=CH), 53.4 (OCH3), 50.8 (NCH), 39.6 (CH), 37.7 
(CH2), 28.6 (CH2), 28.4 (CH2), 27.6 (CH2), 25.6 (CH3), 24.8 (CH2), 17.6 (CH3). 
 Diastereoisomer B δH  1.04 (d, J = 4.1 Hz, 3H, CH3) only 1 distinct peak. δC 137.8 (Cq), 120.0 
(=CH), 120.6 (=CH), 120.5 (=CH), 51.8 (OCH3), 50.7 (NCH), 39.5 (CH), 37.5 (CH2), 28.2 (CH2) 
- only 9 distinct peaks.  
Methyl ((S)-1-((S)-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethyl)carbamate 
443 
 
By general procedure B, to the carbamate 442 (160 mg, 0.6 mmol) in dry dichloromethane (10 ml) 
under nitrogen, concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 0.5 h at room temperature to give the carbamate 443 (157 mg, 98%) as a 
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colourless oil as an inseparable 1:1 mixture of diastereoisomers; δH 4.58 (d, J = 7.5 Hz, 1H, NH), 
3.67 – 3.60 (m, 1H, NCH),  3.64 (s, 3H, OCH3), 1.98 – 1.89 (m, 2H, CH2), 1.87 – 1.78 (m, 2H, 
CH2), 1.75 – 1.63 (m, 2H, CH2), 1.63 – 1.53 (m, 2H, CH2), 1.51 – 1.47 (m, 1H, CH), 1.17 – 1.06 
(m, 4H, 2 x CH2), 0.99 (s, 6H, 2 x CH3), 0.97 (d, J = 2.1 Hz, 3H, CH3). δC 156.6 (CO2), 133.7 
(Cq), 127.1 (Cq), 53.4 (OCH3), 50.8 (NCH), 40.4 (CH2), 40.2 (CH2), 39.7 (CH), 28.3 (2 x CH2), 
28.2 (2 x CH2), 27.3 (CH3), 27.1 (CH3), 19.30 (CH3). 
 
2-(2,2,3-Trimethylcyclopent-3-en-1-yl)acetaldehyde oxime 448 
 
To a solution of the aldehyde 447 (1.50 g, 10 mmol, 1.0 eq) and hydroxylamine hydrochloride 
(1.40 g, 20 mmol, 2 eq) in ethanol (30 ml) was added sodium acetate (1.0 g, 12.2 mmol). The 
reaction mixture was heated at 40 oC for 3 h and then concentrated on a rotary evaporator. The 
residue was partitioned between ether (50 ml) and water (10 ml). The separated organic layer was 
dried and evaporated to give the oxime 448 (1.53 g, 92%) as a colourless liquid, which was used 
directly in the next step. All data obtained were in accordance with those previously reported in 
the literature: δH 9.72 (s, 1H, NOH), 5.16 (t, J = 1.3 Hz, 1H, =CH), 2.46 (ddd, J = 15.5, 4.3, 2.0 
Hz, 1H, CH), 2.37 – 2.27 (m, 2H, CH2), 2.21 (dddd, J = 12.1, 10.2, 6.0, 3.2 Hz, 1H, CH), 1.86 – 
1.78 (m, 1H, CH), 1.54 (d, J = 1.6 Hz, 3H, CH3), 0.93 (s, 3H, CH3), 0.72 (s, 3H, CH3). δC 202.7 
(C=N), 147.9 (Cq), 121.53 (CH), 46.9 (Cq), 45.1 (NCH2), 44.1 (CH), 35.5 (CH2), 25.6 (CH3), 20.1 
(CH3), 12.5 (CH3). 
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2-(2,2,3-Trimethylcyclopent-3-en-1-yl)ethanamine 449 
 
Following general procedure C, the oxime 448 (1.50 g, 9.0 mmol) was reduced using lithium 
aluminium hydride (0.38 g, 10 mmol) to give the amine 449 as a clear oil. (1.10 g, 80%). All data 
obtained were in accordance with those reported for a sample of the amine prepared by reduction 
of the nitrile 456. 
Methyl (2-(2,2,3-trimethylcyclopent-3-en-1-yl)ethyl)carbamate 450 
 
By general procedure A, methyl chloroformate (0.7 ml, 8.9 mmol) was added to the amine 449 
(1.10 g, 7.2 mmol) and Et3N (1 ml, 8.8 mmol) at 0 
oC. The mixture was then stirred for 1 h at 
room temperature to give the carbamate 450 (1.39 g, 91%) as a colourless oil. δH 5.12 (s, 
1H,=CH), 4.82 (br. s, 1H, NH), 3.56 (s, 3H, OCH3), 3.21 – 3.19 (m, 1H, CH), 3.15 – 3.10 (m, 1H, 
CH), 2.25 – 2.19 (m, 1H, CH), 1.84 – 1.78 (m, 1H, CH), 1.73 – 1.70 (m, 1H, CH), 1.62 – 1.60 (m, 
1H, CH),  1.51 (s, 3H, CH3), 1.41 (dd, J = 11.2, 10.1 Hz, 1H), 0.93 (s, 3H, CH3), 0.69 (s, 3H, 
CH3). δC 157.1 (C=O), 148.4 (Cq), 121.5 (=CH), 51.8 (OCH3), 47.4 (CH), 46.8 (Cq), 40.6 
(NCH2), 35.4 (CH2), 30.5 (CH2),  25.7 (CH3), 19.6 (CH3), 12.5 (CH3). IR (neat) υ/cm-1: 3333, 
2955, 1697, 1526, 1445, 1377, 1256, 1194, 912. HRMS (EI) m/z calculated for C12H21NO2 [M]
+ = 
211.1572; found: 211. 1575. 
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Methyl 6,6,6a-trimethylhexahydrocyclopenta[b]pyrrole-1(2H)-carboxylate 451 
 
To a stirred solution of the carbamate 450 (211 mg, 1 mmol) in dry diclromethane (10 ml) under 
nitrogen, cooled in an ice-water bath, was added triflic acid (150 mg, 1 mmol). The resulting 
mixture stirred was stirred at 20 °C for 4 hours to give the bicycle 451 (207 mg, 98%) as a 
colourless oil (3:1). 
major product : δH 3.56 (s, 3H, OCH3), 3.41 – 3.28 (m, 2H, NCH2), 2.38 – 2.29 (m, 2H, CH2), 
1.89 – 1.82 (m, 2H, CH2), 1.78 – 1.66 (m, 1H, CH), 1.45 (ddd, J = 8.7, 7.2, 4.5 Hz, 2H, CH2), 1.35 
(s, 3H, CH3), 1.07 (s, 3H, CH3), 0.88 s, 3H, CH3). δC 156.8 (C=O), 74.8 (Cq), 54.1 (CH), 51.8 
(OCH3), 49.1 (NCH2), 46.0 (Cq), 43.2 (CH2), 29.9 (CH2),  28.8 (CH2),  25.9 (CH3), 24.8 (CH3), 
22.2 (CH3).  
Minor product :  δH 3.74 – 3.68 (m, 2H, NCH2), 3.60 (s, 3H, OCH3), 1.25 (s, 3H, CH3), 0.98 (s, 
3H, CH3), 0.82 (s, 3H, CH3). δC 158.8 (C=O), 74.0 (Cq), 55.8 (CH), 51.5 (OCH3), 49.9 (NCH2), 
46.9 (Cq), 38.8 (CH2), 32.3 (CH2),  28.5 (CH2),  26.4 (CH3), 25.0 (CH3), 23.6 (CH3).  
IR (neat) υ/cm-1: 2957, 2868, 1700, 1530, 1445, 1255. HRMS (APCI) m/z calculated for 
C12H21NO2 [M-H]
+ = 210.1494; found: 210.1497. 
Methyl (2-(2,3,3-trimethylcyclopent-1-en-1-yl)ethyl)carbamate 452 
 
To a stirred solution of the carbamate 450 (211 mg, 1 mmol) in dry toluene (10 ml) under 
nitrogen, cooled in an ice-water bath, was added triflic acid (76 mg, 0.5 mmol, 0.5 eq). The 
resulting mixture stirred was stirred at 80 °C for 2 hours to give the carbamate 452 (203 mg, 96%) 
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as a colourless oil. δH 4.56 (s, 1H, NH), 3.57 (s, 3H, OCH3), 3.17 – 3.12 (m, 2H, NCH2), 2.19 – 
2.2  (m, 4H, 2 x CH2), 1.54 (t, J = 3.8 Hz, 2H, CH2), 1.43 (s, 3H, CH3), 0.89 (s, 6H, 2 x CH3). δC 
157.0 (C=O), 142.1 (Cq), 129.8 (Cq), 51.9 (OCH3), 46.9 (Cq), 49.3 (NCH2), 38.8 (CH2), 32.3 
(CH2),  29.2 (CH2),  26.4 (3 x CH3). 
 
By general procedure B, to the carbamate 450 (211 mg, 1 mmol) in dry dichloromethane (10 ml) 
concentrated sulfuric acid (4 drops) was added and the resulting mixture was stirred for 4 h at 20o 
C to give the bicycle 451 (96 mg, 45%) and the carbamate 452 (92 mg, 44%) 3:2 as colourless 
oils, which were puriﬁed by column chromatography (eluting silca gel with 0 - 100% 
dichloromethane in hexanes). All data obtained were in accordance with those reported above.  
(1S,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one oxime 454 
 
To a solution of camphor 453 (3.10 g, 20 mmol, 1.0 eq) and hydroxylamine hydrochloride (2.09 g, 
30 mmol, 1.5 eq) in ethanol and water (1:1, 30 ml) was added sodium acetate (1.0 g, 12.2 mmol). 
The reaction mixture was heated at 40 oC for 18 h and then concentrated on a rotary evaporator. 
The residue was partitioned between ether (50 ml) and water (10 ml). The separated organic layer 
was dried and evaporated to give the oxime 454 (3.10 g, 93%) as a colourless liquid. All data 
obtained were in accordance with those previously reported in the literature:34  δH 9.62 (s, 1H, 
NOH), 2.51 – 2.44 (m, 1H, CH), 2.00 – 1.94 (m, 1H, CH), 1.83 (t, J = 4.4 Hz, 1H), 1.74 (ddd, J = 
11.5, 7.6, 4.1 Hz, 1H), 1.66 – 1.58 (m, 1H, CH), 1.42 – 1.35 (m, 1H, CH), 1.15 (ddd, J = 9.4, 8.1, 
4.2 Hz, 1H), 0.93 (s, 3H, CH3), 0.83 (s, 3H, CH3), 0.72 (s, 3H, CH3). δC 169.6 (C=N, Cq), 51.8 
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(Cq), 48.3 (Cq), 43.8 (CH), 33.1 (CH2), 32.7 (CH2), 27.3 (CH2), 19.8 (CH3), 18.5 (CH3), 11.1 
(CH3). IR (neat) υ/cm-1: 3298, 2959, 2876, 1740, 1448, 907. HRMS (EI) m/z calculated for 
C10H17NO [M]
+ = 167.1310; found: 167. 1311. 
2-(2,2,3-Trimethylcyclopent-3-en-1-yl)acetonitrile 456 
2-(2,2-Dimethyl-3-methylenecyclopentyl)acetonitrile 45735 
 
The oxime  454 (2.80 g, 16.7 mmol) was dissolved in dry dichloromethane (30 ml) and the 
solution cooled in ice-water. Triethylamine (2.0 ml, 20 mmol) and tosyl chloride (3.81 g, 20 
mmol) were added sequentially. The resulting mixture was allowed to warm to room temperature 
overnight then quenched with water (20 ml). The separated aqueous phase was extracted with 
dichloromethane (3 x 20 ml). The combined organic extracts were washed with brine (5 ml), 
dried, filtered and concentrated to yield the crude nitriles which were purified by column 
chromatography (eluting silica gel with 0 - 100% dichloromethane in hexanes) to give an 
inseparable mixture of the nitriles 456 and 457 (1.80 g, 72%) as a colourless oil. All data obtained 
were in accordance with those previously reported in the literature:36 nitrile 456 δH 5.23 (t, J = 1.2 
Hz, 1H, =CH), 2.44 – 2.37 (m, 1H, CH), 2.35 – 2.27 (m, 1H, CH), 2.22 – 2.11 (m, 1H, CH), 2.04 
– 1.97 (m, 1H, CH), 1.60 (s, 3H, CH3), 1.06 (s, 3H, CH3), 0.84 (s, 3H, CH3). δC 147.4 (Cq), 121.1 
(=CH), 119.3 (CN), 47.5 (Cq), 46.2 (CH), 37.0 (CH2),  22.9 (CH3), 19.8 (CH3), 17.9 (CH2), 12.4 
(CH3). 
nitriles 457 (<5%) δH 4.91 (d, J = 12.2 Hz, 1H, =CHA), 4.85 – 4.76 (m, 1H, =CHB), 0.98 (s, 3H, 
CH3), 0.89 (s, 3H, CH3). δC 161.2 (=Cq), 104.1 (=CH2), 118.3 (CN), 46.5 (Cq), 45.2 (CH), 38.7 
(CH2),  28.8 (CH2), 21.8 (CH2), 19.7 (CH3), 12.0 (CH3). 
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2-(2,2,3-Trimethylcyclopent-3-en-1-yl)ethanamine 458 and 
2-(2,2-dimethyl-3-methylenecyclopentyl)ethanamine 259 
 
Following general procedure C, the nitriles 256 and 457 (1.80 g, 12 mmol, 1.0 eq.) was reduced 
using lithium aluminium hydride (0.57 g, 15 mmol, 1.25 eq.) to give the amines 458 and 459 (1.40 
g, 76%) as a yellow oil, which was used directly in the next step. All data obtained were in 
accordance with those previously reported in the literature:37 amine 258 δH 5.14 (t, J = 1.3 Hz, 1H, 
=CH), 2.73 – 2.65 (m, 1H, CH), 2.63 – 2.54 (m, 1H, CH), 2.25 – 2.14 (m, 1H, CH), 1.80 – 1.64 
(m, 2H, CH2), 1.53 (s, 3H, CH3), 0.90 (s, 3H, CH3), 0.69 (s, 3H, CH3). δC 151.0 (Cq), 121.6 
(=CH), 48.0 (CH), 46.8 (Cq), 41.5 (NCH2), 35.5 (CH2), 34.3 (CH2),  25.8 (CH3), 19.8 (CH3), 12.5 
(CH3). Amine 259 δH 4.77 – 4.66 (m, 1H, =CH2), 0.98 (s, 3H, CH3), 0.97 (s, 3H, CH3) only 3 
distinct peaks. 
4-Methyl-N-(2-(2,2,3-trimethylcyclopent-3-en-1-yl)ethyl)benzenesulfonamide 460 
 
By general procedure A, tosyl chloride (2.10 g, 11 mmol) was added to the above amine (1.40 g, 
9.1 mmol) and Et3N (1.5 ml, 12.1 mmol) at 0 
oC. The mixture was then stirred for 1 h at room 
temperature to give the sulfonamide 460 (2.58 g, 92%) as a colourless oil. All data obtained were 
in accordance with those previously reported in the literature:36 δH 7.68 (d, J = 7.6 Hz, 2H), 7.24 
(d, J = 7.6 Hz, 2H), 5.10 (s, 1H,=CH), 4.28 (s, 1H, NH), 3.05 – 2.91 (m, 1H, CH), 2.89 – 2.75 (m, 
1H, CH), 2.36 (s, 3H, Ar-CH3), 2.15 – 2.09 (m, 1H, CH), 1.74 – 1.58 (m, H, CH), 1.51 (s, 3H, 
CH3), 1.34 (dd, J = 11.7, 10.1 Hz, 1H), 0.83 (s, 3H, CH3), 0.62 (s, 3H, CH3). δC 148.4 (Cq), 143.4 
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(Cq), 137.4 (Cq), 129.6 (2 x CH), 127.2 (2 x CH), 121.6 (=CH), 48.0 (CH), 46.8 (Cq), 42.5 
(NCH2), 35.5 (CH2), 30.3 (CH2),  25.8 (CH3), 21.4 (CH3), 19.8 (CH3), 12.5 (CH3). 
IR (neat) υ/cm-1: 3277, 2955, 2930, 2866, 1435, 1323, 1092, 910, 813. HRMS (EI) m/z calculated 
for C17H25NO2S [M]
+ = 307.1606; found: 307.1603. 
6,6,6a-Trimethyl-1-tosyloctahydrocyclopenta[b]pyrrole 457 
 
By general procedure B, to the sulfonamide 456 (185 mg, 0.6 mmol) in dry dichloromethane (10 
ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture was stirred for 3 h at 
0 oC to give sulfonamide 462 as a mixture 1:1 with azabicyclo-octane 457 (86 mg, 46%), wich 
separated after crystallization in dichloromethane/hexanes as colourless crystals m.p. 124 – 126 
°C. δH 7.68 – 7.64 (d, J = 7.9 Hz, 2H), 7.25 (d, J = 7.9 Hz, 2H), 3.19 – 3.03 (m, 2H, NCH2), 2.44 
(dt, J = 14.8, 5.7 Hz, 1H), 2.36 (s, 3H, Ar-CH3), 2.18 – 2.06 (m, 2H, CH2), 1.94 – 1.83 (m, 4H, 2 x 
CH2), 1.32 (s, 3H, CH3), 1.18 (s, 3H, CH3), 0.87 (s, 3H, CH3). δC 143.4 (Cq), 139.2 (Cq), 129.8 (2 
x CH), 127.1 (2 x CH), 53.7 (NCq), 39.2 (NCH2), 33.3 (CH2), 27.3 (CH2), 27.0 (CH2), 21.5 (CH3), 
19.7 (CH3), 17.3 (CH3), 15.3 (CH3). IR (neat) υ/cm-1: 2951, 2926, 1655, 1329, 1094, 910. HRMS 
(EI) m/z calculated for C17H25NO2S [M]
+ = 307.1606; found: 307.1599. 
4-Methyl-N-(2-(2,3,3-trimethylcyclopent-1-en-1-yl)ethyl)benzenesulfonamide 462 
 
By general procedure B, to the sulfonamide 460 (260 mg, 0.85 mmol) in dry dichloromethane (10 
ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture was stirred for 4 h at 
20 oC to give the sulfonamide 462 (252 mg, 97%) as a colourless oil. δH 7.62 – 7.56 (d, J = 8.1 Hz, 
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2H), 7.15 (d, J = 8.1 Hz, 1H), 4.17 (t, J = 5.7 Hz, 1H, NH), 2.88 – 2.74 (m, 2H, NCH2), 2.28 (s, 
3H, Ar-CH3), 2.07 – 1.96 (m, 2H, CH2), 1.84 – 1.80 (m, 2H, CH2), 1.41 – 1.34 (m, 2H, CH2), 1.30 
(s, 3H, CH3), 0.79 (s, 6H, 2 x CH3). 
(1S,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one O-ethoxycarbonyl oxime 46438 
 
The oxime 454 (3.2 g, 19 mmol) was dissolved in dry dichloromethane (40 ml) and the solution 
cooled in ice-water to 0 °C. Triethylamine (2 ml, 20 mmol) and ethyl chloroformate  (2.17 g, 20 
mmol) were added sequentially. The resulting mixture was allowed to warm to room temperature 
over night then quenched with water (20 ml). The aqueous phase was extracted with 
dichloromethane (3 x 20 ml). The combined organic extracts were washed with brine (5 ml), 
dried, filtered and concentrated to yield the oxime ethyl carbonate 464 (4.50 g, 99%) as a 
colourless oil. δH 4.21 (q, J = 7.1 Hz, 2H, OCH2), 2.61 – 2.54 (m, 1H, CH), 2.11 – 2.09 (m, 1H, 
CH), 1.86 (t, J = 4.4 Hz, 1H), 1.74 (ddd, J = 11.5, 7.6, 4.1 Hz, 1H), 1.66 – 1.58 (m, 1H, CH), 1.42 
– 1.35 (m, 1H, CH), 1.29 (t, J = 7.1 Hz, 3H, CH3), 1.20 (ddd, J = 9.4, 8.1, 4.2 Hz, 1H), 0.93 (s, 
3H, CH3), 0.84 (s, 3H, CH3), 0.72 (s, 3H, CH3). δC 177.2 (C=N, Cq), 154.2 (C=O), 64.3 (OCH2), 
53.0 (Cq), 48.6 (Cq), 43.3 (CH), 34.7 (CH2), 32.4 (CH2), 27.0 (CH2), 19.4 (CH3), 18.4 (CH3), 14.3 
(CH3), 11.1 (CH3). IR (neat) υ/cm-1: 2961, 2876, 1770, 1447, 1361, 997, 984. 
2-(2,2,4-Trimethylcyclopent-3-en-1-yl)acetonitrile 46538 
 
The oxime carbonate 464 (4.50 g, 18.8 mmol) was treated with boron trifluoride etherate (2 M 
solution, 10 ml, 20 mmol) under nitrogen at ice temperature. The resulting solution is stirred for 6 
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h at room temperature and then quenched by the addition of water (20 ml), then the solution was 
extracted with dichloromethane (3 x 20 ml). The combined extracts were dried and concentrated to 
give the nitrile 465 (2.67 g, 95%) as a clear oil, which was used directly in the next step. All data 
obtained were in accordance with those previously reported in the literature:38 δH 5.11 (s, 1H, 
=CH), 2.40 – 2.33 (m, 1H, CH), 2.32 – 2.26 (m, 1H, CH), 2.23 – 2.16 (m, 1H, CH), 2.10 – 2.01 
(m, 1H, CH), 1.90 – 1.85 (m, 1H, CH), 1.49 (s, 3H, CH3), 0.95 (s, 3H, CH3), 0.73 (s, 3H, CH3). δC 
147.8 (Cq), 121.0 (=CH), 119.7 (CN), 46.8 (Cq), 46.1 (CH), 35.5 (CH2),  25.7 (CH3), 19.5 (CH3), 
18.0 (CH2), 12.5 (CH3). IR (neat) υ/cm-1: 2965, 2251, 1703, 1616, 912. HRMS (ES) m/z calculated 
for C10H16N [M+H]
+ = 150.1283; found: 150. 1285. 
2-(2,2,4-Trimethylcyclopent-3-en-1-yl)ethanamine 466 
 
By general procedure C, the nitrile 465 (2.64 g, 17.7 mmol) was reduced using lithium aluminium 
hydride (0.76 g, 20 mmol) to give the amine 466 (2.50 g, 92%) as a yellow oil. δH 5.15 (s, 1H, 
=CH), 2.71 (ddd, J = 12.2, 9.5, 5.1 Hz, 1H, CH), 2.59 (ddd, J = 12.2, 9.0, 6.6 Hz, 1H, CH), 2.23 – 
2.15 (m, 1H, CH), 1.81 – 1.75 (m, 1H, CH), 1.74 – 1.59 (m, 2H, CH2), 1.53 (s, 3H, CH3), 1.41 – 
1.29 (m, 1H, CH), 0.91 (s, 3H, CH3), 0.70 (s, 3H, CH3). δC 148.7 (Cq), 121.6 (=CH), 48.0 (CH), 
46.8 (Cq), 41.6 (NCH2), 35.6 (CH2), 34.4 (CH2),  25.8 (CH3), 19.7 (CH3), 12.6 (CH3). IR (neat) 
υ/cm-1: 3281, 2953, 2932, 1651, 1445, 1375, 1360, 1072, 1015, 910. HRMS (ES) m/z calculated 
for C10H20N [M+H]
+ = 154.1596; found: 154. 1592. 
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Methyl (2-(2,2,4-trimethylcyclopent-3-en-1-yl)ethyl)carbamate 467 
 
By general procedure A, methyl chloroformate (0.7 ml, 8.9 mmol) was added to the amine 466 
(1.00 g, 6.5 mmol) and Et3N (1 ml, 8.8 mmol) at 0 
oC. The mixture was then stirred for 1 h at 
room temperature to give the carbamate 467 (1.12 g, 88%) as a colourless oil. δH 5.15 (s, 
1H,=CH), 4.71 (br. s, 1H, NH), 3.60 (s, 3H, OCH3), 3.18 (dt, J = 14.3, 7.0 Hz, 1H, CH), 3.14 – 
3.02 (m, 1H, CH), 2.28 – 2.18 (m, 1H, CH), 1.83 – 1.73 (m, 1H, CH), 1.73 – 1.63 (m, 1H, CH), 
1.53 (s, 3H, CH3), 1.44 – 1.31 (m, 1H, CH), 0.89 (s, 3H, CH3), 0.67 (s, 3H, CH3). δC 157.1 (C=O), 
148.5 (Cq), 121.5 (=CH), 51.9 (OCH3), 47.7 (Cq), 46.8 (CH), 40.6 (NCH2), 35.4 (CH2), 30.5 
(CH2),  25.7 (CH3), 19.7 (CH3), 12.5 (CH3). HRMS (EI) m/z calculated for C12H21NO2 [M]
+ = 
211.1572; found: 211. 1571. 
4-Methyl-N-(2-(2,2,4-trimethylcyclopent-3-en-1-yl)ethyl)benzenesulfonamide 468 
 
By general procedure A, tosyl chloride (1.96 g, 10 mmol) was added to the amine 466 (1.00 g, 6.5 
mmol) and Et3N (1.5 ml, 12.1 mmol) at 0 
oC. The mixture was then stirred for 1 h at room 
temperature to give the sulfonamide 468 (1.80 g, 90%) as a colourless oil. δH 7.68 (d, J = 8.2 Hz, 
2H), 7.23 (d, J = 8.2 Hz, 2H), 5.09 (s, 1H,=CH), 4.71 (s, 1H, NH), 2.99 – 2.88 (m, 1H, CH), 2.88 
– 2.76 (m, 1H, CH), 2.36 (s, 3H, Ar-CH3), 2.13 – 2.05 (m, 1H, CH), 1.70 – 1.58 (m, 3H, CH and 
CH2), 1.49 (s, 3H, CH3), 1.31 (dddd, J = 12.4, 10.2, 8.1, 4.6 Hz, 1H, CH), 0.82 (s, 3H, CH3), 0.59 
(s, 3H, CH3). δC 148.4 (Cq), 143.3 (Cq), 137.1 (Cq), 129.7 (2 x CH), 127.1 (2 x CH), 121.3 
(=CH), 47.4 (CH), 46.8 (Cq), 42.7 (NCH2), 35.1 (CH2), 30.1 (CH2),  25.6 (CH3), 21.5 (CH3), 19.6 
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(CH3), 12.5 (CH3). IR (neat) υ/cm-1: 3279, 2963, 1699, 1448, 1327, 1094, 815. HRMS (ES) m/z 
calculated for C17H24NO2S [M]
+ = 306.1528; found: 306.1527. 
Methyl (2-(2,3,3-trimethylcyclopent-1-en-1-yl)ethyl)carbamate 452 
 
To a stirred solution of the carbamate 467 (211 mg, 1 mmol) in dry dicloromethane (10 ml) under 
nitrogen, cooled in an ice-water bath, was added sulfuric acid (3 drops). The resulting mixture 
stirred was stirred at 20 °C for 4 hours to give the carbamate 452 (200 mg, 95%) as a colourless 
oil. All data obtained were in accordance with those reported above. 
4-Methyl-N-(2-(2,3,3-trimethylcyclopent-1-en-1-yl)ethyl)benzenesulfonamide 462 
 
By general procedure B, to the sulfonamide 468 (120 mg, 0.39 mmol) in dry dichloromethane (10 
ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture was stirred for 4 h at 
20 oC to give the sulfonamide 462 (109 mg, 91%) as a colourless oil. All data obtained were in 
accordance with those reported above. 
1-(4-Methylcyclohex-3-en-1-yl)ethanol 48239 
          
Following general procedure C, reduction of the ketone 416 (0.70 g, 5 mmol, 1.0 eq.) using 
lithium aluminum hydride (0.38 g, 10 mmol, 2.0 eq.) and a 1 h reflux period gave the alcohol 482 
(623 mg, 89%)  as a clear oil and as an inseparable 1:1 mixture of diastereoisomers. 
Diastereoisomer A  δH 5.37 – 5.22 (m, 1H, =CH), 3.64 – 3.55 (m, 1H, CH), 2.12 – 1.98 (m, 1H, 
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CH), 1.99 – 1.86 (m, 3H, CH and CH2), 1.71 (app. d, J = 14.8 Hz, 1H, CH), 1.58 (s, 3H, CH3), 
1.47 – 1.38 (m, 1H, CH), 1.12 (d, J = 7.1 Hz, 3H, CH3). δC 134.0 (Cq), 120.2 (=CH), 71.7 (OCH), 
41.1 (CH), 30.8 (CH2), 28.0 (CH2), 25.4 (CH2), 23.4 (CH3), 20.8 (CH3). Diastereoisomer B δH 
3.54 – 3.49 (m, 1H, CH) - only 1 distinct peak. δC 134.0 (Cq), 120.1 (=CH), 71.6 (OCH), 41.0 
(CH), 30.8 (CH2), 27.0 (CH2), 24.9 (CH2), 23.4 (CH3), 20.6 (CH3). The whole sample showed IR 
(neat) υ/cm-1: 3351, 2916, 1448, 1375, 1072, 1017, 912. HRMS (EI) m/z calculated for C9H14O 
[M]+ = 122.1096; found: 122.1090. 
1,3-Dimethyl-2-oxabicyclo[2.2.2]octane 483 
 
By general procedure B, to alcohol 482 (153 mg, 1.09 mmol) in dry dichloromethane (10 ml) 
under nitrogen concentrated sulfuric acid (50 mg, 0.5 mmol) was added, the mixture stirred for 3 h 
at 32 oC to give the oxabicyclo-octane 483 (135 mg, 88%) as a pale yellow oil. δH 3.93 (q, J = 6.3 
Hz, 1H, OCH), 1.86 – 1.78 (m, 1H, CH), 1.70 – 1.65 (m, 1H, CH), 1.62 – 1.53 (m, 3H, CH and 
CH2), 1.49 – 1.41 (m, 2H, CH2), 1.41 – 1.36 (m, 2H, CH2), 1.10 (d, J = 6.3 Hz, 3H, CH3), 0.96 (s, 
3H, CH3). δC 73.1 (OCH), 69.1 (Cq),  32.6 (CH2), 32.1(CH2),  29.7 (CH), 27.1 (CH3),  26.5 (CH2),  
20.8 (CH3), 19.7 (CH2). IR (neat) υ/cm-1: 2986, 2912, 2888, 1713, 1458, 1373, 1209, 1055, 957. 
HRMS (EI) m/z calculated for C9H16O [M]
+ = 140.1201; found: 140.1206. 
1-Methyl-2-oxabicyclo[2.2.2]octane 485 
 
By general procedure B, to commercially available (4-methylcyclohex-3-enyl)methanol 427 
(Aldrich, 155 mg, 1.23 mmol) in dry dichloromethane (10 ml) under nitrogen concentrated 
                                                                                                                                                            221 
sulfuric acid (50 mg, 0.5 mmol) was added and the reaction stirred for 1.5 h at 35 oC to give the 
oxabicyclo-octane 485 (143 mg, 92%). δH 3.81 (app. dd, J = 2.9, 1.5 Hz, 2H, CH2), 1.70 (dd, J = 
1.1, 1.1 Hz, 4H, 2 x CH2), 1.56 (br. s, 2H, CH2), 1.54 – 1.45 (m, 2H, CH2), 1.15 (d, J = 8.2 Hz, 
1H), 0.96 (s, 3H, CH3). δC 70.1 (OCH2), 68.1 (Cq),  32.9 (2 x CH2), 27.1 (CH3),  24.9 (CH), 24.8 
(2 x CH2). IR (neat) υ/cm-1: 2924, 2864, 1377, 1262, 1093, 910. HRMS (EI) m/z calculated for 
C8H14O [M]
+ = 126.1045; found: 126.1044. 
Methyl 3-methylcyclopent-3-enecarboxylate 489 
 
The cyclopentene 488 (0.40 g, 2.00 mmol) in dimethyl sulfoxide/water (10 ml : 0.5 ml) containing 
sodium chloride (0.20 g, 3.4 mmol ) was refluxed for 3 h. Cold water was added (3 ml) to the 
cooled mixture and the resulting mixture extracted with ether (3 x 10 ml). The combined organic 
extracts were washed with water (3 x 10 ml) then dried and concentrated to yield the ester 489 
(0.20 g, 72%) as a colourless oil. δH 5.20 – 5.11 (m, 1H, =CH), 3.61 (s, 3H, OCH3), 3.15 – 3.00 
(m, 1H, CH), 2.59 – 2.48 (m, 3H, CH and CH2), 2.47 – 2.35 (m, 1H, CH), 1.63 (s, 3H, CH3). δC 
176.6 (Cq, CO2), 138.6 (Cq), 122.4 (=CH), 51.6 (OCH3), 42.2 (CH), 40.2 (CH2), 36.4 (CH2), 16.1 
(CH3). All data obtained were in accordance with those previously reported in the literature.
40  
 (3-Methylcyclopent-3-en-1-yl)methanol 49038 
 
Following general procedure C, reduction of the ester 489 (0.20 g, 1.4 mmol, 1.0 eq.) using 
lithium aluminum hydride (0.19 g, 5 mmol) and a 1 h reflux period gave the alcohol 490 (126 mg, 
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78%) as a clear oil. δH 5.14 (t, J = 1.6 Hz, 1H, =CH), 3.46 (d, J = 6.8 Hz, 2H, OCH2), 2.49 – 2.42 
(m, 1H, CH), 2.39 – 2.33 (m, 1H, CH), 2.33 – 2.30 (m, 1H, CH), 2.09 (s, 1H, OH), 2.04 – 1.93 (m, 
2H, CH2), 1.63 (d, J = 0.9 Hz, 3H, CH3). δC 139.2 (Cq), 123.1 (=CH), 67.3 (OCH2), 40.1 (CH), 
49.9 (CH2), 35.7 (CH2), 16.5 (CH3). 
1-Methyl-2-oxabicyclo[2.2.1]heptane 491 
 
By general procedure B, to alcohol 490 (83 mg) in dry dichloromethane (5 ml) under nitrogen, 
concentrated sulfuric acid (2 drops) was added, the reaction stirred for 1.5 h at 35 oC to give 491 
(70 mg, 84%). δH 3.70 (d, J = 6.7 Hz, 1H, OCHACHB), 3.49 (d, J = 6.7 Hz, 1H, OCHACHB), 2.33 
(s, 1H), 1.64 (s, 1H), 1.60 (s, 2H), 1.50 (d, J = 2.4 Hz, 1H), 1.48 (s, 1H), 1.40 (d, J = 2.4 Hz, 1H), 
1.36 (s, 1H), 1.32 (s, 3H, CH3). δC 78.2 (OCq), 76.6 (OCH2), 42.2 (CH2), 38.4 (CH), 36.1 (CH2), 
28.8 (CH2), 26.9 (CH3). 
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Typical Procedure D: The preparation of substituted ethyl 2-cyanoacetates41 
To sodium hydride (60% dispersion in mineral oil, 0.80 g, 20 mmol, 1.0 eq.) was added dry DMF 
(20 ml) under nitrogen and the suspension then cooled to 0 °C. To the suspension was slowly 
added ethyl cyanoacetate (6.80 g, 60 mmol, 3.0 eq.) in DMF (10 ml). After 15 min, an alkyl halide 
(20 mmol, 1.0 eq.) were added dropwise via syringe to the solution. The resulting reaction mixture 
was allowed to stir at 0 °C for 3 h, then quenched with water (30 ml) and diluted with ether (30 
ml). The aqueous layer was removed and the organic layer was washed twice with brine (5 ml). 
The combined aqueous and brine layers were then extracted three times with ether (3 x 30 ml). All 
the combined organic extracts were then dried and the solvent was removed. The residue was 
purified by column chromatography on silica gel eluting with ether/hexanes (1:99). Other mono-
substituted cyanoacetates were obtained in a similar manner. 
 
General Procedure E: Alcohol protection by acetate formation42 
A solution of the alcohol (1.0 mmol), acetic anhydride (0.1 ml, 1.1 mmol) and pyridine (0.1 ml) in 
dry dichloromethane (10 ml) was stirred for 6 h at room temperature. The mixture was quenched 
with water (5 ml) and extracted with dichloromethane (2 x 5 ml). The combined organic extracts 
were washed with a saturated aqueous copper(II) sulfate (5 ml), water (5 ml) then dried and 
concentrated to give the protected alcohol. 
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Ethyl 2-cyano-5-methylhex-4-enoate 51143 and  
Ethyl 2-cyano-5-methyl-2-(3-methylbut-2-en-1-yl)hex-4-enoate 512 
 
By typical procedure D, to sodium hydride (60% dispersion in mineral oil, 1.20 g, 30 mmol, 1.0 
eq.) in DMF (25 ml) under nitrogen at 0 °C was slowly added ethyl cyanoacetate 510 (4.40 g, 20 
mmol, 2.0 eq.) in DMF (20 ml). After 15 min, prenyl bromide (1.49 g, 10 mmol, 1.0 eq.) was 
added. The usual work-up then gave the monosubstituted cyanoacetate 511 (1.00 g, 55%) and 
disubstituted cyanoacetate 512 (0.50 g, 20%) as colourless oils, which were separated by column 
chromatography. 
Monosubstituted product 511: δH 4.90 (br. t, J = ca. 7.1 Hz, 1H, =CH), 3.97 (q, J = 7.1 Hz, 2H, 
OCH2), 3.26 (t, J = 6.5 Hz, 1H), 2.42 (dd, J = 7.3 Hz, 6.5, 2H), 1.49 (d, J = 0.9 Hz, 3H, CH3), 1.42 
(app. s, 3H, CH3), 1.07 (t, J = 7.1 Hz, 3H, CH3). δC 165.7 (C=O), 137.3 (Cq), 117.0 (=CH), 116.3 
(CN), 62.5 (OCH2), 37.7 (CH), 28.4 (CH2), 25.6 (CH3), 17.7 (CH3), 13.8 (CH3). IR (neat) υ/cm-1: 
2982, 2932, 2255, 1743, 1445, 1371, 1195, 1030, 908. HRMS (EI) m/z calculated for C10H15NO2 
[M]+ = 181.1103; found: 181.1105. 
Disubstituted product 512 δH 5.13 (br. t, J = 7.6 Hz, 2H, 2 x =CH), 3.97 (q, J = 7.2 Hz, 2H, 
OCH2), 2.62 (dd, J = 14.2, 6.6 Hz, 2H), 2.45 (dd, J = 7.7, 6.6 Hz, 2H) 1.63 (s, 6H, 2 x CH3), 1.60 
(s, 6H, 2 x CH3), 1.27 (t, J = 7.2 Hz, 3H, CH3). δC 168.7 (C=O), 137.3 (Cq), 119.6 (CN), 116.8 (2 
x =CH),  62.1 (OCH2), 49.7 (Cq), 35.0 (2 x CH2), 25.6 (2 x CH3), 17.8 (2 x CH3), 13.8 (CH3). 
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2-(Aminomethyl)-5-methylhex-4-en-1-ol 513 
 
Using general procedure C, the cyanoacetate 511 (4.18 g, 23.1 mmol) was reduced by lithium 
aluminium hydride (0.95 g, 25 mmol) to give the amino-alcohol 513 (2.60 g, 72 %) as a yellow 
oil, which was sufficiently pure to use directly in the next step. δH 4.66 – 4.57 (m, 1H, =CH), 3.31 
– 3.23 (m, 1H), 3.15 – 3.06 (m, 1H), 2.53 (ddd, J = 12.2, 3.7, 1.1 Hz, 1H), 2.29 – 2.19 (m, 1H), 
2.18 – 2.05 (m, 2H), 1.46 – 1.38 (m, 1H), 1.23 (s, 3H, CH3), 1.10 (s, 3H, CH3). δC 132.7 (Cq), 
121.8 (=CH), 67.6 (OCH2), 46.2 (NCH2), 41.9 (CH), 27.7 (CH2), 25.4 (CH3), 17.5 (CH3). IR 
(neat) υ/cm-1: 3323, 2967, 2913, 2856, 1451, 1377, 1038, 910. HRMS (EI) m/z calculated for 
C8H17NO [M]
+ = 143.1310; found: 143.1310. 
Methyl 2-(hydroxymethyl)-5-methylhex-4-en-1-ylcarbamate 514 
 
By general procedure A, methyl chloroformate (1.0 ml, 12.7 mmol) was added to the amino-
alcohol 513 (1.80 g, 12.6 mmol, 1.0 eq.) and Et3N (2.5 ml, 22 mmol, 1.2 eq.) to give the N-
protected amino-alcohol 514 (1.80 g, 71%) as a colourless oil. δH 5.19 (br. s, 1H, NH), 5.16 – 5.04 
(m, 1H, =CH), 3.68 (s, 3H, OCH3), 3.60 (dd, J = 6.6, 6.2 Hz, 1H), 3.50 – 3.38 (m, 1H), 3.37 – 3.21 
(m, 2H), 3.21 – 3.09 (m, 1H), 2.03 – 1.86 (m, 2H), 1.74 (s, 3H, CH3), 1.63 (s, 3H, CH3). δC 158.3 
(C=O), 133.2 (Cq), 121.7 (=CH), 62.9 (CH2OH), 52.2 (OCH3), 41.9 (CH), 41.6 (NCH2), 27.5 
(CH2), 25.6 (CH3), 17.6 (CH3). IR (neat) υ/cm-1: 3343, 2934, 1700, 1526, 1449, 1256, 1194, 1034, 
910. HRMS (EI) m/z calculated for C10H17NO2 [M]
+ = 183.1269; found: 183.1258. 
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2-(Methoxycarbonylaminomethyl)-5-methylhex-4-en-1-yl acetate 515 
 
Using general procedure E, the alcohol 514 (201 mg, 1.0 mmol) was converted into the 
corresponding acetate 515 (243 mg, 100%), a colourless oil. δH 5.02 (dd, J = 11.6, 10.0 Hz, 1H, 
=CH), 4.94 (br. s, 1H, NH), 4.15 (dd, J = 6.8, 4.4 Hz, 1H), 3.95 – 3.85 (m, 1H), 3.52 (s, 3H, 
OCH3),  3.27 – 3.12 (m, 1H), 3.04 (dt, J = 13.7, 7.3 Hz, 1H), 2.00 (s, 3H, Ac-CH3), 1.96 – 1.93 
(m, 2H), 1.89 – 1.74 (m, 1H), 1.64 (s, 3H, CH3), 1.53 (s, 3H, CH3). δC 171.2 (Ac-CO), 157.1 
(CO), 133.9 (Cq), 120.9 (=CH), 64.8 (OCH2), 52.0 (OCH3), 42.2 (NCH2), 39.0 (CH), 37.9 (Ac-
CH3), 27.7 (CH2), 22.2 (CH3), 20.8 (CH3). 
Methyl 5-(acetoxymethyl)-2,2-dimethylpiperidine-1-carboxylate 516 
 
By general procedure B, to the protected amino-alcohol 515 (243 mg, 1.0 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture 
stirred for 1 h at 20 oC to give the piperidine 516 (225 mg, 93%) as a colourless oil. δH 3.85 (dd, J 
= 11.0, 5.7 Hz, 1H), 3.75 (dd, J = 11.0, 8.0 Hz, 1H), 3.65 – 3.59 (m, 1H),  3.55 (s, 3H, OCH3), 
2.90 (dd, J = 13.6, 8.8 Hz, 1H), 1.91 (s, 3H, Ac-CH3), 1.65 – 1.52 (m, 1H), 1.52 – 1.36 (m, 2H, 
CH2), 1.35 (s, 3H, CH3), 1.23 (s, 3H, CH3) 1.17 – 1.05 (m, 2H, CH2). δC 171.0 (Ac-C=O), 156.9 
(C=O), 66.4 (OCH2), 54.8 (NCq), 51.9 (OCH3), 43.1 (CH2N), 36.2 (CH2), 33.8 (CH), 27.9 (CH3), 
24.5 (CH3), 21.3 (CH2), 20.8 (CH3). 
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Methyl (6,6-dimethyltetrahydro-2H-pyran-3-yl)methylcarbamate 517 
 
By general procedure B, to the N-protected amino-alcohol 514 (136 mg, 0.7 mmol) in dry 
dichloromethane (10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added 
and the resulting mixture stirred for 4 h at 0 oC to give the tetrahydropyran 517 as a colourless oil 
(127 mg, 93%). δH 4.60 (app. br. s, NH, 1H), 3.66 (dd, J = 3.9, 1.9 Hz, 1H), 3.65 (s, 3H, OCH3), 
3.62 (dd, J = 4.1, 1.9 Hz, 1H), 3.09 - 2.92 (m, 2H, CH2N), 1.91 (m, 1H), 1.70 - 1.60 (m, 2H) 1.43 - 
1.29 (m, 2H), 1.16 (s, 3H, CH3), 1.12 (s, 3H, CH3). δC 157.2 (C=O), 71.3 (OCq), 64.3 (OCH2), 
52.1 (OCH3), 43.1 (CH2N), 36.2 (CH), 35.1 (CH2), 29.2 (CH3), 23.7 (CH2), 23.3 (CH3). IR (neat) 
υ/cm-1: 3329, 2970, 2930, 1701, 1533, 1452, 1247, 1084, 1009. HRMS (EI) m/z calculated for 
C10H19NO3 [M]
+ = 201.1365; found: 201.1370. 
Methyl 2,2-dimethyl-5-(hydroxymethyl)piperidine-1-carboxylate 518 
 
To a solution of the acetoxymethyl piperidine 516 (122 mg, 0.5 mmol) in undried methanol (5 ml) 
was added potassium carbonate (400 mg, 2.9 mmol). The mixture was stirred for 20 h at room 
temperature. The solvent was evaporated and the residue diluted with water (5 ml) and extracted 
with dichloromethane (3 x 5 ml). The combined organic extracts were dried and concentrated to 
give the piperidine-methanol 518 (92 mg, 91%) as a colourless oil. δH 3.62 (dd, J = 13.7, 4.6 Hz, 
1H), 3.58 (s, 3H, OCH3),  3.46 (dd, J = 10.8, 5.6 Hz, 1H), 3.42 – 3.38 (m, 1H, CH), 3.12 (dd, J = 
13.7, 7.6 Hz, 1H), 1.91 (br. s, 1H, OH), 1.85 – 1.79 (m, 1H, CH), 1.71 – 1.59 (m, 1H, CH),  1.58 – 
1.43 (m, 2H, CH2),  1.39 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.22 – 1.07 (m, 1H, CH).  δC 157.2 
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(C=O), 65.2 (OCH2), 55.1 (NCq), 51.9 (OCH3), 42.7 (CH2N), 38.0 (CH2),  36.8 (CH), 27.6 (CH3), 
24.8 (CH3), 20.8 (CH2). IR (neat) υ/cm-1: 3416, 2947, 2930, 1684, 1539, 1440, 1381, 1157, 1022. 
HRMS (EI) m/z calculated for C10H19NO3 [M]
+ = 201.1365; found: 201.1368.  
Methyl (6,6-dimethyltetrahydro-2H-pyran-3-yl)methylcarbamate 517 
 
By general procedure B, to the alcohol 518 (60 mg, 0.3 mmol) in dry dichloromethane (10 ml) 
concentrated sulfuric acid (12 mg, 0.12 mmol) was added and the resulting mixture stirred for 20 h 
at 20 oC to give the tetrahydropyran 517 as (57 mg, 95%) as a colourless oil, which exhibited 
spectroscopic and analytical data identical to those reported above for a sample of the same 
tetrahydropyran prepared by direct cyclisation of the alcohol 514. 
N-(2-(Hydroxymethyl)-5-methylhex-4-en-1-yl)-4-methylbenzenesulfonamide 519 
 
By general procedure A, tosyl chloride (553 mg, 3.0 mmol) was added to the amino-alcohol 513 
(0.41 g, 2.9 mmol) and Et3N (0.5 ml, 4.4 mmol) at -78 
oC. The mixture was then stirred for 1 h as 
it warmed to room temperature to give the sulfonamide 519 (0.60 g, 70%) as a colourless oil. δH 
7.71 – 7.62 (m, 2H), 7.25 (d, J = 8.0 Hz, 2H), 5.02 (br. s, 1H, NH), 4.94 (td, J = 7.3, 1.4 Hz, 1H, 
=CH), 3.64 (dd, J = 11.0, 4.0 Hz, 1H), 3.46 (dd, J = 11.0, 7.1 Hz, 1H), 2.99 (dd, J = 12.9, 3.9 Hz, 
1H), 2.88 – 2.78 (m, 1H), 2.36 (s, 3H, ArCH3), 1.84 – 1.78 (m, 2H), 1.69 (br. s, 1H, OH), 1.66 – 
1.62 (m, 1H), 1.60 (d, J = 0.9 Hz, 3H, CH3), 1.49 (s, 3H, CH3). δC 143.1 (Cq), 136.4 (Cq), 133.7 
(Cq), 129.5 (2 x CH), 126.8 (2 x CH), 120.9 (CH), 64.2 (OCH2), 44.9 (NCH2), 40.6 (CH), 27.2 
(CH2), 25.5 (ArCH3), 21.3 (CH3), 17.6 (CH3). 
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N-((6,6-Dimethyltetrahydro-2H-pyran-3-yl)methyl)-4-methylbenzenesulfonamide 520 
 
By general procedure B, to the N-tosyl alcohol 519 (100 mg, 0.3 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 0 oC to give the tetrahydropyran 520 (97 mg, 97%) as a colourless oil. δH 
7.68 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 4.37 (t, J = 6.5 Hz, 1H, NH), 3.82 – 3.75 (m, 
1H), 3.61 (ddd, J = 11.9, 4.1, 1.7 Hz, 1H), 3.23 (dd, J = 11.8, 8.8 Hz, 1H), 3.05 – 2.99 (m, 1H), 
2.37 (s, 3H, ArCH3), 1.82 – 1.74 (m, 1H, CH), 1.65 – 1.57 (m, 2H, CH2), 1.47 – 1.39 (m, 2H, 
CH2), 1.12 (s, 3H, CH3), 1.07 (s, 3H, CH3). δC 144.1 (Cq), 129.5 (2 x CH), 127.0 (2 x CH), 71.4 
(OCq) 64.7 (OCH2), 45.3 (NCH2), 39.7 (CH), 38.6 (CH2), 34.7 (CH2), 28.3 (ArCH3), 22.7 (CH3), 
21.5 (CH3). IR (neat) υ/cm-1: 3220, 2974, 2930, 1454, 1325, 1090, 912. HRMS (EI+) m/z 
calculated for C15H23NO3NaS [M+Na]
+ = 320.1296; found: 320.1285. 
5-Methyl-2-((4-methylphenylsulfonamido)methyl)hex-4-en-1-yl acetate 522 
 
By procedure E,  the alcohol 519 (297 mg, 1.0 mmol) was converted into the corresponding 
acetate 522 (339 mg, 100%), a colourless oil. δH 7.72 – 7.62 (m, 2H), 7.24 (d, J = 8.0 Hz, 2H), 
4.98 – 4.87 (m, 1H, =CH), 4.79 (t, J = 6.1 Hz, 1H, NH), 4.01 (dd, J = 11.4, 4.3 Hz, 1H), 3.90 – 
3.75 (m, 1H), 2.87 (ddd, J = 12.5, 6.9, 5.4 Hz, 1H), 2.77 (dt, J = 13.2, 6.7 Hz, 1H), 2.16 (s, 3H, 
ArCH3), 1.93 (s, 3H, AcCH3), 1.93 – 1.86 (m, 2H), 1.80 – 1.69 (m, 1H), 1.61 (d, J = 0.7 Hz, 3H, 
CH3), 1.48 (s, 3H, CH3). δC 171.1 (C=O), 143.4 (Cq), 134.5 (Cq), 129.7 (2 x CH), 127.1 (2 x CH), 
120.5 (=CH), 64.6 (OCH2), 44.2 (NCH2), 38.7 (CH), 27.6 (CH2), 25.7 (ArCH3), 22.1 (CH3), 21.5 
(CH3), 20.8 (CH3). IR (neat) υ/cm-1: 3285, 2969, 1732, 1599, 1447, 1327, 1240, 1092, 1033, 910. 
HRMS (EI) m/z calculated for C17H25NNaO4S [M+Na]
+ = 362.1402; found: 362.1400. 
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Methyl 5-(acetoxymethyl)-2,2-dimethylpiperidine-1-carboxylate 523 
 
By general procedure B, to the protected amino-alcohol 522 (280 mg, 0.8 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the 
resulting mixture was stirred for 1 h at 20o C to give the piperidine 523 as a colourless oil (269 
mg, 96%). δH 7.58 – 7.47 (m, 2H), 7.16 – 7.06 (m, 2H), 3.86 (dd, J = 11.1, 5.4 Hz, 1H), 3.82 – 
3.77 (m, 1H), 3.75 (dd, J = 11.1, 8.0 Hz, 1H), 2.82 (dd, J = 13.3, 9.8 Hz, 1H), 2.27 (s, 3H, 
ArCH3), 1.91 (s, 3H, COCH3), 1.90 – 1.77 (m, 1H), 1.51 (ddd, J = 13.3, 8.3, 4.0 Hz, 1H), 1.46 – 
1.37 (m, 1H), 1.33 (dt, J = 13.3, 4.5 Hz, 1H), 1.25 (s, 3H, CH3), 1.23 – 1.12 (m, 1H), 1.03 (s, 3H, 
CH3). δC 170.9 (C=O), 142.8 (Cq), 140.1 (Cq), 129.4 (2 x CH), 127.0 (2 x CH), 65.9 (OCH2), 57.8 
(NCq), 45.4 (NCH2), 39.8 (CH2), 35.7 (CH), 28.7 (ArCH3), 23.2 (CH2), 23.0 (Ac-CH3),  21.4 
(CH3), 20.8 (CH3). IR (neat) υ/cm-1: 2928, 1737, 1454, 1321, 1228, 1089, 910. HRMS (ES) m/z 
calculated for C17H26NO4S [M+H]
+ = 340.1583; found: 340.1585. 
6,6-Dimethyl-1-tosylpiperidine-3-methanol 521 
 
To a solution of acetoxymethyl piperidine 523 (240 mg, 0.7 mmol) in undried methanol (5 ml) 
was added potassium carbonate (200 mg, 1.5 mmol). The reaction was stirred for 18 h at room 
temperature. The solvent was removed and the residue was diluted with water (5 ml) and extracted 
with dichloromethane (3 x 5 ml). The combined organic layers were dried and concentrated to 
give the piperidine 521 (201 mg, 97%) as a colourless oil. δH δ 7.65 – 7.59 (m, 2H), 7.19 (d, J = 
7.8 Hz, 2H), 3.81 (ddd, J = 13.0, 4.0, 0.8 Hz, 1H), 3.48 (dd, J = 8.8, 2.9 Hz, 2H), 3.00 (dd, J = 
13.0, 9.3 Hz, 1H), 2.34 (s, 3H, ArCH3), 2.01 (br. s, 1H, OH), 1.84 – 1.70 (m, 1H), 1.59 (dq, J = 
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13.3, 4.3 Hz, 1H), 1.51 – 1.35 (m, 2H), 1.30 (s, 3H, CH3), 1.23 (ddd, J = 10.2, 8.0, 4.4 Hz, 1H), 
1.12 (s, 3H, CH3). δC 142.5 (Cq), 139.6 (Cq), 129.2 (2 x CH), 126.7 (2 x CH), 64.3 (OCH2), 57.7 
(NCq), 45.2 (NCH2), 39.5 (CH2), 38.4 (CH), 28.2 (CH3), 23.3 (CH3), 22.5 (CH2), 21.2 (CH3). IR 
(neat) υ/cm-1: 3489, 2926, 1454, 1317, 1089, 1016, 914. HRMS (EI) m/z calculated for 
C15H23NO3S [M]
+ = 297.1399; found: 297.1388. 
N-((6,6-Dimethyltetrahydro-2H-pyran-3-yl)methyl)-4-methylbenzenesulfonamide 520 
 
By general procedure B, to the alcohol 521 (103 mg, 0.35 mmol) in dry dichloromethane (10 ml) 
concentrated sulfuric acid (12 mg, 0.12 mmol) was added and the resulting mixture stirred for 18 h 
at 20 oC to give the tetrahydropyran 520 (98 mg, 97%) as a colourless oil, which exhibited 
spectroscopic and analytical data identical to those reported for a sample of the tetrahydropyran 
prepared by cyclisation of the alcohol 519. 
Ethyl 2-cyanopropanoate 522 
 
By typical procedure C, to potasium hydroxide (1.12 g, 20 mmol, 1.0 eq.) in ethanol (20 ml) under 
nitrogen at 0 °C was slowly added ethyl cyanoacetate 510 (2.27 g, 20 mmol, 1.0 eq.). After 15 
min, methyl iodide (2.84 g, 20 mmol, 1.0 eq.) was added to give the cyanopropanoate 522 (2.14 g, 
84%) as colourless oil. All data obtained were in accordance with those previously reported in the 
literature:44 δH 4.28 (q, J = 7.1 Hz, 2H, OCH2), 3.56 (q, J = 7.4 Hz, 1H, CH), 1.63 (d, J = 7.4 Hz, 
3H, CH3), 1.34 (t, J = 7.1 Hz, 3H, CH3). δC166.5 (CO2), 117.3 (CN), 62.8 (OCH2), 31.5 (CH), 
15.3 (CH3), 13.9 (CH3). 
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Methyl 2-cyano-2,5-dimethylhex-4-enoate 523 
 
By typical procedure D, to sodium hydride (60% dispersion in mineral oil, 0.40 g, 10 mmol, 1.0 
eq.) in dry tetrahydrofuran  (20 ml) under nitrogen at 0 °C was slowly added methyl cyanoacetate 
522 (1.10 g, 10 mmol, 1.0 eq.) in dry tetrahydrofuran  (10 ml). After 15 min, prenyl bromide (1.50 
g, 10 mmol, 1.0 eq.) was added to give the cyanoacetate 523 (1.71 g, 95%) as a colourless oil. δH 
5.11 (dd, J = 7.6, 6.2 Hz, 1H, =CH), 4.23 – 4.11 (m, 2H, OCH2), 2.56 (dd, J = 14.2, 7.6 Hz, 1H, 3-
HA), 2.42 (dd, J = 14.2, 7.6 Hz, 1H, 3-HB), 1.70 (s, 3H, CH3), 1.59 (s, 3H, CH3), 1.50 (d, J = 2.9 
Hz, 3H), 1.23 (t, J = 4.7, 3H, CH3). δC 169.3 (C=O), 137.9 (Cq), 120.1 (CN), 116.5 (=CH), 62.6 
(OCH2), 44.0 (Cq), 36.6 (CH2), 25.9 (CH3), 22.6 (CH3), 18.1 (CH3), 13.7 (CH3). IR (neat) υ/cm-1: 
2986, 2247, 1786, 1717, 1452, 1381, 1236, 1190, 1122, 1111, 1016, 914. HRMS (EI) m/z 
calculated for C11H17NO2 [M]
+ = 195.1259; found: 195.1259. 
2-(Aminomethyl)-2,5-dimethylhex-4-en-1-ol 524 
 
Following generasl procedure C, the cyano-hexenoate 523 (1.70 g, 8.7 mmol, 1.0 eq.) was reduced 
using lithium aluminium hydride (0.76 g, 20 mmol) to give the amino-alcohol  524 (1.30 g, 94%) 
as a colourless oil, which was of sufficient purity to be used directly in the next step. δH 5.14 – 
5.05 (m, 1H, =CH), 3.50 – 3.42 (m, 2H, OCH2), 2.73 (d, J = 12.5 Hz, 1H, NCHAHB), 2.63 (d, J = 
12.5 Hz, 1H, NCHAHB), 2.57 – 2.52 (br. s, 3H, NH2, OH), 1.99 (dd, J = 14.4, 8.0 Hz, 1H, 
=CCHAHB), 1.90 (dd, J = 14.4, 7.4 Hz, 1H, =CCHAHB), 1.65 (d, J = 0.7 Hz, 3H, CH3), 1.53 (s, 
3H, CH3), 0.75 (s, 3H, CH3). δC 133.7 (Cq), 119.7 (=CH), 72.3 (OCH2), 67.9 (NCH2), 51.1 (CH2), 
38.6 (Cq), 33.4 (CH2), 26.0 (CH3), 25.6 (CH2), 19.8 (CH3), 17.8 (CH3). 
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Methyl (2-(hydroxymethyl)-2,5-dimethylhex-4-en-1-yl)carbamate 525 
 
By general procedure A, methyl chloroformate (0.94 g, 10 mmol, 1.2 eq.) was added to the amino-
alcohol 524 (1.25 g, 8 mmol, 1.0 eq.) and Et3N (1.25 ml, 11 mmol, 1.3 eq.) to give the N-protected 
amino-alcohol 525 (1.54 g, 90%) as a colourless oil. δH 5.29 (br. s, 1H, NH), 5.15 – 5.10 (m, 1H, 
=CH), 3.66 (s, 3H, OCH3), 3.23 (dd, J = 11.7, 7.0 Hz, 1H), 3.21 (dd, J = 11.7, 7.0 Hz, 1H), 3.07 
(dd, J = 14.3, 6.7 Hz, 1H), 2.99 (dd, J = 14.3, 6.7 Hz, 1H), 1.91 (d, J = 7.7 Hz, 2H, CH2), 1.70 (s, 
3H, CH3), 1.60 (s, 3H, CH3), 0.79 (s, 3H, CH3). δC 158.6 (C=O), 134.1 (Cq), 119.2 (=CH), 67.1 
(CH2OH), 52.4 (OCH3), 46.4 (NCH2), 40.3 (Cq), 33.3 (CH2), 26.0 (CH3), 19.2 (CH3), 17.8 (CH3). 
IR (neat) υ/cm-1: 3331, 2964, 2928, 1696, 1527, 1454, 1194, 1141, 777, 731. HRMS (EI) m/z 
calculated for C11H19NO2 [M-H2O]
+ = 197.1416; found: 197.1422. 
Methyl (3,6,6-trimethyltetrahydro-2H-pyran-3-ylmethyl)carbamate 526 
 
By general procedure B, to the N-protected amino-alcohol 525 (160 mg, 0.74 mmol) in dry 
dichloromethane (10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added 
and the resulting mixture stirred for 2 h at 0 oC to give the tetrahydropyran 526 as a colourless oil 
(156 mg, 98%). δH 4.73 (br. s, NH, 1H), 3.60 (s, 3H, OCH3), 3.33 – 3.24 (m, 2H), 3.22 (dd, J = 
11.9, 4.8 Hz, 1H), 2.98 (dd, J = 13.8, 6.1 Hz, 1H), 1.55 – 1.41 (m, 2H), 1.41 – 1.26 (m, 2H), 1.13 
(s, 6H, 2 x CH3), 0.80 (s, 3H, CH3).  δC 157.5 (C=O), 71.3 (OCq), 68.5 (OCH2), 52.1 (OCH3), 47.3 
(CH2N), 33.7 (Cq), 32.1 (CH2), 29.1 (CH2), 27.1 (CH3), 25.4 (CH3), 21.3 (CH3). IR (neat) υ/cm-1: 
3354, 2931, 1705, 1537, 1452, 1367, 1074, 1011, 916, 829. HRMS (EI) m/z calculated for 
C11H21NO3 [M]
+ = 215.1521; found: 215.1518. 
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2-(Methoxycarbonylaminomethyl)-2,5-dimethylhex-4-en-1-yl acetate 527 
 
By general procedure E, the alcohol 525 (180 mg, 0.8 mmol) was reacted with acetic anhydride 
(0.1 ml, 1.1 mmol) to give the protected alcohol 527 (215 mg, 100%) as a colourless oil. δH 5.07 
(t, J = 7.8 Hz, 1H, =CH), 4.91 (br. s, 1H, NH), 3.82 (d, J = 11.2 Hz, 1H), 3.75 – 3.70 (m, 1H), 
3.59 (s, 3H, OCH3),  3.09 – 3.03 (m, 1H), 2.99 (dd, J = 13.8, 6.3 Hz, 1H), 2.02 (s, 3H, COCH3), 
1.93 – 1.90 (m, 2H), 1.65 (s, 3H, CH3), 1.54 (s, 3H, CH3), 0.76 (s, 3H, CH3). IR (neat) υ/cm-1: 
3360, 2968, 1699, 1531, 1456, 1369, 1240, 1037, 910, 777. 
Methyl 5-(acetoxymethyl)-2,2,5-trimethylpiperidine-1-carboxylate 528 
 
By general procedure B, to the protected amino-alcohol 527 (190 mg, 0.74 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (2 drops) was added and the resulting mixture 
stirred for 1 h at 20 oC to give the piperidine 528 (184 mg, 97%) as a colourless oil. δH 3.75 (app. 
d, J = 1.9 Hz, 2H, OCH2), 3.54 (s, 3H, OCH3), 3.31 (d, J = 13.9 Hz, 1H, NCHAHB), 2.96 (d, J = 
13.9 Hz, 1H, NCHAHB), 1.99 (s, 3H, COCH3), 1.53 – 1.45 (m, 1H), 1.45 – 1.40 (m, 1H), 1.39 – 
1.34 (m, 1H), 1.33 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.30 – 1.28 (m, 1H), 0.88 (s, 3H, CH3). δC 
171.1 (Me-C=O), 157.0 (CO2), 70.2 (OCH2), 55.0 (NCq),  51.9 (OCH3), 47.6 (CH2N), 36.4 (CH2), 
34.4 (Cq), 28.1 (CH2), 25.9 (CH3), 25.8 (CH3), 22.8 (CH3), 20.8 (CH3). IR (neat) υ/cm-1: 2962, 
1742, 1699, 1526, 1442, 1379, 1138, 1035, 910, 775. HRMS (ES) m/z calculated for 
C13H23NO4Na [M+Na]
+ = 280.1525; found: 280.1534. 
 
                                                                                                                                                            235 
Methyl 5-(hydroxymethyl)-2,2,5-trimethylpiperidine-1-carboxylate 529 
 
To a solution of acetoxymethyl piperidine 528 (150 mg, 0.6 mmol) in undried methanol (5 ml) 
was added potassium carbonate (200 mg, 1.45 mmol). The reaction was stirred for 24 h at room 
temperature. The solvent was removed and the residue was diluted with water (5 ml) and extracted 
with dichloromethane (3 x 5 ml). The combined organic layers were dried and concentrated to 
give the piperidinemethanol 529 (126 mg, 98%) as a colourless oil. δH 3.56 (s, 3H, OCH3),  3.48 
(d, J = 14.1 Hz, 1H), 3.35 (d, J = 11.0 Hz, 1H), 3.22 (d, J = 11.0 Hz, 1H), 2.83 (d, J = 14.1 Hz, 
1H), 1.84 (br. s, 1H, OH), 1.63 – 1.53 (m, 1H), 1.40 (ddd, J = 10.3, 6.6, 3.3 Hz, 1H), 1.34 (s, 3H, 
CH3), 1.32 (app. t, J = 3.3 Hz, 1H), 1.29 (s, 3H, CH3), 1.20 (ddd, J = 14.0, 6.6, 4.0 Hz, 1H), 0.87 
(s, 3H, CH3). δC 157.7 (C=O), 69.4 (OCH2), 55.1 (NCq), 52.0 (OCH3), 47.2 (CH2N), 36.5 (CH2), 
36.1 (Cq), 27.9 (CH2), 26.1 (CH3), 25.9 (CH3), 22.5 (CH2). IR (neat) υ/cm-1: 3447, 2932, 2870, 
1682, 1440, 1364, 1275, 1190, 1154, 1049. HRMS (EI) m/z calculated for C11H21NO3 [M]
+ = 
215.1521; found: 215.1521. 
Methyl ((3,6,6-trimethyltetrahydro-2H-pyran-3-yl)methyl)carbamate 526 
 
By general procedure B, to the alcohol 529 (54 mg, 0.25 mmol) in dry dichloromethane (10 ml) 
concentrated sulfuric acid (12 mg, 0.12 mmol) was added and the resulting mixture stirred for 4 h 
at 20 oC to give the tetrahydropyran 526 as (52 mg, 96%) as a colourless oil, which exhibited 
spectroscopic and analytical data identical to that reported for a sample of the same 
tetrahydropyran prepared by direct cyclisation of the alcohol 525. 
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Methyl 2-cyano-3-phenylpropanoate 530 
 
By general procedure D, to sodium hydride (60% dispersion in mineral oil, 0.80 g, 20 mmol, 1.0 
eq.) in DMF (20 ml) under nitrogen at 0 °C was slowly added ethyl cyanoacetate 510 (6.80 g, 60 
mmol, 3.0 eq.) in DMF (10 ml). After 15 min, benzyl bromide (3.42 g, 20 mmol, 1.0 eq.) was 
added to give the cyanophenylpropanoate 530 (3.30 g, 87%) as a colourless oil. All data obtained 
were in accordance with those previously reported in the literature:45 δH 7.44 – 7.24 (m, 5H), 4.25 
(q, J = 7.1 Hz, 2H, OCH2), 3.75 (dd, J = 8.4, 5.8 Hz, 1H), 3.30 (dd, J = 13.8, 5.8 Hz, 1H, 
PhCHAHB), 3.21 (dd, J = 13.8, 8.4 Hz, 1H, PhCHAHB), 1.29 (t, J = 7.1 Hz, 3H, CH3). δC 165.5 
(C=O), 135.4 (Cq), 130.0 (CH), 129.0 (CH), 128.8 (CH), 128.6 (CH), 127.8 (CH), 116.2 (CN), 
62.9 (OCH2), 39.6 (CH), 35.8 (CH2), 13.9 (CH3).  
IR (neat) υ/cm-1: 3032, 2988, 2251, 1720, 1456, 1260, 1198, 1030. HRMS (APCI) m/z calculated 
for C12H14NO2 [M+H]
+ = 204.1025; found: 204.1019. 
Methyl 2-benzyl-2-cyano-5-methylhex-4-enoate 531 
 
By typical procedure D, to sodium hydride (60% dispersion in mineral oil, 0.40 g) in DMF (20 ml) 
under nitrogen at 0 °C was slowly added ethyl cyanoacetate 530 (1.90 g, 10 mmol) in DMF (10 
ml). After 15 min, prenyl bromide (1.50 g, 10 mmol) was added dropwise to give the cyanoacetate 
531 (2.40 g, 93%) as a colourless oil. δH 7.44 – 7.09 (m, 5H), 5.15 (br. t, J = 7.5 Hz, 1H, =CH), 
4.05 (q, J = 7.1 Hz, 2H, OCH2), 3.12 (d, J = 13.5 Hz, PhCHAHB), 3.00 (d, J = 13.5 Hz, 
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PhCHAHB), 2.65 (dd, J = 14.1, 7.7 Hz, 1H, =CHCHAHB), 2.49 (dd, J = 14.1, 7.3 Hz, 1H, 
=CHCHAHB), 1.68 (s, 3H, CH3), 1.59 (s, 3H, CH3), 1.07 (t, J = 7.1 Hz, 3H, CH3). δC 168.5 (CO2), 
137.9 (Cq), 134.4 (Cq), 129.9 (2 x CH), 128.8 (2 x CH), 127.74 (CH), 119.0 (CN), 116.43 (=CH), 
62.5 (OCH2), 51.5 (Cq), 42.4 (CH2), 36.1 (CH2), 25.9 (CH3), 18.1 (CH3), 13.9 (CH3). IR (neat) 
υ/cm-1: 2984, 2251, 2240, 1738, 1230, 910. HRMS (EI) m/z calculated for C17H21NO2 [M]+ = 
271.1572; found: 271.1568. 
 
2-(Aminomethyl)-2-benzyl-5-methylhex-4-en-1-ol 532 
 
By general procedure C, reduction of the foregoing cyanoacetate 531 (2.37 g, 8.7 mmol) using 
lithium aluminium hydride (0.76 g, 20 mmol) gave the amino-alcohol 532 (1.90 g, 93%) as a 
colourless oil. δH 7.23 – 7.06 (m, 5H), 5.22 – 5.14 (m, 1H, =CH), 3.52 – 3.48 (m, 2H, OCH2), 2.79 
– 2.73 (m, 1H), 2.71 (d, J = 7.5 Hz, 1H), 2.67 (d, J = 7.5 Hz, 1H), 2.60 (br. s, 3H, NH2, OH), 2.46 
(dd, J = 13.4, 3.5 Hz, 1H), 1.92 (dd, J = 13.7, 7.7 Hz, 1H, =CCHAHB), 1.83 (dd, J = 13.7, 5.8 Hz, 
1H, =CCHAHB), 1.68 (d, J = 1.0 Hz, 3H, CH3), 1.53 (s, 3H, CH3). δC 137.9 (Cq), 134.0 (Cq), 
130.5 (2 x CH), 128.0 (2 x CH), 126.1 (CH), 119.4 (=CH), 68.0 (OCH2), 49.2 (NCH2), 41.9 (Cq), 
39.0 (CH2), 30.7 (CH2), 26.1 (CH3), 18.0 (CH3). IR (neat) υ/cm-1: 3387, 2916, 1452, 1063, 1032. 
HRMS (EI) m/z calculated for C15H23NO [M]
+ = 233.1780; found: 233.1782. 
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Methyl (2-(hydroxymethyl)-2,5-dimethylhex-4-en-1-yl)carbamate 533 
 
By general procedure A, methyl chloroformate (0.94 g, 10 mmol, 1.2 eq.) was added to the amino-
alcohol 532 (1.87 g, 8.0 mmol, 1.0 eq.) and Et3N (1.25 ml, 11 mmol, 1.3 eq.) to give the N-
protected amino-alcohol 533 (1.65 g, 71%) as a colourless oil. δH 7.31 – 7.07 (m, 5H), 5.30 – 5.14 
(m, 1H), 4.76 (br. s, NH), 3.62 (s, 3H, OCH3), 3.24 – 3.19 (m, 1H), 3.17 (app. s, 2H, OCH2), 2.89 
(dd, J = 14.6, 5.9 Hz, 1H), 2.65 (d, J = 13.3 Hz, 1H), 2.40 (d, J = 13.3 Hz, 1H), 1.70 (s, 3H, CH3), 
1.69 (d, J = 7.9 Hz, 2H),  1.53 (s, 3H, CH3).  δC 137.6 (Cq), 135.0 (Cq), 130.5 (2 x CH), 128.1 (2 x 
CH), 126.2 (CH), 118.8 (=CH), 65.1 (CH2OH), 52.5 (CH3O), 45.1 (Cq), 44.3 (NCH2), 38.7 (CH2), 
30.1 (CH2), 26.2 (CH3), 18.1 (CH3). IR (neat) υ/cm-1: 3367, 2955, 1699, 1526, 1454, 1385, 1244, 
1260, 1031, 909. HRMS (AP) m/z calculated for C17H25NO3 [M+H]
+ = 292.1913; found: 
292.1916. 
2-Acetyloxymethyl-2-benzyl-1-methoxycarbonylamino-5-methylhex-4-ene 534 
 
By procedure E, but for 16 h, the alcohol 533 (180 mg, 0.8 mmol) was converted into the 
corresponding acetate 534 (215 mg, 100%), a colourless oil. δH 7.26 – 7.12 (m, 4H), 7.06 (d, J = 
7.0 Hz, 1H), 5.19 (br. t, J = 7.0 Hz, 1H, =CH), 4.78 (br. s, 1H, NH), 3.83 (d, J = 11.3 Hz, 1H, 
CHAHBOAc), 3.73 (d, J = 11.3 Hz, 1H, CHAHBOAc), 3.58 (s, 3H, OCH3), 3.13 (d, J = 6.5 Hz, 2H, 
NCH2), 2.58 (d, J = 4.7 Hz, 2H, CH2), 2.04 (s, 3H, Ac-CH3), 1.89 (d, J = 7.3 Hz, 2H, CH2), 1.69 
(s, 3H, CH3), 1.52 (s, 3H, CH3). δC 166.7 (Ac-CO), 157.2 (CO2), 136.8 (Cq), 135.0 (Cq), 130.4 (2 
x CH), 128.3 (2 x CH), 126.5 (CH), 118.3 (=CH), 66.8 (OCH2), 52.1 (OCH3), 45.0 (NCH2), 41.8 
(Cq), 39.1 (CH2), 31.0 (CH2), 26.1 (CH3), 22.1 (CH3), 20.9 (COCH3). 
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Methyl 5-(acetoxymethyl)-5-benzyl-2,2-dimethylpiperidine-1-carboxylate 535 
 
By general procedure B, to the protected amino-alcohol 534 (191 mg, 0.6 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the 
resulting mixture stirred for 1 h at 20 oC to give the piperidine 535 (187 mg, 98%) as a colourless 
oil. δH 7.37 – 6.67 (m, 5H), 3.76 (d, J = 11.1 Hz, 1H, CHAHBOAc), 3.65 (d, J = 11.1 Hz, 1H, 
CHAHBOAc), 3.56 (s, 3H, OCH3), 3.28 (d, J = 14.1 Hz, 1H, NCHAHB), 3.18 (d, J = 14.1 Hz, 1H, 
NCHAHB), 2.64 (d, J = 13.4 Hz, 1H, PhCHAHB), 2.52 (d, J = 13.4 Hz, 1H, PhCHAHB), 2.03 (s, 
3H, Ac-CH3), 1.44 – 1.38 (m, 2H), 1.31 (s, 6H, 2 x CH3), 1.18 – 1.11 (m, 2H, CH2). δC 171.1 (Ac-
CO), 157.1 (CO2), 137.0 (Cq), 132.2 (CH), 130.4 (2 x CH), 128.1 (2 x CH), 67.3 (OCH2), 55.3 
(NCq), 52.1 (OCH3), 46.4 (CH2N), 41.2 (CH2), 38.2 (CH2), 36.3 (Cq), 26.0 (CH3), 25.7 (CH3), 
25.7 (CH2), 20.9 (CH3). 
Methyl 5-benzyl-2,2-dimethyl-5-hydroxymethylpiperidine-1-carboxylate 536 
 
To a solution of the acetoxymethyl piperidine 535 (165 mg, 0.5 mmol) in undried methanol (5 ml) 
was added potassium carbonate (200 mg, 1.45 mmol). The mixture was stirred for 20 h at room 
temperature. The solvent was removed and the solution was diluted with water (5 ml) and 
extracted with dichloromethane (3 x 5 ml). The combined organic layers were dried and 
concentrated to give the piperidine methanol 536 (142 mg, 99%) as a colourless oil. δH 7.34 – 6.71 
(m, 5H), 3.59 (s, 3H, OCH3), 3.49 (d, J = 14.2 Hz, 1H), 3.33 – 3.27 (m, 1H), 3.20 (dd, J = 11.2, 
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5.7 Hz, 1H), 3.00 (d, J = 14.2 Hz, 1H), 3.00 (d, J = 14.2 Hz, 1H), 2.67 (d, J = 13.2 Hz, 1H), 2.46 
(d, J = 13.2 Hz, 1H), 2.22 (br. s, 1H, OH), 1.50 – 1.41 (m, 2H, CH2), 1.37 (t, J = 4.2 Hz, 2H, 
CH2), 1.30 (s, 3H, CH3), 1.27 (s, 3H, CH3). δC 157.6 (Cq, CO2), 147.6 (Cq), 130.5 (2 x CH), 127.9 
(2 x CH), 126.1 (CH),  66.4 (OCH2), 55.3 (NCq), 52.4 (OCH3), 47.0 (CH2N), 40.4 (CH2),  39.1 
(Cq), 26.3 (CH2), 26.1 (CH3), 25.9 (CH3), 22.5 (CH2). 
 
3-Benzyl-6,6-dimethyl-3-(methoxycarbonylaminomethyl)-tetrahydo-2H-pyran 537 
 
By general procedure B, to the N-protected amino-alcohol 533 (170 mg, 0.6 mmol) in dry 
dichloromethane (10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added 
and the resulting mixture stirred for 1 h at 20 oC to give the tetrahydropyran 537 as a colourless 
oil (167 mg, 98%). δH 7.27 – 7.09 (m, 4H), 7.05 (d, J = 7.1 Hz, 1H), 4.55 (br. s, NH, 1H), 3.56 (s, 
3H, OCH3), 3.38 (d, J = 12.1 Hz, 1H), 3.28 (d, J = 12.1 Hz, 1H), 3.21 (dd, J = 14.0, 6.7 Hz, 1H), 
2.95 (dd, J = 14.0, 5.4 Hz, 1H), 2.56 (d, J = 13.6 Hz, 1H), 2.46 (d, J = 13.6 Hz, 1H), 1.51 – 1.37 
(m, 4H), 1.11 (s, 3H, CH3), 1.09 (s, 3H, CH3). δC 158.0 (C=O), 137.6 (Cq), 130.1 (2 x CH), 128.1 
(2 x CH), 126.3 (CH), 71.3 (OCq), 66.6 (OCH2), 52.1 (OCH3), 44.8 (CH2N), 40.5 (CH2), 37.0 
(Cq), 31.9 (CH2), 27.0 (CH3), 26.7 (CH2), 25.4 (CH3). IR (neat) υ/cm-1: 3335, 2931, 1705, 1520, 
1452, 1244, 1074, 1030, 1074, 909. HRMS (EI) m/z calculated for C17H25NO3 [M]
+ = 291.1834; 
found: 291.1830. 
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2-(Aminomethyl)-5-methyl-2-(3-methylbut-2-en-1-yl)hex-4-en-1-ol 538 
 
Using general procedure C, the cyanoacetate 512 (0.50 g, 2 mmol) was reduced by lithium 
aluminium hydride (0.19 g, 5 mmol) to give the amino-alcohol 538 (0.40 g, 94%) as a clear oil. δH 
5.08 (t, J = 7.3 Hz, 2H, 2 x =CH), 3.51 (s, 2H, OCH2), 3.72 (s, 2H, NCH2), 2.68 – 2.53 (br. s, 3H 
OH and NH2), 2.07 (dd, J = 8.0, 7.3 2H, 2 x CH), 1.92 (dd, J = 8.0, 7.3 2H, 2 x CH), 1.65 (s, 6H, 2 
x CH3), 1.54 (s, 6H, 2 x CH3). δC 133.7 (2 x Cq), 119.6 (2 x =CH), 70.9 (OCH2), 49.3 (NCH2), 
41.8 (Cq), 30.9 (2 x CH2), 26.1 (2 x CH3), 17.8 (2 x CH3). IR (neat) υ/cm-1: 3308, 2972, 2916, 
2859, 1452, 1379, 1049. HRMS (APCI) m/z calculated for C13H26NO [M+H]
+ = 212.2014; found: 
212.2012. 
N-(2-(Hydroxymethyl)-5-methyl-2-(3-methylbut-2-en-1-yl)hex-4-en-1-yl)-4-
methylbenzenesulfonamide 539 
 
By general procedure A, tosyl chloride (362 mg, 1.9 mmol) was added to the amino-alcohol 538 
(0.40 g, 1.9 mmol) and Et3N (0.5 ml, 4.4 mmol) at -78 
oC. The mixture was then stirred for 1 h at 
room temperature to give the sulfonamide 539 (0.52 g, 75%) as a colourless thick oil. δH 7.62 (d, J 
= 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 5.02 (t, J = 7.3 Hz, 2H, 2 x =CH) 4.94 (t, J = 6.4 Hz, 1H, 
NH), 3.51 (s, 2H, OCH2), 3.72 (d, J = 6.4, 2H, NCH2), 2.40 (s, 3H, ArCH3), 1.94 (dd, J = 7.5, 7.3 
Hz, 2H), 1.86 (dd, J = 7.5, 7.3 Hz, 2H), 1.62 (s, 6H, 2 x CH3), 1.52 (s, 6H, 2 x CH3). δC 143.1 
(Cq), 136.4 (Cq), 133.3 (Cq), 129.4 (2 x CH), 126.7 (2 x CH), 118.3 (2 x CH), 66.3 (OCH2), 47.6 
                                                                                                                                                            242 
(NCH2), 42.3 (Cq), 30.1 (2 x CH2), 25.8 (ArCH3), 21.2 (2 x CH3), 17.6 (2 x CH3). IR (neat) υ/cm-
1: 3506, 3295, 2982, 2924, 1452, 1331, 1092, 912. HRMS (ES) m/z calculated for C20H30NO3S 
[M-H]+ = 364.1946; found: 364.1933. 
3,3,9,9-Tetramethyl-8-tosyl-2-oxa-8-azaspiro[5.5]undecane 540 
 
By general procedure B, to the N-tosyl alcohol 539 (143 mg, 0.39 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 0 oC to give the oxa-azaspiro 540 as a colourless oil (139 mg, 97%). δH 
7.60 (d, J = 8.2 Hz, 2H), 7.17 (d, J = 8.2 Hz, 2H), 3.40 (d, J = 13.2 Hz, 1H), 3.36 (d, J = 12.0 Hz, 
1H), 3.25 (d, J = 12.0 Hz, 1H), 3.06 (d, J = 13.2 Hz, 1H), 2.31 (s, 3H, Ar-CH3), 1.62 (dt, J = 5.8, 
4.6 Hz, 1H, CH), 1.48 – 1.43 (m, 1H, CH), 1.43 – 1.36 (m, 4H, 2 x CH2), 1.34 (dt, J = 5.8, 4.6 Hz, 
1H, CH), 1.29 (s, 3H, CH3), 1.28 – 1.21 (m, 1H, CH), 1.12 (m, 6H, 2 x CH3), 1.08 (s, 3H, CH3), 
0.73 – 0.81 (m, 2H, CH2). δC 142.7 (Cq), 139.8 (Cq), 129.4 (2 x CH), 127.3 (2 x CH), 71.8 (OCq), 
67.9 (OCH2), 58.2 (NCq), 49.1 (NCH2), 37.9 (CH2), 32.9 (Cq), 31.7 (CH2), 28.5 (CH2), 28.1 
(CH2), 27.3 (ArCH3),  24.9 (2 x CH3),  22.6 (2 x CH3). IR (neat) υ/cm-1: 2972, 2930, 2861, 1454, 
1327, 1221, 1150, 1090, 906, 729. HRMS (EI) m/z calculated for C20H31NO3S [M]
+ = 365.2025; 
found: 365.2022. 
Methyl (E)-2-cyano-5-phenylpent-4-enoate 54246 
 
A mixture of ethyl cyanoacetate 510 (4.60 g, 40 mmol, 1.2 eq.), cinnamyl chloride 541 (5.17 g, 
33.3 mmol, 1.0 eq.), potassium carbonate (5.50 g, 40 mmol, 1.2 eq.) and sodium chloride (0.50 g) 
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in ethanol (50 ml) was reﬂuxed overnight. The solvent was removed and the residue was taken up 
in ether (50 ml) and the solution washed with water (10 ml). The extracts were dried, concentrated 
and the residue purified by column chromatography on silica gel eluting with ether/hexanes (1:99) 
to give the cyanoacetate 542 (4.30 g, 56% yield) as a colourless oil. δH 7.32 – 7.23 (m, 4H), 7.21 – 
7.14 (m, 1H), 6.50 (dt, J = 13.5, 4.3 Hz, 1H, =CH), 6.10 (d, J = 13.5 Hz, 1H, =CH), 4.19 (q, J = 
6.9 Hz, 2H, OCH2), 3.54 (dd, J = 7.1, 6.3 Hz, 1H), 2.77 (dd, J = 7.1, 4.3 Hz, 2H, CH2), 1.23 (t, J = 
6.9 Hz, 3H, CH3). δC 165.5 (CO), 135.8 (Cq), 135.0 (=CH), 128.6 (2 x =CH), 126.5 (2 x =CH), 
116.2 (CN), 62.9 (OCH2), 37.9 (CH), 33.3 (CH2), 14.1 (CH3). IR (neat) υ/cm-1: 2984, 2251, 1741, 
1449, 1256, 1200, 1026, 966. HRMS (EI) m/z calculated for C14H15NO2 [M]
+ = 229.1103; found: 
229.1108. 
(E)-2-(Aminomethyl)-5-phenylpent-4-en-1-ol 544 
 
Reduction of the foregoing cyanoacetate 542 (4.30 g, 18.8 mmol, 1.0 eq.) using lithium aluminium 
hydride (0.95 g, 25 mmol, 2 eq.) as described in general procedure C gave the amino-alcohol 544 
(2.30 g, 61 %) as a yellow oil. δH 6.87 – 6.70 (m, 4H), 6.70 – 6.62 (m, 1H), 5.85 (d, J = 15.8 Hz, 
1H, =CH), 5.66 – 5.59 (m, 1H, =CH), 3.29 (dd, J = 8.4, 3.5 Hz, 1H, OCHACHB), 3.22 – 3.20 (dt, J 
= 4.5, 2.0 Hz, 2H, NCH2), 3.13 (dd, J = 8.4, 5.7 Hz, 1H, OCHACHB), 2.57 – 2.53 (m, 1H), 2.23 
(dd, J = 12.3, 8.7 Hz, 2H, CH2), 1.94 (br. s, 3H, OH and NH2). δC 136.7 (Cq), 128.5 (=CH), 127.9 
(2 x =CH), 127.9 (=CH), 127.1 (=CH), 126.0 (2 x =CH), 68.6 (OCH2), 44.5 (NCH2), 42.4 (CH), 
33.4 (CH2).  
IR (neat) υ/cm-1: 3356, 3254, 2922, 1597, 1448, 1028, 964. HRMS (EI) m/z calculated for 
C12H17NO [M]
+ = 291.1310; found: 291.1309. 
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Methyl (2-(hydroxymethyl)-4-methylpent-4-en-1-yl)carbamate 545 
 
By general procedure A, methyl chloroformate (1.0 ml, 12.7 mmol) was added to the amino-
alcohol 544 (1.17 g, 9 mmol) and Et3N (2.5 ml, 22 mmol) to give the N-protected amino-alcohol 
545 (1.20 g, 71%) as a colourless oil. δH 7.30 – 7.12 (m, 4H), 7.12 (dd, J = 13.3, 6.1 Hz, 1H, 
=CHAr), 6.35 (d, J = 15.8 Hz, 1H, =CH), 6.09 (dt, J = 15.8, 7.4 Hz, 1H, =CH), 5.08 (br. s, 1H, 
NH), 3.60 (s, 3H, OCH3), 3.42 (dd, J = 11.3, 6.5 Hz, 1H, OCHACHB), 3.30 – 3.25 (m, 1H, 
OCHACHB), 3.18 – 3.11 (m, 2H, NCH2), 2.19 – 2.17 (m, 1H, CH), 2.09 – 2.06 (m, 1H, CH), 1.78 
– 1.67 (br. s, 1H, OH), 1.63 – 1.52 (m, 1H, CH). δC 158.4 (C=O), 137.3 (Cq), 132.0 (=CH), 128.3 
(2 x =CH), 126.03 (2 x =CH), 127.9 (=CH), 127.2 (=CH), 62.6 (OCH2), 52.4 (OCH3), 41.6 (CH), 
41.5 (NCH2), 32.7 (CH2). IR (neat) υ/cm-1: 3343, 2928, 1696, 1523, 1449, 1255, 1192, 1028, 966. 
HRMS (EI) m/z calculated for C14H17NO2 [M-H2O]
+ = 231.1259; found: 231.1250. 
(E)-2-((Methoxycarbonylamino)methyl)-5-phenylpent-4-en-1-yl acetate 547 
 
By general procedure E, the alcohol 545 (249 mg, 1.0 mmol) was reacted with acetic anhydride 
(0.1 ml, 1.1 mmol) for 17 h at room temperature to give the acetate 547 (291 mg, 100%) as a 
colourless oil. δH 7.31 – 7.21 (m, 4H), 7.17 – 7.11 (m, 1H), 6.36 (d, J = 12.3 Hz, 1H, =CH), 6.14 – 
6.06 (m, 1H, =CH), 4.92 (br. s, 1H, NH), 4.11 (dd, J = 11.3, 4.6 Hz, 1H, OCHACHB), 3.98 – 3.96 
(m, 1H, OCHACHB), 3.59 (s, 3H, OCH3), 3.21 – 3.16 (m, 1H, NCHACHB), 3.08 (dd, J = 14.0, 6.6 
Hz, 1H, NCHACHB), 2.20 (dd, J = 6.7, 5.0 Hz, 2H, CH2), 2.01 (s, 3H, COCH3), 1.67 – 1.60 (m, 
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1H, CH). δC 171.1 (Ac-CO), 157.2 (C=O), 137.2 (Cq), 134.9 (=CH), 128.7 (2 x =CH), 127.7 
(=CH), 126.2 (2 x =CH), 127.2 (=CH), 64.7 (OCH2), 52.1 (OCH3), 42.0 (NCH2), 38.8 (CH), 32.8 
(CH2), 20.9 (Ac-CH3). IR (neat) υ/cm-1: 3349, 2949, 1705, 1524, 1449, 1368, 1192, 1030, 968. 
HRMS (EI) m/z calculated for C16H21NO4 [M]
+ = 291.1471; found: 291.1471. 
Methyl 5-(acetoxymethyl)-2-phenylpiperidine-1-carboxylate 548 
 
The protected amino-alcohol 547 (267 mg, 0.92 mmol) under nitrogen was dissolved in 
dichloromethane (10 ml) and to this triflic acid (76 mg, 46 µl, 0.5 mmol) was added. The resulting 
mixture stirred for 6 h at 20 oC. The reaction was allowed to cool and was then quenched with 
saturated aqueous potassium carbonate (10 ml) and extracted with dichloromethane (3 x 10 ml). 
The combined organic layers were dried and evaporated to give the piperidine 251 (224 mg, 84%) 
as a yellow oil and as a 1:1 ratio of stereoisomers, which were not separated.  
The first isomer: δH 7.31 – 7.21 (m, 4H), 7.17 – 7.11 (m, 1H), 5.30 (t, J = 4.7 Hz, 1H, NCH), 4.09 
– 4.01 (m, 1H, CH), 3.99 (dd, J = 10.5, 7.2 Hz, 1H, CH), 3.64 (s, 3H, OCH3), 3.25 – 3.13 (m, 1H, 
CH), 2.98 (dd, J = 11.0, 4.2 Hz, 1H, CH), 2.38 – 2.31 (m, 1H, CH), 1.98 (s, 3H, Ac-CH3), 1.93 – 
1.83 (m, 2H, CH2), 1.81 – 1.75 (m, 1H, CH), 1.48 – 1.40 (m, 1H, CH). δC 171.1 (Ac-CO), 157.2 
(C=O), 142.0 (Cq) 128.8 (2 x =CH), 126.9 (=CH), 126.6 (2 x =CH), 64.9 (OCH2), 52.9 (NCH), 
52.1 (OCH3), 42.1 (NCH2), 32.5 (CH), 28.5 (CH2), 23.9 (CH2), 20.9 (Ac-CH3). 
The second isomer: δH 4.88 (br. s, 1H), 3.90 (dd, J = 11.3, 6.2 Hz, 11H), 3.66 (m, 3H, OCH3), 
1.96 (s, 3H, Ac-CH3) only 4 distinct peaks. δC 171.1 (Ac-CO), 156.7 (C=O), 140.0 (Cq) 128.7 (2 x 
=CH), 128.1 (=CH), 126.2 (2 x =CH), 64.5 (OCH2), 52.1 (NCH), 52.1 (OCH3), 43.0 (NCH2), 38.2 
(CH), 28.5 (CH2), 20.9 (Ac-CH3), 23.8 (CH2). 
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The whole sample showed : IR (neat) υ/cm-1: 2945, 2860, 1728, 1699, 1529, 1447, 1190, 1034, 
912, 735. HRMS (EI) m/z calculated for C16H21NO4 [M]
+ = 291.1471; found: 291.1479. 
(E)-N-(2-(Hydroxymethyl)-5-phenylpent-4-en-1-yl)-4-methylbenzenesulfonamide 549 
 
By general procedure A, tosyl chloride (496 mg, 2.6 mmol) was added to the amino-alcohol 544 
(0.50 g, 2.6 mmol) and Et3N (0.5 ml, 4.4 mmol) at -78 oC. The mixture was then stirred for 1 h as 
it warmed to room temperature to give the sulfonamide 549 (0.76 g, 85%) as a colourless oil. δH 
7.26 – 7.22 (d, J = 8.3 Hz, 2H), 6.83 – 6.77 (m, 6H), 6.71 (dd, J = 9.5, 6.8 Hz, 1H), 5.87 (d, J = 
15.7 Hz, 1H, =CH), 5.58 (dt, J = 15.7, 7.5 Hz, 1H, =CH), 4.70 (t, J = 6.4 Hz, 1H, NH), 3.27 (dd, J 
= 9.7, 5.4 Hz, 1H, OCHACHB), 3.15 – 3.08 (m, 1H, OCHACHB), 2.63 – 2.56 (m, 1H, NCHACHB), 
2.51 – 2.43 (m, 1H, OCHACHB), 1.92 (s, 3H, Ar-CH3), 1.65 (dd, J = 12.9, 7.5, 6.5 Hz, 2H, CH2), 
1.40 – 1.30 (m, 1H, CH). δC 143.4 (Cq), 137.2 (Cq), 136.9 (Cq), 132.3 (CH), 129.8 (2 x CH), 
128.5 (2 x CH), 127.2 (2 x CH), 127.1 (CH), 126.1 (CH), 64.0 (OCH2), 44.6 (NCH2), 40.6 (CH), 
32.4 (CH2), 21.5 (ArCH3). IR (neat) υ/cm-1: 3520, 3290, 2924, 1598, 1321, 1091, 1070, 968. 
HRMS (ES) m/z calculated for C19H23NNaO3S [M+Na]
+ = 368.1296; found: 368.1294. 
6-Phenyl-1-tosylpiperidine-3-methanol 550 
 
To a stirred solution of the sulfonamide 549 (173 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
under nitrogen, cooled in an ice-water bath, was added triflic acid (38 mg, 23 µl, 0.25 mmol). The 
resulting solution was stirred at 20 °C for 1 h to give the piperidine 550 (170 mg, 98%) as a 
colourless oil and as a 2:1 ratio of stereoisomers, which were not separated.  
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Major isomer: δH 7.52 (d, J = 8.3 Hz, 2H), 7.19 – 7.12 (m, 5H), 6.96 – 6.92 (m, 2H), 5.05 (t, J = 
4.5 Hz, 1H, 6-H), 3.70 – 3.66 (m, 2H, OCH2), 3.15 – 3.09 (dd, J = 8.3, 5.6 Hz, 2H, NCH2), 2.59 
(dd, J = 14.2, 11.8 Hz, 1H), 2.33 (s, 3H, Ar-CH3), 1.97 (td, J = 10.4, 4.4 Hz, 2H, CH2), 1.70 (br. s, 
1H, OH), 1.63 – 1.53 (m, 2H, CH2). δC 143.0 (Cq), 139.0 (Cq), 129.7 (2 x CH), 129.5 (2 x CH), 
128.6 (CH), 128.5 (CH), 127.0 (CH), 126.9 (CH), 126.8 (CH), 62.2 (OCH2), 56.4 (NCH), 41.9 
(NCH2), 35.4 (CH),  25.8 (CH2), 21.5 (Ar-CH3), 20.8 (CH2).  
The minor  isomer was identified by: δH 7.70 (d, J = 8.3 Hz, 2H), 7.19 – 7.12 (m, 7H), 5.21 (d, J = 
4.8 Hz, 1H, 6-H), 3.92 (dd, J = 14.2, 4.2, 1H), 3.39 (dd, J = 11.3, 5.6 Hz, 2H), 2.34 (s, 3H, Ar-
CH3), 3.24 (dd, J = 10.8, 5.4 Hz, 1H), 2.21 – 2.15 (m, 1H), 1.47 – 1.40 (m, 2H, CH2), 1.34 – 1.27 
(m, 1H), 0.98 (tt, J = 13.2, 6.5 Hz, 1H). δC 66. (OCH2), 54.9 (NCH), 44.2 (NCH2), 37.4 (CH), 26.8 
(CH2), 22.0 (CH2), 21.5 (Ar-CH3). 
The whole sample showed IR (neat) υ/cm-1: 3530, 2926, 2859, 1452, 1334, 1329, 1155, 1090, 907. 
HRMS (EI) m/z calculated for C19H23NO3S [M]
+ = 345.1399; found: 345.1396. 
(E)-2-((4-Methylphenylsulfonamido)methyl)-5-phenylpent-4-en-1-yl acetate 552 
 
Following general procedure E, reaction between the alcohol 549 (346 mg, 1.0 mmol) and acetic 
anhydride (0.1 ml, 1.1 mmol) gave the acetate  552 (388 mg, 100%) as a colourless oil. δH 7.64 (d, 
J = 8.2 Hz, 2H), 7.25 – 7.20 (m, 6H), 7.18 – 7.11 (m, 1H), 6.32 (d, J = 15.8 Hz, 1H, =CH), 6.05 – 
5.93 (m, 1H, =CH), 4.77 (t, J = 6.8 Hz, 1H, NH), 4.08 (dd, J = 11.7, 4.3 Hz, 1H), 3.95 – 3.88 (m, 
1H), 2.91 (ddd, J = 12.4, 6.8, 5.4 Hz, 1H), 2.82 (dt, J = 13.1, 6.5 Hz, 1H), 2.34 (s, 3H, Ac-CH3), 
2.19 – 2.14 (m, 2H, CH2), 1.96 (s, 3H, Ar-CH3), 1.95 – 1.87 (m, 1H). δC 156.4 (C=O, Cq), 143.6 
(Cq), 137.4 (Cq), 133.9 (Cq), 132.9 (CH), 129.7 (2 x CH), 128.6 (2 x CH), 127.4 (CH), 127.1 
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(CH), 126.3 (CH), 126.1 (CH), 64.0 (OCH2), 43.8 (NCH2), 38.5 (CH), 32.5 (CH2), 21.5 (Ar-CH3), 
21.0 (Ac-CH3). IR (neat) υ/cm-1: 3298, 2958, 1740, 1599, 1327, 1238, 1096, 970. HRMS (E) m/z 
calculated for C21H25NO4SNa [M+Na]
+ = 410.1402; found: 410.1392. 
5-Acetoxymethyl-2-phenyl-1-tosylpiperidine 553 
 
To a stirred solution of the protected amino-alcohol 552 (388 mg, 1.0 mmol) in dry 
dichloromethane (10 ml) under nitrogen, cooled in an ice-water bath, was added triflic acid (61 
mg, 37 µl, 0.5 mmol). The resulting mixture stirred was stirred at 20 °C for 30 min to give the 
piperidine 553 (358 mg, 92%) as a colourless oil, consisting of a 2:1 ratio of stereoisomers. 
 Major isomer : δH 7.54 (d, J = 7.8 Hz,  2H), 7.26 – 7.14 (m, 7H), 4.97 (t, J = 4.6 Hz, 1H, 6-H), 
3.80 (dd, J = 11.0, 6.1 Hz, 1H), 3.61 (dd, J = 11.0, 9.0 Hz, 1H), 3.45 (dd, J = 13.7, 3.5 Hz, 1H), 
3.34 (dd, J = 13.7, 3.8 Hz, 1H), 2.33 (s, 3H, Ac-CH3), 2.24 – 2.18 (m, 1H), 2.00 (s, 3H, Ar-CH3), 
1.96 – 192 (m, 2H, CH2), 1.66 – 1.50 (m, 2H, CH2). δC 170.7 (C=O), 143.2 (Cq), 139.2 (Cq), 
137.5 (Cq), 129.8 (CH), 129.7 (2 x CH), 129.5 (CH), 128.7 (CH), 128.5 (CH), 127.0 (CH), 126.8 
(CH), 126.8 (CH), 64.6 (OCH2), 56.9 (NCH), 43.2 (NCH2), 32.6 (CH),  26.3 (CH2), 21.5 (Ar-
CH3), 21.1 (CH2), 20.9 (Ac-CH3).  
Minor  isomer δH 7.67 (d, J = 8.3 Hz,  2H), 7.20 – 7.12 (m, 7H), 5.22 (d, J = 4.8 Hz, 1H, 6-H), 
3.90 (dd, J = 14.4, 4.2 Hz, 1H), 3.74 (dd, J = 11.2, 5.3 Hz, 1H), 3.53 (d, J = 8.2 Hz, 1H), 3.50 (d, J 
= 8.2 Hz, 1H), 2.36 (s, 3H, Ac-CH3), 2.25 – 2.17 (m, 1H, CH), 1.57 – 1.49 (m, 2H, CH2), 1.29 
(ddd, J = 13.7, 9.0, 4.4 Hz, 1H), 1.03 (ddd, J = 13.5, 13.3, 3.4 Hz, 1H). δC 170.7 (C=O), 143.2 
(Cq), 138.2 (Cq), 138.0 (Cq), 129.7 (2 x CH), 129.5 (CH), 128.7 (2 x CH), 127.0 (2 x CH), 126.8 
(2 x CH), 66.3 (OCH2), 54.7 (NCH), 44.3 (NCH2), 34.5 (CH),  26.5 (CH2), 22.2 (CH2), 21.5 (Ar-
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CH3), 20.7 (Ac-CH3). The whole sample showed IR (neat) υ/cm-1: 2928, 1738, 1452, 1334 1236, 
1159, 1092, 907. HRMS (EI) m/z calculated for C21H25NO4S [M]
+ = 387.1504; found: 387.1487. 
(6-Phenyl-1-tosylpiperidin-3-yl)methanol 550 
 
To a solution of foregoing acetoxymethyl piperidine 553 (350 mg, 0.9 mmol) in undried methanol 
(5 ml) was added potassium carbonate (200 mg, 1.5 mmol). The reaction was stirred for 17 h at 
room temperature. The solvent was removed and the residue was diluted with water (5 ml) and 
extracted with dichloromethane (3 x 10 ml). The combined organic layers were dried and 
concentrated to give the piperidine methanol 550 (305 mg, 98%) as a colourless oil, which 
exhibited spectroscopic and analytical data identical to those reported above for a sample of the 
piperidine methanol 550 prepared by cyclisation of the amino-alcohol 549, except for a slight 
difference in the ratio of stereoisomers (p. 246).  
Ethyl 2-cyano-4-methylpent-4-enoate 558 and  
Ethyl 2-cyano-4-methyl-2-(2-methylallyl)pent-4-enoate 559 
 
By typical procedure D, to sodium hydride (60% dispersion in mineral oil, 0.40 g, 10 mmol, 1.0 
eq.) in DMF (20 ml) under nitrogen at 0 °C was slowly added ethyl cyanoacetate 510 (2.20 g, 20 
mmol, 2.0 eq.) in DMF (10 ml). After 15 min, 3-chloro-2-methylprop-1-ene 557 (0.90 g, 10 
mmol, 1.0 eq.) was added to give, after the usual work-up and chromatographic separation, the 
cyanopentenoates 558 (1.10 g, 69%) and 559 (0.44 g, 20%) as colourless oil. 
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Ethyl 2-cyano-4-methylpent-4-enoate 558: δH 4.90 (app. s, 1H, =CHA), 4.83 (app. s, 1H, =CHB), 
4.20 (q, J = 7.1 Hz, 2H, OCH2), 3.58 (dd, J = 8.7, 6.2 Hz, 1H), 2.58 (qd, J = 14.5, 7.5 Hz, 2H, 
CH2), 1.73 (s, 3H, CH3), 1.26 (t, J = 7.1 Hz, 3H, CH3).  δC 165.8 (C=O, Cq), 139.3 (Cq), 116.2 
(CN), 114.8 (CH2), 62.9 (OCH2), 37.7 (CH), 36.4 (CH2), 21.9 (CH3), 14.0 (CH3). IR (neat) υ/cm-1: 
2984, 2251, 1722, 1457, 1370, 1260, 1202, 1022, 902. HRMS (ES) m/z calculated for C9H12NO2 
[M-H]+ = 166.0868; found: 166.0868. 
Ethyl 2-cyano-4-methyl-2-(2-methylallyl)pent-4-enoate 559: δH 4.90 (app. s, 2H, 2 x =CHA), 
4.82 (app. s, 2H, 2 x =CHB), 4.17 (q, J = 7.1 Hz, 2H, OCH2), 2.62 (d, J = 14.0 Hz, 2H, 2 x CH), 
2.43 (d, J = 14.0 Hz, 2H, 2 x CH), 1.78 (s, 6H, 2 x CH3), 1.24 (t, J = 7.1 Hz, 3H, CH3). δC 168.6 
(C=O), 139.2 (2 x Cq), 119.3 (CN, Cq), 116.4 (2 x =CH), 62.6 (OCH2), 48.3 (Cq), 45.7 (2 x CH2) 
23.0 (2 x CH3), 13.8 (CH3). 
2-(Aminomethyl)-4-methylpent-4-en-1-ol 560 
 
Following general procedure C, the cyanoacetate 558 (1.67 g, 10 mmol, 1.0 eq.) was reduced 
using lithium aluminium hydride (0.76 g, 20 mmol, 2.0 eq.) to give the amino-alcohol 560 (1.19 g, 
92%) as a clear oil, which was used directly in the next step. δH 4.58 (d, J = 13.2 Hz, 1H, =CHA), 
4.53 (s, 1H, =CHB), 3.59 – 3.56 (m, 2H, OCH2), 3.42 (dd, J = 10.7, 7.6 Hz, 1H, NCHAHB), 2.85 
(ddd, J = 12.3, 3.5, 1.4 Hz, 1H, NCHAHB), 2.54 (d, J = 3.8 Hz, 2H, CH2), 2.48 (br. s, 3H, NH2, 
OH), 1.72 - 165 (m, 1H), 1.55 (s, 3H, CH3). δC 143.5 (Cq), 112.0 (=CH2), 67.9 (OCH2), 46.4 
(NCH2), 39.0 (CH), 38.1 (CH2), 22.1 (CH3). 
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Methyl (2-(hydroxymethyl)-4-methylpent-4-en-1-yl)carbamate 561 
 
By general procedure A, methyl chloroformate (1.0 ml, 12.7 mmol) was added to the amino-
alcohol 560 (1.17 g, 9.0 mmol) and Et3N (2.5 ml, 22 mmol) to give the N-protected amino-alcohol 
561 (1.20 g, 71%) as a colourless oil. δH 5.08 (br. s, 1H, NH), 4.81 (app. s, 1H, =CHA), 4.73 (d, J 
= 0.8 Hz, 1H, =CHB), 3.70 (s, 3H, OCH3), 3.60 (ddd, J = 11.2, 7.1, 3.9 Hz, 1H), 3.40 (ddd, J = 
10.5, 10.1, 5.2 Hz, 2H), 3.30 (t, J = 6.6 Hz, 1H), 3.11 (dt, J = 14.3, 6.4 Hz, 1H), 2.03 (dd, J = 13.5, 
7.0 Hz, 1H), 1.96 (t, J = 6.6 Hz, 1H), 1.90 – 1.85 (m, 1H), 1.73 (s, 3H, CH3). δC 158.4 (C=O), 
143.3 (Cq), 112.4 (=CH2), 62.9 (CH2OH), 52.3 (OCH3), 41.2 (NCH2), 38.9 (CH), 37.5 (CH2), 22.1 
(CH3). IR (neat) υ/cm-1: 3329, 2928, 1695, 1525, 1444, 1377, 1257, 1194, 1033, 891. HRMS (ES) 
m/z calculated for C9H18NO3 [M+H]
+ = 188.1287; found: 188.1281. 
Methyl ((5,5-dimethyltetrahydrofuran-3-yl)methyl)carbamate 562 
 
By general procedure B, to the N-protected amino-alcohol 561 (116 mg, 0.62 mmol) in dry 
dichloromethane (10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added 
and the resulting mixture stirred for 1 h at 0 oC to give the tetrahydrofuran 562 as a colourless oil 
(112 mg, 97%). δH 4.80 (br. s, NH, 1H), 3.88 (dd, J = 8.8, 7.3 Hz, 1H), 3.60 (s, 3H, OCH3), 3.47 
(dt, J = 14.5, 7.2 Hz, 1H), 3.21 – 3.05 (m, 2H), 2.50 (dt, J = 14.5, 7.4 Hz, 1H), 1.85 (dd, J = 12.4, 
8.2 Hz, 1H), 1.34 (dt, J = 9.2, 7.3 Hz, 1H), 1.23 (s, 3H, CH3), 1.12 (s, 3H, CH3). δC 157.2 (C=O), 
80.9 (OCq), 69.9 (OCH2), 52.8 (OCH3), 44.1 (CH2N), 42.7 (CH2), 40.4 (CH), 28.7 (CH3), 27.7 
(CH3). IR (neat) υ/cm-1: 3327, 2969, 2932, 1701, 1537, 1449, 1368, 1192, 1146, 775. HRMS (ES) 
m/z calculated for C9H18NO3 [M+H]
+ = 188.1287; found: 188.1283. 
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2-((Methoxycarbonylamino)methyl)-4-methylpent-4-en-1-yl acetate 564 
 
By general procedure E, the alcohol 561 (187 mg, 1.0 mmol) was converted into the acetate 564 
(229 mg, 100%), a colourless oil.  δH 4.92 (br. s, 1H, NH), 4.75 (app. s, 1H, =CHA), 4.67 (app. s, 
1H, =CHB), 4.09 (dd, J = 11.3, 3.5 Hz, 1H), 3.87 (dd, J = 11.3, 5.5 Hz, 1H), 3.59 (s, 3H, OCH3), 
3.25 – 3.17 (m, 1H), 3.02 – 2.94 (m, 1H), 2.01 (s, 3H, Ac-CH3), 1.99 – 1.93 (m, 2H, CH2), 1.67 (s, 
3H, CH3). δC 172.2 (Ac-CO), 157.7 (C=O), 133.9 (Cq), 112.9 (=CH2), 64.8 (OCH2), 52.1 (OCH3), 
42.2 (NCH2), 37.9 (CH2), 36.1 (CH), 22.1 (Ac-CH3), 20.8 (CH3). 
Methyl 4-(acetoxymethyl)-2,2-dimethylpyrrolidine-1-carboxylate 565 
 
By general procedure B, to the protected amino-alcohol 564 (200 mg, 0.9 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (2 drops) was added and the resulting mixture 
stirred for 1 h at 20 oC to give the pyrrolidine 565 (197 mg, 99%) as a colourless oil. δH 4.02 (dd, J 
= 10.9, 5.9 Hz, 1H), 3.87 (dd, J = 11.2, 3.7 Hz, 1H), 3.60 (d, J = 14.7 Hz, 1H), 3.55 (s, 3H, 
OCH3), 2.99 (t, J = 10.4 Hz, 1H), 2.51 – 2.36 (m, 1H), 1.97 (s, 3H, Ac-CH3), 1.87 – 1.76 (m, 1H), 
1.50 (dt, J = 24.1, 12.1 Hz, 1H), 1.41 (s, 3H, CH3), 1.25 (d, J = 15.7 Hz, 3H, CH3). δC 170.8 (Ac-
CO), 154.4 (Cq, CO), 65.8 (OCH2), 60.9 (NCq), 51.6 (OCH3), 50.6 (CH2N), 44.7 (CH2), 34.6 
(CH), 27.3 (Ac-CH3), 25.5 (CH3), 20.8 (CH3). IR (neat) υ/cm-1: 2961, 1743, 1699, 1445, 1233, 
1190, 1111, 1084, 1033. HRMS (EI) m/z calculated for C13H23NO2 [M]
+ = 229.1314; found: 
229.1316. 
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Methyl 2,2-dimethyl-4-(hydroxymethyl)pyrrolidine-1-carboxylate 563 
 
To a solution of the acetoxymethyl pyrrolidine 565 (170 mg, 0.74 mmol) in undried methanol (5 
ml) was added potassium carbonate (200 mg, 1.5 mmol). The reaction was stirred for 18 h at room 
temperature. The solvent was removed and the residue was diluted with water (5 ml) extracted 
with dichloromethane (3 x 5 ml). The combined organic layers were dried and concentrated to 
give the pyrrolidine  563 (131 mg, 95%) as a colourless oil. δH 3.61 (d, J = 11.0 Hz, 2H, OCH2), 
3.60 (s, 3H, OCH3), 3.04 (t, J = 10.1 Hz, 1H), 2.43 – 2.29 (m, 1H), 1.83 (dd, J = 11.7, 6.2 Hz, 1H), 
1.73 (br. s, 1H, OH), 1.62 – 1.45 (m, 1H), 1.43 (s, 3H, CH3), 1.34 (t, J = 11.1 Hz, 1H), 1.29 (s, 3H, 
CH3). δC 64.8 (OCH2), 60.9 (NCq), 51.8 (OCH3), 50.5 (CH2N), 37.6 (CH), 29.8 (CH2), 25.6 (2 x 
CH3). 
Methyl ((5,5-dimethyltetrahydrofuran-3-yl)methyl)carbamate 562 
 
By general procedure B, to the alcohol 563 (90 mg, 0.5 mmol) in dry dichloromethane (10 ml) 
concentrated sulfuric acid (12 mg, 0.12 mmol) was added and the resulting mixture stirred for 20 h 
at 20o C to give the tetrahydrofuran 562 as (87 mg, 97%) as colourless oil, which exhibited 
spectroscopic and analytical data identical to that reported above for a sample of the 
tetrahydrofuran prepared by cyclisation of the alcohol 561. 
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N-(2-(Hydroxymethyl)-4-methylpent-4-en-1-yl)-4-methylbenzenesulfonamide 566 
 
By general procedure A, tosyl chloride (553 mg, 3.0 mmol) was added to the amino-alcohol 560 
(0.28 g, 2.2 mmol) and Et3N (0.5 ml, 4.4 mmol) at 0 
oC. The mixture was then stirred for 1 h at 
room temperature to give the sulfonamide 566 (0.52 g, 83%) as a colourless oil. δH 7.72 (d, J = 7.9 
Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 5.44 (t, J = 3.8 Hz, 1H, NH), 4.76 (td, J = 1.4, 0.9 Hz, 1H, 
=CH), 4.67 (d, J = 0.9 Hz, 1H, =CH), 3.70 (d, J = 11.0 Hz, 1H, OCHACHB), 3.52 (d, J = 11.0 Hz, 
1H, OCHACHB), 3.05 (dd, J = 11.7, 3.8 Hz, 1H, NCHACHB), 2.88 (dd, J = 11.7, 3.8 Hz, 1H, 
NCHACHB), 2.44 (s, 3H, ArCH3), 1.93 – 1.88 (m, 3H, CH and CH2), 1.65 (s, 3H, CH3). δC 143.4 
(Cq), 142.8 (Cq), 137.0 (Cq), 129.8 (CH), 129.7 (CH), 127.0 (CH), 112.6 (=CH2), 64.0 (OCH2), 
44.8 (NCH2), 37.9 (CH), 37.4 (CH2), 22.0 (ArCH3), 21.5 (CH3). IR (neat) υ/cm-1: 3520, 3281, 
2922, 1599, 1445, 1319, 1092, 893. HRMS (APCI) m/z calculated for C14H22NO3S [M+H]
+ = 
284.1320; found: 284.1316. 
N-((5,5-Dimethyltetrahydrofuran-3-yl)methyl)-4-methylbenzenesulfonamide 567 
 
By general procedure B, to the N-tosyl alcohol 566 (120 mg, 0.4 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 0o C to give the tetrahydrofuran 567 as inseparable mixture with ca. 20% 
of pyrrolidine 568 as a colourless oil (116 mg, total 97%).  
The tetrahydrofuran 567 : δH 7.65 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.2 Hz, 2H), 4.95 (t, J = 6.3 Hz, 
1H, NH), 3.78 (dd, J = 9.5, 7.2 Hz, 1H), 3.35 (dd, J = 9.5, 3.7 Hz, 1H), 2.85 – 2.79 (m, 2H, 
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NCH2), 2.48 – 2.39 (m, 1H), 2.34 (s, 3H, ArCH3), 1.82 – 1.71 (m, 2H, CH2), 1.13 (s, 3H, CH3), 
1.05 (s, 3H, CH3). δC 14.5 (Cq), 136.9 (Cq), 129.8 (2 x CH), 127.2 (2 x CH), 81.0 (OCq), 69.7 
(OCH2), 46.3 (NCH2), 42.7 (CH2), 40.0 (CH), 29.2 (ArCH3), 27.6 (CH3), 21.5 (CH3). IR (neat) 
υ/cm-1: 3266, 2971, 2930, 2868, 1599, 1456, 1329, 1091, 910. HRMS (APCI) m/z calculated for 
C14H22NO3S [M+H]
+ = 284.1320; found: 284.1320. 
4-Methyl-2-((4-methylphenylsulfonamido)methyl)pent-4-en-1-yl acetate 569 
 
By general procedure E, the alcohol 566 (283 mg, 1.0 mmol) was reacted with acetic anhydride 
(0.1 ml, 1.1 mmol) for 19 h to give the acetate 569 (325 mg, 100%) as a colourless oil. δH 7.66 (d, 
J = 8.2 Hz, 2H), 7.24 (d, J = 8.2 Hz, 2H), 4.95 (br. s, 1H, NH), 4.72 (s, 1H, =CH), 4.61 (d, J = 0.8 
Hz, 1H, =CH), 4.05 (dd, J = 11.4, 3.6 Hz, 1H, CH), 3.83 – 3.77 (m, 1H, CH), 2.90 – 2.84 (m, 1H, 
CH), 2.76 (dt, J = 12.9, 4.3 Hz, 1H, CH), 2.36 (s, 3H, ArCH3), 1.96 (s, 3H, AcCH3), 1.59 (s, 3H, 
CH3). δC 171.1 (C=O), 143.4 (Cq), 142.1 (Cq), 129.7 (2 x CH), 127.1 (2 x CH), 113.1 (=CH2), 
64.5 (OCH2), 44.1 (NCH2), 37.6 (CH2), 35.9 (CH), 22.0 (Ar-CH3), 22.5 (Ac-CH3), 20.7 (CH3). IR 
(neat) υ/cm-1: 3283, 2961, 2934, 2872, 1738, 1647, 1599, 1446, 1369, 1027, 1238, 1094, 1038, 
899, 814. HRMS (ES) m/z calculated for C16H24NO4S [M+H]
+ = 326.1426; found: 326.1425. 
(5,5-Dimethyl-1-tosylpyrrolidin-3-yl)methyl acetate 570 
 
By general procedure B, to the sulfonamide 569 (292 mg, 0.9 mmol) in dry dichloromethane (10 
ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture was stirred for 1 h at 
0o C to give the pyrrolidine 570 as a colourless oil (289 mg, 99%). δH 7.58 (d, J = 8.3 Hz, 2H), 
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7.14 (d, J = 8.3 Hz, 2H), 3.91 (dd, J = 11.0, 5.8 Hz, 1H), 3.74 (dd, J = 11.0, 7.8 Hz, 1H), 3.51 (dd, 
J = 11.0, 7.8 Hz, 1H), 2.85 (dd, J = 12.3, 6.5 Hz, 3H), 2.47 – 2.36 (m, 1H), 2.28 (s, 3H, ArCH3), 
1.90 (s, 3H, AcCH3), 1.82 – 1.78 (m, 1H), 1.77 – 1.72 (m, 1H), 1.34 (s, 3H, CH3), 1.30 (s, 3H, 
CH3). δC 170.8 (C=O), 142.8 (Cq), 138.4 (Cq), 129.4 (2 x CH), 127.3 (2 x CH), 65.4 (NCq), 65.4 
(OCH2), 52.0 (CH2), 45.7 (CH2), 34.8 (CH), 28.6 (AcCH3), 28.4 (ArCH3), 21.43 (CH3), 20.74 
(CH3). IR (neat) υ/cm-1: 29681, 2928, 2870, 1740, 1456, 1369, 1332, 1230, 1090, 1034, 912. 
HRMS (ES) m/z calculated for C16H24NO4S [M+H]
+ = 326.1426; found: 326.1426. 
(5,5-Dimethyl-1-tosylpyrrolidin-3-yl)methanol 569 
 
To a solution of acetoxymethyl pyrrolidine 570 (270 mg, 0.83 mmol) in undried methanol (5 ml) 
was added potassium carbonate (200 mg, 1.5 mmol). The reaction was stirred for 18 h at room 
temperature. The solvent was removed and the residue was diluted with water (5 ml) and extracted 
with dichloromethane (3 x 5 ml). The combined organic layers were dried and concentrated to 
give the pyrrolidine 568 (231 mg, 98%) as a colourless oil. δH 7.66 (d, J = 8.3 Hz, 2H), 7.21 (d, J 
= 8.3 Hz, 2H), 3.60 – 3.52 (m, 2H, 2 x CH), 3.47 (dd, J = 10.1, 6.6 Hz, 1H), 2.97 (t, J = 9.3 Hz, 
1H), 2.35 (s, 3H, ArCH3), 1.81 (dd, J = 12.4, 6.7 Hz, 1H), 1.56 (br. s, 1H, OH), 1.55 – 1.46 (m, 
2H, CH2), 1.43 (s, 3H, CH3), 1.36 (s, 3H, CH3). δC 142.8 (Cq), 138.4 (Cq), 129.4 (2 x CH), 127.2 
(2 x CH), 65.5 (NCq), 64.4 (OCH2), 51.8 (CH2), 45.6 (CH2), 38.0 (CH), 28.6 (2 x CH3), 21.5 
(CH3). IR (neat) υ/cm-1: 3513, 2924, 1330, 1261, 1091, 941. HRMS (EI) m/z calculated for 
C14H21NO3S [M]
+ = 283.1242; found: 283.1236. 
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N-((5,5-Dimethyltetrahydrofuran-3-yl)methyl)-4-methylbenzenesulfonamide 567 
 
By general procedure B, to the alcohol 568 (174 mg, 0.7 mmol) in dry dichloromethane (10 ml) 
concentrated sulfuric acid (2 drops) was added and the resulting mixture stirred for 18 h at 20o C 
to give the tetrahydrofuran 567 as inseparable mixture with of pyrrolidine 568* as colourless oil 
(162 mg, total 93%), which exhibited spectroscopic and analytical data identical to those reported 
above for a sample of the trahydrofuran prepared by cyclisation of the alcohol 566, except for a 
slight difference in the ratio of the two compounds. 
*The structure of pyrrolidine 568 was confirmed by different way (p. 256). 
2-(Aminomethyl)-4-methyl-2-(2-methylallyl)pent-4-en-1-ol 56947 
 
Using general procedure C, the cyanoacetate 559 (0.44 g, 2 mmol) was reduced by lithium 
aluminium hydride (0.19 g, 5 mmol) to give the amino-alcohol 569 (0.35 g, 96%) as a clear oil, 
which was used directly in the next step. δH 4.88 (d, J = 1.2 Hz, 1H, 2 x =CHA), 4.63 (app. s, 1H, 
2 x =CHB), 3.75 (t, J = 6.4, 2H, NCH2), 3.62 (s, 2H, OCH2), 2.90 (s, 2H, NH2), 2.73 – 2.33 (br. s, 
OH), 2.17 (d, J = 13.6, 2H, 2 x CHA), 2.12 (d, J = 13.6, 2H, 2 x CHB), 1.55 (s, 6H, 2 x CH3). δC 
142.7 (2 x Cq), 115.0 (2 x =CH2), 70.4 (OCH2), 67.9 (NCH2), 49.7 (Cq), 41.8 (2 x CH2), 25.4 (2 x 
CH3). 
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N-(2-(Hydroxymethyl)-4-methyl-2-(2-methylallyl)pent-4-en-1-yl)-4-ethylbenzenesulfonamide 
57047 
 
By general procedure A, tosyl chloride (191 mg, 1 mmol) was added to the amino-alcohol 569 
(156 mg, 0.85 mmol) and Et3N (0.2 ml) at -78 
oC. The mixture was then stirred for 1 h without 
additional cooling to give, after the usual work-up, the sulfonamide 570 (253 mg, 88%) as a 
colourless oil. δH 7.73 (d, J = 8.2 Hz 2H), 7.34 (d, J = 8.2 Hz, 2H), 5.12 (t, J = 6.8 Hz, 1H, NH), 
4.90 (d, J = 1.2 Hz, 2H, 2 x =CH), 4.76 (d, J = 1.2 Hz, 2H, 2 x =CH), 3.60 (s, 2H, OCH2), 2.91 (d, 
J = 6.8 Hz, 2H, NCH2), 2.45 (s, 3H, Ar-CH3), 2.29 (br. s, 1H, OH), 2.16 (dd, J = 13.8, 0.5 Hz, 
2H), 2.05 (dd, J = 13.8, 0.5 Hz, 2H), 1.79 (s, 6H, 2 x CH3). δC 142.6 (Cq), 136.6 (Cq),  129.6 (2 x 
CH), 126.8 (2 x CH), 115.5 (2 x CH2), 67.6 (OCH2), 48.6 (NCH2), 44.1 (Cq), 41.5 (2 x CH2), 25.1 
(2 x CH3). 
3,3,8,8-Tetramethyl-7-tosyl-2-oxa-7-azaspiro[4.4]nonane 57147 
 
By general procedure B, to the N-tosyl alcohol 570 (115 mg, 0.34 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 20 oC to give the oxa-azaspiro 571 as a colourless oil (114 mg, 99%). δH 
7.65 (d, J = 8.6 Hz 2H), 7.19 (d, J = 8.6 Hz, 2H), 3.55 (d, J = 8.8 Hz, 1H), 3.46 (d, J = 8.8 Hz, 
1H), 3.32 (d, J = 9.4 Hz, 1H), 3.13 (d, J = 9.4, 1H), 2.32 (s, 3H, Ar-CH3), 1.80 (d, J = 1.8 Hz, 2H), 
1.63 (d, J = 6.9 Hz, 2H), 1.39 (s, 3H, CH3), 1.35 (s, 3H, CH3), 1.12 (s, 6H, 2 x CH3). δC 142.8 
                                                                                                                                                            259 
(Cq), 138.1 (Cq), 129.4 (2 x CH), 127.3 (2 x CH), 80.2 (OCq), 75.6 (OCH2), 64.8 (NCq), 59.2 
(NCH2), 52.7 (CH2), 49.7 (Cq), 48.5 (CH2), 29.2 (CH3), 29.1 (CH3), 29.0 (CH3), 28.3 (CH3), 21.5 
(ArCH3). IR (neat) υ/cm-1: 2971, 2930, 2868, 1599, 1451, 1334, 1090, 1007, 814, 677. HRMS (EI) 
m/z calculated for C18H27NO3S [M]
+ = 337.1712; found: 337.1710. 
Methyl (2-(hydroxymethyl)-4-methyl-2-(2-methylallyl)pent-4-en-1-yl)carbamate 572 
 
By general procedure A, methyl chloroformate (0.1 ml, 1.2 mmol) was added to the amino-alcohol 
569 (183 mg, 1 mmol) and Et3N (2.5 ml, 22 mmol) to give the N-protected amino-alcohol 572 
(231 mg, 96%) as a colourless oil. δH 5.72 (t, J = 6.4 Hz, 1H, NH), 4.90 (d, J = 0.8 Hz, 2H, 2 x 
=CH), 4.76 (app. s, 2H, 2 x =CH), 3.71 (s, 3H, OCH3), 3.51 (br. s, 1H, OH), 3.41 (d, J = 6.8 Hz, 
2H, OCH2), 2.27 (d, J = 6.4 Hz, 2H, NCH2), 2.16 (dd, J = 13.8, 1.5 Hz, 2H), 2.05 (dd, J = 13.8, 
1.5 Hz, 2H), 1.79 (s, 6H, 2 x CH3). δC 158.5 (C=O), 143.1 (2 x Cq), 115.3 (2 x CH2), 65.4 (OCH2), 
45.9 (NCH2), 43.7 (Cq), 41.3 (2 x CH2), 25.4 (2 x CH3). IR (neat) υ/cm-1: 3345, 2970, 2948, 1705, 
1520, 1450, 1244, 1046, 907. HRMS (EI) m/z calculated for C13H23NO2 [M]
+ = 241.1678; found: 
241.1677. 
Methyl 3,3,8,8-tetramethyl-2-oxa-7-azaspiro[4.4]nonane-7-carboxylate 573 
 
By general procedure B, to the N-tosyl alcohol 572 (177 mg, 0.55 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 0 oC to give the oxa-azaspiro 573 as a colourless oil (172 mg, 97%). δH 
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3.58 (d, J = 8.7 Hz, 1H), 3.44 (d, J = 8.7 Hz, 1H), 3.43 (s, 3H, CH3), 3.37 (d, J = 10.7 Hz, 1H), 
3.16 (d, J = 10.7, 1H), 1.80 (d, J = 2.8 Hz, 2H), 1.63 (d, J = 1.2 Hz, 2H), 1.22 (s, 3H, CH3), 1.15 
(s, 3H, CH3), 1.05 (s, 6H, 2 x CH3). δC 153.8 (C=O, Cq), 79.9 (OCq), 75.8 (OCH2), 60.3 (NCq), 
58.2 (NCH2), 51.4 (OCH3), 50.7 (CH2), 50.0 (CH2), 48.2 (Cq), 29.4 (CH3), 28.8 (CH3), 27.2 
(CH3), 26.8 (CH3). HRMS (APCI) m/z calculated for C13H23NO3 [M+H]
+ = 242.1756; found: 
242.1755. 
Ethyl 2-allyl-2-cyano-4-methylpent-4-enoate 579 
 
By general procedure D, to sodium hydride (60% dispersion in mineral oil, 0.40 g, 10 mmol, 1 
eq.) in DMF (20 ml) under nitrogen at 0 °C was slowly added cyanoacetate 558 (1.10 g, 6.6 
mmol) in DMF (10 ml). After 15 min, allyl bromide 577 (1.20 g, 10 mmol) was added. To give 
cyanomethylpentenoate 579 (1.40 g, 84%) as a colourless oil. δH 5.90 – 5.80 (m, 1H, =CH), 5.27 
(d, J = 14.5 Hz, 2H, =CH2), 4.99 (app. s, 1H), 4.91 (app. s, 1H), 4.26 (q, J = 6.5 Hz, 2H, OCH2), 
2.72 – 2.63 (m, 2H, CH2), 2.61 – 2.49 (m, 2H, CH2), 1.86 (s, 3H, CH3), 1.33 (t, J = 6.5 Hz, 3H, 
CH3). δC 168.3 (C=O), 139.2 (Cq), 130.5 (=CH), 121.0 (=CH2), 118.9 (CN, Cq), 116.3 (=CH2),  
62.7 (OCH2), 48.8 (Cq), 44.4 (CH2), 42.1 (CH2), 23.0 (CH3), 14.0 (CH3). IR (neat) υ/cm-1: 3082, 
2984, 2928, 2868, 2245, 1720, 1645, 1442, 1213, 993, 910, 733. HRMS (APCI) m/z calculated for 
C12H18NO2 [M+H]
+ = 208.1338; found: 208.1343. 
Ethyl 1-cyano-3-methylcyclopent-3-enecarboxylate 580 
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A solution of the cyanoacetate 579 (0.70 g, 3.4 mmol) and Grubbs II catalyst (20 mg, 0.024 mmol) 
in dry dichloromethane (10 ml) was stirred at room temperature overnight. The solvent was 
evaporated to give the cyanopentene 580 (0.66 g, 100%) as a colourless oil. δH 5.82 – 5.69 (m, 1H, 
=CH), 4.20 (q, J = 6.7 Hz, 2H, OCH2), 2.98 (d, J = 9.4 Hz, 2H, CH2), 2.60 (d, J = 8.7 Hz, 1H), 
2.46 (d, J = 8.7 Hz, 1H), 1.68 (s, 3H, CH3), 1.32 (t, J = 6.7 Hz, 3H, OCH3). δC 169.3 (C=O, Cq), 
137.4 (Cq), 121.3 (CN, Cq), 120.9 (=CH), 62.9 (OCH2), 47.3 (CH2), 46.2 (Cq), 44.0 (CH2), 15.8 
(CH3), 13.9 (CH3).  
(1-(Aminomethyl)-3-methylcyclopent-3-en-1-yl)methanol 581 
 
Following general procedure C, the cyanoacetate 580 (0.66 g, 3.4 mmol) was reduced using 
lithium aluminium hydride (0.38 g, 10 mmol) to give the amino-alcohol 581 (0.46 g, 96 %) as a 
yellow oil, which was used directly in the next step. δH 4.99 (s, 1H, =CH), 3.42 (s, 2H, OCH2), 
2.71 (s, 2H, NCH2), 2.49 –  2.30 (br. s, 3H, OH and NH2), 1.99 (d, J = 11.7 Hz, 2H, CH2), 1.80 (s, 
2H, CH2), 1.48 (s, 2H, CH3). δC 138.3 (Cq), 122.3 (=CH), 68.0 (OCH2), 51.7 (NCH2), 47.2 (Cq), 
43.8 (CH2), 39.7 (CH2), 16.7 (CH3). 
N-((1-(Hydroxymethyl)-3-methylcyclopent-3-en-1-yl)methyl)-4-methylbenzenesulfonamide 
582 
 
By general procedure A, tosyl chloride (0.66 g, 3.2 mmol) was added to the amino-alcohol 581 
(0.44 g, 3.1 mmol) and Et3N (0.5 ml, 4.4 mmol) at -78 
oC. The mixture was then stirred for 1 h 
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without additional cooling. The usual work-up then gave the sulfonamide 582 (0.61 g, 66%) as a 
colourless oil.  δH 7.66 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.2 Hz, 2H), 5.34 (t, J = 6.3 Hz, 1H, NH), 
5.06 (d, J = 4.5 Hz, 1H, =CH), 3.49 (d, J = 4.3 Hz, 2H, OCH2), 2.89 (dd, J = 6.3 Hz, 2H, NCH2), 
2.54 – 2.41 (br. s, 1H, OH), 2.36 (s, 3H, Ar-CH3), 2.11 – 1.99 (m, 2H, CH2), 1.93 (m, 2H, CH2), 
1.56 (s, 3H, CH3). δC 143.4 (Cq), 138.3 (Cq), 137.3 (Cq), 129.7 (2 x CH), 127.0 (2 x CH), 122.1 
(=CH), 68.0 (OCH2), 49.4 (NCH2), 47.5 (Cq), 43.7 (CH2), 39.6 (CH2), 21.5 (CH3), 16.5 (CH3). 
4-Methyl-N-((1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)methyl)benzenesulfonamide 583 and  
1-Methyl-2-tosyl-2-azabicyclo[2.2.1]heptan-4-yl)methanol 584 and 
 
By general procedure B, to the N-tosyl alcohol 582 (143 mg, 0.48 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 20o C to give the oxabicyclo 583 as a mixture with azabicyclo 584* as an 
inseparable mixture (3:1) as a colourless oil (132 mg, 92%). δH 7.55 (d, J = 8.3 Hz, 2H), 7.14 (d, J 
= 8.3 Hz, 2H), 4.51 (t, J = 6.8 Hz, 1H, NH), 3.42 (s, 2H, OCH2), 2.48 (d, J = 6.9 Hz, NCH2), 2.25 
(s, 3H, Ar-CH3), 1.58 (dd, J = 9.8, 4.0 Hz, 2H, CH2), 1.41 – 1.20 (m, 6H, 3 x CH2), 0.90 (s, 3H, 
CH3). δC 143.5 (Cq), 136.9 (Cq), 129.8 (2 x CH), 127.0 (2 x CH), 71.7 (OCH2), 69.1 (OCq), 49.4 
(NCH2), 32.4 (Cq), 32.1 (2 x CH2), 28.0 (2 x CH2), 26.3 (CH3), 21.5 (CH3). 
*The structure of azabicyclo 584 was confirmed by different way (p. 264). 
(3-Methyl-1-((4-methylphenylsulfonamido)methyl)cyclopent-3-en-1-yl)methyl acetate 586 
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By general procedure E, but with a reaction time of 19 h, the alcohol 582 (295 mg, 1.0 mmol) was 
converted into the acetate 586 (337 mg, 100%), a colourless oil. δH 7.65 (t, J = 8.1 Hz, 2H), 7.24 
(d, J = 8.1 Hz, 2H), 5.09 (s, 1H, =CH), 4.99 (t, J = 6.8 Hz, 1H, NH), 3.93 (d, J = 4.9 Hz, 1H, 
OCHACHB), 3.89 (d, J = 4.9 Hz, 1H, OCHACHB), 2.78 (d, J = 6.8 Hz, 2H, NCH2), 2.36 (s, 3H, 
Ar-CH3), 2.10 (s, 2H, CH2), 2.04 (s, 2H, CH2), 1.94 (s, 3H, Ac-CH3), 1.58 (s, 3H, CH3). δC 171.4 
(C=O), 143.3 (Cq), 138.2 (Cq), 137.1 (Cq), 129.7 (2 x CH), 127.1 (2 x CH), 121.9 (=CH), 68.2 
(OCH2), 48.5 (NCH2), 46.0 (Cq), 43.9 (CH2), 39.8 (CH2), 22.1 (CH3), 21.5 (CH3), 20.8 (CH3). IR 
(neat) υ/cm-1: 3269, 2957, 2915, 1740, 1437, 1333, 1248, 1094, 1037, 814. HRMS (ES) m/z 
calculated for C17H23NO4SNa [M+Na]
+ = 360.1245; found: 360.1239. 
(1-Methyl-2-tosyl-2-azabicyclo[2.2.1]heptan-4-yl)methyl acetate 587 
 
By general procedure B, to the protected amino-alcohol 586 (302 mg, 0.9 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture 
was stirred for 1 h at 20 oC to give the azabicycloheptane 587 as a colourless oil (287 mg, 95%). 
δH 7.68 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 4.05 (s, 2H, OCH2), 3.31 (d, J = 2.3 Hz, 1H, 
NCHACHB), 3.27 (d, J = 2.3 Hz, 1H, NCHACHB), 2.36 (s, 3H, Ar-CH3), 1.99 (s, 3H, Ac-CH3), 
1.94 (d, J = 1.3 Hz, 1H, CH), 1.83 – 1.77 (m, 1H, CH), 1.56 (s, 3H, CH3), 1.53 (d, J = 1.3 Hz, 1H, 
CH), 1.44 (d, J = 3.1 Hz, 1H, CH), 1.41 (t, J = 3.1 Hz, 1H, CH), 1.33 (d, J = 0.8 Hz, 1H, CH). δC 
170.5 (C=O) 143.0 (Cq), 138.2 (Cq), 129.5 (2 x CH), 127.1 (2 x CH), 70.8 (NCq), 65.5 (OCH2),  
58.5 (NCH2), 49.0 (CH2), 46.8 (Cq), 36.1 (CH2), 32.1 (CH2), 21.5 (CH3), 20.7 (CH3), 19.4 (CH3). 
IR (neat) υ/cm-1: 2937, 1740, 1339, 1240, 1094, 1034, 815. HRMS (EI) m/z calculated for 
C17H23NO4S [M]
+ = 337.1348; found: 337.1336. 
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(1-Methyl-2-tosyl-2-azabicyclo[2.2.1]heptan-4-yl)methanol 584 
 
To a solution of foregoing azabicycloheptane 587 (263 mg, 0.78 mmol) in undried methanol (5 
ml) was added potassium carbonate (200 mg, 1.5 mmol). The reaction was stirred for 18 h at room 
temperature. The solvent was removed and the residue was diluted with water (5 ml) and extracted 
with dichloromethane (3 x 10 ml). The combined organic layers were dried and concentrated to 
give the azabicyclo methanol 584 (209 mg, 91%) as a colourless oil. δH 7.65 (d, J = 8.0 Hz, 2H), 
7.20 (d, J = 8.0 Hz, 2H), 3.62 (s, 2H, NCH2), 3.35 (dd, J = 8.5, 3.2 Hz, 1H, OCHACHB), 3.27 (dd, 
J = 8.5, 1.4 Hz, 1H, OCHACHB), 2.35 (s, 3H, Ar-CH3), 1.83 – 1.74 (m, 1H, CH), 1.62 – 1.58 (m, 
1H, CH), 1.56 – 1.54 (m, 1H, CH), 1.52 (s, 3H, CH3), 1.42 (d, J = 5.2 Hz, 1H, CH), 1.38 (d, J = 
2.1 Hz, 1H, CH), 1.32 – 1.29 (m, 1H, CH). δC 142.9 (Cq), 138.9 (Cq), 129.5 (2 x CH), 127.1 (2 x 
CH), 70.9 (NCq), 64.4 (OCH2), 58.6 (NCH2), 49.2 (Cq), 48.6 (CH2), 36.1 (CH2), 31.6 (CH2), 21.5 
(CH3), 19.5 (CH3). IR (neat) υ/cm-1: 3510, 2932, 2872, 1333, 1288, 1012, 814. HRMS (EI) m/z 
calculated for C15H21NO3S [M]
+ = 295.1242; found: 295.1239. 
4-methyl-N-((1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)methyl)benzenesulfonamide 583 
 
By general procedure B, to the azabicyclo methanol 584 (170 mg, 0.59 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture 
stirred for 20 h at 20 oC to give the oxabicycloheptane 583 (162 mg, 95%) as a colourless oil, 
which exhibited spectroscopic and analytical data identical to those reported above for a sample of 
the oxabicyclo 583 prepared by cyclisation of the alcohol 582 (p. 262). 
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Ethyl 1-cyano-4-methylcyclohex-3-enecarboxylate 58848 
 
A mixture of ethyl cyanoacetate 510 (4.52 g, 40 mmol), isoprene 591 (8.17 g, 120 mmol), 
paraformaldehyde (2.40 g, 80 mmol) and copper(II) acetate monohydrate (0.25 g, 0.125 mmol) 
were heated at 80 OC for 24 h in acetic acid and toluene (25 ml, 1:1). The reaction mixture was 
cooled to room temperature and evaporated under reduced pressure, and the oily residue taken up 
in ether (50 ml) and the solution washed with water (10 ml) then dried and evaporated and the 
residue purified by column chromatography on silica gel eluting with ether/hexanes (1:99) to give 
cyanoacetate 588 (3.50 g, 94%) as a colourless oil. All data obtained were in accordance with 
those previously reported in the literature:48 δH 5.30 (t, J = 1.4 Hz, 1H, =CH), 4.21 (q, J = 7.1 Hz, 
2H, OCH2), 2.50 (d, J = 1.4 Hz, 2H, CH2), 2.20 – 2.03 (m, 2H, CH2), 2.01 – 1.86 (m, 2H, CH2), 
1.65 (s, 3H, CH3), 1.26 (t, J = 7.1 Hz, 3H, CH2). δC 169.1 (Cq), 134.1 (Cq), 120.5 (CN), 115.9 
(=CH), 62.8 (OCH2), 42.2 (Cq), 32.5 (CH2), 29.3 (CH2), 26.8 (CH2), 23.2 (CH3), 14.0 (CH3).  
(1-(Aminomethyl)-4-methylcyclohex-3-en-1-yl)methanol 59248 
 
Following general procedure C, the cyanoacetate 588 (3.50 g, 18.1 mmol) was reduced using 
lithium aluminium hydride (1.52 g, 40 mmol) to give the amino-alcohol 592 (2.50 g, 89 %) as a 
yellowish oil, which was used directly in the next step. δH 5.21 (d, J = 1.5 Hz, 1H, =CH), 3.48 (s, 
2H, OCH2), 3.00 – 2.84 (br. s, 3H, OH and NH2), 2.68 (t, J = 8.6 Hz, 2H, NCH2), 1.94 – 1.80 (m, 
2H, CH2), 1.75 – 1.63 (m, 2H, CH2), 1.57 (s, 3H, CH3), 1.50 – 1.43 (m, 2H, CH2). δC 133.3 (Cq), 
118.6 (=CH), 70.2 (OCH2), 50.3 (NCH2), 35.8 (Cq), 31.0 (CH2), 26.7 (CH2), 26.3 (CH2), 23.3 
(CH3).  
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N-((1-(Hydroxymethyl)-4-methylcyclohex-3-en-1-yl)methyl)-4-methylbenzenesulfonamide 
592 
 
By general procedure A, tosyl chloride (1.36 g, 7.7 mmol) was added to the amino-alcohol 591 
(1.20 g, 7.7 mmol) and Et3N (1 ml, 8.8 mmol) at -78 
oC. The mixture was then stirred for 1 h 
without additional cooling to give the sulfonamide 592 (1.76 g, 74%) as a colourless oil. δH 7.67 
(d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 5.15 (d, J = 1.5 Hz, 1H, =CH), 5.10 – 4.93 (br. s, 1H, 
NH), 3.44 (s, 2H, OCH2), 2.83 (d, J = 13.0 Hz, 1H), 2.73 (d, J = 13.0 Hz, 1H), 2.36 (s, 3H, Ar-
CH3), 1.94 – 1.83 (m, 2H, CH2), 1.69 – 1.60 (m, 2H, CH2), 1.54 (s, 3H, CH3), 1.50 – 1.35 (m, 2H, 
CH2). δC 142.6 (Cq), 136.6 (Cq), 133.5 (Cq), 129.7 (2 x CH), 127.0 (2 x CH), 118.0 (CH), 67.7 
(OCH2), 48.1 (NCH2), 36.6 (Cq), 30.7 (CH2), 26.9 (CH2), 26,3 (CH2), 23.3 (CH3), 21.5 (CH3). IR 
(neat) υ/cm-1: 3505, 3295, 2926, 1452, 1327, 1094, 814. HRMS (EI) m/z calculated for 
C16H24NO3S [M+H]
+ = 310.1477; found: 310.1465. 
4-Methyl-N-((1-methyl-2-oxabicyclo[2.2.2]octan-4-yl)methyl)benzenesulfonamide 693 
 
By general procedure B, to the N-tosyl alcohol 592 (137 mg, 0.44 mmol) in dry dichloromethane 
(10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added and the resulting 
mixture stirred for 1 h at 0 oC to give the oxabicyclo-octane 593 as a colourless oil (124 mg, 91%). 
δH 7.55 (d, J = 8.3 Hz, 2H), 7.14 (d, J = 8.3 Hz, 2H), 4.51 (t, J = 6.8 Hz, 1H, NH), 3.42 (s, 2H, 
OCH2), 2.48 (d, J = 6.8 Hz, NCH2), 2.25 (s, 3H, Ar-CH3), 1.58 (dd, J = 9.8, 4.0 Hz, 2H, CH2), 
1.41 – 1.20 (m, 6H, 3 x CH2), 0.90 (s, 3H, CH3). δC 143.5 (Cq), 136.9 (Cq), 129.8 (2 x CH), 127.0 
                                                                                                                                                            267 
(2 x CH), 71.7 (OCH2), 69.1 (OCq), 49.4 (NCH2), 32.4 (Cq), 32.1 (2 x CH2), 28.0 (2 x CH2), 26.3 
(CH3), 21.5 (CH3). IR (neat) υ/cm-1: 3283, 2924, 2862, 1452, 1321, 1094, 814. HRMS (EI) m/z 
calculated for C16H24NO3S [M+H]
+ = 310.1477; found: 310.1471. 
(4-Methyl-1-((4-methylphenylsulfonamido)methyl)cyclohex-3-en-1-yl)methyl acetate 594 
 
By general procedure E, the alcohol 592 (309 mg, 1.0 mmol) was converted during 18 h into the 
acetate 594 (351 mg, 100%), a colourless oil. δH 7.66 (d, J = 8.1 Hz, 3H), 7.23 (d, J = 8.1 Hz, 2H), 
5.14 (d, J = 1.5 Hz, 1H, =CH), 4.98 (t, J = 7.3 Hz, 1H, NH), 3.88 (d, J = 11.4 Hz, 1H, OCHACHB), 
3.78 (d, J = 11.4 Hz, 1H, OCHACHB), 2.74 (dd, J = 7.3, 6.8 Hz, 1H), 2.60 (dd, J = 7.3, 6.8 Hz, 
1H), 2.36 (s, 3H, Ar-CH3), 1.93 (s, 3H, Ac-CH3), 1.82 (t, J = 5.3 Hz, 2H, CH2), 1.77 – 1.71 (m, 
2H, CH2), 1.55 (s, 3H, CH3), 1.45 – 1.40 (m, 2H, CH2). δC 171.3 (C=O), 143.2 (Cq), 137.1 (Cq), 
133.4 (Cq), 129.6 (2 x CH), 127.1 (2 x CH), 117.7 (=CH), 67.5 (OCH2), 47.3 (NCH2), 35.7 (Cq), 
31.0 (CH2), 26.9 (CH2), 26.1 (CH2), 23.2 (CH3), 21.5 (CH3), 20.7 (CH3). IR (neat) υ/cm-1: 3286, 
2934, 1732, 1327, 1236, 1092, 1036, 910. HRMS (ES) m/z calculated for C18H25NNaO4S 
[M+Na]+ = 374.1402; found: 374.1399. 
(1-Methyl-2-tosyl-2-azabicyclo[2.2.2]octan-4-yl)methyl acetate 595 
 
By general procedure B, to the protected amino-alcohol 594 (325 mg, 0.93 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture 
was stirred for 1h at 20 oC to give the azabicyclo-octane 595 as a colourless oil (306 mg, 94%). δH 
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7.67 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 3.73 (s, 2H, OCH2), 3.43 (s, 2H, NCH2), 2.36 (s, 
3H, Ar-CH3), 2.01 (s, 3H, Ac-CH3), 1.73 (s, 2H, CH2), 1.60 (d, J = 9.5 Hz, 2H), 1.51 (s, 2H, CH2), 
1.44 – 1.34 (m, 2H, CH2), 1.27 (s, 3H, CH3). δC 171.5 (C=O) 143.4 (Cq), 139.2 (Cq), 129.5 (2 x 
CH), 127.0 (2 x CH), 69.4 (OCH2), 55.2 (NCq), 53.8 (NCH2), 34.0 (Cq), 33.0 (2 x CH2), 27.1 (2 x 
CH2), 25.4 (CH3), 21.5 (CH3), 20.8 (CH3). IR (neat) υ/cm-1: 2940, 2870, 1740, 1458, 1331, 1235, 
1092, 1040, 1010, 980. HRMS (EI) m/z calculated for C18H25NO4S [M]
+ = 351.1504; found: 
351.1491. 
Methyl ((1-(hydroxymethyl)-4-methylcyclohex-3-en-1-yl)methyl)carbamate 596 
 
By general procedure A, methyl chloroformate (0.7 ml, 8.9 mmol) was added to the amino-alcohol 
591 (1.30 g, 8.4 mmol) and Et3N (1 ml, 8.8 mmol) at 0 
oC. The mixture was then stirred for 1 h at 
room temperature to give the carbamate 596 (1.26 g, 71%) as a colourless oil. δH 5.30 (s, 1H, 
=CH), 5.21 (d, J = 1.5 Hz, 1H, NH), 3.61 (s, 3H, OCH3), 3.24 (d, J = 6.4 Hz, 2H, OCH2), 3.03 – 
2.89 (m, 2H, NCH2), 1.80 (d, J = 2.5 Hz, 2H, CH2), 1.76 – 1.65 (m, 2H, CH2), 1.57 (s, 3H, CH3), 
1.42 (t, J = 6.5 Hz, 2H, CH2). δC  158.8 (C=O, Cq), 133.2 (Cq), 118.5 (CH), 66.1 (OCH2), 52.4 
(OCH3), 45.2 (NCH2), 38.3 (Cq), 30.8 (CH2), 27.0 (CH2), 26.5 (CH2), 23.3 (CH3). 
Methyl (1-methyl-2-oxabicyclo[2.2.2]octan-4-yl)methyl)carbamate 597 
 
By general procedure B, to the N-protected amino-alcohol 596 (106 mg, 0.5 mmol) in dry 
dichloromethane (10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added 
and the resulting mixture stirred for 1 h at 20 oC to give the oxabicyclo-octane 597 (104 mg, 98%) 
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as sharp, colourless crystals, m.p. 92 – 94 °C. δH 4.65 (br. s, 1H, NH), 3.71 – 3.49 (m, 2H, OCH2), 
3.61 (s, 3H, OCH3), 2.89 (d, J = 6.5 Hz, 2H, NCH2), 1.79 – 1.67 (m, 2H, CH2), 1.57 – 1.40 (m, 
6H, 3 x CH2), 1.02 (s, 3H, CH3). δC  157.2 (C=O, Cq), 71.7 (OCH2), 68.9 (OCq), 52.1 (OCH3), 
47.1 (NCH2), 33.0 (Cq), 32.1 (2 x CH2), 27.8 (2 x CH2), 26.3 (CH3). IR (neat) υ/cm-1: 3335, 2930, 
2862, 1722, 1694, 1545, 1447, 1192, 1117, 1047, 997. HRMS (EI) m/z calculated for C11H19NO3 
[M]+ = 213.1365; found: 213.1373. 
(1-((Methoxycarbonylamino)methyl)-4-methylcyclohex-3-en-1-yl)methyl acetate 598 
 
By general procedure B, to the alcohol 596 (213 mg, 1.0 mmol) in dry dichloromethane (10 ml) 
was added acetic anhydride (0.1 ml, 1.1 mmol) and pyridine (0.1 ml). The mixture was stirred 18 
h at room temperature then the organic layer was washed with a saturated aqueous copper sulphate 
(5 ml) and water (5 ml), dried and concentrated to give the protected alcohol 598 (255 mg, 100%) 
as a colourless oil.  δH 5.21 (d, J = 1.5 Hz, 1H, =CH), 5.01 (br. s, 1H, NH), 3.85 (dd, J = 15.4, 9.2 
Hz, 2H, OCH2), 3.59 (s, 3H, OCH3), 3.18 (dd, J = 14.0, 6.5 Hz, 1H), 3.02 (dd, J = 14.0, 6.5 Hz, 
1H), 2.01 (s, 3H, Ac-CH3), 1.88 (d, J = 1.5 Hz, 2H, CH2), 1.76 – 1.72  (m, 2H, CH2), 1.58 (s, 3H, 
CH3), 1.48 – 1.39 (m, 2H, CH2). δC 166.3 (C=O, Cq), 133.3 (Cq), 118.0 (CH), 67.5 (OCH2), 52.1 
(OCH3), 45.6 (NCH2), 36.9 (Cq), 30.7 (CH2), 27.0 (CH2), 26.4 (CH2), 23.3 (CH3), 22.1 (CH3). 
Methyl 4-(acetoxymethyl)-1-methyl-2-azabicyclo[2.2.2]octane-2-carboxylate 599 
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By general procedure B, to the protected amino-alcohol 598 (220 mg, 0.86 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture 
stirred for 1 h at 20o C to give the azabicyclo 599 (204 mg, 93%) as a colourless oil. δH 3.71 (s, 
2H, OCH2), 3.55 (s, 3H, OCH3), 3.21 (s, 2H, NCH2), 1.97 (s, 3H, Ac-CH3), 1.87 – 1.79 (m, 2H, 
CH2), 1.51 – 1. 45 (m, 6H, 3 x CH2), 1.42 (s, 3H, CH3). δC  157.2 (C=O, Cq), 71.7 (OCH2), 68.9 
(NCq), 52.1 (OCH3), 47.1 (NCH2), 33.0 (Cq), 32.1 (2 x CH2), 27.8 (2 x CH2), 26.3 (CH3).  
IR (neat) υ/cm-1: 2932, 2864, 1695, 1537, 1445, 1246, 1195, 1040, 912. HRMS (EI) m/z calculated 
for C13H21NO4 [M]
+ = 255.1471; found: 255.1460. 
(E)-Ethyl 2-cyano-5,9-dimethyldeca-4,8-dienoate 60149 
 
A mixture of ethyl cyanoacetate 510 (2.26 g, 20 mmol), geranyl bromide 600 (2.17 g, 10 mmol), 
potassium carbonate (2.75 g, 20 mmol), sodium chloride (0.50 g) in ethanol (50 ml) was reﬂuxed 
overnight. The solvent was removed and the residue was taken up in ether (3 x 20 ml) and the 
solution washed with water (10 ml). The extracts were dried, concentrated and the residue purified 
by column chromatography on silica gel eluting with ether/hexanes (1:99) to give the cyanoacetate 
601 (1.86 g, 75% yield) as a colourless oil. δH 5.11 (t, J = 7.4 Hz, 1H, =CH), 5.01 (t, J = 6.6 Hz, 
1H, =CH), 4.18 (q, J = 7.1, 2H, OCH2), 3.42 (t, J = 6.9 Hz, 1H, CH), 2.60 (q, J = 7.1 Hz, 2H, 
CH2), 2.02 – 1.94 (m, 4H, 2 x CH2), 1.62 (s, 3H, CH3), 1.60 (s, 3H, CH3), 1.53 (s, 3H, CH3), 1.25 
(t, J = 7.1, 3H, CH3). δC 165.9 (C=O), 141.1 (Cq), 131.7 (Cq), 123.7 (=CH), 117.3 (=CH), 116.5 
(CN), 62.6 (OCH2), 39.6 (CH2), 37.9 (CH), 28.6 (CH2), 26.4 (CH2), 25.6 (CH3) 17.6 (CH3), 16.3 
(CH3), 14.0 (CH3).  
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(E)-2-(Aminomethyl)-5,9-dimethyldeca-4,8-dien-1-ol 602 
 
The foregoing cyanoacetate 601 (1.80 g, 7.2 mmol) was dissolved in dry tetrahydrofuran (30 ml) 
and the solution added dropwise to a suspension of lithium aluminium hydride (0.76 g, 20 mmol) 
in tetrahydrofuran (20 ml) at 0 °C. The suspension was then refluxed for 3 hours subsequently 
cooled to 0 °C. When it was cold, water (5 ml), 15% aquous NaOH (5 ml) were added 
sequentially and the resulting mixture then stirred for one hour, the precipitated salts were then 
filtered off and washed with tetrahydrofuran (40 ml). The combined filtrate was concentrated, then 
the liquid residue extracted with dichloromethane (2 x 10 ml) and the combined extracts dried and 
concentrated to give the amino-alcohol 602 (1.23 g, 81 %) as a yellow oil, which was used 
directly in the next step. δH 5.07 – 4.96 (m, 2H, 2 x =CH), 3.69 (dd, J = 9.1, 7.3 Hz, 1H), 3.56 – 
3.49 (m, 1H), 3.40 – 3.22 (br. s, 3H, OH and NH2), 2.99 (d, J = 10.3 Hz, 1H), 2.70 (dd, J = 10.3 
Hz, 1H), 2.01 – 1.96 (m, 1H, CH), 1.95 – 1.89 (m, 4H, 2 x CH2), 1.85 – 1.82 (m, 2H, CH2), 1.61 
(s, 3H, CH3), 1.53 (s, 3H, CH3), 1.51 (s, 3H, CH3). δC 136.7 (Cq), 131.4 (Cq), 124.3 (=CH), 121.9 
(=CH), 62.9 (OCH2), 46.0 (NCH2), 41.8 (CH), 39.8 (CH2), 27.8 (CH2), 26.7 (CH2), 25.7 (CH3), 
16.3 (CH3). IR (neat) υ/cm-1: 3370, 2967, 2918, 2853, 1648, 1443, 1375, 1150, 1105, 908. HRMS 
(EI) m/z calculated for C13H25NO [M]
+ = 211.1936; found: 211.1931. 
(E)-Methyl (2-(hydroxymethyl)-5,9-dimethyldeca-4,8-dien-1-yl)carbamate 603 and  
(E)-5-(3,7-Dimethylocta-2,6-dien-1-yl)-1,3-oxazinan-2-one 604 
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By general procedure A, methyl chloroformate (0.25 ml, 3 mmol) was added to the amino-alcohol 
602 (0.6 g, 2.9 mmol) and Et3N (0.5 ml, 4.4 mmol) at 0 
oC. The mixture was then stirred for 18 h 
at room temperature to give the carbamate 603 (0.66 g, 87%) as a colourless oil, with a trace of 
cyclic carbamate 604 (less than 2%). 
Carbamate 603: δH 5.16 – 5.03 (m, 3H, 2 x =CH and NH), 3.61 (dd, J = 11.6, 3.9 Hz, 1H, CH), 
3.45 – 3.40 (m, 1H, CH), 3.40 – 3.30 (m, 1H, CH), 3.20 – 3.11 (m, 1H, CH), 2.08 – 2.06 (m, 1H, 
CH), 2.05 – 1.93 (m, 6H, 3 x CH2), 1.68 (s, 3H, CH3), 1.61 (s, 6H, 2 x CH3). δC 158.4 (C=O, Cq), 
138.6 (Cq), 137.0 (Cq), 131.5 (Cq), 124.2 (=CH), 121.8 (=CH), 62.9 (OCH2), 52.3 (OCH3), 44.9 
(NCH2), 42.0 (CH), 27.5 (CH2), 27.3 (CH2), 26.6 (CH2), 25.7 (CH3), 17.7 (CH3), 16.0 (CH3). 
Cyclic carbamate 604: δH 5.08 (s, 1H, NH), 5.06 – 4.95 (m, 2H, 2 x =CH), 4.22 – 4.17 (m, 1H, 
CH), 3.94 – 3.89 (m, 1H, CH), 3.32 (d, J = 11.2 Hz, 1H, CH), 3.01 – 2.95 (m, 1H, CH), 2.06 – 
1.98 (m, 5H, 2 x CH2 and CH), 1.98 – 1.88 (m, 2H, CH2), 1.61 (s, 3H, CH3), 1.53 (s, 6H, 2 x 
CH3). δC 154.4 (C=O, Cq), 139.6 (Cq), 137.0 (Cq), 124.2 (=CH), 119.7 (=CH), 70.2 (OCH2), 45.3 
(NCH2), 39.7 (CH2), 31.7 (CH), 27.3 (CH2), 26.5 (CH2), 25.7 (CH3), 17.7 (CH3), 16.1 (CH3). 
Methyl ((5,5,8a-trimethyloctahydro-2H-chromen-3-yl)methyl)carbamate 608 
 
By general procedure B, to the N-protected amino-alcohol 603 (135 mg, 0.5 mmol) in dry 
dichloromethane (10 ml) under nitrogen concentrated sulfuric acid (25 mg, 0.25 mmol) was added 
and the resulting mixture stirred for 1 h at 20 oC to give the trimethyloctahydro chromen 608 (122 
mg, 90%) as a colourless oil and an inseparable 2:1 mixture of diastereoisomers.  
The major diastereoisomer showed: δH 8.91 (s, 1H, NH), 3.59 (s, 3H, OCH3), 3.28 (dd, J = 12.4, 
9.8 Hz, 2H, CH2), 2.97 (d, J = 7.0 Hz, 2H, CH2), 1.76 (ddd, J = 11.6, 8.2, 4.1 Hz, 1H, CH), 1.61 – 
1.55 (m, 1H, CH), 1.49 (ddd, J = 7.4, 6.1, 2.4 Hz, 1H, CH), 1.33 – 1.25 (m, 6H), 1.12 (s, 3H, 
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CH3), 0.76 (s, 3H, CH3), 0.65 (s, 3H, CH3). δC 157.2 (Cq), 74.7 (OCq), 64.0 (OCH2), 52.9 (CH), 
52.0 (OCH3), 42.4 (NCH2), 41.5 (CH2), 40.0 (CH2), 38.8 (CH), 34.0 (Cq), 31.9 (CH3) 23.6 (CH2), 
21.3 (CH3), 21.1 (CH2), 19.2 (CH3).  
The minor diastereoisomer could be characterized by: δH 4.87 (s, 1H, NH), 3.79 (dd, J = 12.4, 3.2 
Hz, 2H, CH2), 3.42 (d, J = 12.5 Hz, 1H, CH), 1.90 (d, J = 6.5 Hz, 1H, CH), 1.19 (s, 3H, CH3), 
0.77 (s, 3H, CH3), 0.67 (s, 3H, CH3). δC 75.4 (OCq), 61.4 (OCH2), 43.7 (CH), 52.1 (OCH3), 40.2 
(CH2), 33.2 (Cq), 30.6 (CH3), 20.7 (CH3), 18.7 (CH3). 
The whole sample showed IR (neat) υ/cm-1: 3327, 2930, 2866, 1701, 1533, 1458, 1375, 1256, 
1090, 777. HRMS (APCI) m/z calculated for C15H27NO3Na [M+Na]
+ = 292.1889; found: 
292.1877. 
 (E)-2-(((Methoxycarbonyl)amino)methyl)-5,9-dimethyldeca-4,8-dien-1-yl acetate 609 
 
By general procedure E, the alcohol 603 (269 mg, 1.0 mmol) was converted into the acetate 609 
(302 mg, 97%), a colourless oil.  δH 5.09 – 4.96 (m, 2H, 2 x =CH), 4.90 (s, 1H, NH), 4.04 (dd, J = 
11.2, 4.4 Hz, 1H, CH), 3.89 (dd, J = 11.2, 6.0 Hz, 1H, CH), 3.59 (s, 3H, OCH3), 3.18 (dd, J = 
12.1, 6.0 Hz, 1H, CH), 3.10 – 3.00 (m, 1H, CH), 2.00 (s, 3H, Ac-CH3), 1.98 – 1.89 (m, 6H, 3 x 
CH2), 1.85 – 1.81 (m, 1H, CH), 1.61 (s, 3H, CH3), 1.53 (s, 6H, 2 x CH3). δC 154.4 (C=O, Cq), 
137.1 (Cq), 136.9 (Cq), 133.5 (Cq), 126.2 (=CH), 122.3 (=CH), 66.8 (OCH2), 53.2 (OCH3), 44.3 
(NCH2), 42.6 (CH), 27.6 (CH2), 27.0 (CH2), 26.2 (CH2), 26.0 (CH3), 19.8 (CH3), 17.7 (CH3), 16.1 
(CH3). 
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Methyl 3-(acetoxymethyl)-5,5,8a-trimethyloctahydroquinoline-1(2H)-carboxylate 610 
 
By general procedure B, to the protected amino-alcohol 609 (291 mg, 0.93 mmol) in dry 
dichloromethane (10 ml) concentrated sulfuric acid (3 drops) was added and the resulting mixture 
stirred for 1 h at 20 oC to give the octahydroquinoline 610 (245 mg, 84%) as a colourless oil and 
an inseparable 2:1 mixture of diastereoisomers. 
The major diastereoisomer showed: δH 3.98 – 3.89 (m, 1H, CH), 3.89 – 3.79 (m, 1H, CH), 3.59 (s, 
3H, OCH3), 2.99 (ddd, J = 17.2, 11.3, 5.1 Hz, 1H, CH), 2.93 – 2.81 (m, 1H, CH), 2.77 (d, J = 13.3 
Hz, 1H, CH), 2.11 – 2.02 (m, 1H, CH), 2.00 (s, 3H, AcCH3), 1.89 (dd, J = 12.2, 6.0 Hz, 2H, CH2), 
1.63 – 1.57 (m, 2H, CH2), 1.53 – 1.47 (m, 4H, 2 x CH2), 0.93 (s, 3H, CH3), 0.84 (s, 3H, CH3), 0.75 
(s, 3H, CH3). δC 171.1 (Cq), 156.5 (Cq), 66.8 (OCH2), 60.9 (NCq), 52.2 (OCH3), 51.9 (CH), 44.3 
(NCH2), 41.2 (CH2), 38.5 (CH2), 36.4 (CH), 34.2 (Cq), 32.8 (CH2), 22.9 (CH2), 21.3 (CH3), 20.8 
(CH3), 19.98 (CH3), 18.14 (CH3). 
The minor diastereoisomer could be characterized by: δH 4.18 (dd, J = 10.8, 3.8, Hz, 1H, CH), 
4.08 (dd, J = 11.2, 3.1 Hz, 1H, CH), 3.53 (OCH3), 3.29 (dddd, J = 11.0, 5.4, 3.6, 2.1 Hz, 1H, CH), 
3.19 (dd, J = 12.4, 7.1 Hz, 1H, CH), 1.99 (s, 3H, AcCH3), 1.25 (s, 3H, CH3), 0.94 (s, 3H, CH3), 
0.80 (s, 3H, CH3). δC 157.3 (Cq), 70.3 (OCH2), 59.3 (NCq), 45.1 (CH2), 40.2 (CH2), 38.3 (CH2), 
34.8 (CH2), 19.9 (CH2), 13.6 (CH3).  
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Appendix 1 
1-Toluenesulfonyl-2,2,6-trimethylpiperidine 237  
m.p. 82 – 83°C 
 
 
 
 
 
 
 
 
CCDC 797890 
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Table 2.  Crystal data and structure refinement for CCDC 797890. 
Identification code  CCDC 797890 
Empirical formula  C15 H23 N O2 S 
Formula weight  281.40 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.3290(3) Å α = 93.562(2)°. 
 b = 11.4162(5) Å β = 91.070(3)°. 
 c = 20.4228(8) Å  = 96.162(2)°. 
Volume 1463.77(11) Å3 
Z 4 
Density (calculated) 1.277 Mg/m3 
Absorption coefficient 0.220 mm-1 
F(000) 608 
Crystal size 0.50 x 0.10 x 0.06 mm3 
Theta range for data collection 1.80 to 27.58°. 
Index ranges -8<=h<=8, -13<=k<=14, -24<=l<=26 
Reflections collected 9269 
Independent reflections 6609 [R(int) = 0.0452] 
Completeness to theta = 27.58° 97.4 %  
Max. and min. transmission 0.9869 and 0.8981 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6609 / 0 / 351 
Goodness-of-fit on F2 1.035 
Final R indices [I>2sigma(I)] R1 = 0.1073, wR2 = 0.2578 
R indices (all data) R1 = 0.1557, wR2 = 0.2870 
Largest diff. peak and hole 1.101 and -0.493 e.Å-3 
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Appendix 2 
2,2-Dimethyl-1-tosylpiperidine 250 
 m.p. 66 – 67 °C 
 
 
 
CCDC 1021610
 
 
 
 
 
 
 
 
 
 
282 
 
Table 1.  Crystal data and structure refinement for CCDC 1021610. 
Identification code  CCDC 1021610 
Empirical formula  C14 H21 N O2 S 
Formula weight  267.38 
Temperature  170(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 8.1099(2) Å α = 90°. 
 b = 11.2069(2) Å β = 92.522(2)°. 
 c = 15.4545(3) Å   = 90°. 
Volume 1403.25(5) Å3 
Z 4 
Density (calculated) 1.266 Mg/m3 
Absorption coefficient 2.002 mm-1 
F(000) 576 
Crystal size 0.279 x 0.214 x 0.024 mm3 
Theta range for data collection 4.876 to 73.966°. 
Index ranges -10<=h<=7, -10<=k<=13, -19<=l<=19 
Reflections collected 5574 
Independent reflections 2752 [R(int) = 0.0157] 
Completeness to theta = 67.684° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.990 and 0.921 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2752 / 0 / 166 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0327, wR2 = 0.0887 
R indices (all data) R1 = 0.0374, wR2 = 0.0926 
Extinction coefficient n/a 
Largest diff. peak and hole 0.296 and -0.296 e.Å-3 
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  Appendix 3 
1-(4-Nitrophenylsulfonyl)-2,2,6-trimethyl piperidine 261   
m.p. 124 – 127 °C 
 
 
 
 
CCDC 797889 
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Table 1.  Crystal data and structure refinement for CCDC 797889. 
Identification code  CCDC 797889 
Empirical formula  C14 H20 N2 O4 S 
Formula weight  312.38 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/a 
Unit cell dimensions a = 6.2943(18) Å α = 90°. 
 b = 19.982(7) Å β = 96.79(2)°. 
 c = 11.764(3) Å  = 90°. 
Volume 1469.2(8) Å3 
Z 4 
Density (calculated) 1.412 Mg/m3 
Absorption coefficient 0.238 mm-1 
F(000) 664 
Crystal size 0.30 x 0.04 x 0.02 mm3 
Theta range for data collection 3.42 to 20.92°. 
Index ranges -6<=h<=6, -18<=k<=20, -11<=l<=11 
Reflections collected 2647 
Independent reflections 1534 [R(int) = 0.0947] 
Completeness to theta = 20.92° 98.1 %  
Max. and min. transmission 0.9953 and 0.9320 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1534 / 0 / 193 
Goodness-of-fit on F2 1.164 
Final R indices [I>2sigma(I)] R1 = 0.0865, wR2 = 0.1593 
R indices (all data) R1 = 0.1428, wR2 = 0.1816 
Largest diff. peak and hole 0.264 and -0.304 e.Å-3 
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Appendix 4 
1,3-Dimethyl-2-tosyl-2-azabicyclo[2.2.2]octane 420  
m.p. 112 – 114 °C 
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Table 4.  Crystal data and structure refinement for dwk1016. 
Identification code  dwk1016 
Empirical formula  C16 H23 N O2 S 
Formula weight  293.41 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/a 
Unit cell dimensions a = 15.4205(9) Å α = 90°. 
 b = 11.3763(9) Å β = 114.435(4)°. 
 c = 18.7020(14) Å  = 90°. 
Volume 2987.0(4) Å3 
Z 8 
Density (calculated) 1.305 Mg/m3 
Absorption coefficient 0.218 mm-1 
F(000) 1264 
Crystal size 0.200 x 0.200 x 0.020 mm3 
Theta range for data collection 1.196 to 23.872°. 
Index ranges -17<=h<=17, -12<=k<=12, -21<=l<=21 
Reflections collected 13023 
Independent reflections 4500 [R(int) = 0.0868] 
Completeness to theta = 25.242° 83.3 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4500 / 24 / 367 
Goodness-of-fit on F2 2.807 
Final R indices [I>2sigma(I)] R1 = 0.2994, wR2 = 0.6171 
R indices (all data) R1 = 0.3274, wR2 = 0.6287 
Extinction coefficient n/a 
Largest diff. peak and hole 7.679 and -1.056 e.Å-3 
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Appendix 5 
4,7-Dimethyl-6-((4-nitrophenyl)sulfonyl)-6-azabicyclo[3.2.1]octane  242 
m.p. 174 – 177 °C 
 
 
 
 
CCDC 1021607 
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Table 1.  Crystal data and structure refinement for CCDC 1021607. 
Identification code  CCDC 1021607 
Empirical formula  C15 H20 N2 O4 S 
Formula weight  324.39 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 6.2309(10) Å α = 90°. 
 b = 10.869(3) Å β = 102.250(18)°. 
 c = 11.970(3) Å  = 90°. 
Volume 792.2(3) Å3 
Z 2 
Density (calculated) 1.360 Mg/m3 
Absorption coefficient 0.224 mm-1 
F(000) 344 
Crystal size 0.500 x 0.040 x 0.010 mm3 
Theta range for data collection 1.741 to 20.796°. 
Independent reflections 1642  
Completeness to theta = 25.242° 58.1 %  
Refinement method Full-matrix-block least-squares on F2 
Data / restraints / parameters 1642 / 104 / 181 
Goodness-of-fit on F2 1.240 
Final R indices [I>2sigma(I)] R1 = 0.1183, wR2 = 0.2744 
R indices (all data) R1 = 0.2021, wR2 = 0.3613 
Absolute structure parameter 0.5(6) 
Largest diff. peak and hole 1.044 and -0.576 e.Å-3 
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Appendix 6 
1-Methyl-2-tosyl-2-azabicyclo[2.2.2]octane 430 
m.p. 135 – 138 °C 
 
 
 
 
CCDC 1061506 
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Table 1.  Crystal data and structure refinement for exp_769. 
Identification code  CCDC 1061506 
Empirical formula  C15 H21 N O2 S 
Formula weight  279.39 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P n a 21 
Unit cell dimensions a = 7.6489(4) Å α = 90°. 
 b = 16.1308(7) Å β = 90°. 
 c = 11.3067(6) Å  = 90°. 
Volume 1395.05(12) Å3 
Z 4 
Density (calculated) 1.330 Mg/m3 
Absorption coefficient 0.230 mm-1 
F(000) 600 
Crystal size 0.200 x 0.101 x 0.055 mm3 
Theta range for data collection 3.455 to 29.574°. 
Index ranges -10<=h<=7, -15<=k<=22, -15<=l<=9 
Reflections collected 4434 
Independent reflections 2636 [R(int) = 0.0426] 
Completeness to theta = 25.242° 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.71986 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2636 / 425 / 257 
Goodness-of-fit on F2 1.089 
Final R indices [I>2sigma(I)] R1 = 0.0567, wR2 = 0.1293 
R indices (all data) R1 = 0.0745, wR2 = 0.1410 
Absolute structure parameter 0.6(3) 
Largest diff. peak and hole 0.460 and -0.328 e.Å-3 
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Appendix 7 
4-Iodo-6-tosyl-6-azabicyclo[3.2.1]octane 436  
m.p. 116 – 118 °C 
 
 
 
 
CCDC 1021608 
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Table 1.  Crystal data and structure refinement for CCDC 1021608 
Identification code  CCDC 1021608 
Empirical formula  C14 H18 I N O2 S 
Formula weight  391.25 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 7.2761(2) Å α = 69.202(2)°. 
 b = 9.8338(3) Å β = 80.029(2)°. 
 c = 11.1700(3) Å  = 80.879(2)°. 
Volume 731.77(4) Å3 
Z 2 
Density (calculated) 1.776 Mg/m3 
Absorption coefficient 2.328 mm-1 
F(000) 388 
Crystal size 0.150 x 0.100 x 0.100 mm3 
Theta range for data collection 2.228 to 27.867°. 
Index ranges -9<=h<=9, -10<=k<=12, -14<=l<=13 
Reflections collected 4991 
Independent reflections 3447 [R(int) = 0.0259] 
Completeness to theta = 25.242° 99.1 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3447 / 0 / 174 
Goodness-of-fit on F2 1.119 
Final R indices [I>2sigma(I)] R1 = 0.0385, wR2 = 0.0891 
R indices (all data) R1 = 0.0419, wR2 = 0.0921 
Extinction coefficient 0.054(3) 
Largest diff. peak and hole 1.563 and -1.267 e.Å-3 
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Appendix 8 
Methyl (1-methyl-2-oxabicyclo[2.2.2]octan-4-yl)methyl)carbamate 597 
m.p. 92 – 94 °C 
 
 
 
CCDC 1021609 
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Table 1.  Crystal data and structure refinement for CCDC 1021609. 
Identification code  CCDC 1021609 
Empirical formula  C22 H38 N2 O6 
Formula weight  426.54 
Temperature  293(2) K 
Wavelength  1.54184 Å 
Crystal system  Orthorhombic 
Space group  P b c a 
Unit cell dimensions a = 9.6049(2) Å α = 90°. 
 b = 10.7454(3) Å β = 90°. 
 c = 22.5611(6) Å  = 90°. 
Volume 2328.50(10) Å3 
Z 4 
Density (calculated) 1.217 Mg/m3 
Absorption coefficient 0.717 mm-1 
F(000) 928 
Crystal size 0.305 x 0.242 x 0.115 mm3 
Theta range for data collection 3.919 to 73.920°. 
Index ranges -11<=h<=11, -8<=k<=12, -27<=l<=22 
Reflections collected 7806 
Independent reflections 2316 [R(int) = 0.0162] 
Completeness to theta = 67.684° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2316 / 0 / 139 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0465, wR2 = 0.1283 
R indices (all data) R1 = 0.0525, wR2 = 0.1370 
Extinction coefficient 0.00079(17) 
Largest diff. peak and hole 0.283 and -0.219 e.Å-3 
 
